Quarterlytics / Technology / Hardware, Equipment & Parts / Eastman Kodak Company / FY2020 Annual Report

Eastman Kodak Company
Annual Report 2020

KODK · NYSE Technology
Claim this profile
Ticker KODK
Exchange NYSE
Sector Technology
Industry Hardware, Equipment & Parts
Employees 3900
← All annual reports
FY2020 Annual Report · Eastman Kodak Company
Loading PDF…
Eastman Kodak Company 2020 Annual Report on Form 10-K 
and Notice of 2021 Annual Meeting and Proxy Statement

E

a

s

t

m

a

n

K

o

d

a

k

C

o

m

p

a

n

y

2

0

1

8

A

n

n

u

a

l

R

e

p

o

r

t

o

n

F

o

r

m

1

0

-

K

a

n

d

N

o

t

i

c

e

o

f

2

0

1

9

A

n

n

u

a

l

M

e

e

t

i

n

g

a

n

d

P

r

o

x

y

S

t

a

t

e

m

e

n

t

Eastman Kodak Company 

343 State Street 

Rochester, NY 14650 

www.kodak.com

This document was produced using KODAK INSITE prepress portal software, KODAK PRINERGY workflow software,  

KODAK MAGNUS and TRENDSETTER platesetters, KODAK ELECTRA XD thermal printing plates, KODAK plate developing 

products, KODAK APPROVAL proofsetter and other Kodak printing technologies.

This document was printed using 100% renewable wind energy and soy-based inks.

© 2019 Eastman Kodak Company.  KODAK, INSITE, PRINERGY, MAGNUS, TRENDSETTER, ELECTRA and APPROVAL 

are trademarks.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 10-K 

☒ 

☐ 

Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

For the year ended December 31, 2019 or 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

For the transition period from _____ to_____ 

Commission File Number 1-87 

EASTMAN KODAK COMPANY 

(Exact name of registrant as specified in its charter) 

NEW JERSEY 

(State of incorporation) 

343 STATE STREET, ROCHESTER, NEW YORK 

(Address of principal executive offices) 

16-0417150 

(IRS Employer Identification No.) 

14650 

(Zip Code) 

Registrant’s telephone number, including area code:  585-724-4000 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class 

Common Stock, $0.01 par value 

Trading Symbols 

KODK 

Name of each exchange on which registered 

New York Stock Exchange 

Securities registered pursuant to Section 12(g) of the Act: None 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes ☐    No ☒ 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes ☐    No ☒ 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during 

the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐ 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of 

Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such 

files).    Yes ☒    No ☐ 

emerging growth company. 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an 

See definition of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company in Rule 12b-2 of the Exchange Act. 

Large accelerated filer 

Non-accelerated filer 

Emerging growth company 

   

     

   

    Accelerated filer 

    Smaller reporting company 

 

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or 

revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐    No ☒ 

The aggregate market value of the voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, 

as of the last business day of the registrant's most recently completed second fiscal quarter, June 30, 2019 was approximately $48 million.  The registrant has 

no non-voting common stock. 

The number of shares outstanding of the registrant's common stock as of March 2, 2020 was 43,578,870 shares of common stock. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 

☒ 

☐ 

SECURITIES AND EXCHANGE COMMISSION 
Washington, D.C. 20549 

FORM 10-K 

Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

For the year ended December 31, 2020 or 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 

For the transition period from _____ to_____ 

Commission File Number 1-87 

EASTMAN KODAK COMPANY 
(Exact name of registrant as specified in its charter) 

NEW JERSEY 
(State of incorporation) 

343 STATE STREET, ROCHESTER, NEW YORK 
(Address of principal executive offices) 

16-0417150 
(IRS Employer Identification No.) 

14650 
(Zip Code) 

Registrant’s telephone number, including area code:  585-724-4000 

Securities registered pursuant to Section 12(b) of the Act: 

Title of each class 

Common Stock, $0.01 par value 

Trading Symbols 

KODK 

Name of each exchange on which registered 

New York Stock Exchange 

Securities registered pursuant to Section 12(g) of the Act: None 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes ☐    No ☒ 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes ☐    No ☒ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 
months, and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐ 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 
232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐ 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth 
company. 

See definition of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company in Rule 12b-2 of the Exchange Act. 

Large accelerated filer 

Non-accelerated filer 

Emerging growth company 

☐ 
☒  
☐ 

    Accelerated filer 

    Smaller reporting company 

☐ 
 ☒ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial 
accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial 
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐    No ☒ 
The aggregate market value of the voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, as of the last 
business day of the registrant's most recently completed second fiscal quarter, June 30, 2020 was approximately $44 million.  The registrant has no non-voting common stock. 

The number of shares outstanding of the registrant's common stock as of March 1, 2021 was 78,503,476 shares of common stock. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Eastman Kodak Company 
Form 10-K 
December 31, 2020 

Table of Contents 

Part I 

Business ...................................................................................................................................................................
Risk Factors ..............................................................................................................................................................
Unresolved Staff Comments .....................................................................................................................................
Properties .................................................................................................................................................................
Legal Proceedings ....................................................................................................................................................
Mine Safety Disclosures ...........................................................................................................................................
Information About its Executive Officers ...................................................................................................................

Part II 

Page 

   3 
   8 
   22 
   22 
   22 
   23 
   23 

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity 
Securities ..................................................................................................................................................................
Selected Financial Data ............................................................................................................................................
Management's Discussion and Analysis of Financial Condition and Results of Operations ....................................
Liquidity and Capital Resources ...............................................................................................................................
Quantitative and Qualitative Disclosures About Market Risk ....................................................................................
Financial Statements and Supplementary Data .......................................................................................................
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure ..................................
Controls and Procedures ..........................................................................................................................................
Other Information ......................................................................................................................................................

25 

   27 
   28 
   41 
   44 
   45 
   104 
   104 
   105 

Part III 

Directors, Executive Officers and Corporate Governance ........................................................................................
Executive Compensation ..........................................................................................................................................
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters ..................
Certain Relationships and Related Transactions, and Director Independence ........................................................
Principal Accounting Fees and Services ..................................................................................................................

   105 
   105 
   105 
   105 
   105 

Part IV 

Financial Statement Schedules, Exhibits ..................................................................................................................
Index to Exhibits .......................................................................................................................................................
Form 10-K Summary ................................................................................................................................................  
Signatures.................................................................................................................................................................

   105 
   107 
111 
   112 

Item 1. 
Item 1A. 
Item 1B. 
Item 2. 
Item 3. 
Item 4. 

Item 5. 

Item 6. 
Item 7. 

Item 7A. 
Item 8. 
Item 9. 
Item 9A. 
Item 9B. 

Item 10. 
Item 11. 
Item 12. 
Item 13. 
Item 14. 

Item 15. 

Item 16. 

2 

 
  
  
  
 
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
  
  
 
 
 
 
 
ITEM 1. 

BUSINESS 

PART I 

When used in this report, unless otherwise indicated by the context, “we,” “our,” “us,” and “Kodak” refer to the consolidated company on the basis of 
consolidation described in Note 1 to the consolidated financial statements in Part II, Item 8, “Financial Statements and Supplementary Data” of this 
Form 10-K Report.  Also, unless otherwise indicated by the context, “EKC” and the “Company” refer to the parent company, Eastman Kodak 
Company. 

Kodak is a global technology company focused on print, advanced materials and chemicals. Kodak provides industry-leading hardware, software, 
consumables and services primarily to customers in commercial print, packaging, publishing, manufacturing and entertainment. Kodak is committed 
to environmental stewardship and ongoing leadership in developing sustainable solutions. Kodak’s broad portfolio of superior products, responsive 
support and world-class R&D make Kodak solutions a smart investment for customers looking to improve their profitability and drive growth.  

The Company was founded by George Eastman in 1880 and incorporated in 1901 in the State of New Jersey.  Kodak is headquartered in 
Rochester, New York. 

REPORTABLE SEGMENTS 
Kodak has four reportable segments:  Traditional Printing, Digital Printing, Advanced Materials and Chemicals and Brand.  The balance of Kodak’s 
continuing operations, which do not meet the criteria of a reportable segment, are reported in All Other and primarily represent the Eastman 
Business Park operations.  

Traditional Printing  

The Traditional Printing segment is comprised of Prepress Solutions, which includes Kodak’s digital offset plate offerings and computer-to-plate 
(“CTP”) imaging solutions.  The Traditional Printing segment provides digital and traditional product and service offerings to a variety of commercial 
industries, including commercial print, direct mail, book publishing, newspapers and magazines and packaging.  

While this segment is experiencing challenges from digital substitution and competitive pricing pressures, innovations in Kodak product lines that can 
command premium prices offset some of the long-term market price erosion.  Additionally, Kodak seeks to mitigate the impact of market dynamics 
on pricing and volume pressures and of increases in manufacturing costs, including aluminum prices, through a combination of price increases, 
commodity contracts, improved production efficiency and cost reduction initiatives.    

Prepress Solutions capitalizes on a contract-based, stable and recurring cash flow-generative business model. The average duration of customer 
contracts is two years. These contracts offer stability and generate recurring revenue. The core of the business is the manufacturing of aluminum 
digital printing plates of varying sizes. These plates can be as small as 23cm x 27cm and as large as 126cm x 287cm.  Unexposed plates are sold to 
commercial printing companies for use in the offset printing process. Kodak also manufactures equipment, known as CTP equipment, which images 
the plates with a laser. The plates are used in the offset printing process, which transfers ink from the plate onto a rubber blanket and then onto the 
substrate to be printed. Due to the nature of the imaging and printing process, a new plate must be used for each printing run. As a result, there is a 
recurring revenue stream from the sale of these plates.  

The Traditional Printing products and services are sold globally to customers through both a direct sales team as well as indirectly through dealers. 

Primary competitors are Fuji and Agfa.  Kodak expects to benefit from current industry trends, including customers’ increasing focus on sustainability 
initiatives, which strengthens demand for Kodak’s process-free solutions.   

Digital offset plate offerings include KODAK SONORA Process Free Plates. KODAK SONORA Process Free Plates are prepared directly with a CTP 
thermal output device and do not require subsequent processing chemistry, processing equipment or chemical disposal. As a result, the plates 
deliver cost savings and efficiency for customers and promote environmental sustainability practices. 

Net sales for Traditional Printing accounted for 58% and 59% of Kodak’s total net revenue for the years ended December 31, 2020 and 2019, 
respectively. 

The Traditional Printing segment also provides service and support related to these products. 

On September 1, 2019 Kodak established a strategic relationship with Lucky HuaGuang Graphics Co. Ltd (“HuaGuang”) in the People’s Republic of 
China.   

The relationship is comprised of an agreement under which Kodak sold its shares of the Kodak (China) Graphic Communication Co. Ltd. entity, 
which included the offset printing plates facility in Xiamen, China, and related assets and liabilities, to HuaGuang; a supply agreement from 
HuaGuang to Kodak; and a license agreement under which Kodak licensed its plates technology to HuaGuang to sell into the plates market in China.   

3 

 
 
 
   
 
 
 
 
 
 
For further information on the relationship with HuaGuang, refer to Management’s Discussion and Analysis of Financial Condition and Results of 
Operations under Item 7 of this Annual Report on Form 10-K (“MD&A”) and Note 16, “Other Operating (Income) Expense, net” in the Financial 
Statements and Supplementary Data under Item 8 of this Annual Report on Form 10-K. 

Digital Printing  

The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software.  Digital Printing products include 
high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables (primarily ink), inkjet 
components, software and services.  Digital Printing products are distributed directly by Kodak and indirectly through dealers. The markets that the 
Digital Printing segment serves are highly competitive in variable printing applications like direct mail, newspapers, books, and packaging/labels.  
Key competitors are HP, Canon, Ricoh, and Screen. 

•  Electrophotographic Printing Solutions: 

•  NEXFINITY printers produce high-quality, differentiated printing of short-run, personalized print applications, such as direct mail, books, 

marketing collateral and photo products. 

•  DIGIMASTER printers use monochrome electrophotographic printing technology for transactional printing, short-run books, corporate 

documentation, manuals and direct mail.  Kodak has ceased manufacturing Digimaster printers but continues to sell consumables into the 
installed base.   

•  Prosper: 

• 

• 

• 

The Prosper business product offerings, including the PROSPER Press systems and PROSPER Components, feature ultrafast inkjet 
droplet generation. This includes the PROSPER 6000 Press, which delivers a continuous flow of ink that enables constant and consistent 
operation, with uniform ink droplet size and accurate placement, even at very high print speeds. Applications of the PROSPER Press 
include publishing, commercial print, direct mail and packaging.  PROSPER System Components are integrated into original equipment 
manufacturer (“OEM”) partner products and systems. Sales of equipment that incorporate the PROSPER Writing Systems result in 
recurring revenue from sales of ink and other consumables and equipment service. The level of recurring revenue depends on the 
application for which the equipment is used, which drives the total number of pages printed and, therefore, the amount of ink usage.  The 
business model is further supplemented by consumption of other consumables including refurbished jetting modules and service. 

The focus of the Prosper business is on developing the next generation platform, Ultrastream, with solutions that place writing systems in 
OEMs products and systems as well as direct sale press products that widens its reach into applications for packaging and décor and 
expands the substrate range to include plastics.  The Prosper business closed on the first sale of a writing system for use in a packaging 
application in December of 2019 with Uteco Group.  Uteco Group is integrating Ultrastream in a packaging press solution. 

The Prosper business includes Kodak Print Services.  Kodak Print Services prints the Jersey Evening Post as well as the majority of U.K. 
national newspapers for distribution in both Jersey and Guernsey islands.  The business is used to demonstrate the value of the Kodak 
Prosper presses to customers around the world. 

•  Versamark: 

• 

The KODAK VERSAMARK Products are the predecessor products to the PROSPER business.  Kodak has ceased manufacturing 
VERSAMARK Press Systems.  Users of KODAK VERSAMARK products continue to purchase ink and other consumables as well as 
service from Kodak.  Applications of the VERSAMARK products include publishing, transactional, commercial print and direct mail. 

•  Software: 

• 

The Software business offers a leading suite of solutions for print production workflow, including the PRINERGY workflow production 
software, by providing customer value through automation, web integration and integration with other Kodak products and third-party 
offerings. Production workflow software is used by customers to manage digital and conventional print content from file creation to output.   
Production workflow software manages content and color, reduces manual errors and helps customers manage the collaborative creative 
process. Kodak believes it is a leader in production workflow solutions for the commercial print and packaging industries with over 15,000 
systems installed in some of the largest printing and packaging establishments around the world. 

4 

 
 
 
 
 
 
 
 
 
 
 
 
• 

The Software business includes digital front-end controllers which manage the delivery of personalized content to digital presses while 
controlling color and print consistency. 

Net sales for Digital Printing accounted for 23% and 24% of Kodak’s total net revenue for the years ended December 31, 2020 and 2019, 
respectively. 

Advanced Materials and Chemicals  

The Advanced Materials and Chemicals segment is comprised of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced 
Materials and Functional Printing and Kodak Services for Business (“KSB”).  Kodak’s Advanced Materials and Chemicals products are distributed 
directly by Kodak and indirectly through dealers.  Kodak Alaris, a professional and consumer still photographic film and chemicals customer, 
represented approximately 30% and 20% of total Advanced Materials and Chemicals segment revenues in 2020 and 2019, respectively. 

The Advanced Materials and Chemicals segment includes the Kodak Research Laboratories which conduct research, develop new product or new 
business opportunities and file patent applications for its inventions and innovations.  The Advanced Materials and Chemicals segment also 
manages licensing of its intellectual property to third parties and is a supporting participant for any licensing of Kodak intellectual property to a third 
party.  Kodak maintains a large worldwide portfolio of pending applications and issued patents.    

• 

Industrial Film and Chemicals: 

•  Offers industrial film, including films used by the electronics industry to produce printed circuit boards, as well as professional and 

consumer still photographic film. 

• 

Includes related component businesses: Polyester Film; Solvent Recovery; and Specialty Chemicals.  Specialty Chemicals include 
unregulated key starting materials (“KSMs”) for pharmaceuticals.  Kodak intends to continue organic expansion of its KSM production and 
is exploring opportunities to further expand its pharmaceutical offerings.  

•  Offers specialty inks and dispersions to third parties. 

•  Offers Coating and Product Commercialization Services: Offerings include both pilot-scale and production scale roll-to-roll coating 

capabilities utilizing Kodak’s assets and know-how to commercialize and manufacture 3rd party products. 

• 

Includes Consumer Inkjet Solutions.  Starting in 2013, Kodak stopped manufacturing consumer inkjet printers and focused on the sale of 
ink to its installed printer base.  Kodak’s final build of ink inventory was depleted in the second quarter of 2020. 

5 

 
 
 
 
 
  
 
 
 
 
 
•  Motion Picture 

• 

Includes the motion picture film business serving the entertainment industry. Motion picture products are sold directly to studios, external 
laboratories and independent filmmakers. 

•  Kodak motion picture film processing laboratories offer onsite processing services at strategic locations in the U.S. and Europe. 

•  Advanced Materials 

•  Advanced Materials develops solutions for component smart materials based on the materials science inventions and innovations from the 
research laboratories.  There are multiple applications that Kodak contemplates addressing in this category.  Currently, the primary focus is 
on light blocking particles (Kodalux) for the textile market. In addition, a specialty material is manufactured by this group for use by a 3D 
printing customer. 

• 

Functional Printing: 

• 

Functional Printing concentrates on contract manufacturing, development partnerships, and/or licensing opportunities in very high-
resolution 3D printing solutions such as printed electronics.  Development partnerships may include non-recurring engineering payments 
for Kodak’s efforts to further develop such technologies into products.  Also, a portfolio of products is offered to enable others to utilize 
functional printing.  

• 

IP Licensing and Analytical Services: 

•  Kodak actively seeks opportunities to leverage its patents and associated technology in licensing and/or cross-licensing deals to support 
both revenue growth and its ongoing businesses.  While revenues from these licensing activities tend to be unpredictable in nature, this 
segment still carries the potential for revenue generation from intellectual property licensing and new materials businesses. Kodak also 
provides a wide range of analytical services to external clients at market rates. 

•  Kodak Services for Business: 

•  KSB provides business process outsourcing services, scan and capture solutions, records conversion services, workflow solutions, content 
management, and print and managed media services that assist customers with solutions that meet their business requirements.  During 
2020, KSB operated exclusively in Asia, primarily in China and Hong Kong. 

•  KSB was sold to Swiss Post Solutions in December 2020. 

•  Kodakit 

•  Kodakit was a platform that connected businesses with professional photographers to cater to their photography needs. Customers 
included global hotels and online travel agencies, real estate companies, marketplaces, advertising agencies and global brands. 

• 

In October 2019, Kodak decided to discontinue the operation of Kodakit. 

Net sales for Motion Picture and Industrial Film and Chemicals accounted for 15% and 14% of Kodak’s total net revenue for the years ended 
December 31, 2020 and 2019, respectively. 

Brand 

The Brand segment includes licensing of the Kodak brand to third parties.  Kodak currently licenses its brand for use with a range of products 
including digital, instant print and 35mm film cameras, printing and scanning consumer use devices, batteries, apparel and eyewear.  Kodak intends 
to continue efforts to grow its portfolio of brand licenses to generate both ongoing royalty streams and upfront payments. Brand licensees use the 
Kodak brand on their products and use their own distribution channels.  

DISCONTINUED OPERATIONS 

Discontinued operations of Kodak include the Flexographic Packaging business.  Refer to Note 29, “Discontinued Operations” in the Notes to 
Financial Statements for additional information. 

6 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RAW MATERIALS 

The raw materials used by Kodak are many and varied and are generally readily available.  Lithographic aluminum is the primary material used in 
the manufacture of offset printing plates.  Kodak procures lithographic aluminum coils from several suppliers with pricing based, in part, on either 
prevailing market prices for aluminum or on fixed prices for aluminum agreed to up to eighteen months prior.  Electronic components are used in the 
manufacturing of commercial printers and other electronic devices.  The film and chemicals business uses many raw materials, including silver, from 
a broad range of suppliers.  While most raw materials are generally available from multiple sources, certain key electronic components and other 
components included in the finished goods manufactured by Kodak and manufactured by and purchased from Kodak’s third-party suppliers are 
obtained from single or limited sources, which subjects Kodak to supply risks.  Also, tariffs imposed in the U.S. have the practical effect of reducing 
to a single source the potential suppliers of lithographic aluminum coils for U.S. production purposes. 

SEASONALITY OF BUSINESS 

Printing equipment and plate unit sales generally are higher in the fourth quarter, resulting from customer or industry budgeting practices and buying 
patterns. 

RESEARCH AND DEVELOPMENT 

Kodak's general practice is to protect its investment in research and development and its freedom to use its inventions by obtaining patents. The 
ownership of these patents contributes to Kodak's ability to provide industry-leading products.  Kodak holds portfolios of patents in several areas 
important to its business, including specific technologies such as lithographic printing plates and related equipment systems; digital printing workflow 
and color management proofing systems; color and black-and-white electrophotographic printing systems including key press components and 
toners; commercial inkjet writing systems and components, presses and inks; consumer inkjet inks and media; custom and specialty materials for 3D 
printing, functional printing materials, material formulations, and deposition modalities; engineered microparticles for specific functions; security 
materials; embedded information; and color negative films, processing and print films.  Each of these areas is important to existing and emerging 
business opportunities that bear directly on Kodak's overall business performance.  

In addition to patents, Kodak’s intellectual property includes know-how in many of the areas noted above, but in other businesses as well; such as, 
manufacturing of KSMs for the pharmaceutical industry.  

Kodak's major products are not dependent upon one single, material patent.  Rather, the technologies that underlie Kodak's products are supported 
by an aggregation of patents having various remaining lives and expiration dates.  There is no individual patent, or group of patents, whose 
expiration is expected to have a material impact on Kodak's results of operations. 

ENVIRONMENTAL PROTECTION 

Kodak is subject to various laws and governmental regulations concerning environmental matters.  The U.S. federal environmental legislation and 
state regulatory programs having an impact on Kodak include the Toxic Substances Control Act, the Resource Conservation and Recovery Act, the 
Clean Air Act, the Clean Water Act, the NY State Chemical Bulk Storage Regulations and the Comprehensive Environmental Response, 
Compensation and Liability Act of 1980, as amended (the “Superfund Law”). 

It is Kodak’s policy to carry out its business activities in a manner consistent with sound health, safety and environmental management practices, 
and to comply with applicable health, safety and environmental laws and regulations.  Kodak continues to engage in programs for environmental, 
health and safety protection and control. 

Based upon information presently available, future costs associated with environmental compliance are not expected to have a material effect on 
Kodak's capital expenditures or competitive position, although costs could be material to a particular quarter or year. 

EMPLOYMENT 

At the end of 2020, Kodak employed the full time equivalent of approximately 4,500 people globally, of whom approximately 1,900 were employed in 
the U.S.  The actual number of employees may be greater because some individuals work part time. 

AVAILABLE INFORMATION 

Kodak files many reports with the Securities and Exchange Commission (“SEC”) (www.sec.gov), including annual reports on Form 10-K, quarterly 
reports on Form 10-Q and current reports on Form 8-K.  These reports, and amendments to these reports, are made available free of charge as 
soon as reasonably practicable after being electronically filed with or furnished to the SEC.  They are available through Kodak's website at 
www.Kodak.com.  To reach the SEC filings, follow the links to About Kodak, Investor Center, Financial Information and then SEC Filings. 

7 

 
 
 
 
 
 
 
 
 
ITEM 1A. 

RISK FACTORS 

Kodak operates in rapidly changing economic and technological environments which present numerous risks, many of which are driven by factors it 
cannot control or predict. Certain factors may have a material adverse effect on its business, financial condition, and results of operations and make 
an investment in its securities risky.  You should consider carefully the risks and uncertainties described below in addition to other information 
contained in this Annual Report on Form 10-K, including the Management’s Discussion and Analysis of Financial Condition and Results of 
Operations (MD&A) section and the consolidated financial statements and related notes. The following discussion of “risk factors” identifies Kodak’s 
assessment of the most significant factors which may adversely affect its business, operations, financial position, stock price or future financial 
performance.  Additional risks and uncertainties Kodak is unaware of, or currently believes are not material, may also become important factors 
which could adversely affect its business, operations, financial position or future financial performance. 

Risks Related to Kodak’s Business 

If Kodak is not able to successfully implement its business plans, or experiences implementation delays in cost structure reduction, 
Kodak’s consolidated results of operations, financial position and liquidity could be negatively affected. 

Kodak’s business plans are subject to a number of assumptions, projections, and analysis. If these assumptions prove to be incorrect, Kodak may be 
unsuccessful in executing its business plans or achieving the projected results, which could adversely impact its financial results and liquidity. In 
addition, Kodak continues to rationalize its workforce and streamline operations to a leaner and more focused organization aligned with its business 
initiatives. There are no assurances such measures will prove to be successful or the cost savings or other results it achieves through these plans 
will be consistent with its expectations. As a result, its results of operations, financial position and liquidity could be negatively impacted. If 
restructuring plans are not effectively managed, it may experience lost customer sales, product delays, additional costs and other unanticipated 
effects, causing harm to its business and customer relationships. 

Finally, the timing and implementation of these plans require compliance with numerous laws and regulations, including local labor laws, and the 
failure to comply with such requirements may result in damages, fines and penalties which could adversely affect Kodak’s business. 

The ability to generate positive operating cash flows will be necessary for Kodak to continue to operate its business.  

The positive cash flow from operations generated by Kodak in 2019 were derived from working capital improvements and individual transactions 
which occurred during the year and are not expected to be recurring.  Kodak has not generated positive operating cash flows without supplementing 
such cash flow from operations with monetization transactions over the past several years.  The Traditional Printing segment, Kodak’s largest 
segment, has had, and is expected to continue to have, declining revenues.  Kodak’s stable and remaining growth businesses may not grow or 
continue to generate the same or enough cash flow to offset businesses with declining cash flows and investments needed for certain growth 
businesses.  It may take Kodak longer to generate positive cash flow from operations than planned, which would have a material adverse effect on 
its liquidity and financial position.  If Kodak is unable to generate positive cash flow from operations for an extended period in the future or to 
adequately supplement such cash flow from operations with proceeds from monetization transactions, its ability to continue as a going concern could 
be impaired or limited. 

Continued investment, capital needs, restructuring payments, dividends and servicing the Company’s debt require a significant amount of 
cash and it may not be able to generate sufficient cash to fund these activities, which could adversely affect its business, operating 
results and financial condition. 

8 

 
Kodak’s business may not generate cash flow in an amount sufficient to enable it to pay the principal or mandatory redemption price of, or interest 
and dividends on, the senior secured first lien term loans (the “Term Loans”) borrowed under the Credit Agreement, dated February 26, 2021, by and 
among the Company, the lenders party thereto (the “Term Loan Lenders”), and Alter Domus (US) LLC, as Administrative Agent (the “Credit 
Agreement”), the 5.0% unsecured convertible notes held by the Term Loan Lenders (the “Convertible Notes”), the 4.0% Series B Convertible 
Preferred Stock of the Company (the “Series B Preferred Stock”), and the 5.0% Series C Convertible Preferred Stock of the Company (the “Series C 
Preferred Stock”), or to fund Kodak’s other liquidity needs, including working capital, capital expenditures, product development efforts, restructuring 
actions, strategic acquisitions, investments and alliances and other general corporate requirements. Its film manufacturing facilities are aged and 
without significant updates to equipment and systems will be more prone to failure.  Capital improvements are planned but there is risk to 
manufacturing operations especially due to the complexity of the processes and technology and the loss of knowledge as employees leave who are 
familiar with the processes and technology.  The longer these updates are delayed the higher the risk due to equipment failures, further 
obsolescence and additional loss of employees with the specific knowledge base. 

Kodak’s ability to generate cash is subject to general economic, financial, competitive, litigation, regulatory and other factors beyond its control. 
There are no assurances: 

• 
• 
• 

• 

• 
• 

Kodak’s businesses will generate sufficient cash flow from operations; 
Kodak will be able to repatriate or move cash to locations where and when it is needed; 
the Company will meet all the conditions associated with borrowings or issuing letters of credit under the ABL Credit 
Agreement; 
Kodak will realize cost savings, earnings growth and operating improvements resulting from the execution of its business 
and restructuring plan; 
Kodak will not have to expend cash defending lawsuits regardless of the merits of any claims raised; or 
Future sources of funding will be available in amounts sufficient to enable funding of its liquidity needs. 

If Kodak cannot fund its liquidity needs, it will have to take actions, such as reducing or delaying capital expenditures, product development efforts, 
strategic acquisitions, and investments and alliances; selling additional assets; restructuring or refinancing the Company’s debt; or seeking additional 
equity capital. Such actions could increase the Company’s debt, negatively impact customer confidence in its ability to provide products and 
services, reduce its ability to raise additional capital and delay sustained profitability. There are no assurances any of these actions could, if 
necessary, be taken on commercially reasonable terms, or at all, or they would satisfy Kodak’s liquidity needs.  

If Kodak is unable to continue successful development, funding, and commercialization of products in businesses upon which it is 
focused or do so within an acceptable timeframe, its financial performance could be adversely affected.  

Kodak has focused its investments in print, advanced materials, and chemicals. These investment areas include offset plates and CTP devices, 
digital printing using commercial inkjet and electrophotography, high resolution functional printing for electronic and optical solutions, specialty 
chemicals (including pharmaceutical products) and smart materials for light control and 3D printing. Each of these businesses requires additional 
investment and may not be successful. The introduction of successful innovative products at market competitive prices and the achievement of scale 
are necessary for Kodak to grow these businesses, improve margins and achieve its financial objectives. Additionally, its strategy is based on a 
number of factors and assumptions, some of which are not within its control, such as the actions of third parties. There can be no assurance that it 
will be able to successfully execute all or any elements of its strategy, or that its ability to successfully execute its strategy will be unaffected by 
external factors. If Kodak is unsuccessful in growing its investment businesses as planned, or perceiving the needs of its target customers, its 
financial performance could be adversely affected. 

Due to the nature of the products it sells and Kodak’s worldwide distribution, Kodak is exposed to fluctuations in foreign currency 
exchange rates, interest rates and commodity costs which, together with tariffs that may be imposed, may adversely impact its results of 
operations and financial position.  

As a result of Kodak’s global operating and financing activities, it is exposed to changes in currency exchange rates and interest rates, which may 
adversely affect its results of operations and financial position.  Exchange rates and interest rates in markets in which it does business tend to be 
volatile and, at times, its sales and profitability can be negatively impacted across all its segments depending upon the value of the U.S. dollar and 
other major currencies such as the euro, the Japanese yen, the British pound and the Chinese yuan. In addition, Kodak’s products contain 
aluminum, silver, petroleum-based or other commodity-based raw materials, the prices of which have been, and may continue to be, volatile. In the 
case of aluminum and other raw materials and components imported by Kodak, tariffs imposed from time to time may give rise to future cost 
increases.  Tariffs or duties may also be imposed on exported products produced by Kodak, making such products less competitive in jurisdictions 
imposing such tariffs or duties.  If the global economic situation remains uncertain or worsens, there could be further volatility in changes in currency 
exchange rates, interest rates and commodity prices, which could have negative effects on its revenue and earnings. 

Weakness or worsening of global economic conditions could adversely affect Kodak’s financial performance and liquidity. 

The global economic environment may adversely affect sales of Kodak’s products, profitability and liquidity. Global financial markets have been 
experiencing extreme volatility, including as a result of the global outbreak of the coronavirus formally known as COVID-19.  Economic conditions 
could accelerate any decline in demand for products, which could also place pressure on its results of operations and liquidity. 

9 

 
 
  
  
  
  
  
  
In particular, if the coronavirus has a significant impact on the printing industry it could adversely impact the demand for Kodak’s products.  Certain 
known consequences to Kodak from the COVID-19 pandemic are disclosed in the financial statements contained in this Form 10-K and under the 
caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The full extent to which the COVID-19 pandemic 
will impact Kodak’s results will depend on future developments, which are highly uncertain and cannot be predicted at the time of this filing, including 
new information which may emerge concerning the scope and duration of the pandemic and the restrictions and other actions implemented to fight it, 
among others.  Direct and indirect effects from the COVID-19 pandemic could have a material adverse effect on the continuity of Kodak’s business 
operations and its results of operations and financial position, particularly if such effects have an extended duration. There is no guarantee that 
anticipated economic growth levels in markets which have experienced some economic strength will continue in the future, or Kodak will succeed in 
expanding sales in these markets. 

In addition, accounts receivable and past due accounts could increase due to a decline in its customers’ ability to pay as a result of an economic 
downturn, including as a result of the COVID 19 pandemic, and its liquidity, including its ability to use credit lines, could be negatively impacted by 
failures of financial instrument counterparties, including banks and other financial institutions. If global economic weakness and tightness in the credit 
markets exist, worsen or are attenuated, Kodak’s profitability and related cash generation capability could be adversely affected and, therefore, affect 
its ability to meet its anticipated cash needs, impair its liquidity or increase its costs of borrowing. 

Following an implementation period after the UK left the EU on 31 January 2020, and as of 1 January 2021 the UK is no longer a member of the EU 
single market and customs union. However, in December 2020 the UK reached a deal with the EU on certain key points, notably trade so that no 
duty is paid on goods moving between the UK and the EU.  Additional border checks have been introduced for goods leaving and entering the UK 
and these have resulted in some delays early in 2021. New export / import documentation required has resulted in some incremental costs. 

The uncertainty concerning Brexit has also caused global stock market volatility and currency exchange rate fluctuations that resulted in 
strengthening of the U.S. dollar relative to other foreign currencies in which we conduct business. There may also be broader uncertainty over the 
position the United States will take with respect to certain treaty and trade relationships with other countries. This uncertainty may impact (i) the 
ability or willingness of non-U.S. companies to transact business in the United States, including with the Company, (ii) regulation and trade 
agreements affecting U.S. companies, (iii) global stock markets and (iv) general global economic conditions. All of these factors are outside Kodak’s 
control but may cause it to adjust its strategy in order to compete effectively in global markets and could adversely affect its business, financial 
condition, operating results and cash flows. 

If Kodak is unable to successfully develop or commercialize new products or do so in a timely manner, its business, financial position and 
operating results may suffer.  

Kodak generally sells its products in industries which are characterized by rapid technological changes, frequent new product and service 
introductions and changing industry standards. 

Without the timely introduction of new products, services and enhancements, its products and services will become technologically obsolete over 
time, in which case its revenue and operating results would suffer. Therefore, its future results of operations will depend to a significant extent upon 
its ability to successfully commercialize new products in a timely manner. The success of its new products and services will depend on several 
factors, including its ability to: 

• 
• 
• 
• 
• 
• 
• 
• 
• 

identify customer needs; 
innovate and develop new technologies, services, and applications; 
commercialize new technologies in a timely manner; 
manufacture and deliver its products in sufficient volumes and on time; 
differentiate its offerings from its competitors’ offerings; 
price its products and services competitively; 
anticipate its competitors’ development of new products, services or technological innovations; 
work successfully alongside its partners; and 
control product quality in its manufacturing processes. 

As a result of these and other factors, products currently in development by Kodak (for example, UltraStream technology, new generations of Sonora 
offset plates, and small particle technology) may or may not be successfully commercialized in a timely manner, or at all. In connection with new 
products, Kodak will face risks relating to talent acquisition, construction, obtaining regulatory approvals, cost overruns, delays, product development 
and market development, among others.  If any of its key products cannot be successfully or timely commercialized, its operating results could be 
adversely affected. Moreover, it cannot guarantee any investment made in developing products will be recouped, even if it is successful in 
commercializing those products, which could have a material adverse effect on its business, financial position and operating results. 

If Kodak’s commercialization and manufacturing processes fail to prevent issues with product reliability, yield and quality, its product 
launch plans may be delayed, its financial results may be adversely impacted, and its reputation may be harmed. 

In developing, commercializing and manufacturing Kodak’s products and services it must adequately address reliability and prevent yield and other 
quality issues, including defects in its engineering, design and manufacturing processes, as well as defects in third-party components included in its 

10 

 
  
  
  
  
  
  
  
  
  
products. Because Kodak’s products are sophisticated and complicated to develop and commercialize with rapid advances in technologies, the 
occurrence of defects may increase, particularly with the introduction of new product lines. 

Unanticipated issues with product performance may delay product launch plans which could result in additional expenses, lost revenue and 
earnings. Although it has established internal procedures to minimize risks which may arise from product quality issues, there can be no assurance it 
will be able to eliminate or mitigate occurrences of these issues and associated liabilities. Product reliability, yield and quality issues can impair its 
relationships with new or existing customers and adversely affect its brand image; product quality issues can result in recalls, warranty, or other 
service obligations and litigation; and its reputation as a producer of high quality products could suffer, all of which could adversely affect its business 
as well as its financial results. 

If the reputation of Kodak or its brand erodes significantly, it could have a material impact on its financial results. 

Kodak’s reputation, and the reputation of its brand, form the foundation of its relationships with key stakeholders and other constituencies, including 
customers, suppliers and consumers. The quality and safety of Kodak’s products are critical to its business.  Kodak’s products have worldwide 
recognition, and its financial success is directly dependent on the success of its product offering.  One aspect of Kodak’s business is licensing others 
to use Kodak’s brand in connection with the sale of such licensees’ products and services, and activities by such licensees may be perceived by the 
market as being activities of Kodak. 

The success of Kodak’s brand can suffer if its or its licensees’ marketing plans, product initiatives or activities do not have the desired impact on the 
brand’s image or ability to attract customers.  Kodak’s results could also be negatively impacted if its brand suffers substantial harm to its reputation 
due to significant product reliability and quality issues, and product-related litigation.  Additionally, negative or inaccurate postings or comments on 
social media or networking websites about Kodak, its licensees or its brand could generate adverse publicity which could damage the reputation of 
the brand.  Kodak takes measures to research licensees prior to entering into agreements, assesses the quality of licensee products, and maintains 
strict requirements to govern licensees use of the brand.  Kodak also devotes significant time and resources to programs consistent with its 
corporate values and commitments that are designed to protect and preserve its reputation, such as social responsibility and environmental 
sustainability. If these programs are not executed as planned or suffer negative publicity, Kodak’s reputation and financial results could be adversely 
impacted. 

Increased competition, including price competition, could have a material adverse impact on Kodak’s revenue, gross margins, cash flow 
and market share.  

The markets in which Kodak does business are highly competitive with large, entrenched, and well financed industry participants, many of which are 
larger than Kodak. In addition, it encounters aggressive price competition for many of its products and services from numerous companies globally. 
Any of its competitors may: 

• 
• 
• 
• 
• 
• 
• 

foresee the course of market developments more accurately than it does; 
sell superior products and provide superior services or offer a broader variety of products and services; 
have the ability to produce or supply similar products and services at a lower cost; 
have better access to materials and supplies and the ability to acquire materials and supplies at a lower cost; 
develop stronger relationships with its suppliers or customers; 
adapt more quickly to new technologies or evolving customer requirements than it does; or 
have access to capital markets or other financing sources on more favorable terms than it can obtain. 

As a result, Kodak may not be able to compete successfully with its competitors. Finally, it may not be able to maintain its operating costs or prices at 
levels which would allow it to compete effectively. Kodak’s results of operations and financial condition may be adversely affected by these and other 
industry-wide pricing pressures. If its products, services and pricing are not sufficiently competitive with current and future competitors, it could also 
lose market share, adversely affecting its revenue, gross margins and cash flow. 

An inability to provide competitive financing arrangements to Kodak’s customers or extension of credit to customers whose 
creditworthiness deteriorates could adversely impact its revenue, profitability and financial position.  

The competitive environment in which Kodak operates may require it to facilitate or provide financing to its customers. Customer financing 
arrangements may cover all or a portion of the purchase price invoices for its products and services. It may also assist customers in obtaining 
financing from banks and other sources. Its success may be dependent, in part, upon its ability to provide customer financing on competitive terms 
and on its customers’ creditworthiness. Tightening of credit in the global financial markets can adversely affect the ability of Kodak’s customers to 
obtain financing for significant purchases, which may result in a decrease in, or cancellation of, orders for its products and services. If Kodak is 
unable to provide competitive financing solutions to its customers or if it extends credit to customers whose creditworthiness deteriorates, its 
revenues, profitability and financial position could be adversely impacted. 

11 

 
 
  
  
  
  
  
  
  
 
 
The loss of one or more of Kodak’s key personnel, or its failure to attract and retain other highly qualified personnel in the future, could 
harm its business. 

In order for it to be successful, Kodak must continue to attract, retain and motivate executives and other key employees, including technical, 
managerial, marketing, sales, research and support positions. Hiring and retaining qualified executives, research and engineering professionals, and 
qualified sales representatives, particularly in Kodak’s targeted growth markets, are critical to its future. It may be unable to attract and retain highly 
qualified management and employees, particularly if it does not offer employment terms competitive with the rest of the market. Failure to attract and 
retain qualified individuals, key leaders, executives and employees, or failure to develop and implement a viable succession plan, could result in 
inadequate depth of institutional knowledge or skill sets, which could adversely affect its business. 

If Kodak cannot effectively anticipate or rapidly respond to technology trends and develop and market new products to respond to 
changing customer needs and preferences, its revenue, earnings and cash flow could be adversely affected.  

Kodak serves imaging/print needs for business markets, including graphic communications, packaging, enterprise services, and printed electronics. 
Its success in these markets depends on its ability to offer differentiated solutions and technologies to capture market share and grow scale. To 
enable this, it must continually develop and introduce new products and services in a timely manner to keep pace with technological developments 
and achieve customer acceptance. In addition, the services and products it provides to customers may not or may no longer meet the needs of its 
customers as the business models of its customers evolve. Its customers may decide to outsource their imaging needs or may purchase imaging 
services and needs from other suppliers. In addition, it is difficult to predict successfully the products and services its customers will demand. The 
success of Kodak’s business depends in part on its ability to identify and respond promptly to changes in customer preferences, expectations and 
needs. If it does not timely assess and respond to changing customer expectations, preferences and needs, its financial condition, results of 
operations or cash flows could be adversely affected. 

If Kodak is unable to timely anticipate new technology trends, develop improvements to its current technology to address changing customer 
preferences, and effectively communicate its businesses, products, and the markets it serves, its revenue, earnings and cash flow could be 
adversely affected. The success of Kodak’s technology development efforts may be affected by the development efforts of its competitors, which 
may have more financial and other resources to better ascertain technology trends, changing customer preferences, and changing business 
expectations or models. Kodak’s assessment and response may as a result be incomplete or inferior when compared to its competitors, which could 
adversely affect its product roadmaps and associated revenue streams. 

Kodak has reduced the scope of its corporate-focused research and development activities.  If its investment in research and product development is 
inadequate, its response to changing customer needs and changing market dynamics may be too slow and this may adversely affect revenue 
streams from new products and services. 

Kodak makes investments in new products and services that may not achieve expected returns.  

Commercial success depends on many factors, including innovativeness, developer support, and effective distribution and marketing. If customers 
do not perceive Kodak’s latest offerings as providing significant new functionality or other value, they may reduce their purchases of new products or 
upgrades, unfavorably affecting revenue. Kodak may not achieve significant revenue from new product, service, and distribution channel 
investments for several years, if at all.   

New products and services may not be profitable, and even if they are profitable, operating margins for some new products and businesses may not 
be as high as the margins Kodak has experienced historically. Developing new technologies is complex. It can require long development and testing 
periods. Significant delays in new releases or significant problems in creating new products or services could adversely affect Kodak’s revenue. 

Kodak relies on third-party suppliers and service providers to support its manufacturing, logistics, and business operations and faces the 
risks associated with reliance on external business partners.  

Kodak relies on third-party suppliers for goods and services to support its manufacturing, logistics, and business operations.  To the extent it relies 
on third-parties, it faces the risks that those third parties may not be able to: 

develop manufacturing methods appropriate to Kodak’s products; 

• 
•  maintain an adequate control environment; 
• 
• 
•  mitigate the impact of labor shortages and/or other disruptions. 

quickly respond to changes in customer demand for Kodak’s products; 
obtain supplies and materials necessary to deliver goods or services to Kodak; or 

Suppliers may choose to unilaterally withhold products, components or services. In addition, Kodak may experience shortages in supply and 
disruptions in service and supply as a result of unexpected demand, transportation and logistical limitations, and/or disruptions or production 
difficulties at its suppliers, such as disruptions due to fires, medical epidemics, other natural disasters or events outside of a supplier’s control. In 
addition, disruptions could result from a reduction in the number of its suppliers due to their own financial difficulties or a reduction in the products 
offered by such suppliers. As a result of the loss of any supplier, or a substantial decrease in the availability of products from its suppliers, Kodak 
may be unable to meet its customer commitments, its costs could be higher than planned, and its cash flows and the reliability of its products could 
be negatively impacted. Kodak will vigorously enforce its contractual rights under such circumstances, but there is no guarantee it will be successful 
in preventing or mitigating the effects of unilateral actions by its suppliers. 

12 

 
  
  
  
  
  
Other supplier problems that Kodak could encounter include electronic component shortages, excess supply, interruption of IT services, risks related 
to the duration and termination of its contracts with suppliers for components and materials, non-competitive pricing due to tariffs, and risks related to 
the ability to obtain products, components or services from single source suppliers on favorable terms or at all. The realization of any of these risks, 
should alternative third-party relationships not be available or established, could cause interruptions in supply or increases in costs which might 
result in Kodak’s inability to meet customer demand for its products, damage to its relationships with its customers, and reduced market share, all of 
which could adversely affect its results of operations and financial condition. 

Any significant negative change in the payment terms that Kodak has with its suppliers could adversely affect its liquidity.  There is a risk that 
Kodak’s key suppliers could respond to any actual or apparent decrease in or any concern with its financial results or liquidity by requiring or 
conditioning their sale of goods or services to Kodak on more stringent or more costly payment terms, such as by requiring standby letters of credit, 
earlier or advance payment of invoices, payment upon delivery, or shorter payment terms. Kodak’s need for additional liquidity could significantly 
increase and its supply could be materially disrupted if a significant portion of its key suppliers and vendors took one or more of the actions described 
above, which could have a material adverse effect on its sales, customer satisfaction, cash flows, liquidity and financial position. 

Business disruptions could seriously harm Kodak’s future revenue and financial condition and increase its costs and expenses. 
Worldwide operations could be subject to earthquakes, power shortages, telecommunications failures, cyber-attacks, terrorism and other physical 
security threats, water shortages, tsunamis, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics, political or economic 
instability, and other natural or manmade disasters or business interruptions, for which Kodak is predominantly self-insured. The occurrence of any 
of these business disruptions could seriously harm its revenue and financial condition and increase its costs and expenses.  

The ongoing outbreak of the coronavirus formally known as COVID-19 has resulted in travel restrictions, disruptions to suppliers’ performance and 
delivery, as well as the temporary shutdown of many businesses. 

Certain of Kodak’s critical business functions, including its manufacturing and field service operations, cannot be performed remotely, and an inability 
of Kodak’s employees to physically work at its or its customers locations due to government restrictions, health concerns or illness may disrupt its 
operations, perhaps significantly.  Kodak has experienced some disruptions in its manufacturing and logistics operations due to the coronavirus 
outbreak.  The full extent to which the coronavirus outbreak continues to impact Kodak’s results will depend on future developments, which are 
highly uncertain and cannot be predicted at the time of this filing, including new information which may emerge concerning the coronavirus and the 
actions taken to contain the virus or treat its impact, among others. Complications from the coronavirus outbreak could have a material adverse 
effect on the continuity of our business operations and our results of operations and financial position. 

In addition, some areas, including parts of the east and west coasts of the United States, have previously experienced, and may experience in the 
future, major power shortages and blackouts. These blackouts could cause disruptions to Kodak’s operations or the operations of its suppliers, 
distributors and resellers, or customers. Kodak has operations including research and development facilities in geographically disparate locations, 
such as Israel, Japan, China, Canada and Germany. 

The impact of these risks is greater in areas where products are manufactured at a sole or limited number of location(s), and where the sourcing of 
materials is limited to a sole or limited base of suppliers, since any material interruption in operations in such locations or suppliers could impact 
Kodak’s ability to provide a particular product or service for a period of time. 

Kodak’s inability to effectively complete and manage strategic transactions could adversely impact its business performance, including 
its financial results.  

As part of Kodak’s strategy, it may be engaged in discussions with third parties regarding possible investments, acquisitions, strategic alliances, joint 
ventures, divestitures, asset sales, spin-offs and outsourcing transactions and may enter into agreements relating to such transactions in order to 
further its business objectives.  In order to successfully pursue its strategic transaction strategy, it must identify suitable sellers, buyers and partners 
and successfully complete transactions, some of which may be large and complex, and manage post-closing issues such as the elimination of any 
remaining post-sale costs related to divested businesses.  Transaction risk can be more pronounced for larger and more complicated transactions or 
when multiple transactions are pursued simultaneously.  There are no assurances Kodak will be able to consummate any strategic transactions 
which it undertakes or, if consummated, Kodak will achieve the benefits sought to be achieved from such strategic transactions.  If Kodak fails to 
identify and successfully complete transactions that further its strategic objectives, it may be required to expend resources to develop products and 
technology internally, it may be at a competitive disadvantage or it may be adversely affected by negative market perceptions. Any of these factors 
could have an adverse effect on its revenue, gross margins and profitability. In addition, unpredictability surrounding the timing of such transactions 
could adversely affect its financial results. 

13 

 
Kodak may pursue acquisitions or combinations which could fail or present unanticipated problems for its business in the future, which 
would adversely affect its ability to realize the anticipated benefits of those transactions or increase the price it would be required to pay.  

Kodak may seek to enter into transactions which may include acquiring or combining with other businesses. It may not be able to identify suitable 
acquisition or combination opportunities or finance and complete any particular acquisition or combination successfully. Furthermore, acquisitions 
and combinations involve a number of risks and challenges, including: 

• 
• 
• 
• 

• 
• 
• 
• 
• 

the ability to obtain required regulatory and other approvals; 
the need to integrate acquired or combined operations with its business; 
potential loss of key employees; 
difficulty in evaluating operating costs, infrastructure requirements, environmental and other liabilities and other factors 
beyond its control; 
wrong, inaccurate or changing business assumptions on which such acquisitions or combinations are predicated; 
potential lack of operating experience in new business or geographic areas; 
an increase in its expenses and working capital requirements; 
management’s attention may be temporarily diverted; and 
the possibility it may be required to issue a substantial amount of additional equity or debt securities or assume additional 
debt in connection with any such transactions. 

Any of these factors could adversely affect its ability to achieve anticipated levels of cash flows or realize synergies or other anticipated benefits from 
a strategic transaction. Furthermore, the market for transactions is highly competitive, which may adversely affect its ability to find transactions which 
fit its strategic objectives or increase the price it would be required to pay (which could decrease the benefit of the transaction or hinder its desire or 
ability to consummate the transaction). Strategic transactions may occur at any time and may be significant in size relative to its assets and 
operations. 

Cyber-attacks or other data security incidents that disrupt Kodak’s operations or result in the breach or other compromise of proprietary 
of confidential information about its workforce, its customers, or other third parties could disrupt its business, harm its reputation, cause 
it to lose customers, and expose it to costly regulatory enforcement and litigation.  

To effectively manage Kodak’s global business, it depends on secure and reliable information technology systems with accurate data. These 
systems and their underlying infrastructure are provided by a combination of Kodak and third-parties, and if unavailable or unreliable, could disrupt 
Kodak’s operations, causing delays or cancellation of customer orders, impeding the manufacturing or delivery of products, delaying the reporting of 
financial results, or impacting other business processes critical to running its business. 

Kodak’s IT systems contain critical information about its business, including intellectual property and confidential information of its customers, 
business partners, and employees.  Cyber-attacks or defects in its systems could result in this proprietary information being disclosed or modified, 
which could cause significant damage to its business or its reputation. 

Kodak has system controls and security measures in place that are designed to protect its IT systems against intentional or unintentional disruptions 
of its operations or disclosure of confidential information, but it may not be able to implement solutions that result in stopping or detecting all of these 
threats to its internal information systems or those of its third-party providers.  A breach of Kodak’s security measures could result in unauthorized 
access to and misuse of its information, corruption of data, or disruption of operations, any of which could have a material adverse impact on its 
business. 

Kodak also provides IT-based products and services to its customers, and operates services used by its customers and hosted by Kodak, both 
businesses and consumers, and a breach of its security or reliability measures, or those of its third-party service providers, could negatively impact 
its customers’ operations or data privacy. 

Attacks on IT systems continue to grow in frequency, complexity and sophistication, and Kodak is regularly targeted by unauthorized parties using 
malicious tactics, code and viruses.  

Kodak has programs in place to prevent, detect and respond to data or cyber security incidents. However, because the techniques used to obtain 
unauthorized access, disable or degrade service, or sabotage systems change frequently, are increasingly more complex and sophisticated and may 
be difficult to detect for long periods of time, Kodak may be unable or fail to anticipate these techniques or implement adequate or timely preventive 
or responsive measures. 

Failure to comply with anti-corruption laws and regulations, anti-money laundering laws and regulations, economic and trade sanctions, 
and similar laws could have a materially adverse effect on Kodak’s reputation, results of operations or financial condition, or have other 
adverse consequences.  

Regulators worldwide are exercising heightened scrutiny with respect to anti-corruption, economic and trade sanctions, and anti-money laundering 
laws and regulations. Such heightened scrutiny has resulted in more aggressive investigations and enforcement of such laws and more burdensome 
regulations, any of which could adversely impact Kodak’s business.  Kodak has a global operating presence, including in numerous developing 

14 

 
  
  
  
  
 
  
  
  
  
economies where companies and government officials are more likely to engage in business practices that are prohibited by domestic and foreign 
laws and regulations, including the United States Foreign Corrupt Practices Act and the U.K. Bribery Act. 

Such laws generally prohibit improper payments or offers of payments to foreign government officials and leaders of political parties, and in some 
cases, to other persons, for the purpose of obtaining or retaining business.  Kodak is also subject to economic and trade sanctions programs, 
including those administered by the U.S. Treasury Department’s Office of Foreign Assets Control, which prohibit or restrict transactions or dealings 
with specified countries, their governments, and in certain circumstances, their nationals, and with individuals and entities that are specially 
designated, including narcotics traffickers and terrorists or terrorist organizations, among others.  In addition, Kodak is subject to anti-money 
laundering laws and regulations.  

Kodak has implemented policies and procedures to monitor and address compliance with applicable anti-corruption, economic and trade sanctions 
and anti-money laundering laws and regulations, and it periodically reviews, upgrades and enhances certain of its policies and procedures. However, 
there can be no assurance that its employees, consultants or agents will not take actions in violation of its policies for which it may be ultimately 
responsible, or that its policies and procedures will be adequate or will be determined to be adequate by regulators.  Any violations of applicable anti-
corruption, economic and trade sanctions or anti-money laundering laws or regulations could limit certain of Kodak’s business activities until they are 
satisfactorily remediated and could result in civil and criminal penalties, including fines, which could damage its reputation and have a materially 
adverse effect on its results of operation or financial condition.  

Failure to comply with privacy, data protection and cyber security laws and regulations could have a materially adverse effect on Kodak’s 
reputation, results of operations or financial condition.  

Kodak receives, processes, transmits and stores information relating to identifiable individuals (personal information), both in its role as a technology 
provider and as an employer. As a result, Kodak is subject to numerous U.S. federal and state and foreign laws and regulations relating to personal 
information. These laws have been subject to frequent changes, and new legislation in this area may be enacted at any time.  
More recent examples of data privacy laws include the EU’s General Data Protection Regulation (GDPR), California’s Consumer Privacy Act (CCPA) 
and Privacy Rights Act (CPRA), and Brazil’s General Data Protection Law (LGPD). 

Recently enacted laws and regulations, as well as any other change to existing laws, the introduction of new laws in this area, or the failure to 
comply with existing laws that are applicable, may subject Kodak to, among other things, additional costs or changes to its business practices, 
liability for monetary damages, fines and/or criminal prosecution, unfavorable publicity, restrictions on its ability to obtain and process information and 
allegations by its customers and clients that it has not performed its contractual obligations. At the same time, the risk of cyber-attacks is relevant to 
the requirements regarding storage, transfer, sharing and handling of personal information.   

This environment demands Kodak continuously improve its design and coordination of security controls and contractual arrangements across its 
businesses and geographies.  Despite these efforts, it is possible its security controls over personal data, its training of employees and vendors on 
data privacy and data security, and other practices it follows may not prevent the improper disclosure of personal information.  Improper disclosure of 
this information could harm its reputation or subject it to liability under laws which protect personal data, resulting in increased costs or loss of 
revenue. 

If Kodak cannot protect the intellectual property rights on which its business depends, or if third parties assert it violates their intellectual 
property rights, its revenue, earnings, expenses and liquidity may be adversely impacted.  

A key differentiator for Kodak in many of its businesses is its technological advantage over competitors’ products and solutions. Its technological 
advantage is supported by Kodak’s intellectual property rights. Patent, copyright, trademark and trade secret laws in the United States and similar 
laws in other countries, and non-disclosure, confidentiality and other types of agreements with Kodak’s employees, customers, suppliers and other 
parties, may not be effective in establishing, maintaining, protecting and enforcing Kodak’s intellectual property rights.  

Any of Kodak’s direct or indirect intellectual property rights could be challenged, invalidated, circumvented, infringed, diluted, disclosed or 
misappropriated, or such intellectual property rights may not be sufficient to permit it to take advantage of current market trends or otherwise to 
provide competitive advantages, which could result in costly product redesign efforts, discontinuance of certain product offerings or other competitive 
harm. Further, the laws of certain countries do not protect proprietary rights to the same degree as the laws of the United States. 

Therefore, in certain jurisdictions, Kodak may be unable to protect its proprietary technology adequately against unauthorized third party copying, 
infringement or use, which could adversely affect its competitive position.  Also, some of Kodak’s business and some of its products rely on key 
technologies developed or licensed by third parties and, because of the rapid pace of technological change in the information technology industry, it 
may not be able to obtain or continue to obtain licenses and technologies from relevant third parties on reasonable terms, or at all. 

Kodak also licenses third parties to use its trademarks. In an effort to preserve its trademark rights, Kodak enters into license agreements with these 
third parties which govern the use of its trademarks and require its licensees to abide by quality control standards with respect to the goods and 
services they provide under the trademarks. Although Kodak makes efforts to police the use of its trademarks by its licensees, there can be no 
assurance these efforts will be sufficient to ensure the licensees abide by the terms of their licenses. In the event Kodak’s licensees fail to do so, its 
trademark rights could be diluted and its reputation harmed by its licensees’ activities.  Also, failure by Kodak and its licensees to sufficiently exploit 
any of Kodak’s trademarks in any markets could erode Kodak’s trademark rights with respect to the relevant trademarks. Because the laws and 

15 

 
enforcement regimes of certain countries do not protect proprietary rights to the same degree as those in the United States, in certain jurisdictions 
Kodak may be unable to adequately prevent such unauthorized uses, which could result in impairment of its trademark rights. 

Kodak has made substantial investments in new, proprietary technologies and has filed patent applications and obtained patents to protect its 
intellectual property rights in these technologies as well as the interests of its licensees. 

There can be no assurance Kodak’s patent applications will be approved, any patents issued will be of sufficient scope or strength to provide it with 
meaningful protection, or such patents will not be challenged by third parties. Furthermore, Kodak may fail to accurately predict all of the countries 
where patent protection will ultimately be desirable, and if it fails to timely file a patent application in any such country, it may be precluded from 
doing so at a later date. The patents issuing may vary in scope of coverage depending on the country in which such patents issue. 

In addition, the intellectual property rights of others could inhibit Kodak’s ability to conduct its business. Other companies may hold patents on 
technologies used in Kodak’s industries and some of these companies may be aggressively seeking to expand, enforce or license their patent 
portfolios.  Third parties may claim Kodak and its customers, licensees or other parties indemnified by it are infringing upon their intellectual property 
rights. Such claims may be made by competitors seeking to block or limit Kodak’s access to certain markets. Additionally, certain individuals and 
groups have purchased intellectual property assets for the sole purpose of making claims of infringement and attempting to extract settlements from 
large companies like Kodak. Even if it believes the claims are without merit, these claims may have the following negative impacts on its business: 

• 
• 

• 

• 

claims can be time consuming and costly to defend and may distract management’s attention and resources; 
claims of intellectual property infringement may require it to redesign affected products, enter into costly settlement 
or license agreements or pay costly damage awards, or face a temporary or permanent injunction prohibiting it from 
marketing or selling certain of its products; 
even if it has an agreement with a third party to indemnify it against such costs, the indemnifying party may be 
unable to uphold such party’s contractual obligations; and 
if it cannot or does not license the infringed technology at all, license the technology on reasonable terms or 
substitute similar technology from another source, its revenue and earnings could be adversely impacted. 

Finally, Kodak uses open source software in connection with some of its products and services. Companies which incorporate open source software 
into their products have, from time to time, faced claims challenging the ownership of open source software and/or compliance with open source 
license terms. As a result, Kodak could be subject to suits by parties claiming ownership of what it believes to be open source software or 
noncompliance with open source licensing terms. Some open source software licenses require users who distribute open source software as part of 
their software to publicly disclose all or part of the source code to such software and/or make available any derivative works of the open source code 
on unfavorable terms or at no cost.  Any requirement to disclose Kodak’s source code or pay damages for breach of contract could be harmful to its 
business results of operations and financial condition. 

Kodak’s future pension and other postretirement benefit plan costs and required level of contributions could be unfavorably impacted by 
changes in actuarial assumptions, market performance of plan assets and obligations imposed by legislation or pension authorities which 
could adversely affect its financial position, results of operations, and cash flow.  

Kodak has significant defined benefit pension and other postretirement benefit obligations.  

The funded status of its U.S. and non-U.S. defined benefit pension plans (and other postretirement benefit plans), and the related cost reflected in its 
financial statements, are affected by various factors subject to an inherent degree of uncertainty. Key assumptions used to value these benefit 
obligations, funded status and expense recognition include the discount rate for future payment obligations, the long term expected rate of return on 
plan assets, salary growth, healthcare cost trend rates, mortality trends, and other economic and demographic factors. Significant differences in 
actual experience, or significant changes in future assumptions or obligations imposed by legislation or pension authorities, could lead to a potential 
future need to contribute cash or assets to Kodak’s plans in excess of currently estimated contributions and benefit payments and could have an 
adverse effect on Kodak’s consolidated results of operations, financial position or liquidity. 

In past years, Kodak has experienced increases in the costs of these defined benefit pension and postretirement benefit obligations as a result of 
macro-economic factors beyond its control, including increases in health care costs, declines in investment returns on pension plan assets, and 
changes in discount rates and mortality rates used to calculate pension and related liabilities. At least some of these macro-economic factors may 
again put pressure on the cost of providing pension and medical benefits. There can be no assurance it will succeed in limiting cost increases. In 
addition, continued upward pressure, including any as a result of new legislation, could reduce the profitability of its businesses. 

Kodak may be required to recognize impairments in the value of its goodwill and/or other long-lived assets which could adversely affect 
its results of operations.  

Upon emergence from bankruptcy, Kodak applied fresh start accounting pursuant to which the reorganization value was allocated to the individual 
assets and liabilities based on their estimated fair values. The excess reorganization value over the fair value of identified tangible and intangible 
assets is reported as goodwill. In connection with fresh start, Kodak also determined the fair value of its other long-lived assets, including intangible 
assets. The determination of reorganization value, equity value of the Company’s common stock and fair value of assets and liabilities is dependent 
on various estimates and assumptions, including financial projections and the realization of certain events. Kodak tests goodwill and indefinite lived 
intangible assets for impairment annually or whenever events occur or circumstances change that would more likely than not reduce the fair value of 

16 

 
  
  
  
  
a reporting unit below its carrying amount. Kodak evaluates other long-lived assets for impairments whenever events or changes in circumstances 
indicate the carrying value may not be recoverable. Impairments could occur in the future if Kodak’s expected future cash flows decline, market or 
interest rate environments deteriorate, or if carrying values change materially compared with changes in their respective fair values. 

Kodak’s businesses experience seasonality of sales. Therefore, lower demand for Kodak’s products or increases in costs during periods 
which are expected to be at peak in seasonality may have a pronounced negative effect on its results of operations.  

Equipment and consumables sales generally exhibit higher levels in the fourth quarter due to the seasonal nature of placements, resulting from 
customer or industry budgeting practices. As a result, a sequential quarter-to-quarter comparison is not a good indication of Kodak’s performance or 
how it will perform in the future. In addition, adverse developments during what are expected to be peak periods in seasonality, such as lower-than-
anticipated demand for its products, an internal systems failure, increases in materials costs, or failure of or performance problems with one of its key 
logistics, components supply, or manufacturing partners, could have a material adverse impact on its financial condition and operating results. Tight 
credit markets which limit capital investments or a weak economy which decreases print demand could negatively impact equipment or consumable 
sales. These external developments are often unpredictable and may have an adverse impact on its business and results of operations.   

If Kodak fails to manage distribution of its products and services properly, its revenue, gross margins and earnings could be adversely 
impacted. 

Kodak uses a variety of distribution methods to sell and deliver its products and services, including direct sales, third-party resellers and distributors. 
Successfully managing the interaction of direct and indirect channels across customer segments for its products and services is complex. Since each 
distribution method has distinct risks and financial implications, Kodak’s failure to achieve the most advantageous delivery model for its products and 
services could adversely affect its revenue and earnings. 

Kodak’s future results could be harmed if it is unsuccessful in its sales in emerging markets.  

Because Kodak is seeking to expand its sales and number of customer relationships outside the United States, including in emerging markets in 
Asia, Latin America and Eastern Europe, Kodak’s business is subject to risks associated with doing business internationally, such as: 

• 
• 

• 

• 
• 
• 

• 

• 
• 
• 
• 
• 

support of multiple languages; 
recruitment of sales and technical support personnel with the skills to design, manufacture, sell and supply 
products; 
compliance with governmental regulation of imports and exports, including obtaining required import or export 
approval for its products; 
complexity of managing international operations; 
exposure to foreign currency exchange rate fluctuations; 
commercial laws and business practices which may favor local competition and the imposition of tariffs on 
products or raw materials imported into or exported from the U.S.; 
multiple, potentially conflicting, and changing governmental laws, regulations and practices, including differing 
export, import, tax, anti-corruption, anti-dumping, economic sanction, labor, and employment laws; 
difficulties in collecting accounts receivable; 
limitations or restrictions on the repatriation of cash; 
limitations or reductions in protection of intellectual property rights; 
complications in logistics and distribution arrangements; and 
political or economic instability. 

There can be no assurance Kodak will be able to market and sell its products in all of its targeted markets. If its efforts are not successful, its 
business growth and results of operations could be harmed.  

As a global company, Kodak is subject to regulatory requirements and laws in the jurisdictions in which it operates, and any alleged non-compliance 
with these requirements or laws could result in an adverse financial or reputational impact. 

Kodak is subject to environmental laws and regulations.  Failure to comply with such laws and regulations or liabilities imposed as a 
result of such laws and regulations could have an adverse effect on its business, results of operations and financial condition.  

Kodak is subject to environmental laws and regulations world-wide that govern, for example, the discharge of pollutants, the management of 
hazardous materials, the cleanup of contaminated sites, and the composition and end-of-life management of its products. 

Non-compliance with applicable laws or liability incurred without regard to fault could have a material adverse effect on its business, results of 
operations and financial condition. The cost of complying with such laws could have a material adverse effect on its business, results of operations 
and financial condition.  Any uncertainties related to environmental conditions or obligations at Kodak’s properties may impact its ability to further 
develop or sell such properties. 

Kodak may have additional tax liabilities.  

17 

 
 
  
  
  
  
  
  
  
  
  
  
  
  
Kodak is subject to income taxes in the U.S. and in many foreign jurisdictions. Significant judgment is required in determining Kodak’s worldwide 
provision for income taxes.  In the course of its business, there are transactions and calculations where the ultimate tax determination is uncertain.  

Kodak operates within multiple taxing jurisdictions worldwide and is subject to audit in these jurisdictions.  These audits can involve complex issues, 
which may require an extended period of time for resolution. 

Management’s ongoing assessments of the outcomes of these issues and related tax positions require judgment, and although management 
believes that adequate provisions have been made for such issues, there is the possibility that the ultimate resolution of such issues could have an 
adverse effect on the earnings and cash flow of Kodak. 

Kodak’s business, financial position, results of operations, cash flows and reputation may be negatively impacted by legal matters.  

Kodak has various contingencies which are not reflected on its balance sheet, including those arising as a result of being involved from time to time 
in a variety of claims, lawsuits, investigations, remediations and proceedings concerning commercial, tax, tort, customs, employment, health and 
safety and intellectual property matters, licensee activities, and compliance with various domestic and international laws and regulations.  Should 
developments in any of these matters cause a change in its determination as to an unfavorable outcome and result in the need to recognize a 
material accrual or should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material 
adverse effect on its business, financial position, results of operations, and cash flows. 

On July 28, 2020, the U.S. International Development Finance Corporation (the “DFC”) announced (the “DFC Announcement”) the signing of a non-
binding letter of interest to provide a subsidiary of the Company with a potential $765 million loan (the “DFC Loan”) to support the launch of Kodak 
Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs (the “DFC Pharmaceutical Project”).  
The DFC Announcement and circumstances surrounding it prompted congressional investigations, an SEC investigation and a New York Attorney 
General’s investigation.  A number of lawsuits have been filed or threatened alleging various securities law violations and breaches of fiduciary 
duties based on circumstances surrounding the DFC Announcement.  If the findings of the ongoing investigations are unfavorable or the Company is 
not successful in defending the lawsuits associated with the DFC Announcement, Kodak’s reputation could be damaged, its existing business could 
be adversely affected, and it may incur significant costs which may not be fully covered by insurance. 

Regulations related to “conflict minerals” may require Kodak to incur additional expenses and could limit the supply and increase the 
cost of certain metals used in manufacturing Kodak’s products.  

The Dodd-Frank Wall Street Reform and Consumer Protection Act contains provisions to improve transparency and accountability concerning the 
supply of minerals originating from the conflict zones of the Democratic Republic of Congo (“DRC”) and adjoining countries. 

As a result, in August 2012, the SEC adopted rules requiring disclosure related to sourcing of specified minerals, known as “conflict minerals,” which 
are necessary to the functionality or production of products manufactured or contracted to be manufactured by public companies. Kodak has 
designed its overall conflict minerals policies and procedures to be consistent with the guidance issued by the Organization for Economic Co-
operation and Development (“OECD”) and continues to perform due diligence on its supply chain.  Kodak filed its most recent Conflict Minerals 
Disclosure report for the reporting period from January 1, 2019 to December 31, 2019 on May 29, 2020.  As of the date of the report, Kodak 
determined certain of its products contain such specified minerals but was unable to determine whether or not such minerals originate from the DRC 
or an adjoining country.  Kodak may incur additional costs to comply with these disclosure requirements, including costs related to determining the 
sources of the specified minerals used in its products, in addition to the cost of any changes to products, processes, or sources of supply as a 
consequence of such verification activities, which may adversely affect its business. 

In addition, the number of suppliers who provide “conflict-free” minerals may be limited, which may make it difficult to satisfy customers who require 
all of the components of its products be certified as conflict-free, which could place it at a competitive disadvantage if it is unable to do so. Because 
Kodak’s supply chain is complex, it may also not be able to sufficiently verify the origins of the relevant minerals used in its products through its due 
diligence procedures, which may harm its reputation. 

Risks Related to the Company’s Indebtedness and Access to Capital Markets 

There can be no assurance the Company will be able to comply with the terms of its various credit facilities.  

A breach of any of the financial or other covenants contained in the cash collateralized Letter of Credit Facility Agreement (the “LC Credit 
Agreement”), Asset Based Revolving Credit Agreement (the “ABL Credit Agreement”), Term Loan Credit Agreement or the Convertible Notes, 
(together, the “Credit Agreements”) could result in an event of default under these facilities.  

If any default or event of default occurs under the LC Credit Agreement or ABL Credit Agreement and the Company is not able to either cure it or 
obtain a waiver from the requisite lenders under the LC Credit Agreement and ABL Credit Agreement, the administrative agent under the LC Credit 
Agreement and ABL Credit Agreement may, and at the request of the requisite lenders for that facility must, declare all of the Company’s outstanding 
obligations under the LC Credit Agreement and ABL Credit Agreement, together with accrued interest and fees, to be immediately due and payable.  
In addition, the agent under the LC Credit Agreement and ABL Credit Agreement may, and at the request of the requisite lenders must, terminate the 
lenders’ commitments under that facility and cease making further loans. If any default or event of default occurs under the Term Loan Credit 
Agreement or Convertible Notes and the Company is not able to either cure it or obtain a waiver from the holders of the Term Loan Credit 
Agreement or Convertible Notes, such holders may declare all of the Company’s outstanding obligations under the Term Loan Credit Agreement and 

18 

 
 
Convertible Notes, together with accrued interest and fees, to be immediately due and payable.  If applicable, the administrative agent under the LC 
Credit Agreement, ABL Credit Agreement and Term Loan Credit Agreement and the collateral agent for the Convertible Notes could institute 
foreclosure proceedings against the pledged assets. Any of these outcomes would likely have an adverse effect on the Company’s operations and 
its ability to satisfy its obligations as they come due. 

On March 6, 2020 Kodak obtained a waiver from the agent and lenders under the ABL Credit Agreement with respect to any event of default under 
the reporting covenant in the ABL Credit Agreement that may be deemed to have occurred in relation to the going concern explanatory paragraph 
contained in the audit report on Kodak’s financial statements as of and for the year ended December 31, 2019.  The additional liquidity provided by 
the financing transactions which closed on February 26, 2021, the extension of the maturity date of the ABL Credit Agreement, and the repurchase 
and exchange of the Series A Preferred Stock alleviated the substantial doubt about Kodak’s ability to continue as a going concern within one year 
after the date its financial statements are issued (March 16, 2021) and therefore a waiver from the agent and lenders under the ABL Credit 
Agreement was not required for the financial statements as of and for the year ended December 31, 2020.  For more information on the reporting 
covenants under the Credit Agreements and the potential impact of the explanatory paragraph in the audit report refer to Item 7. “Management’s 
Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Sources of Liquidity.” 

The current non-investment grade status and Kodak’s financial condition may adversely impact Kodak’s commercial operations, increase 
its liquidity requirements and increase the cost of refinancing opportunities. It may not have adequate liquidity to post required amounts 
of additional collateral.  

The Company’s corporate family credit rating is currently below investment grade and there are no assurances its credit ratings will improve, or they 
will not decline, in the future.  In addition, the Company may not continue to maintain credit ratings from the recognized rating agencies.   

Its credit ratings and financial condition may affect the evaluation of its creditworthiness by trading counterparties and lenders, which could put it at a 
disadvantage to competitors with higher or investment grade ratings. 

In carrying out its commercial business strategy, the current non-investment grade credit ratings have resulted and will likely continue to result in 
requirements that Kodak either prepay obligations or post significant amounts of collateral to support its business.  

Should its ratings continue at their current levels, or should its ratings be further downgraded, it would expect these negative effects to continue and, 
in the case of a downgrade, become more pronounced.  In particular, given the Company’s current credit ratings it would be required, if requested, to 
provide up to $3 million of additional letters of credit to the issuers of certain surety bonds to fully collateralize such bonds. 

The availability of borrowings and letters of credit under the ABL Credit Agreement and LC Credit Agreement is limited by the amount of 
various types of assets and, under certain circumstances, the administrative agent under the ABL Credit Agreement will have greater 
control over Kodak’s cash.  

Availability under the Company’s ABL Credit Agreement is based on the amount of Eligible Receivables, Eligible Inventory, Eligible Machinery and 
Equipment less specified reserves as described in Note 9, “Debt and Finance Leases” to the consolidated financial statements.  Kodak’s U.S. 
Accounts Receivable and Inventory levels have declined over the past four years, and Machinery and Equipment for purposes of the ABL Credit 
Agreement amortizes down by $1 million per quarter.   

Availability under the Company’s LC Credit Agreement is based on cash collateral in an amount greater than or equal to 103% of the aggregate 
amount of letters of credit issued and outstanding at any given time (the “LC Cash Collateral”).   

If Eligible Receivables, Eligible Inventory and Eligible Machinery and Equipment continue to decline and an asset base cannot be maintained to 
support the $42 million of letters of credit outstanding under the ABL Credit Agreement and the $11 million of Excess Availability required under the 
ABL Credit Agreement,  or if LC Cash Collateral is not maintained to support the 103% of the $49 million of letters of credit outstanding under the LC 
Credit Agreement, the Company would be required to remain in compliance with the ABL Credit Agreement’s Fixed Charge Coverage Ratio and 
operate under cash dominion by the administrative agent under the ABL Credit Agreement.   

Additional LC Cash Collateral would be classified as restricted cash and would not be available to support ongoing working capital and investment 
needs. 

If the administrative agent under the ABL Credit Agreement executed cash dominion, it would increase operational complexities for the Company.  
An event of default would occur under these circumstances if the Company is unable to remain in compliance with the ABL Credit Agreement’s Fixed 
Charge Coverage Ratio and operate under cash dominion by the administrative agent under the ABL Credit Agreement. 

The Company’s substantial monetary obligations require a portion of its cash flow be used to fund other obligations rather than be 
invested in the business and could adversely affect its ability to fund its operations.  

The Company’s indebtedness under the Credit Agreements and its other obligations could have important negative consequences to the Company 
and investors in its securities. These include the following: 

• 

• 

it may not be able to satisfy all of its obligations, including, but not limited to, its obligations under the Credit 
Agreements, which may cause a cross-default or cross-acceleration on other debt it may have incurred; 
it could have difficulties obtaining necessary financing in the future for working capital, capital expenditures, debt 

19 

 
  
  
service requirements, refinancing or other purposes; 
it will have to use a significant part of its cash flow or cash balances to make payments on its debt and Series B 
Preferred Stock and to satisfy the other obligations set forth above, which may reduce the capital available for 
operations and expansion; and 
adverse economic or industry conditions may have more of a negative impact. 

• 

• 

The Company cannot be sure cash generated from its business will be as high as it expects, or its expenses will not be higher than it expects. 
Because a portion of its expenses are fixed in any given year, its operating cash flow margins are highly dependent on revenues, which are largely 
driven by customer demand. A lower amount of cash generated from its business or higher expenses than expected, when coupled with its debt 
obligations, could adversely affect its ability to fund its operations. 

Kodak may desire additional capital funding and such capital may not be available to it and/or may be limited.  

Kodak may desire to raise additional capital, including to pursue additional growth opportunities, strategic transactions or additional reorganization 
initiatives or refinance or redeem outstanding debt or preferred stock.  Because of Kodak’s current non-investment grade credit rating and financial 
condition, and/or general conditions in the financial and credit markets, its access to the capital markets may be limited. 

Kodak’s ability to obtain capital and the costs of such capital are dependent on numerous factors, including: 

• 
• 

• 
• 

• 
• 
• 
• 
• 
• 
• 

covenants in the Credit Agreements; 
obtaining a consent from the holders of Series B and C Preferred Stock for the issuance of additional preferred shares 
which rank senior or pari passu to the Series B and C Preferred Stock; 
investor confidence in Kodak and the markets in which it operates; 
its financial performance and projected financial performance and the financial performance and projected financial 
performance of its subsidiaries; 
its levels of debt and redemption obligations; 
its ability to generate positive cash flow; 
its ability to consummate monetization transactions including asset sales; 
its requirements for posting collateral under various commercial agreements; 
its current non-investment grade credit rating; 
its long-term business prospects; and 
general economic and capital market conditions. 

Kodak may not be successful in obtaining additional capital for these or other reasons. An inability to access capital may limit its ability to capitalize 
on growth or efficiency opportunities or refinancings it would otherwise like to pursue. 

Risks Related to the Company’s Common Stock 

The conversion of the Series B Preferred Stock, Series C Preferred Stock and Convertible Notes into shares of the Company’s common 
stock may dilute the value for the current holders of the Company’s common stock.  

The 1,000,000 outstanding shares of the Company’s Series B Preferred Stock are convertible into shares of the Company’s common stock at a 
conversion rate of 9.5238 shares of common stock per share of Series B Preferred Stock, the 750,000 outstanding shares of the Company’s Series 
C Preferred Stock (expected to increase to 1,000,000 outstanding shares) are convertible into shares of the Company’s common stock at a 
conversion rate of 10 shares of common stock per share of Series C Preferred Stock, and the Convertible Notes are convertible into shares of the 
Company’s common stock at a conversion rate of 100 shares of common stock per $1,000 principal amount of Convertible Notes.  The outstanding 
shares of Series C Preferred Stock and outstanding principal amount of the Convertible Notes are expected to increase as a result of the payment of 
dividends and interest in kind at a rate of 5.0% per annum.  As a result of the conversion of any issued and outstanding Series B Preferred Stock, 
Series C Preferred Stock or Convertible Notes (collectively, the “Convertible Securities”), the Company’s existing shareholders will own a smaller 
percentage of its outstanding common stock. Based on the capitalization of the Company as of February 26, 2021 after giving effect to the issuance 
of the Convertible Securities, the conversion of all Convertible Securities would result in the issuance to holders thereof of approximately 22% of the 
outstanding common stock after giving effect to such conversion.  Further, additional shares of common stock may be issuable pursuant to certain 
other features of the Convertible Securities, with such issuances being further dilutive to existing holders of common stock. 

If Convertible Securities are converted into common stock, holders of such converted common stock will be entitled to the same dividend and 
distribution rights as holders of the common stock currently authorized and outstanding. As such, another dilutive effect resulting from the conversion 
of any issued and outstanding Convertible Securities will be a dilution to dividends and distributions. 

Holders of the Company’s common stock will not realize any dilution in their ownership, dividend or distribution rights solely as a result of the 
reservation of any shares of common stock for issuance upon conversion of the Convertible Securities or for issuance of additional shares of 
common stock pursuant to certain other features of the Convertible Securities, but will experience such dilution to the extent additional shares of 
common stock are issued in the future as described above. 

20 

 
  
  
  
  
  
  
  
  
 
  
  
  
  
The holder of the Series C Preferred Stock own a large portion of the voting power of the Company’s outstanding securities, and the 
holders of the Series C Preferred Stock and Convertible Notes each have the right to nominate one member for election to the Company’s 
Board. As a result, these holders may influence the composition of the Board and future actions taken by the Board. 

The holder of the Company’s Series C Preferred Stock are entitled to vote upon all matters upon which holders of the Company’s common stock 
have the right to vote and is entitled to the number of votes equal to the number of full shares of common stock into which such shares of Series C 
Preferred Stock could be converted at the then applicable conversion rate.  

Assuming the issuance of all shares of Series C Preferred Stock under contract to be issued, the holder of the Series C Preferred Stock would hold 
approximately 11% of the voting power of the Company on an as-converted basis. As a result, this holder may have the ability to influence future 
actions by the Company requiring shareholder approval. 

The holder of the Series C Preferred Stock also has the right to nominate one member for election to the Company’s board of directors (the “Board”).  
This nomination right expires upon the earlier to occur of the third anniversary of the initial issuance of the Series C Preferred Stock or the holder 
ceasing to directly or indirectly hold at least a majority of the shares of Series C Preferred Stock purchased or the common stock received upon the 
conversion of such shares, and is exclusive to the initial holder and does not transfer with the Series C Preferred Stock. 

Also, an affiliate of the Term Loan Lenders has the right to nominate one member for election to the Board until the third anniversary of the initial 
issuance of the Term Loans or until the Term Loan Lenders cease to hold at least 50% of the original principal amount of the Term Loans and 
commitments under the Credit Agreement, whichever is earlier.  Until the Term Loan Lenders cease to hold at least 50% of the original principal 
amount of the Term Loans and commitments under the Credit Agreement, at any time that the director nominated by the affiliate of the Term Loan 
Lenders is not serving on the Board, such affiliate will have the right to designate a non-voting observer to the Board. 

Also, if dividends on the Series B Preferred Stock are in arrears for six or more consecutive or non-consecutive dividend periods, the holders of the 
Series B Preferred Stock will be entitled to nominate one director at the next annual shareholder meeting and all subsequent shareholder meetings 
until all accumulated dividends on the Series B Preferred Stock have been paid or set aside. As a result, the presence of directors on the Board 
nominated by the current holder of Series C Preferred Stock or an affiliate of the Term Loan Lenders or nominated in the future by the holders of 
Series B Preferred Stock would enable such holders and lenders to influence the composition of the Board and, in turn, potentially influence and 
impact future actions taken by the Board. 

The Company has registered, and has a duty to register, the resale of a large portion of its outstanding securities.  The resale of the 
Company’s common stock, or the perception that such resale may occur, may adversely affect the price of its common stock. 

In compliance with a Registration Rights Agreement to which the Company is a party, it has registered the resale of an aggregate of approximately 
16.5 million shares of outstanding common stock.  The Company is also a party to Registration Rights Agreements pursuant to which it is obligated 
to register for resale the approximately 22 million shares of common stock issuable upon conversion of the Convertible Securities.  The resale of a 
substantial number of shares of common stock in the public market, or the perception that such resale might occur, could cause the market price of 
the Company’s common stock to decline. Under the terms of the Registration Rights Agreements to which the Company is subject, certain of the 
counterparties to such Registration Rights Agreements can, in certain circumstances, require the Company to participate in an underwritten public 
offering of the registered securities. Any shares sold in a registered resale will be freely tradable without restriction under the Securities Act. While 
the Company cannot predict the size of future resales or distributions of its common stock, if there is a perception that such resales or distributions 
could occur, or if the holders of the Company’s securities registered for resale sell a large number of the registered securities, the market price for 
the Company’s common stock could be adversely affected. 

The resale of a significant portion of the Company’s securities or certain accumulations or transfers of the Company’s securities could 
result in a change of control of the Company and the loss of favorable tax attributes. 

Holders of the Convertible Securities and holders of large blocks of the Company’s common stock collectively have a significant influence over 
matters presented to the Company’s shareholders for approval, including election of members to the Board and change of control transactions. In 
addition, the holders of such securities collectively would be able to cause a significant change in the ownership of the Company by selling a 
sufficient portion of the Company’s securities held by them.  If such a transaction, in combination with other transactions in securities of the Company 
which have already occurred or future issuances of securities by the Company, were to result in an “ownership change” as determined under Section 
382 of the Internal Revenue Code of 1986, as amended, then the Company’s ability to offset taxable income with tax attributes generated prior to the 
ownership change date could be limited, possibly substantially.  Certain accumulations or transfers of the Company’s outstanding securities not 
involving these holders, could also cause such an “ownership change”.  For more information on the Company’s tax attributes refer to Note 18, 
“Income Taxes”.  The interests of the holders of the Convertible Securities and holders of large blocks of the Company’s common stock may not 
always coincide with the interests of the other holders of our common stock. 

The Company’s stock price has been and may continue to be volatile. 

The market price of the Company’s common stock has fluctuated substantially, experienced extreme volatility in the context of the DFC 
Announcement and may continue to fluctuate significantly. Future announcements or disclosures concerning the Company, its strategic initiatives 
(including the potential DFC Loan and any announcement concerning any initiatives concerning pharmaceuticals), its sales and profitability, quarterly 
variations in actual or anticipated operating results or comparable sales, any failure to meet analysts’ expectations, sales of large blocks of its 

21 

 
common stock and developments concerning the investigations, lawsuits and claims relating to the DFC Announcement, among other factors, could 
cause the market price of its common stock to fluctuate substantially. 

ITEM 1B. UNRESOLVED STAFF COMMENTS 

None. 

ITEM 2.  PROPERTIES 

Kodak's worldwide headquarters is located in Rochester, New York. 

Kodak owns 11 million square feet and leases, as a lessee, approximately 4 million square feet of space that includes administrative, research and 
development, manufacturing and marketing facilities in several worldwide locations.  Out of the owned space, Kodak leases out approximately 1 
million square feet to third party tenants.  The leases are for various periods and are generally renewable. 

Kodak’s principal manufacturing facilities, by segment, are listed below.  Properties in a location may be shared by all segments operating in that 
location. 

Digital Printing 
Rochester, New York, USA 
Dayton, Ohio, USA 
Vancouver, Canada 
(software development) 
Shanghai, China 
(software development) 

Traditional Printing 

   Rochester, New York, USA 
Columbus, Georgia, USA 
Osterode, Germany 
Gunma, Japan 
Shanghai, China 
Vancouver, Canada 

Advanced Materials and Chemicals 
Rochester, New York, USA 
Xiamen, China 

Regional distribution centers are located in various places within and outside of the United States.   

Research and development is headquartered at the Kodak Research Laboratories which is part of the Eastman Business Park in Rochester, New 
York, where Kodak conducts research and files patent applications with fundamental inventions.  Other U.S. research and development groups are 
located in Dayton, Ohio and Columbus, Georgia.  Outside the U.S., research and development groups are located in Canada, Israel, Germany, 
Japan and China.  The research and development groups work in close cooperation with manufacturing units and marketing organizations to 
develop new products and applications to serve both existing and new markets. 

Kodak has excess capacity in some locations.  Kodak is pursuing monetizing its excess capacity by selling or leasing the associated properties. 

ITEM 3. 

LEGAL PROCEEDINGS 

On August 13, 2020 Tiandong Tang commenced a class action lawsuit against the Company, its Executive Chairman and Chief Executive Officer 
and its Chief Financial Officer in Federal District Court in the District of New Jersey, and on August 26, 2020 Jimmie A. McAdams and Judy P. 
McAdams commenced a class action lawsuit against the Company and its Executive Chairman and Chief Executive Officer in Federal District Court 
in the Southern District of New York (collectively, the “Securities Class Actions”).  The Securities Class Actions seek damages and other relief based 
on alleged violations of federal securities laws in the context of the DFC Announcement of the potential DFC Loan and DFC Pharmaceutical Project 
discussed under Item 1A. Risk Factors above.  Since the filing of the Securities Class Actions, procedural activities have been ongoing relating to the 
determination of venue and lead plaintiff.  The Company intends to vigorously defend itself against the Securities Class Actions.  

In addition to the Securities Class Actions, on December 29, 2020 Robert Garfield commenced a class action lawsuit against the Company and each 
of the members of its Board of Directors in the Superior Court of Mercer County, New Jersey seeking equitable relief and damages in favor of the 
Company based on alleged breaches of fiduciary duty by the Company’s Board of Directors associated with alleged false and misleading proxy 
statement disclosure (the “Fiduciary Class Action”).  The Company has also received three requests under New Jersey law demanding, among other 
things, that the Company take certain actions in response to alleged breaches of fiduciary duty relating to option grants and securities transactions in 
the context of the DFC Announcement and alleged proxy statement disclosure deficiencies.  The Company has responded to and engaged in 
discussions concerning these requests, and its response and discussions may serve as the basis for the requestors to bring shareholder derivative 

22 

 
 
 
 
 
 
  
     
     
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
     
  
  
 
 
 
 
 
 
 
 
 
 
  
     
     
lawsuits (any such lawsuits, collectively with the Fiduciary Class Action, the “Fiduciary Matters”).  The Company intends to vigorously defend the 
Fiduciary Matters.  

The DFC Announcement has also prompted investigations by several congressional committees, the SEC and the New York Attorney General’s 
office.  The Company is cooperating in those investigations. 

Kodak’s Brazilian operations are involved in various litigation matters and have received or been the subject of numerous governmental 
assessments related to indirect and other taxes in various stages of litigation, as well as civil litigation and disputes associated with former 
employees and contract labor.   

The tax matters, which comprise the majority of the litigation matters, are primarily related to federal and state value-added taxes and income taxes.  
Kodak’s Brazilian operations are disputing these matters and intend to vigorously defend their position.  Kodak routinely assesses these matters as 
to the probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it 
assesses the likelihood of loss as probable.  As of December 31, 2020, Kodak’s Brazilian operations maintained accruals of approximately $3 million 
for claims aggregating approximately $117 million inclusive of interest and penalties where appropriate.  In connection with assessments and 
litigation in Brazil, local regulations may require Kodak’s Brazilian operations to post security for a portion of the amounts in dispute.  Generally, any 
encumbrances of the Brazilian assets would be removed to the extent the matter is resolved in Kodak’s favor. 

Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, 
employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. 

Kodak is also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, 
including patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s products. These matters are in 
various stages of investigation and litigation and are being vigorously defended. Based on information currently available, Kodak does not believe 
that it is probable that the outcomes in any of these matters, individually or collectively, will have a material adverse effect on its financial condition or 
results of operations. Litigation is inherently unpredictable, and judgments could be rendered or settlements entered that could adversely affect 
Kodak’s operating results or cash flows in a particular period.  Kodak routinely assesses all of its litigation and threatened litigation as to the 
probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as 
probable. 

ITEM 4. 

MINE SAFETY DISCLOSURES 

None. 

INFORMATION ABOUT ITS EXECUTIVE OFFICERS 

Pursuant to General Instructions G (3) of Form 10-K, the following list is included as an unnumbered item in Part I of this report in lieu of being 
included in the Proxy Statement for the Annual Meeting of Shareholders. 

Name 
James V. Continenza 
David E. Bullwinkle 
Roger W. Byrd 
John O'Grady 
Eric H. Samuels 
Terry R. Taber 
Randy D. Vandagriff 

Age 
58 
46 
55 
57 
53 
66 
58 

   Positions Held 

   Executive Chairman and Chief Executive Officer 
   Chief Financial Officer and Senior Vice President 
   General Counsel, Secretary and Senior Vice President 
   Vice President 
   Chief Accounting Officer and Corporate Controller 
   Vice President 
   Vice President 

The executive officers' biographies follow: 

James V. Continenza 

James V. Continenza leads the transformation of Kodak as Executive Chairman and Chief Executive Officer.  He was appointed Executive Chairman 
by the Board of Directors on February 20, 2019 and was appointed Chief Executive Officer by the Board of Directors on July 27, 2020.  Continenza 
joined the Board of Directors of Kodak in April 2013 and became Chairman of the Board in September 2013.   

Continenza brings a proven track record of guiding leading technology companies through transformations. Since September 2012, Continenza has 
served as the Chairman and Chief Executive Officer of Vivial Inc., a privately held marketing technology and communications company. He has also 
held leadership roles at STi Prepaid, LLC, a telecommunications company; Anchor Glass Container Corp., a leading manufacturer of glass 
containers; Teligent, Inc., a provider of communications services including voice, data, and internet access; Lucent Technologies Product Finance, a 
global leader in telecom equipment; and AT&T.  

23 

 
 
 
In addition to his management experience, Continenza currently serves on the board of Cenveo Corporation, an industry leader in transformative 
publishing solutions.  He has also served on the boards of Datasite LLC (formerly known as Merrill Corp.), NII Holdings, Inc., Tembec, Inc. and Neff 
Corporation.  He also serves or has served on the boards of a number of private companies.   

David E. Bullwinkle 

Dave Bullwinkle is the Chief Financial Officer and Senior Vice President of Kodak. The Board of Directors elected Bullwinkle to this position effective 
July 2016. Effective November 6,2018, Bullwinkle is President of the Eastman Business Park Division. Bullwinkle is responsible for advancing the 
growth strategy for Eastman Business Park and leading Kodak's worldwide finance, corporate development, internal audit and purchasing teams. 
Bullwinkle reports to Executive Chairman Jim Continenza.  

Bullwinkle joined Kodak in 2004 and has worked in several financial management roles at the company including Worldwide BU Controller, Assistant 
Corporate Controller and External Reporting Manager. He served as the Director of Corporate Financial Planning and Analysis and Vice President, 
Finance at Kodak from November 2010 to June 2016, and Director of Investor Relations from August 2013 to June 2016. 

Prior to joining Kodak, Bullwinkle worked as the Manager of Financial Reporting at Birds Eye Foods, Inc. and previously at PricewaterhouseCoopers 
from 1996 to 2002 in various roles including serving as an Assurance Manager.  

Bullwinkle has an MBA from St. John Fisher College and Bachelor of Science in Accounting degree from SUNY Geneseo. Bullwinkle is also a 
Certified Public Accountant in the State of New York. 

Roger W. Byrd 

Roger Byrd was appointed General Counsel, Secretary and Senior Vice President of Kodak in January 2019. He is responsible for leading the 
company's global legal function and for providing legal guidance to senior leadership and the Board of Directors. He also oversees the corporate 
development function. Byrd reports to Executive Chairman Jim Continenza. 

Byrd joined Kodak in 2015 as Assistant General Counsel and Vice President, Legal Department and while at Kodak has focused on M&A and 
financing transactions, joint ventures, and other strategic initiatives.  Byrd has also been active in providing credit agreement compliance, securities 
reporting and corporate governance support to the Company. The Board of Directors elected him to Senior Vice President and Secretary in January 
2019. 

Prior to joining Kodak, Byrd was a Partner at Nixon Peabody LLP.  During his 23-year career at Nixon Peabody, he represented a broad range of 
clients in connection with a variety of M&A, financing and other corporate transactions. Byrd also served as General Counsel at Choice One 
Communications, Inc. from 2005 – 2006, a competitive local exchange carrier.  

Byrd received a B.S. degree in accounting from Bob Jones University and a J.D. from Duke University School of Law. 

John O’Grady 

Effective January 2020, John O’Grady is Senior Vice President of Print, with senior responsibilities relating to the Traditional Printing segment.  He 
reports to Executive Chairman Jim Continenza.  

From April 24, 2018 to January 2020, O'Grady was President, Print Systems Division, which served graphic arts and commercial print customers 
with printing plates, computer to plate imaging solutions, electrophotographic printing solutions, OEM toner, and equipment services. From 
December 1, 2017 to April 24, 2018, O'Grady was President of Consumer Imaging Division. In this role, he was responsible for motion picture and 
commercial films, synthetic chemicals, and consumer products, including products from Kodak brand licensees. From January 2016 to December 
2017, O'Grady was General Manager, Worldwide Sales, Print Systems Division, responsible for managing the sales, service and regional marketing 
for the Print Systems Division on a worldwide basis in addition to the go-to-market back office operations for Kodak. From January 2015 to 
December 2015, O'Grady was Managing Director of the Europe, United States and Canada, Australia and New Zealand (EUCAN) Region. From 
December 2010 to December 2014, he was Managing Director, U.S. & Canada Region. From December 2008 to December 2010, O'Grady was 
Regional Managing Director, Europe, Africa and Middle East Region (EAMER) and Chairman Eastman Kodak Sàrl, and from May 2007 to December 
2008, he was Managing Director, EAMER, Consumer Businesses. O’Grady has served as a corporate vice president since March 2007, including as 
a senior vice president from August 2016 through February 2020.    

O'Grady joined Kodak in 1997 and has held key business development and regional management positions in Kodak's digital imaging businesses.  

Prior to joining Kodak, O'Grady had a 12-year career at Verbatim.  

O'Grady graduated from the University of Limerick in Ireland with a B.S. degree in Electronics. 

Eric H. Samuels 

Eric Samuels was appointed Corporate Controller and Chief Accounting Officer in July 2009.  Samuels previously served as the Company’s 
Assistant Corporate Controller and brings to his position more than 20 years of leadership experience in corporate finance and public accounting. He 
joined Kodak in 2004 as Director, Accounting Research and Policy. Samuels reports to Chief Financial Officer David Bullwinkle. 

24 

 
Prior to joining Kodak, Samuels had a 14-year career in public accounting during which he served as a senior manager at KPMG LLP's Department 
of Professional Practice (National Office) in New York City. Prior to joining KPMG in 1996, he worked in Ernst & Young's New York City office. 

Samuels has a B.S. degree in business economics from the State University of New York College at Oneonta.  He is a Certified Public Accountant in 
New York and a member of the American Institute of Certified Public Accountants. 

Terry R. Taber, PhD 

Terry Taber has served as Kodak's Chief Technical Officer since January 2009. Effective January 2020, he is a Senior Vice President of Advanced 
Materials and Chemicals. He reports to Executive Chairman Jim Continenza.   

From May 1, 2017 to January 2020, Taber was named President of the Advanced Materials and 3D Printing Technology Division which contained 
the research laboratories and included licensing as well as new business development activities related to Kodak's patents and proprietary 
technology, and focused on opportunities in smart material applications, printed electronics markets and 3D printing materials.  

From January 1, 2015 to May 1, 2017, Taber was named President of the Intellectual Property Solutions Division. From January 2007 to December 
2008 he was the Chief Operating Officer of Kodak's Image Sensor Solutions ("ISS") business, a leading developer of advanced CCD and CMOS 
sensors serving imaging and industrial markets, and prior to Taber’s role with ISS, he held a series of senior positions in Kodak's research and 
development and product organizations. Taber has served as a corporate vice president since December 2008, including as a senior vice president 
from December 2010 through February 2020.   

During his more than 40 years at Kodak, Taber has been involved in new materials research, product development and commercialization, 
manufacturing, and executive positions in R&D and business management. 

Taber's early responsibilities included research on new synthetic materials, an area in which he holds several patents, program manager for several 
film products, worldwide consumer film business product manager, Associate Director of R&D and director of Materials & Media R&D.  

Taber received a B.S. degree in Chemistry from Purdue University and a Ph.D. in Organic Chemistry from the California Institute of Technology. He 
also received an M.S. in General Management from MIT as a Kodak Sloan Fellow. In past board service, he was a founding Board Member of the 
Innovation & Material Sciences Institute and served on the Executive Advisory Board of FIRST Rochester (For Inspiration and Recognition of 
Science and Technology). Taber currently serves on the George Eastman Museum Board, effective June 2018. He also serves on the Executive 
Committee of the Greater Rochester Chamber of Commerce and on the Board of Trustees for Roberts Wesleyan College and Northeastern 
Seminary. 

Randy D. Vandagriff 

Effective January 2020, Randy D. Vandagriff is Senior Vice President of Print, with senior responsibilities relating to the Digital Print segment. He 
reports to Executive Chairman Jim Continenza.   

From May 1, 2017 to January 2020 Vandagriff was President, Enterprise Inkjet Systems Division, responsible for delivering commercial inkjet 
technology, printers and solutions to the market. Vandagriff has spent his 37-year career innovating inkjet technology for the printing market. From 
January 2004 to August 2012, Vandagriff was Vice President, Research and Development for Kodak Versamark, responsible for leading a worldwide 
R&D organization responsible for developing four generations of inkjet technologies and delivering industry-leading performance, including Kodak 
Stream and Ultrastream inkjet technologies.  From January 2015 to May 2017, Vandagriff led the Kodak Creo Server business located in Tel Aviv, 
Israel.  He has served as a corporate vice president since May 2017.  

In addition to his strong product development capabilities, Vandagriff has traveled internationally, working with key Kodak customers to successfully 
implement commercial inkjet into their production processes. His respected knowledge, broad background, and deep industry network has 
contributed to making Kodak the world's leader in high volume variable printing solutions.   

Vandagriff holds an MBA degree from the University of Phoenix and a Bachelor of Science in Mechanical Engineering from Wright State University. 

PART II 

ITEM 5.  MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY 

SECURITIES 

The Company’s common stock is listed on the New York Stock Exchange (NYSE) under the symbol “KODK”. 

There were 2,082 shareholders of record of common stock on December 31, 2020. 

Information regarding securities authorized for issuance under equity compensation plans is included in Item 12. “Security Ownership of Certain 
Beneficial Owners and Management and Related Stockholder Matters” under the caption “Equity Compensation Plan Information.”  

25 

 
 
 
 
 
 
 
DIVIDEND INFORMATION 

No dividends on common stock were declared or paid during 2020 or 2019. 

Dividends for common shareholders may be restricted under Kodak’s Term Loan Credit Agreement, ABL Credit Agreement, the Series B Preferred 
Stock and the Series C Preferred Stock. 

26 

 
 
 
 
ISSUER PURCHASES OF EQUITY SECURITIES DURING THE QUARTER ENDED DECEMBER 31, 2020  

There were no issuer purchases of equity securities with an effective date in the quarter ended December 31, 2020. 

ITEM 6. SELECTED FINANCIAL DATA 

Kodak is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this item. 

27 

 
 
 
 
 
 
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader 
understand the results of operations and financial condition of Kodak for the years ended December 31, 2020 and 2019.  All references to Notes 
relate to Notes to the Financial Statements in Item 8. “Financial Statements and Supplementary Data.” 

CAUTIONARY STATEMENT PURSUANT TO SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 

This report on Form 10-K includes "forward–looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995. 

Forward–looking statements include statements concerning Kodak’s plans, objectives, goals, strategies, future events, future revenue or 
performance, capital expenditures, liquidity, investments, financing needs and business trends and other information that is not historical information. 
When used in this document, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “predicts,” “forecasts,” 
“strategy,” “continues,” “goals,” “targets” or future or conditional verbs, such as “will,” “should,” “could,” or “may,” and similar expressions, as well as 
statements that do not relate strictly to historical or current facts, are intended to identify forward–looking statements. All forward–looking statements, 
including management’s examination of historical operating trends and data, are based upon Kodak’s expectations and various assumptions. Future 
events or results may differ from those anticipated or expressed in the forward-looking statements. Important factors that could cause actual events 
or results to differ materially from the forward-looking statements include, among others, the risks and uncertainties described in more detail in this 
report on Form 10–K under the headings “Business,” “Risk Factors,” “Legal Proceedings” and/or “Management’s Discussion and Analysis of 
Financial Condition and Results of Operations–Liquidity and Capital Resources,” and in other filings the Company makes with the SEC from time to 
time, as well as the following: 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

Kodak’s ability to improve and sustain its operating structure, cash flow, profitability and other financial results; 

Kodak’s ability to achieve cash forecasts, financial projections, and projected growth; 

Kodak’s ability to achieve the financial and operational results contained in its business plans; 

Kodak’s ability to comply with the covenants in its various credit facilities; 

Kodak’s ability to fund continued investments, capital needs and restructuring payments and service its debt and Series B Preferred 
Stock and Series C Preferred Stock; 

The impact of the global economic environment or medical epidemics such as the COVID-19 pandemic; 

The impact of the investigations, litigations and claims arising out of the circumstances surrounding the DFC Announcement; 

Changes in foreign currency exchange rates, commodity prices, interest rates and tariff rates; 

Kodak’s ability to effectively anticipate technology trends and develop and market new products, solutions and technologies; 

Kodak’s ability to effectively compete with large, well-financed industry participants; 

Continued sufficient availability of borrowings and letters of credit under the ABL Credit Agreement and L/C Facility Agreement, 
Kodak’s ability to obtain additional financing if and as needed and Kodak’s ability to provide or facilitate financing for its customers; 

The performance by third parties of their obligations to supply products, components or services to Kodak and the ability to address 
supply chain disruptions and continue to obtain raw materials and components available from single sources of supply; and 

Kodak’s ability to effect strategic transactions, such as acquisitions, strategic alliances, divestitures and similar transactions, or to 
achieve the benefits sought to be achieved from such strategic transactions. 

There may be other factors that may cause Kodak’s actual results to differ materially from the forward–looking statements. All forward–looking 
statements attributable to Kodak or persons acting on its behalf apply only as of the date of this report on Form 10-K and are expressly qualified in 
their entirety by the cautionary statements included in this document. Kodak undertakes no obligation to update or revise forward–looking statements 
to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events, except as required by law. 

28 

 
 
CRITICAL ACCOUNTING POLICIES AND ESTIMATES  

Revenue Recognition 

Kodak's revenue transactions include sales of products (such as components and consumables for use in Kodak, and other manufacturers’ 
equipment, specialty materials and film-based products), equipment, software, services, integrated solutions, and intellectual property and brand 
licensing.   Complex arrangements with nonstandard terms and conditions may require significant contract interpretation to determine the 
appropriate accounting, including the allocation of transaction price to the various performance obligations and determination of the stand-alone 
selling price of each performance obligation.  For equipment sales, revenue recognition may depend on completion of installation based on the type 
of equipment, level of customer specific customization and other contractual terms.  In instances in which the agreement with the customer contains 
a customer acceptance clause, revenue is deferred until customer acceptance is obtained, provided the customer acceptance clause is considered 
to be substantive. 

At the time revenue is recognized, Kodak also records reductions to revenue for customer incentive programs.  Such incentive programs include 
cash and volume discounts and promotional allowances.  For those incentives that require the estimation of sales volumes or redemption rates, such 
as for volume rebates, Kodak uses historical experience and both internal and customer data to estimate the sales incentive at the time revenue is 
recognized.  In the event that the actual results of these items differ from the estimates, adjustments to the sales incentive accruals are recorded.  
Future market conditions and product transitions may require Kodak to take actions to increase customer incentive offers, possibly resulting in an 
incremental reduction of revenue at the time the incentive is offered. 

Valuation and Useful Lives of Long-Lived Assets, Including Goodwill and Intangible Assets 

Kodak performs a test for goodwill impairment annually and whenever events or changes in circumstances occur that would more likely than not 
reduce the fair value of the reporting unit below its’ carrying amount. 

Goodwill is tested for impairment at a level of reporting referred to as a reporting unit, which is an operating segment or one level below an operating 
segment (a component) if the component constitutes a business for which discrete financial information is available and regularly reviewed by 
segment management. 

As a result of the change in segments that became effective as of January 1, 2020, Kodak’s goodwill reporting units changed. The Digital Printing 
segment has three goodwill reporting units: Electrophotographic Printing Solutions, Prosper and Versamark, and Software. The Advanced Materials 
and Chemicals segment has two goodwill reporting units: Motion Picture and Industrial Films and Chemicals, and Advanced Materials and 
Functional Printing. The Traditional Printing segment, Brand segment and Eastman Business Park segment each have one goodwill reporting unit.  

As of December 31, 2019, the goodwill balance of $12 million under the prior year segment reporting structure was comprised of $6 million for the 
Brand, Film and Imaging segment and $6 million for the Kodak Software segment, which had only one reporting unit (Software).  The goodwill in the 
Brand, Film and Imaging segment was reported in the Consumer Products reporting unit.  

The goodwill previously reported in the Consumer Products goodwill reporting unit was transferred to the Brand goodwill reporting unit using a 
relative fair value allocation to affected reporting units.  Goodwill previously reported in the Software reporting unit was transferred to the Digital 
Printing segment and remains in its own reporting unit. As of December 31, 2020, goodwill is recorded in the Brand and Software reporting units.   

Determining the fair value of a reporting unit involves the use of significant estimates and assumptions.  Kodak estimates the fair value of its 
reporting units using the guideline public company method and discounted cash flow method.  To estimate fair value utilizing the guideline public 
company method, Kodak applies valuation multiples, derived from the operating data of publicly-traded benchmark companies, to the same 
operating data of the reporting units.   The valuation multiples are based on earnings before interest, taxes, depreciation and amortization 
(“EBITDA”).  To estimate fair value utilizing the discounted cash flow method, Kodak establishes an estimate of future cash flows for each reporting 
unit and discounts those estimated future cash flows to present value.  

Kodak performed a quantitative test of impairment for all reporting units for its annual goodwill impairment test as of December 31, 2020.  Kodak 
utilized the discounted cash flow method and guideline public company method to estimate the fair value of reporting units with goodwill.  For these 
reporting units, Kodak selected equal weighting of the guideline public company method and the discounted cash flow method as the valuation 
approaches produced comparable ranges of fair value.  Fair values for the other reporting units were estimated using the discounted cash flow 
method only. 

29 

 
 
 
 
 
 
 
  
 
 
To estimate fair value utilizing the discounted cash flow method, Kodak established an estimate of future cash flows for the period ranging from 
January 1, 2021 to December 31, 2025 and discounted the estimated future cash flows to present value. The expected cash flows were derived from 
earnings forecasts and assumptions regarding growth and margin projections, as applicable. The discount rates are estimated based on an after-tax 
weighted average cost of capital (“WACC”) for each reporting unit reflecting the rate of return that would be expected by a market participant.  The 
WACC also takes into consideration a company specific risk premium for each reporting unit reflecting the risk associated with the overall uncertainty 
of the financial projections.  Discount rates of 14% to 30% were utilized in the valuation based on Kodak’s best estimates of the after-tax WACC of 
each reporting unit. 

A terminal value was included for all reporting units at the end of the cash flow projection period to reflect the remaining value that the reporting unit 
is expected to generate.  The terminal value was calculated using either the constant growth method (“CGM”) based on the cash flows of the final 
year of the discrete period or the H-model, which assumes the growth during the terminal period starts at a higher rate and declines in a linear 
manner over a specified transition period toward a stable growth rate. 

Based upon the results of Kodak’s December 31, 2020 analysis, Kodak concluded that the fair value of the reporting units substantially exceeded 
their carrying values, therefore no impairment of goodwill was indicated.  Impairment of goodwill could occur in the future if a reporting unit’s fair 
value changes significantly, if Kodak’s market capitalization significantly declines, if a reporting unit’s carrying value changes materially compared 
with changes in its fair values, or as a result of changes in operating segments or reporting units. 

Kodak performed interim tests of impairment for goodwill as of June 30, 2020 due to the continued uncertainty regarding the negative impact of the 
COVID-19 pandemic on its operations, and as of March 31, 2020, due to the decline in market capitalization as of that date since the last goodwill 
impairment test (December 31, 2019) and the uncertainty regarding the negative impact of the COVID-19 pandemic at that time.   Kodak utilized the 
discounted cash flow method to estimate the fair value of all reporting units for both tests.  Kodak established an estimate of future cash flows for the 
period ranging from July 1, 2020 to December 31, 2024 for the June 30, 2020 interim test, and April 1, 2020 to December 31, 2024 for the March 31, 
2020 interim test.  The future cash flows were discounted to present value.  The expected cash flows were derived from earnings forecasts and 
assumptions regarding the timing and impact of the COVID-19 pandemic on each reporting unit as of each applicable interim test date.  The discount 
rates are estimated based on an after-tax WACC for each reporting unit reflecting the rate of return that would be expected by a market participant. 
The WACC also takes into consideration a company specific risk premium for each reporting unit reflecting the risk associated with the overall 
uncertainty of the financial projections.  Discount rates of 16% to 55% were utilized in the June 30, 2020 valuation, and 21% to 55% for the March 
31, 2020 valuation, both based on Kodak’s best estimates of the after-tax WACC of each reporting unit as of the applicable valuation date.  

A terminal value was included for all reporting units at the end of the cash flow projection period to reflect the remaining value that the reporting unit 
is expected to generate. The terminal value was calculated using either the CGM based on the cash flows of the final year of the discrete period or 
the H-model, which assumes the growth during the terminal period starts at a higher rate and declines in a linear manner over a specified transition 
period toward a stable growth rate.  

Based upon the results of Kodak’s June 30, 2020 and March 31, 2020 analyses, no impairment of goodwill was indicated.  No interim impairment 
test for goodwill was performed as of September 30, 2020.   

The carrying value of the indefinite-lived intangible asset related to the Kodak trade name is evaluated for potential impairment annually or whenever 
events or changes in circumstances indicate that it is more likely than not that the asset is impaired.    

Kodak performed its annual test of impairment for the Kodak trade name as of December 31, 2020.  The fair value of the Kodak trade name was 
valued using the income approach, specifically the relief from royalty method based on the following significant assumptions: (a) forecasted revenues 
ranging from January 1, 2021 to December 31, 2025, including a terminal year with growth rates ranging from -4.5% to 2.5%; (b) an after-tax royalty 
rate of 0.4% of expected net sales determined with regard to comparable market transactions and profitability analysis; and (c) discount rates 
ranging from 16% to 30%, which were based on the after-tax WACC. 

Based on the results of Kodak’s December 31, 2020 assessment, the fair value of the Kodak trade name exceeded its carrying value. Impairment of 
the Kodak trade name could occur in the future if expected revenues decline or if there are significant changes in the discount rates or royalty rates.  
A one percent increase in the discount rate and a 10% miss in expected revenues would impact the fair value of the Kodak trade name by $3 million. 

Kodak performed an interim impairment test of the Kodak trade name as of June 30, 2020 and March 31, 2020. The fair value of the Kodak trade 
name was valued using the income approach, specifically the relief from royalty method based on the following significant assumptions: (a) 
forecasted revenues ranging from July 1, 2020 to December 31, 2024 for the June 30, 2020 interim test, and April 1, 2020 to December 31, 2024 for 
the March 31, 2020 interim test, both valuations included a terminal year with growth rates ranging from -3% to 2.5% (b) an after-tax royalty rate of 
0.4% of expected net sales, and (c) discount rates ranging from 16% to 25% for the June 30, 2020 interim test, and 23% to 32% for the March 31, 
2020 interim test. The discount rates are based on the after-tax WACC. 

30 

 
 
 
  
  
 
 
 
 
 
Based on the results of Kodak’s March 31, 2020 assessment, the carrying value of the Kodak trade name exceeded its fair value and Kodak 
recorded a pre-tax impairment charge of $3 million.  Based on the results of Kodak’s June 30, 2020 assessment, the fair value of the Kodak trade 
name exceeded its’ carrying value.  No interim impairment test for the Kodak tradename was deemed necessary as of September 30, 2020.   

Long-lived assets other than goodwill and indefinite-lived intangible assets are evaluated for impairment whenever events or changes in 
circumstances indicate the carrying value may not be recoverable.  When evaluating long-lived assets for impairment, the carrying value of an asset 
group is compared to its estimated undiscounted future cash flows.  An impairment is indicated if the estimated future cash flows are less than the 
carrying value of the asset group.  The impairment is the excess of the carrying value over the fair value of the long-lived asset group.  Kodak 
updated its estimate of undiscounted cash flows for each asset group as of June 30, 2020 and March 31, 2020 using a probability weighted 
approach in determining the likelihood of possible adverse impacts from the COVID-19 pandemic as of each applicable interim test date.  In addition, 
Kodak updated its estimate of undiscounted cash flows for each asset group as of December 31, 2020.  Based on the results of the impairment 
tests, no impairments were recorded.  

The value of property, plant, and equipment is depreciated over its expected useful life in such a way as to allocate it as equitably as possible to the 
periods during which services are obtained from their use, which aims to distribute the value over the remaining estimated useful life of the unit in a 
systematic and rational manner.  An estimate of useful life not only considers the economic life of the asset, but also the remaining life of the asset to 
the entity.  Impairment of long-lived assets other than goodwill and indefinite lived intangible assets could occur in the future if expected future cash 
flows decline or if there are significant changes in the estimated useful life of the assets. 

Series A Preferred Stock and Convertible Notes Embedded Conversion Features and Term Extension Derivatives 

On November 15, 2016, the Company issued 2,000,000 shares of Series A Preferred Stock no par value per share.  On May 24, 2019, the Company 
issued $100 million aggregate principal amount of Convertible Notes.  The Company concluded that the Series A Preferred Stock and Convertible 
Notes are considered more akin to debt-type instruments and that the economic characteristics and risks of the embedded conversion features and 
term extension at the Company’s option (in the case of the Convertible Notes), except where the conversion price is increased to the liquidation 
preference in the case of the Series A Preferred Stock, were not considered clearly and closely related to the Series A Preferred Stock or the 
Convertible Notes.  Accordingly, these embedded features were bifurcated from the Series A Preferred Stock and Convertible Notes and separately 
accounted for on a combined basis at fair value as two single derivatives.  The Company allocated $43 million of the net Series A Preferred Stock 
proceeds to the Series A Preferred Stock derivative liability based on the aggregate fair value of the embedded conversion features on the date of 
issuance which reduced the original carrying value of the Series A Preferred Stock.  The Company allocated $14 million of the net Convertible Notes 
proceeds to the Convertible Notes derivative liability based on the aggregate fair value of the embedded features on the date of issuance which 
reduced the original carrying value of the Convertible Notes.  The derivatives are being accounted for at fair value with subsequent changes in the 
fair value being reported as part of Other charges, net in the Consolidated Statement of Operations.  With the conversion of the Convertible Notes in 
the third quarter of 2020, the Convertible Notes derivative liability expired.  The fair value of the Convertible Notes derivative was a liability of $51 
million at December 31, 2019 and was reported in Other long-term liabilities in the Consolidated Statement of Financial Position. The fair value of the 
Series A Preferred Stock derivative as of December 31, 2020 was a liability of $9 million which is reported in Other current liabilities and as of 
December 31, 2019 was a liability of $1 million which is included in Other long-term liabilities in the accompanying Consolidated Statement of 
Financial Position.   

The fair value of the embedded conversion features derivative is calculated using unobservable inputs (Level 3 fair measurements).  The value of the 
Optional Conversion associated with the Series A Preferred Stock is calculated using a binomial lattice model.   

The following table presents the key inputs in the determination of fair value for the Series A Preferred Stock embedded conversion features 
derivative: 

Total value of embedded derivative liability (in millions) 
Kodak's closing stock price 
Expected stock price volatility 
Risk free rate 
Yield on the preferred stock 

  $ 

Valuation Date 
December 31, 

2020 

2019 

9      $ 
8.14        
133.44 %     
0.10 %     
11.97 %     

1   
4.65   
104.61 % 
1.58 % 
16.27 % 

31 

 
 
 
 
 
 
  
  
  
  
  
  
  
  
     
  
    
    
    
    
The Fundamental Change and Reorganization Conversion values at issuance were calculated as the difference between the total value of the Series 
A Preferred Stock and the sum of the net present value of the cash flows if the Series A Preferred Stock is redeemed on its fifth anniversary and the 
values of the other embedded derivatives.  The Fundamental Change and Reorganization Conversion values reduce the value of the embedded 
conversion features derivative liability.  Other than events which alter the likelihood of a fundamental change or reorganization event, the value of the 
Fundamental Change and Reorganization Conversion reflects the value as of the issuance date, amortized for the passage of time.  

Taxes 

Kodak recognizes deferred tax liabilities and assets for the expected future tax consequences of operating losses, credit carry-forwards and 
temporary differences between the carrying amounts and tax basis of Kodak’s assets and liabilities. 

Kodak records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.  Kodak has 
considered forecasted earnings, future taxable income, the geographical mix of earnings in the jurisdictions in which Kodak operates and prudent 
and feasible tax planning strategies in determining the need for these valuation allowances.  As of December 31, 2020, Kodak has net deferred tax 
assets before valuation allowances of approximately $1,081 million and a valuation allowance related to those net deferred tax assets of 
approximately $1,112 million, resulting in net deferred tax liabilities of approximately $31 million. 

Kodak considers both positive and negative evidence, in determining whether a valuation allowance is needed by territory, including, but not limited 
to, whether particular entities are in three-year cumulative income positions. As of March 31, 2020, Kodak determined that it was more likely than not 
that deferred tax assets outside the U.S. which were not offset with valuation allowances as of March 31, 2020 would not be realized due to 
reductions in estimates of future profitability as a result of the COVID-19 pandemic in locations outside the U.S.  Accordingly, Kodak recorded a 
provision of $167 million associated with the establishment of a valuation allowance on those deferred tax assets.  During 2019, Kodak determined 
that it was more likely than not that a portion of the deferred tax assets outside the U.S. would not be realized due to reduced sales volumes and 
profits in locations outside the U.S. and accordingly recorded a provision of $19 million associated with the establishment of a valuation allowance on 
those deferred tax assets.   

Kodak may be able to make the determination that the realization of deferred tax assets in certain foreign jurisdictions is more likely than not in the 
future.  Kodak will continue to evaluate whether valuation allowances are needed, at a jurisdictional level, in future reporting periods. It is possible 
that sufficient positive evidence, including sustained profitability, may become available in future periods with respect to one or more jurisdictions to 
reach a conclusion that all or part of the valuation allowance with respect to such jurisdictions could be reversed.   

Utilization of net operating losses (“NOL”) and tax credits may be subject to limitations in the event of significant changes in stock ownership of the 
Company in the future. Section 382 of the Internal Revenue Code of 1986, as amended, imposes annual limitations on the utilization of NOL 
carryforwards, other tax carryforwards, and certain built-in losses as defined under that Section, upon an ownership change. In general terms, an 
ownership change may result from transactions that increase the aggregate ownership of five percent stockholders in Kodak’s stock by more than 50 
percentage points over a three-year testing period.  The Company has a relatively high concentration of stockholders that hold 5% or more of the 
outstanding stock.  Future transactions, when combined with reported transactions within the testing period could aggregate an ownership change 
during the testing period in excess of 50 percentage points.  A Section 382 ownership change would significantly impair Kodak’s ability to utilize 
NOLs and tax credits in the U.S.  As of December 31, 2020, Kodak had available U.S. NOL carry-forwards for income tax purposes of approximately 
$1,309 million and unused foreign tax credits of $358 million.  Any impairment of these tax attributes would be fully offset by a corresponding 
decrease in Kodak’s U.S. valuation allowance, which would result in no net tax provision. 

Kodak has deferred tax liabilities of $22 million and $19 million for potential taxes on undistributed earnings, including foreign withholding 
taxes, as of December 31, 2020 and 2019, respectively. 

In general, the amount of tax expense or benefit from continuing operations is determined without regard to the tax effects of other categories of 
income or loss, such as Other comprehensive (loss) income.  However, an exception to this rule applies when there is a loss from continuing 
operations and income from items outside of continuing operations that must be considered.  This exception requires that income from discontinued 
operations, extraordinary items, and items charged or credited directly to other comprehensive income be considered in determining the amount of 
tax benefit that results from a loss in continuing operations.  This exception affects the allocation of the tax provision amongst categories of income. 

Kodak operates within multiple taxing jurisdictions worldwide and is subject to audit in these jurisdictions.  These audits can involve complex issues, 
which may require an extended period of time for resolution.  Management’s ongoing assessments of the outcomes of these issues and related tax 
positions require judgment, and although management believes that adequate provisions have been made for such issues, there is the possibility 
that the ultimate resolution of such issues could have an adverse effect on the earnings of Kodak.  Conversely, if these issues are resolved favorably 
in the future, the related provisions would be reduced, thus having a positive impact on earnings. 

32 

 
 
 
 
 
 
 
 
 
 
 
  
Pension and Other Postretirement Benefits 

Kodak’s defined benefit pension and other postretirement benefit costs and obligations are estimated using several key assumptions.  These 
assumptions, which are reviewed at least annually by Kodak, include the discount rate, long-term expected rate of return on plan assets (“EROA”), 
salary growth, healthcare cost trend rate, mortality trends and other economic and demographic factors.  Actual results that differ from Kodak’s 
assumptions are recorded as unrecognized gains and losses and are amortized to earnings over the estimated future service period of the active 
participants in the plan or, if the plan is almost entirely inactive, the average remaining lifetime expectancy of inactive participants, to the extent such 
total net unrecognized gains and losses exceed 10% of the greater of the plan's projected benefit obligation or the calculated value of plan 
assets.  Significant differences in actual experience or significant changes in future assumptions would affect Kodak’s pension and other 
postretirement benefit costs and obligations. 

Asset and liability modeling studies are utilized by Kodak to adjust asset exposures and review a liability hedging program through the use of 
forward-looking correlation, risk and return estimates. 

Those forward-looking estimates of correlation, risk and return generated from the modeling studies are also used to estimate the EROA.  The 
EROA is estimated utilizing a forward-looking building block model factoring in the expected risk of each asset category, return and correlation over a 
five to seven-year horizon, and weighting the exposures by the current asset allocation. 

Historical inputs are utilized in the forecasting model to frame the current market environment with adjustments made based on the forward-looking 
view.  Kodak aggregates investments into major asset categories based on the underlying benchmark of the strategy.  Kodak’s asset categories 
include broadly diversified exposure to U.S. and non-U.S. equities, U.S. and non-U.S. government and corporate bonds, inflation-linked bonds, 
commodities and absolute return strategies.  Each allocation to these major asset categories is determined within the overall asset allocation to 
accomplish unique objectives, including enhancing portfolio return, providing portfolio diversification, or hedging plan liabilities. 

The EROA, once set, is applied to the calculated value of plan assets in the determination of the expected return component of Kodak’s pension 
expense.  Kodak uses a calculated value of plan assets, which recognizes gains and losses in the fair value of assets over a four-year period, to 
calculate expected return on assets.   At December 31, 2020, the calculated value of the assets of Kodak’s major U.S. and non-U.S. defined benefit 
pension plans was approximately $4.1 billion and the fair value of the assets of Kodak’s major U.S. and non-U.S. defined benefit pension plans was 
approximately $4.4 billion.  Asset gains and losses that are not yet reflected in the calculated value of plan assets are not included in amortization of 
unrecognized gains and losses. 

Kodak reviews its EROA assumption annually.  To facilitate this review, every three years, or when market conditions change materially, Kodak’s 
larger plans will undertake asset allocation or asset and liability modeling studies.  The weighted average EROA used to determine the 2020 net 
pension expense for major U.S. and non-U.S. defined benefit pension plans was 6.00% and 3.27%, respectively. 

Generally, Kodak bases the discount rate assumption for its significant plans on high quality corporate bond yields in the respective countries as of 
the measurement date.  Specifically, for its U.S., Canadian, Euro-zone and UK plans, Kodak determines a discount rate using a cash flow model to 
incorporate the expected timing of benefit payments and an AA-rated corporate bond yield curve.  For Kodak's U.S. plans, the Citigroup Above 
Median Pension Discount Curve is used.  For Kodak’s other non-U.S. plans, discount rates are determined by comparison to published local high-
quality bond yields or indices considering estimated plan duration and removing any outlying bonds, as warranted. 

Kodak uses the spot yield curve approach to estimate the service and interest costs by applying the specific spot rates along the yield curve used to 
determine the benefit obligations to relevant projected cash outflows. 

The salary growth assumptions are determined based on Kodak’s long-term actual experience and future and near-term outlook.  The healthcare 
cost trend rate assumptions are based on historical cost and payment data, the near-term outlook and an assessment of the likely long-term trends. 

The following table illustrates the sensitivity to a change to certain key assumptions used in the calculation of expense for the year ending December 
31, 2021 and the projected benefit obligation (“PBO”) at December 31, 2020 for Kodak's major U.S. and non-U.S. defined benefit pension plans: 

(in millions) 

Change in assumption: 

25 basis point decrease in discount rate 
25 basis point increase in discount rate 
25 basis point decrease in EROA 
25 basis point increase in EROA 

Impact on 2021 
Pre-Tax Pension Expense 
Increase (Decrease) 
U.S. 

     Non-U.S. 

Impact on PBO 
December 31, 2020 
Increase (Decrease) 
U.S. 

     Non-U.S. 

   $ 

6      $ 
(3 )      
8        
(8 )      

1      $ 
—        
2     
(2 )   

99      $ 
(74 )      
N/A     
N/A     

34   
(25 ) 
N/A   
N/A   

Total pension income from continuing operations before special termination benefits, curtailments and settlements for the major defined benefit 
pension plan in the U.S. was $91 million for 2020 and is expected to be approximately $86 million in 2021.  Pension income from continuing 

33 

 
 
 
  
    
  
  
  
     
  
       
         
         
         
  
     
     
     
 
operations before special termination benefits, curtailments and settlements for the major non-U.S. defined benefit pension plans was less than $1 
million for 2020 and is projected to be $3 million of expense in 2021. 

Workers’ Compensation 

Kodak self-insures and participates in high-deductible insurance programs with retention and per occurrence deductible levels for claims related to 
workers’ compensation.  The estimated liability for workers’ compensation is based on actuarially estimated, discounted cost of claims, including claims 
incurred but not reported.  Historical loss development factors are utilized to project the future development of incurred losses, and the amounts are 
adjusted based on actual claim experience, settlements, claim development trends, changes in state regulations and judicial interpretations. 

A 25 basis-point change in the discount rate would have had a $2 million impact on the expense and net liability as of December 31, 2020. 

Stock Compensation 

Officers, directors and employees of the Company and its consolidated subsidiaries are eligible to receive awards.  The principal awards issued are 
non-qualified stock options and restricted stock units.  Stock options are at exercise prices equal to or greater than the closing price of Kodak’s stock 
on the date of grant and expire seven years after the grant date.  Stock-based compensation awards granted under Kodak’s stock incentive plan are 
generally subject to a three-year vesting period from the date of grant, or a later date as determined by the Executive Compensation Committee.   

Compensation expense is recognized over the service or performance period for each separately vesting tranche of the award and is adjusted for 
actual forfeitures before vesting.  Kodak assesses the likelihood that performance-based shares will be earned based on the probability of meeting 
the performance criteria.  For those performance-based awards that are deemed probable of achievement, expense is recorded, and for those 
awards that are deemed not probable of achievement, no expense is recorded. Kodak assesses the probability of achievement each quarter. 

The fair value of restricted stock units is based on the closing market price of the Company’s stock on the grant date.   

Kodak generally utilizes the Black-Scholes option valuation model to estimate the fair value of stock options.  The expected term of options granted 
is the period of time the options are expected to be outstanding and is calculated using a simplified method based on the option’s vesting period and 
original contractual term.  The historical volatility of the Company’s stock is used to estimate expected volatility. The risk-free rate is based on the 
yield on U.S. Treasury notes with a term equal to the option’s expected term.  

Given the volatility of the Company’s stock price in the third quarter of 2020, the Company utilized a lattice-based valuation model to value time-
based vesting awards granted July 27, 2020 and a Monte Carlo simulation valuation model to value options granted on July 27, 2020 which vested 
upon conversion of the Convertible Notes. 

Inventories 

Inventories are stated at the lower of cost or market.  Carrying values of excess and obsolete inventories are reduced to net realizable value.  Judgment 
is required to assess the ultimate demand for and realizable value of inventory.  The analysis of inventory carrying values considers several factors 
including length of time inventory is on hand, historical sales, product shelf life, product life cycle, product category, and product obsolescence. 

Accounts Receivable Reserves 

Accounts receivable reserves are based on historical collections experience as well as reserves for specific receivables deemed to be at risk for 
collection.  The collectability of customer receivables is reviewed on an ongoing basis considering past due invoices and the current creditworthiness 
of each customer.  Judgment is required in assessing the ultimate realization of accounts receivables. 

New Accounting Pronouncements 

A description of new accounting pronouncements is contained in Note 1, “Summary of Significant Accounting Policies”. 

34 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
OVERVIEW 

Revenue declined $213 million (17%) from 2019 to 2020.  Currency impacted revenue favorably in 2020 compared to 2019 ($9 million). 

Segments within the print industry and the film industry face competition from digital substitution.  Kodak’s strategy is to: 

• 

Focus product investment in core competency areas of print, advanced materials and chemicals, leveraging Kodak’s proprietary 
technologies to deliver technologically advanced products in the product goods packaging, graphic communications, and functional 
printing markets; 

•  Grow revenues through a focus on customers across Kodak’s print divisions, increasing overall share; 

•  Promote the use of film and expand the applications of Kodak’s film and chemicals to best utilize the existing infrastructure; and 

•  Continue to streamline processes to drive cost reductions and improve operating leverage. 

A discussion of opportunities and challenges related to Kodak’s strategy follows: 

• 

• 

The COVID-19 pandemic had a material impact on 2020 revenues and earnings. The duration and extent of demand declines and 
recovery is unclear.  Kodak has worked closely with government officials in the jurisdictions where it operates to keep its manufacturing 
facilities open.  The manufacturing facilities have generally been operating at below normal capacity during the pandemic to date.  
Kodak has endeavored to address the recommended actions of government and health authorities to protect employees world-wide, 
with particular measures in place for those working in plants and distribution facilities.  Kodak intends to continue to work with 
government authorities and implement employee safety measures so that the manufacturing and distribution of products during the 
pandemic can continue. However, uncertainty resulting from the pandemic could result in an unforeseen disruption to Kodak’s 
operations or supply chain.  Kodak reduced operating costs, largely beginning in the second quarter of 2020, through the use of 
temporary furloughs and pay cuts (approximately $25 million in 2020) for its employees and direct government assistance around the 
world reimbursing certain salary and benefits of employees (approximately $8 million in 2020).  The furloughs and pay cuts were 
maintained through the end of 2020 and largely ended in January 2021.  

Traditional Printing’s digital plate products include traditional digital plates and KODAK SONORA Process Free Plates.  SONORA 
Process Free Plates allow Kodak customers to skip the plate processing step prior to mounting plates on a printing press.  This 
improvement in the printing process saves time and costs for customers.  Also, SONORA Process Free Plates reduce the environmental 
impact of the printing process because they eliminate the use of chemicals (including solvents), water and power that is otherwise 
required to process a traditional plate.  While traditional digital plate offerings are experiencing volume and pricing pressure, innovations 
in Kodak product lines which command premium prices, such as SONORA Process Free Plates, are expected to offset some of the 
long-term price erosion in the market and manufacturing efficiencies.  Traditional Printing’s revenues accounted for 58% of Kodak’s total 
revenues in 2020.  Traditional Printing’s revenues declined $135 million (19%) in 2020.  The prior year period included $13 million of 
intellectual property licensing revenue associated with the strategic relationship established with HuaGuang in September 2019.  
Excluding the $13 million of licensing revenue, 2020 revenues declined $122 million, primarily reflecting volume and pricing declines.  
Segment earnings declined by $27 million (56%) compared to the prior year period, reflecting the license revenue in the prior year, the 
impact of reduced volumes on manufacturing costs and revenue partially offset by operating cost reductions through the use of 
temporary furloughs and pay cuts.   

None of the Traditional Printing segment’s manufacturing facilities were ordered to close by governmental authorities.  Many of the 
segment’s customers around the globe continued to operate, but at decreased volumes.  Therefore, demand for the segment’s products 
declined.  The Traditional Printing segment may also be impacted by supply chain disruptions and travel restrictions.  With the decline in 
customer demand, manufacturing volumes were reduced.  The duration and extent of demand declines and recovery is unclear.  
Manufacturing employees were temporarily furloughed, as necessary, under reduced production plans.  The segment utilized furloughs 
and pay-cuts for non-manufacturing employees in a way which allowed continued operation and product development. 

• 

In Digital Printing, the legacy Versamark business is expected to continue to decline as a percentage of the segment’s total revenue as 
the Prosper business continues to grow.  The Prosper Inkjet Systems business is expected to continue to build profitability, excluding 
the negative impacts during the COVID-19 pandemic.  Investment in the next generation technology, Ultrastream, is focused on the 
ability to place Ultrastream writing systems in OEM and hybrid applications.  Digital Printing revenue declined $52 million (18%) in 2020, 
primarily reflecting volume declines.  Despite the revenue declines, segment earnings only declined $1 million (11%) from 2019 to 2020 
driven by cost reductions. 

None of the Digital Printing segment’s manufacturing facilities were ordered to close by governmental authorities.  Many of the 
segment’s customers around the globe continued to operate, but at decreased volumes.  Therefore, demand for the segment’s products 

35 

 
 
 
  
 
 
 
declined.  The Digital Printing segment may also be impacted by supply chain disruptions and travel restrictions.  With the decline in 
customer demand, manufacturing volumes were reduced. 
The duration and extent of demand declines and recovery is unclear.  Manufacturing employees were temporarily furloughed, as 
necessary, under reduced production plans.  The segment utilized furloughs and pay-cuts for non-manufacturing employees in a way 
which allowed continued operation and product development. 

•  Advanced Materials and Chemicals revenue declined $28 million (14%) from 2019 to 2020.  The segment loss improved $11 million 

(32%) from 2019 to 2020 due to price increases on consumer still photographic film and solvents as well as operating cost reductions.  
Kodak plans to continue to promote the use of film to utilize as much film manufacturing capacity as possible.   

Advanced Materials and Chemicals has experienced adverse impacts from the COVID-19 pandemic, most notably in Motion Picture 
where the industry has been heavily impacted and productions in affected regions had been suspended.  None of the Advanced 
Materials and Chemicals segment’s manufacturing facilities were ordered to close by governmental authorities.  However, each of the 
segment’s product lines was impacted by lowered demand and may also be impacted by supply chain disruptions and travel restrictions.  
The duration and extent of demand declines and recovery is unclear.  Manufacturing volumes were reduced due to the customer 
demand decline in the near-term.  Manufacturing employees were temporarily furloughed, as necessary, under reduced production 
plans. 

•  Kodak is working to organically expand its KSM production at Eastman Business Park in Rochester, New York while exploring 

alternatives to obtain necessary cGMP and FDA certification to make regulated KSMs and active pharmaceutical ingredients (“APIs”) 
and otherwise utilize its assets and technology in the healthcare space.  Depending on its assessment of the business opportunity and 
availability of capital, Kodak may also explore alternative means to further expand its chemical manufacturing operations for purposes of 
producing materials to support the healthcare industry.  A portion of the capital raised by the Company on February 26, 2021 is being 
used to fund these exploratory activities and may be used to fund expansion opportunities that the Company considers attractive. 

• 

Film and related component manufacturing operations and Kodak Research Laboratories utilize capacity at Eastman Business Park 
(“EBP”), which helps cost absorption for both Kodak operations and tenants at Eastman Business Park. 

•  Kodak plans to capitalize on its intellectual property through new business or licensing opportunities, focusing on opportunities in smart 

material applications and printed electronics markets and also pursuing limited opportunities in 3D printing materials. 

DETAILED RESULTS OF OPERATIONS 

Net Revenues from Continuing Operations by Reportable Segment 

(in millions) 
Traditional Printing 
Digital Printing 
Advanced Materials and Chemicals 
Brand 

Total of reportable segments 

Other 

Consolidated total 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

592      $ 
241        
172        
13        
1,018        
11        
1,029      $ 

727   
293   
200   
12   
1,232   
10   
1,242   

36 

 
 
 
  
 
 
  
 
  
  
  
  
  
    
  
     
  
       
  
  
     
     
     
     
     
 
Segment Operational EBITDA and Consolidated Loss from Continuing Operations Before Income Taxes 

(in millions) 
Traditional Printing 
Digital Printing 
Advanced Materials and Chemicals 
Brand 
Other 
Depreciation and amortization 
Restructuring costs and other 
Stock-based compensation 
Consulting and other costs (1) 
Idle costs (2) 
Former CEO separation agreement compensation 
Other operating income (expense), net, excluding income 
   from transition services agreement (3) 
Interest expense (4) 
Pension income excluding service cost component (4) 
Loss on early extinguishment of debt 
Other charges, net (4) 
Consolidated loss from continuing operations 
   before income taxes 

Year Ended December 31, 

2020 

2019 

   $ 

21      $ 
(10 )      
(23 )      
11        
1        
(37 )      
(17 )      
(15 )      
(9 )      
(3 )      
—        

7        
(12 )      
98        
(2 )      
(386 )      

   $ 

(376 )    $ 

48   
(9 ) 
(34 ) 
8   
(1 ) 
(55 ) 
(16 ) 
(7 ) 
(7 ) 
(5 ) 
(2 ) 

(22 ) 
(16 ) 
104   
—   
(46 ) 

(60 ) 

(1)  Consulting and other costs are primarily professional services and internal costs associated with certain corporate strategic initiatives and 

investigations, including the divestiture of FPD and debt refinancing in 2019. 

(2)  Consists of third-party costs such as security, maintenance, and utilities required to maintain land and buildings in certain locations not used in 

any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties. 

(3)  $6 million of income from the transition services agreement with the purchaser of FPD (“Purchaser”) was recognized in the each of the years 
ended December 31, 2020 and 2019.  The income was reported in Other operating (income) expense, net in the Consolidated Statement of 
Operations. Other operating (income) expense, net is typically excluded from the segment measure. However, the income from the transition 
services agreement was included in the segment measure. 

(4)  As reported in the Consolidated Statement of Operations. 

Kodak increased employee benefit reserves by approximately $4 million in 2020 reflecting an increase in workers’ compensation reserves ($7 
million) partially offset by a decrease in postemployment benefit reserves ($3 million).  In 2019 workers’ compensation reserves increased by 
approximately $3 million.  The increase in reserves in 2020 impacted gross profit and SG&A each by approximately $2 million. The increase in 
reserves in 2019 impacted gross profit by approximately $2 million and SG&A by approximately $1 million.  

37 

 
 
    
  
  
     
  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
 
 
 
 
 
RESULTS OF OPERATIONS 

Year Ended 
December 31,      % of 
     Sales 

2020 

Year Ended 
December 31,      % of 
     Sales 

2019 

  $ Change vs.   
2019 

Revenues 
Cost of revenues 
Gross profit 

  $ 

Selling, general and administrative expenses 
Research and development costs 
Restructuring costs and other 
Other operating (income) expense, net 
Loss from continuing operations before interest expense, pension 
income excluding service cost component, loss on early 
extinguishment of debt, other charges, net and income taxes 
Interest expense 
Pension income excluding service cost component 
Loss on early extinguishment of debt 
Other charges, net 
Loss from continuing operations before income taxes 
Provision for income taxes 
Loss from continuing operations 
Earnings from discontinued operations, net of income taxes 
NET (LOSS) EARNINGS 

  $ 

1,029         
894         
135       
172       
34       
17       
(14 )     

(74 )     
12       
(98 )     
2       
386       
(376 )     
168       
(544 )     
3       
(541 )     

  $ 

13 %      
17 %      
3 %      
2 %      
-1 %      

(7 %)     
1 %      
(10 %)     
0 %      
38 %      
(37 %)     
16 %      
(53 %)     
0 %      
(53 %)   $ 

1,242         
1,060         
182       
211       
42       
16       
15       

(102 )     
16       
(104 )     
—       
46       
(60 )     
31       
(91 )     
207       
116       

15 %      
17 %      
3 %      
1 %      
1 %      

(8 %)     
1 %      
(8 %)     
—   
4 %      
(5 %)     
2 %      
(7 %)     
17 %      
9 %      

(213 ) 
(166 ) 
(47 ) 
(39 ) 
(8 ) 
1   
(29 ) 

28   
(4 ) 
6   
2   
340   
(316 ) 
137   
(453 ) 
(204 ) 
(657 ) 

Revenues 
For the year ended December 31, 2020, revenues decreased by approximately $213 million compared with the same period in 2019.  Volume 
declines and pricing and product mix within Traditional Printing ($112 million and $16 million, respectively) and volume declines in Digital Printing 
and Advanced Materials and Chemicals ($58 million and $42 million, respectively) drove the revenue declines. The revenue declines were offset by 
improved pricing and product mix in Advanced Materials and Chemicals ($14 million) and favorable mix of products in Digital Printing ($4 million) and 
favorable foreign currency ($9 million). The prior year period also included intellectual property licensing revenue ($13 million) associated with the 
HuaGuang relationship entered into in September 2019. See segment discussions for additional details. 

Gross Profit 
Gross profit for 2020 decreased by approximately $47 million. The decrease reflected volume declines, unfavorable pricing and product mix as well 
as increased costs in Traditional Printing ($13 million, $16 million and $4 million, respectively), volume declines and increased costs in Advanced 
Materials and Chemicals (each $11 million), volume declines and unfavorable costs in Digital Printing ($5 million and $13 million, respectively) 
partially offset by favorable pricing and product mix in Advanced Materials and Chemicals ($14 million), favorable mix of products in Digital Printing 
($4 million) and lower depreciation and amortization expenses ($17 million).  The prior year period also included intellectual property licensing 
revenue ($13 million) associated with the HuaGuang relationship entered into in September 2019.   See segment discussions for additional details. 

Selling, General and Administrative Expenses 
Consolidated SG&A for 2020 decreased $39 million primarily due to lower investment in selling and marketing activities driven by cost reduction 
efforts ($48 million).  The temporary furloughs and pay cuts provided approximately $7 million of the $48 million reduction in 2020.  Temporary 
government assistance programs provided approximately $3 million. Additional savings were provided by headcount reductions. The savings 
provided by the lower investment in selling and marketing activities was partially offset by increased stock compensation expense ($10 million) as 
discussed in Note 23, Stock-Based Compensation and an increase of $2 million in consulting and project costs with the internal and external 
investigations that started in the third quarter of 2020.  The 2019 period also included $2 million of compensation related to the former CEO 
separation agreement while the 2020 period included increased bad debt expense primarily attributed to increased collection risk related to the 
COVID-19 pandemic ($3 million). 

Research and Development Costs 
Consolidated R&D expenses decreased $8 million in 2020 primarily due primarily due to cost reduction efforts.   

Restructuring Costs and Other 
These costs, as well as the restructuring costs reported in Cost of revenues, are discussed under the "Restructuring Costs and Other" section in this 
MD&A. 

38 

 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
    
  
    
  
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
 
 
 
Other Operating (Income) Expense, Net 
For details, refer to Note 16, “Other Operating (Income) Expense, Net.” 

Other Charges, Net 
The change in Other charges, net was primarily driven by the embedded conversion features derivative liability associated with the Convertible 
Notes.  Refer to Note 14, “Financial Instruments” and Note 17, “Other Charges, Net”. 

Pension Income 
For details, refer to Note 20, “Retirement Plans.” 

Provision for Income Taxes  
The Provision for income taxes in the year-to-date period was primarily driven by the $167 million provision associated with the establishment of a 
valuation allowance on deferred tax assets outside the U.S.  Refer to Note 18, “Income Taxes”. 

Discontinued Operations 
Discontinued operations of Kodak include the Flexographic Packaging segment.  Refer to Note 29, “Discontinued Operations” in the Notes to 
Financial Statements for additional information. 

TRADITIONAL PRINTING SEGMENT 

Revenues 

Revenues 

Operational EBITDA 
Operational EBITDA as a % of revenues 

Year Ended December 31, 
2019 

2020 

$ Change 

   $ 

592       $ 

727       $ 

(135 ) 

21         
4 %      

48         
7 %        

(27 ) 

Revenues 
The decrease in Traditional Printing revenues of approximately $135 million primarily reflected volume and pricing declines ($97 million and $16 
million, respectively) in Prepress Solutions consumables and volume declines in Prepress Solutions service ($6 million) and equipment ($10 million) 
offset by favorable pricing and product mix ($2 million) in Prepress equipment and favorable foreign currency ($6 million).  In addition, the prior year 
period included $13 million of intellectual property licensing revenue associated with the HuaGuang relationship.  The volume declines were primarily 
driven by COVID-19 pandemic related declines in customer demand. 

Operational EBITDA 
Traditional Printing Operational EBITDA declined approximately $27 million primarily due to volume and pricing declines ($11 million and $16 million, 
respectively) in Prepress Solutions consumables, volume declines in Prepress service ($3 million) and higher manufacturing costs driven by 
unfavorable cost absorption from the volume declines ($10 million) partially offset by lower SG&A expenses ($22 million) driven by headcount 
reductions, temporary furloughs and pay cuts as well as lower aluminum costs in the current year ($8 million).  In addition, the prior year period 
included $13 million of intellectual property licensing revenue associated with the HuaGuang relationship and $2 million of cost reductions due to 
retroactive exemptions from U.S. tariffs imposed on aluminum purchases in 2018.  The U.S tariffs were imposed on aluminum purchases in 2018 
and were included as part of the cost of plates sold in 2018. 

DIGITAL PRINTING SEGMENT 

Year Ended December 31, 
2019 

2020 

$ Change 

Revenues 

   $ 

241       $ 

293       $ 

Operational EBITDA 
Operational EBITDA as a % of revenues 

(10 )       
-4 %      

(9 )       
-3 %        

(52 ) 

(1 ) 

Revenues 
The decrease in Digital Printing revenues of approximately $52 million primarily reflected volume declines in Electrophotographic Printing Solutions 
consumables and service ($27 million), Electrophotographic Printing Solutions equipment ($14 million), PROSPER consumables and service ($5 

39 

 
 
 
 
 
 
 
 
  
  
  
  
  
     
     
  
  
       
          
          
  
     
     
  
 
 
 
 
  
  
  
  
  
     
     
  
  
       
          
          
  
     
     
  
million), PROSPER systems ($3 million) and Software ($4 million) as well as product mix in PROSPER systems ($3 million), all of which were driven 
by the decline in customer demand due to the COVID-19 pandemic. 
There were also volume declines in VERSAMARK service and consumables ($10 million) due to both declines in the installed base of VERSAMARK 
systems and the COVID 19 pandemic.  The declines were partially offset by improved volume and favorable product mix in PROSPER components 
($5 million and $3 million, respectively) and favorable product mix in Electrophotographic Printing Solutions equipment ($2 million) and well as 
favorable foreign currency ($2 million). 

Operational EBITDA 
The decrease in Digital Printing Operational EBITDA of $1 million was driven by higher manufacturing costs in Electrophotographic Printing Solutions 
($14 million), primarily due to unfavorable cost absorption from the volume declines in Electrophotographic Printing Solutions consumables and 
service ($4 million).  There were also volume declines in Software ($4 million), VERSAMARK service and consumables ($3 million) and PROSPER 
consumables and service ($2 million) partially offset by improved volume and favorable product mix in PROSPER components ($3 million and $2 
million, respectively), volume changes in Electrophotographic Printing Solutions equipment ($3 million), favorable costs in Software ($3 million), 
favorable product mix in VERSAMARK equipment ($2 million) and lower SG&A costs ($11 million) driven by headcount reductions, temporary 
furloughs and pay cuts. 

ADVANCED MATERIALS AND CHEMICALS SEGMENT 

Year Ended December 31, 
2019 

2020 

$ Change 

Revenues 

   $ 

172       $ 

200       $ 

Operational EBITDA 
Operational EBITDA as a % of revenues 

(23 )       
-13 %      

(34 )       
-17 %        

(28 ) 

11   

Revenues 
The decrease in Advanced Materials and Chemicals revenues of approximately $28 million is the result of volume declines in Motion Picture ($16 
million) driven by productions halted as a result of the pandemic, Industrial Film and Chemicals ($11 million) primarily due to the COVID-19 
pandemic’s impacts on its customers, and Consumer Inkjet Solutions ($7 million) driven by lower sales of ink to the existing installed base of printers.  
Additionally, current year revenues for KSB declined ($5 million) primarily due to operations in Asia being impacted by the COVID-19 pandemic, and 
the prior year period included revenues from Kodakit ($4 million) which ceased operations in January 2020.  Partially offsetting these impacts was 
improved pricing in Industrial Film and Chemicals ($13 million) driven by higher pricing in professional and consumer still photographic film and 
solvents.  

Operational EBITDA 
Advanced Materials and Chemicals Operational EBITDA improved approximately 11 million primarily due to favorable pricing ($13 million) in 
Industrial Film and Chemicals.  Also contributing to the improvement were lower selling and administrative expenses ($14 million) driven by 
headcount reductions, temporary furloughs and pay cuts as well as lower R&D costs ($5 million).  Partially offsetting were volume declines in Motion 
Picture ($5 million) and Consumer Inkjet Solutions ($4 million) as well as unfavorable cost impacts in Industrial Film and Chemicals ($8 million) and 
Motion Picture ($3 million) driven by unfavorable cost absorption. 

RESTRUCTURING COSTS AND OTHER 

2020 

Restructuring actions taken in 2020 were initiated to reduce Kodak’s cost structure as part of its commitment to drive sustainable profitability and 
included various targeted reductions in manufacturing, service, sales and other administrative functions. 

As a result of these actions, for the year ended December 31, 2020 Kodak recorded $17 million of charges which were reported as Restructuring 
costs and other in the accompanying Consolidated Statement of Operations. 

Kodak made cash payments related to restructuring of approximately $15 million for the year ended December 31, 2020. 

The restructuring actions implemented in 2020 are expected to generate future annual cash savings of approximately $24 million. These savings are 
expected to reduce future annual Cost of revenues and SG&A expenses by $9 million and $15 million, respectively.  Kodak expects the majority of 
the annual savings to be in effect by the end of 2021 as actions are completed. 

2019 

For the year ended December 31, 2019 Kodak recorded $16 million of charges which were reported as Restructuring costs and other in the 
accompanying Consolidated Statement of Operations. 

40 

 
 
 
 
  
  
  
  
  
     
     
  
  
       
          
          
  
     
     
  
 
 
LIQUIDITY AND CAPITAL RESOURCES 

Kodak’s products are sold and serviced in numerous countries across the globe with more than half of sales generated outside the U.S.  Current 
global economic conditions are highly volatile due to the COVID-19 pandemic.  The conversion of accounts receivable to cash is taking longer and 
collection risk has increased since before the pandemic.  The economic uncertainty surrounding the COVID-19 pandemic is an additional complexity 
in Kodak’s plans to return to sustainable positive cash flow.  To mitigate the economic impacts of the pandemic Kodak employed temporary 
furloughs and pay reductions and adjusted manufacturing volumes to meet changing expectations around production requirements. 
The Company is also seeking to take advantage of any available government incentives around the world in response to the COVID-19 pandemic 
such as employee related tax deferrals or holidays, wage subsidies and loan programs including those under the U.S. CARES Act, although the 
Company has not yet been able to take advantage of any loan programs and may not qualify for any loans under the programs created under the 
U.S. CARES Act.  Many of the available government incentives for which the Company qualifies are in the form of deferrals of payments that will be 
required to be paid in the future.  

(in millions) 
Cash, cash equivalents and restricted cash 

As of December 31, 
2019 
2020 

   $ 

256      $ 

290   

Cash Flow Activity 

(in millions) 
Cash flows from operating activities: 
Net cash (used in) provided by in operating activities 
Cash flows from investing activities: 
Net cash (used in) provided by investing activities 
Cash flows from financing activities: 
Net cash provided by (used in) financing activities 
Effect of exchange rate changes on cash and restricted cash 
Net (decrease) increase in cash, cash equivalents, restricted cash 
and cash in assets held for sale 

Year Ended December 31, 

2020 

2019 

Year-Over-Year 
Change 

   $ 

(35 )   $ 

12      $ 

(47 ) 

(13 )     

311        

(324 ) 

10       
4       

(298 )      
(2 )      

   $ 

(34 )   $ 

23      $ 

308   
6   

(57 ) 

Operating Activities 
Net cash (used in) provided by operating activities declined $47 million for the year ended December 31, 2020 as compared with the prior year 
primarily due to increased cash use for accounts payable and other liabilities, including the payment of $6 million of interest upon the conversion of 
the Convertible Notes, partially offset by higher reductions of accounts receivable in 2020 and lower cash operating losses.  Additionally, cash used 
in operations in 2019 benefitted from the allocation of $10 million of the proceeds from the divestiture of FPD as consideration for a brand license, 
the allocation of $13 million of the proceeds from entering the relationship with HuaGuang as consideration for an intellectual property license receipt 
and the receipt of a $15 million prepayment for transition services, products, and other services as a part of the divestiture of FPD. 

Investing Activities 
Net cash (used in) provided by investing activities decreased $324 million for the year ended December 31, 2020 as compared to the prior year due 
to proceeds from the sale of FPD in the prior year.  

Financing Activities 
Net cash provided by (used in) financing activities improved $308 million in the year ended December 31, 2020 as compared to the prior year driven 
by the current year proceeds received from option exercises, the prior year repayment of the Company’s term credit agreement and the prior year 
payment of contingent consideration partially offset by the issuance of the Convertible Notes and the proceeds from the RED – Rochester borrowing 
and the current year payment of preferred stock dividends. 

Sources of Liquidity 
Available liquidity includes cash balances and the unused portion of the ABL Credit Agreement.  The amount of available liquidity is subject to 
fluctuations and includes cash balances held by various entities worldwide.  At December 31, 2020 and 2019, approximately $99 million and $72 
million, respectively, of cash and cash equivalents were held within the U.S. and approximately $97 million and $161 million, respectively, of cash 
and cash equivalents were held outside the U.S. 

41 

 
 
 
 
 
 
  
  
  
  
     
  
 
  
  
       
  
  
  
     
    
  
       
        
         
  
       
        
         
  
     
       
        
         
  
     
     
 
 
Cash balances held outside of the U.S. are generally required to support local country operations, may have high tax costs or other limitations that 
delay the ability to repatriate, and therefore may not be readily available for transfer to other jurisdictions.  Kodak utilizes cash balances outside the 
U.S. to fund needs in the U.S. through the use of intercompany loans.  As of December 31, 2020 and 2019 outstanding intercompany loans to the 
U.S. were $449 million and $408 million, respectively, which includes short-term intercompany loans from Kodak’s international finance center of 
$150 million and $110 million.   
In China, where approximately $34 million and $89 million, respectively, of cash and cash equivalents were held as of December 31, 2020 and 2019, 
there are limitations related to net asset balances that impact the ability to make cash available to other jurisdictions in the world.  On May 12, 2020, 
a Chinese subsidiary of Kodak transferred approximately $70 million to a U.S. subsidiary of Kodak in an inter-company transaction. 

ABL Credit Agreement 
On January 27, 2020 Kodak exercised its right under the Amended and Restated Credit Agreement (the “ABL Credit Agreement”) to permanently 
reduce lender commitments, reducing the commitments from $150 million to $120 million.  As a result, the minimum Excess Availability decreased to 
$15 million from the previous minimum of $18.75 million.  (Refer to the Amended and Restated Credit Agreement section of Note 9, “Debt and 
Finance Leases”, for the definition of Excess Availability). 

On March 27, 2020, the Company and the subsidiaries of the Company that are guarantors (the “Subsidiary Guarantors”) entered into Amendment 
No. 3 to the ABL Credit Agreement (the “Amendment”) with the Lenders and Bank of America, N.A., as administrative and collateral agent.  The 
Amendment decreased the available asset-based revolving loans (the “ABL Loans”) and letters of credit from an aggregate amount of up to $120 
million to $110 million, subject to the Borrowing Base.  

As a result of the additional reduction in lender commitments, the minimum Excess Availability decreased to $13.75 million from the previous amount 
of $15 million. 

The changes provided by the Amendment to the Excess Availability and Equipment Availability combined with increases in Eligible Receivables and 
Eligible Inventory allowed the Company to decrease Eligible Cash by $13 million at the time of the Amendment without causing Excess Availability to 
fall below the minimum required. 

The Amendment also changed Equipment Availability from (i) the lesser of 75% of Net Orderly Liquidation Value of Eligible Equipment or $6 million 
to (ii) the lesser of 70% of Net Orderly Liquidation Value of Eligible Equipment or $14.75 million as of March 31, 2020.  The Equipment Availability 
was $14.75 million for September 30, 2020.  The $14.75 million amount decreases by $1 million per quarter starting on July 1, 2020 until maturity or 
the amount is decreased to $0, whichever comes first. 

The Company had issued approximately $90 million and $80 million of letters of credit under the ABL Credit Agreement as of December 31, 2020 
and 2019, respectively.  Under the ABL Credit Agreement the Company is required to maintain Excess Availability above 12.5% of lender 
commitments ($13.75 million at December 31, 2020).  If Excess Availability is below 12.5% of lender commitments the Company has the ability to 
fund amounts into the Eligible Cash account which will increase Excess Availability for purposes of the previous month-end compliance reporting.  
The Company had approximately $20 million of Excess Availability under the ABL Credit Agreement for the December 31, 2020 compliance 
reporting and $22 million of Excess Availability under the ABL Credit Agreement as of December 31, 2019.  To maintain Excess Availability of 
greater than 12.5% of lender commitments ($13.75 million and $18.75 million as of December 31, 2020 and 2019, respectively), Kodak funded $35 
million and $22 million to the Eligible Cash account held with the ABL Credit Agreement Administrative Agent as of December 31, 2020 and 2019, 
respectively, which is classified as Restricted Cash in the Consolidated Statement of Financial Position.   

Under the ABL Credit Agreement, if Excess Availability falls below 12.5% of lender commitments, Kodak may, in addition to the requirement to be in 
compliance with a minimum Fixed Charge Coverage Ratio, become subject to cash dominion control.  Kodak intends to continue to maintain Excess 
Availability above the minimum threshold which may require additional funding of Eligible Cash.  In addition to Eligible Cash, the borrowing base is 
supported by Eligible Receivables, Eligible Inventory and Eligible Equipment.  To the extent the assets supporting the borrowing base decline, if the 
remaining assets included in the borrowing base are not sufficient to support the required Excess Availability amount, additional funding of Eligible 
Cash may be required.  Since Excess Availability was greater than 12.5% of lender commitments Kodak is not required to have a minimum Fixed 
Charge Coverage Ratio of 1.0 to 1.0.  As of December 31, 2020 Fixed Charges (as defined in the ABL Credit Agreement) exceeded EBITDA by 
approximately $37 million, therefore the Fixed Charges Coverage Ratio was less than 1.0 to 1.0.  See “February 26, 2021 Financing Transactions” 
below for a summary of subsequent amendments to the ABL Credit Agreement. 

Other Collateral Requirements 
The New York State Workers’ Compensation Board (“NYSWCB”) requires security deposits related to self-insured workers’ compensation 
obligations.  The security deposit required by NYSWCB is based on actuarial calculations of the Company’s obligations and company specific factors 
such as its declining workforce and reducing exposure.  The NYSWCB calculation also includes a financial contingency based on the employer’s 
credit rating and a calculation of unallocated loss adjustment expenses.  In 2020 the NYSWCB waived these charges to provide employers some 
relief while they endure the economic impacts of COVID.  The waived security deposits amounted to $16.7 million in 2020.  The increase to the 

42 

 
 
 
 
 
 
 
 
 
security deposit required by NYSWCB in 2020, not including the waived amounts, was $14.9 million.  The Company has agreed to post additional 
collateral of approximately $3 million for each of the next five years to satisfy the current security deposit obligation. 
The collateral obligation can be satisfied by issuing letters of credit or through other means.  The amount of security deposit required by NYSWCB 
will be re-calculated annually.  Therefore, the amount of additional collateral required may change each year. 

As a result of the Company’s current credit ratings, during the second quarter of 2020 two surety bond holders notified the Company they required 
approximately $9 million of incremental collateral. 
The Company reduced the surety bond value by approximately $9 million in July 2020 with an equivalent increase to an existing letter of credit with 
the New York Workers’ Compensation board.  The Company could be required to provide up to $3 million of letters of credit to the issuers of certain 
surety bonds in the future to fully collateralize the bonds. 

On September 1, 2019 Kodak established a strategic relationship with HuaGuang in the People’s Republic of China.  The relationship is comprised 
of an agreement under which Kodak sold its shares of the Kodak (China) Graphic Communication Co. Ltd. entity which included the offset printing 
plates facility in Xiamen, China, and related assets and liabilities, to HuaGuang, a supply agreement for HuaGuang to help Kodak fulfill customer 
demand and a license agreement under which Kodak licensed its plates technology, including its Sonora Process Free plates technology, to 
HuaGuang with the intent of expanding the plates market in China.  Upon the establishment of the relationship, Kodak received net cash proceeds of 
$30 million, of which $13 million was received in the United States.  As part of the arrangement, Kodak established an escrow of $14 million in China 
to secure minimum payments required under the supply agreement. 

February 26, 2021 Financing Transactions 
On February 26, 2021 the Company entered into a five-year Term Credit Agreement (the “Term Loan Credit Agreement”), a Series C Preferred 
Stock Purchase Agreement (the “Purchase Agreement”), a Securities Purchase Agreement (the “Securities Purchase Agreement”), and a Series A 
Preferred Stock Repurchase and Exchange Agreement (the “Repurchase and Exchange Agreement”).  

The Term Loan Credit Agreement provides for an initial term loan in the amount of $225 million and a commitment to provide delayed draw term 
loans in an aggregate principal amount of up to $50 million on or before February 26, 2023.  The term loan bears interest at a rate of 8.5% per 
annum payable in cash and 4.0% per annum payable “in-kind” or in cash at the Company’s option, for an aggregate interest rate of 12.5% per 
annum.  The Purchase Agreement provides for the sale of a total of $100 million of Series C Preferred Stock, with an initial sale of $75 million of 
Series C Preferred Stock and an additional $25 million of this series of preferred stock subject to Hart-Scott-Rodino Antitrust Improvements Act 
clearance. The Series C Preferred Stock provides for cumulative dividends payable quarterly “in-kind” in the form of additional shares of Series C 
Preferred Stock at a rate of 5.0% per annum.  The Securities Purchase Agreement provides for the issuance of an aggregate of one million shares of 
common stock for a purchase price of $10.00 in cash per share for an aggregate purchase price of $10 million and $25 million aggregate principal 
amount of the Company’s newly issued 5.0% unsecured convertible promissory notes due May 28, 2026 to the lenders under the Term Loan Credit 
Agreement.  The convertible notes bear interest at a rate of 5.0% per annum, which will be payable in cash on the maturity date and in additional 
shares of Common Stock on any conversion date.  With the proceeds from these transactions, the Company repurchased one million shares of the 
Series A Preferred Stock under the terms of the Repurchase and Exchange Agreement for $100 million plus accrued and unpaid dividends.  In 
addition, Kodak has issued one million shares of Series B Preferred Stock in exchange for the remaining Series A Preferred Stock.  The Series B 
Preferred Stock provides for cumulative dividends payable quarterly in cash at a rate of 4.0% per annum.  The Company received net proceeds of 
approximately $235 million on February 26, 2021, before fees of approximately $10 million, as a result of these transactions. 

On February 26, 2021 the Company also entered into a cash collateralized Letter of Credit Facility Agreement for up to $50 million and amended its 
ABL Credit Agreement to decrease the commitments from $110 million to $90 million and to extend the maturity date to February 26, 2024, or the 
date that is 90 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s outstanding term loan, 
convertible notes, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock or any refinancing of any of the foregoing.  Pursuant to 
the Letter of Credit Facility Agreement, the Letter of Credit Lenders committed to issue letters of credit on the Company’s behalf in an aggregate 
amount of up to $50 million, provided that the Company posts cash collateral in an amount greater than or equal to 103% of the aggregate amount of 
letters of credit issued and outstanding at any given time (the “L/C Cash Collateral”). The term of the Letter of Credit Facility Agreement is three 
years, subject to the same automatic springing maturity as the Amended ABL Credit Agreement. The balance on deposit as of February 26, 2021 in 
the L/C Cash Collateral account was approximately $49 million, of which approximately $14 million was deposited into the L/C Cash Collateral 
account from proceeds of the financing transactions described herein and the remainder of which was cash collateral previously used to secure 
letters of credit under the ABL Credit Agreement. The amendment to the ABL Credit Agreement also removed Eligible Cash from the Borrowing 
Base.  Therefore, amounts funded into the Eligible Cash account will no longer increase Excess Availability for purposes of the month-end 
compliance reporting.  The ABL Amendment also adds a requirement, tested quarterly, that the Company maintain Minimum Liquidity (as defined in 
the Amended ABL Credit Agreement) of at least $80 million, and a corresponding requirement is contained in the Letter of Credit Facility Agreement. 

Other Sources/Uses of Cash Related to Financing Transactions 
The holders of Series A Preferred Stock are entitled to cumulative dividends payable quarterly in cash at a rate of 5.5% per annum.  Until the third 
quarter of 2018 all dividends owed on the Series A Preferred Stock were declared and paid when due.  No quarterly dividend was declared in the 
third or fourth quarters of 2018 or the first and second quarters of 2019.  The Company declared quarterly cash dividends in the third and fourth 

43 

 
 
 
 
 
 
  
quarters of 2019 and each quarter of 2020 that were paid when due.  In July 2020, the Company declared and paid the four quarterly dividends that 
were in arrears in the aggregate amount of $11 million.  Due to exercises of stock options primarily by ex-employees, the Company received 
approximately $33 million, net of tax payments, in 2020. 

Defined Benefit Pension and Postretirement Plans 
Kodak made contributions (funded plans) or paid net benefits (unfunded plans) totaling approximately $17 million relating to its defined benefit 
pension and postretirement benefit plans in 2020.  For 2021, the forecasted contribution (funded plans) and net benefit payment (unfunded plans) 
requirements for its defined benefit pension and postretirement plans are approximately $17 million. 

Capital Expenditures 
Cash flows from investing activities included $17 million for capital expenditures for the year ended December 31, 2020.  Kodak expects 
approximately $15 million to $25 million of cash flows for investing activities from capital expenditures for the year ending December 31, 2021, before 
consideration of any investment Kodak may make utilizing proceeds from the February 26, 2021 financing transactions.  Kodak plans to invest some 
of the proceeds from those financing transactions in growth opportunities in Kodak’s core businesses of print, advanced materials and chemicals as 
well as corporate infrastructure investments expected to contribute to improvements in cash flow.   

U.S. International Development Finance Corporation Non-Binding Letter of Interest 
On July 28, 2020 the U.S. International Development Finance Corporation signed a non-binding letter of interest to provide a subsidiary of the 
Company with a potential $765 million loan to support the launch of Kodak Pharmaceuticals, an initiative that would manufacture pharmaceutical 
ingredients for essential generic drugs.  The DFC Loan would be for facility upgrades and construction, provide working capital, and finance other 
necessary direct expenditures supporting the launch of Kodak Pharmaceuticals.  The signing of the letter of interest indicated Kodak’s successful 
completion of the DFC’s initial screening, which would be followed by standard due diligence conducted by the DFC before financing would be 
formally committed.  The application process for the DFC Loan was put on hold when investigations were commenced with respect to the 
circumstances surrounding the DFC Announcement.  While the letter of interest with the DFC has never been formally terminated and the Company 
has not received any communication from the DFC rejecting its application, given the time that has elapsed and the recent changes in administration 
at the federal government and the DFC the Company is operating on the basis that the DFC Loan as envisioned at the time of the DFC 
Announcement will not proceed.  The Company remains interested in working with the DFC and other governmental agencies to leverage its assets 
and technology to on-shore manufacturing of pharmaceutical and other healthcare materials.  As described under “Overview” above, the Company is 
also continuing to explore expanding further into the pharmaceutical space on a smaller scale than contemplated by the DFC Loan using other 
sources of capital, including a portion of the capital raised by the Company on February 26, 2021. 

Off-Balance Sheet Arrangements 

In connection with the settlement of certain of the Company’s historical environmental liabilities at EBP and in accordance with the terms of the 
associated settlement agreement (“Amended EBP Settlement Agreement”), in the event the historical EBP liabilities exceed $99 million, the 
Company will become liable for 50% of the portion above $99 million with no limitation to the maximum potential future payments.  There is no 
liability recorded related to this guarantee. 

Kodak issues indemnifications in certain instances when it sells businesses and real estate, and in the ordinary course of business with its 
customers, suppliers, service providers and business partners.   

Further, the Company indemnifies its directors and officers who are, or were, serving at the Company's request in such capacities.  Historically, costs 
incurred to settle claims related to these indemnifications have not been material to Kodak’s financial position, results of operations or cash flows.  
Additionally, the fair value of the indemnifications that Kodak issued during the year ended December 31, 2020 was not material to Kodak’s financial 
position, results of operations or cash flows. 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 

Kodak is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this item. 

44 

 
 
 
 
 
 
 
 
 
 
ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 

Report of Independent Registered Public Accounting Firm 

To the Shareholders and the Board of Directors of Eastman Kodak Company 

Opinion on the Financial Statements 

We have audited the accompanying consolidated statement of financial position of Eastman Kodak Company (the Company) as of December 31, 
2020, the related consolidated statements of operations, comprehensive (loss) income, equity (deficit) and cash flow for the year ended December 
31,  2020,  and  the  related  notes  and  schedule  for  the  year  ended  December  31,  2020  appearing  in  Item  15  (collectively  referred  to  as  the 
“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position 
of the Company at December 31, 2020, and the results of its operations and its cash flows for the year ended December 31, 2020, in conformity with 
U.S. generally accepted accounting principles. 

Basis for Opinion 

These  financial  statements  are  the  responsibility  of  the  Company's  management.  Our  responsibility  is  to  express  an  opinion  on  the  Company’s 
financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United 
States)  (PCAOB)  and  are  required  to  be  independent  with  respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the 
applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. 

We  conducted  our  audit  in  accordance  with  the  standards  of  the PCAOB.  Those  standards  require  that  we  plan  and  perform  the audit  to  obtain 
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not 
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to 
obtain  an  understanding  of  internal  control  over  financial  reporting  but  not  for  the  purpose  of  expressing  an  opinion  on  the  effectiveness  of  the 
Company's internal control over financial reporting. Accordingly, we express no such opinion. 

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and 
performing  procedures  that  respond  to  those  risks.  Such  procedures  included  examining,  on  a  test  basis,  evidence  regarding  the  amounts  and 
disclosures  in  the  financial  statements.  Our  audit  also  included  evaluating  the  accounting  principles  used  and  significant  estimates  made  by 
management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our 
opinion. 

Critical Audit Matters 

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated 
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements 
and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way 
our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing 
separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. 

Income Taxes Valuation Allowance 

Description of the 
Matter 

As  discussed  in  Note  18  to  the  consolidated  financial  statements,  as  of  March  31,  2020  the  Company  recorded  a 
provision  of  $167  million  associated  with  the  establishment  of  a  valuation  allowance  for  deferred  taxes  at  locations 
outside  the  U.S.  and,  at  December  31,  2020,  the  Company  had  deferred  tax  assets  related  to  deductible  temporary 
differences  and  carryforwards  of  $1,113  million  and  a  $1,112  million  valuation  allowance.  The  Company  records  a 
valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. 

Management’s analysis of the realizability of its deferred tax assets was significant to our audit because the amounts and 
disclosures are material to the consolidated financial statements and involved complex audit judgment. 

45 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How We Addressed 
the Matter in Our Audit 

As  part  of  our  audit  procedures  over  the  valuation  allowance,  we  evaluated  the  Company’s  assessment  of  the 
realizability of deferred tax assets, including management’s evaluation of the sources of taxable income considered in 
determining  whether  a  valuation  allowance  is  required  and  management’s  assessment  of  all  available  evidence,  both 
positive and negative, to determine the amount of the valuation allowance. We involved our tax professionals to evaluate 
the  application  of  tax  law  in  the  Company’s  assessment  and  the  resultant  valuation  allowance.  We  also  tested  the 
Company’s scheduling of the timing and amount of reversal of taxable temporary differences.  

  Accounting for Conversion of Convertible Notes 

Description of the 
Matter 

How We Addressed 
the Matter in Our Audit 

As discussed in Notes 9 and 14 of the consolidated financial statements, on May 24, 2019 the Company issued in the 
aggregate  $100  million  in  5%  Secured  Convertible  Notes  due  2021  (the  “Convertible  Notes”).  The  Convertible  Notes 
contained conversion features and a term extension option that were not considered clearly and closely related to the 
Convertible  Notes.  Accordingly,  these  embedded  features  were  bifurcated  from  the  Convertible  Notes  and  separately 
accounted  for  on  a  combined  basis  at  fair  value  as  a  single  derivative  liability.  All  of  the  Convertible  Notes  were 
converted  to  shares  of  the  Company’s  common  stock  in  two  separate  conversion  transactions  with  effective  dates  of 
August 3, 2020 and September 30, 2020.  The embedded conversion features and term extension option were revalued 
as of the effective dates of the conversion transactions and resulted in the recognition of an aggregate of $416 million in 
net  expense  recorded  within  Other  charges,  net,  in  the  Consolidated  Statement  of  Operations  for  the  year  ended 
December 31, 2020. 

Auditing management’s evaluation of the transactions was especially challenging due to the complexity in assessing the 
key  inputs  used  in  the  valuation  of  the  bifurcated  embedded  features  as  of  the  effective  dates  of  the  conversion 
transactions. Additionally, the fair value of the embedded derivative was sensitive to changes in these key inputs which 
required judgement in evaluating their reasonableness.  

To test the accounting for the conversion transactions, our audit procedures included, among others, inspection of the 
contract, the conversion notices received from the Convertible Note holders, and testing completeness and accuracy of 
the data used as well as management’s application of the relevant accounting guidance. We also involved our valuation 
specialists to evaluate the Company’s determination of the fair value of the Convertible Notes inclusive of the embedded 
features,  including  testing  the  appropriateness  of  the  methodology  and  underlying  inputs  used  and  assessing  the 
reasonableness of those inputs. We also evaluated the Company’s presentation of the net expense recognized on the 
conversion transactions in its Consolidated Statement of Operations and the Company’s disclosures included in Notes 9 
and 14 related to the fair value of the embedded features.    

/s/ Ernst & Young LLP 

We have served as the Company’s auditor since 2020. 

Rochester, New York 
March 16, 2021 

46 

 
 
 
 
 
 
 
Report of Independent Registered Public Accounting Firm 

To the Board of Directors and Shareholders of Eastman Kodak Company  

Opinion on the Financial Statements  

Report of Independent Registered Public Accounting Firm 

To the Board of Directors and Shareholders of Eastman Kodak Company  

Opinion on the Financial Statements  

We have audited the consolidated statement of financial position of Eastman Kodak Company and its subsidiaries (the “Company”) as of December 
31, 2019, and the related consolidated statements of operations, comprehensive (loss) income, equity (deficit) and cash flow for the year ended 
December 31, 2019, including the related notes and schedule of valuation and qualifying accounts for the year ended December 31, 2019 appearing 
under Item 15(1) (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present 
fairly, in all material respects, the financial position of the Company as of December 31, 2019, and the results of its operations and its cash flows for 
the year ended December 31, 2019 in conformity with accounting principles generally accepted in the United States of America.     

Substantial Doubt About the Company’s Ability to Continue as a Going Concern 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.  As 
discussed in Note 1 (not presented herein) to the consolidated financial statements, the Company has limitations on its ability to repatriate cash held 
outside the U.S. to other jurisdictions, experienced recent operating losses and negative cash flow from operations, redemption dates in 2021 for 
debt and preferred stock and significant cash requirements to fund ongoing operations and other obligations that raise substantial doubt about its 
ability to continue as a going concern.  Management’s plans in regard to these matters are also described in Note 1 (not presented herein).  The 
consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. 

Change in Accounting Principle 

As discussed in Note 1 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019. 

Basis for Opinion  

These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the 
Company’s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting 
Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal 
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.   

We conducted our audit of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we 
plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, 
whether due to error or fraud.  

Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error 
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the 
amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant 
estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit 
provides a reasonable basis for our opinion.  

/s/ PricewaterhouseCoopers LLP 
Rochester, New York 
March 17, 2020, except for the change in composition of reportable segments discussed in Note 27 to the consolidated financial statements, as to 
which the date is March 16, 2021 

We served as the Company's auditor from at least 1924 to 2020.  We have not been able to determine the specific year we began serving as auditor 
of the Company. 

47 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF OPERATIONS 

(in millions, except per share data) 

Revenues 
Sales 
Services 
Total net revenues 
Cost of revenues 

Sales 
Services 

Total cost of revenues 

Gross profit 

Selling, general and administrative expenses 
Research and development costs 
Restructuring costs and other 
Other operating (income) expense, net 
Loss from continuing operations before interest expense, pension income excluding service cost 
component, loss on early extinguishment of debt, other charges, net and income taxes 
Interest expense 
Pension income excluding service cost component 
Loss on early extinguishment of debt 
Other charges, net 
Loss from continuing operations before income taxes 
Provision for income taxes 
Loss from continuing operations 
Earnings from discontinued operations, net of income taxes 
NET (LOSS) EARNINGS 

Basic and diluted (loss) earnings per share attributable to 
   Eastman Kodak Company common shareholders: 

Continuing operations 
Discontinued operations 
Total 

Number of common shares used in basic and diluted (loss) earnings per share 

The accompanying notes are an integral part of these consolidated financial statements. 

   $ 

   $ 

   $ 

   $ 

Year Ended December 31, 
2019 
2020 

806      $ 
223        
1,029        

743        
151        
894        
135        
172        
34        
17        
(14 )      

(74 )      
12        
(98 )      
2        
386        
(376 )      
168        
(544 )      
3        
(541 )    $ 

(9.83 )    $ 
0.06        
(9.77 )    $ 

57.4        

979   
263   
1,242   

877   
183   
1,060   
182   
211   
42   
16   
15   

(102 ) 
16   
(104 ) 
—   
46   
(60 ) 
31   
(91 ) 
207   
116   

(2.58 ) 
4.81   
2.23   

43.0   

48 

 
 
  
  
  
  
  
     
  
       
         
  
     
     
       
         
  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
  
       
         
  
  
    
  
  
    
  
     
  
       
         
  
     
 
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF COMPREHENSIVE (LOSS) INCOME 

(in millions) 

NET (LOSS) EARNINGS 

Year Ended December 31, 

2020 

2019 

   $ 

(541 )    $ 

Other comprehensive loss, net: 
Currency translation adjustments and other 
Pension and other postretirement benefit plan obligation activity, net of tax 
Other comprehensive loss, net attributable to Eastman Kodak Company 
COMPREHENSIVE (LOSS) INCOME, NET 

(16 )   
(13 )   
(29 )   
(570 )    $ 

   $ 

The accompanying notes are an integral part of these consolidated financial statements. 

116   

6   
(12 ) 
(6 ) 
110   

49 

 
 
  
  
  
  
  
     
  
  
  
    
    
    
  
  
    
    
    
  
  
  
  
  
  
  
  
  
  
 
 
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF FINANCIAL POSITION 

(in millions) 

ASSETS 
Cash and cash equivalents 
Trade receivables, net of allowances of $10 and $8 
Inventories, net 
Restricted cash - current portion 
Other current assets 
Current assets held for sale 
Total current assets 

Property, plant and equipment, net 
Goodwill 
Intangible assets, net 
Operating lease right-of-use assets 
Restricted cash 
Deferred income taxes 
Other long-term assets 
TOTAL ASSETS 

LIABILITIES, REDEEMABLE, CONVERTIBLE PREFERRED STOCK AND EQUITY 
Accounts payable, trade 
Short-term borrowings and current portion of long-term debt 
Current portion of operating leases 
Other current liabilities 

Total current liabilities 

Long-term debt, net of current portion 
Pension and other postretirement liabilities 
Operating leases, net of current portion 
Other long-term liabilities 
Total liabilities 

Commitments and contingencies (Note 12) 

   $ 

   $ 

   $ 

As of December 31, 

2020 

2019 

196      $ 
177        
206        
7        
39        
2        
627        
152        
12        
39        
48        
53        
—        
317        
1,248      $ 

118      $ 
2        
12        
164        
296        
17        
406        
49        
212        
980        

233   
208   
215   
12   
36   
2   
706   
181   
12   
47   
49   
45   
147   
228   
1,415   

153   
2   
12   
201   
368   
109   
378   
48   
231   
1,134   

Redeemable, convertible Series A preferred stock, no par value, $100 per share liquidation preference      

191        

182   

Equity 
Common stock, $0.01 par value 
Additional paid in capital 
Treasury stock, at cost 
Accumulated deficit 
Accumulated other comprehensive loss 

Total equity 
TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND EQUITY 

   $ 

The accompanying notes are an integral part of these consolidated financial statements. 

—        
1,152        
(9 )      
(620 )      
(446 )      
77        
1,248      $ 

—   
604   
(9 ) 
(79 ) 
(417 ) 
99   
1,415   

50 

 
 
  
  
  
  
  
     
  
       
         
  
     
     
     
     
     
     
     
     
     
     
     
     
     
  
       
         
  
       
         
  
     
     
     
     
     
     
     
     
     
  
       
         
  
       
         
  
  
       
         
  
  
       
         
  
       
         
  
     
     
     
     
     
     
 
 
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF EQUITY (DEFICIT)  

(in millions, except share data) 

Common 
Stock (1) 

Additional 
Paid in 
Capital 

Accumulated 
Deficit 

Accumulated 
Other 
Comprehensive 
Loss 

Treasury 
Stock 

Total 

Series A 
Redeemable 
Convertible 
Preferred 
Stock 

Equity (deficit) as of December 31, 2018 
Net earnings 
Adjustments due to ASU 2016-02 
Other comprehensive loss (net of tax): 
Currency translation adjustments 
Pension and other postretirement 
   liability adjustments 
Series A preferred stock cash 
   dividends 
Series A preferred stock deemed 
   dividends 
Stock-based compensation 
Equity (deficit) as of December 31, 2019 
Net loss 
Other comprehensive loss (net of tax): 
Currency translation adjustments 
Pension and other postretirement 
   liability adjustments 

Series A preferred stock cash and accrued 
   dividends 
Series A preferred stock deemed 
   dividends 
Conversion of Convertible Notes 
Stock option exercises 
Stock-based compensation 
Equity (deficit) as of December 31, 2020 

   $ 

   $ 

—   
—   
—   

—   

—   

—   

—   
—   
—   
—   

—   

—   

—   

—   

  $ 

  $ 

  $ 

617   
—   
—   

  $ 

(200 ) 
116   
5   

  $ 

(411 ) 
—   
—   

—   

—   

—   

6   

(12 ) 

—   

—   
—   
(79 ) 
(541 ) 

  $ 

—   
—   
(417 ) 
—   

  $ 

  $ 

—   

—   

—   

—   

(16 ) 

(13 ) 

—   

—   

—   

—   

(11 ) 

(9 ) 
7   
604   
—   

—   

—   

(11 ) 

(9 ) 
520   
29   
19   
1,152   

(9 ) 
—   
—   

—   

—   

—   

—   
—   
(9 ) 
—   

—   

—   

—   

—   

  $ 

(3 ) 
116   
5   

6   

(12 ) 

(11 ) 

(9 ) 
7   
99   
(541 ) 

  $ 

  $ 

(16 ) 

(13 ) 

(11 ) 

(9 ) 
520   
29   
19   
77   

   $ 

—   
—   

  $ 

—   
(620 ) 

  $ 

—   
(446 ) 

  $ 

  $ 

—   
(9 ) 

  $ 

—   
191   

  $ 

173   
—   
—   

—   

—   

—   

9   
—   
182   
—   

—   

—   

—   

9   

(1)  There are 60 million shares of no par value preferred stock authorized, 2 million of which have been issued.  

The accompanying notes are an integral part of these consolidated financial statements. 

51 

 
 
  
  
     
  
  
  
  
  
  
  
  
  
  
  
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
    
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
    
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
     
    
    
    
    
    
    
    
    
    
    
    
     
    
    
    
    
    
    
    
    
    
    
    
     
    
    
    
    
    
    
 
 
 
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF CASH FLOW 

(in millions) 
Cash flows from operating activities: 
Net (loss) earnings 
Adjustments to reconcile to net cash (used in) provided by operating activities: 
Depreciation and amortization 
Pension and other postretirement income 
Change in fair value of embedded derivatives in the Series A 
   Preferred Stock and the Convertible Notes 
Asset impairments 
Stock based compensation 
Non-cash changes in workers' compensation and postemployment reserves 
Net gains on sales of businesses/assets 
Loss on early extinguishment of debt 
Provision for deferred income taxes 
Decrease in trade receivables 
Decrease in inventories 
(Decrease) increase in trade accounts payable 
Decrease in liabilities excluding borrowings 
Other items, net 
Total adjustments 
Net cash (used in) provided by operating activities 

Cash flows from investing activities: 
Additions to properties 
Net proceeds from sales of businesses/assets, net 
Net proceeds from return of equity investment 
Net cash (used in) provided by investing activities 

Cash flows from financing activities: 
Proceeds from stock option exercises 
Repayment of emergence credit facilities 
Proceeds from issuance of convertible notes 
Proceeds from other borrowings 
Payment of contingent consideration related to the sale of a business 
Preferred stock dividend payments 
Finance lease payments 
Net cash provided by (used in) financing activities 
Effect of exchange rate changes on cash, cash equivalents and 
   restricted cash 
Net (decrease) increase in cash, cash equivalents, restricted cash 
   and cash in assets held for sale 
Cash, cash equivalents, restricted cash and cash in assets held for sale, 
   beginning of period 
Cash, cash equivalents and restricted cash, end of period (1) 

Year Ended December 31, 

2020 

2019 

   $ 

(541 )    $ 

37        
(77 )      

382        
3        
15        
4        
(10 )      
2        
160        
33        
12        
(36 )      
(26 )      
7        
506        
(35 )      

(17 )      
2        
2        
(13 )      

33        
—        
—        
—        
—        
(22 )      
(1 )      
10        

4        

(34 )      

   $ 

290        
256      $ 

116   

55   
(91 ) 

42   
6   
7   
3   
(201 ) 
—   
21   
21   
11   
25   
(10 ) 
7   
(104 ) 
12   

(15 ) 
326   
—   
311   

—   
(395 ) 
98   
14   
(10 ) 
(3 ) 
(2 ) 
(298 ) 

(2 ) 

23   

267   
290   

(1)  Refer to Note 2, “Cash, Cash Equivalents and Restricted Cash” for a breakdown of cash, cash equivalents and restricted cash. 

The accompanying notes are an integral part of these consolidated financial statements. 

52 

 
  
  
  
  
     
  
       
         
  
     
         
    
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
  
     
         
    
     
         
    
     
     
     
     
  
     
         
    
     
         
    
     
     
     
     
     
     
     
     
     
     
     
 
EASTMAN KODAK COMPANY 
CONSOLIDATED STATEMENT OF CASH FLOW (Continued) 

(in millions) 

SUPPLEMENTAL CASH FLOW INFORMATION 

Cash paid for interest and income taxes was: 
Interest 
Income taxes (net of refunds) 

The accompanying notes are an integral part of these consolidated financial statements. 

Year Ended December 31, 

2020 

2019 

   $ 
   $ 

8      $ 
8      $ 

21   
17   

53 

 
 
  
  
  
  
  
     
  
       
         
  
 
 
 
EASTMAN KODAK COMPANY 
NOTES TO FINANCIAL STATEMENTS 

NOTE 1: BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 

ACCOUNTING PRINCIPLES 

The consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the 
United States of America (“U.S. GAAP”).  The following is a description of the significant accounting policies of Kodak. 

When used in this report, unless otherwise indicated by the context, “EKC” or the “Company” means the parent company, Eastman Kodak Company, 
and “Kodak” refers to the consolidated group,  

BASIS OF CONSOLIDATION 

The consolidated financial statements include the accounts of EKC and all companies directly or indirectly controlled by EKC, either through majority 
ownership or otherwise.  Kodak consolidates variable interest entities if Kodak has a controlling financial interest and is determined to be the primary 
beneficiary of the entity. 

GOING CONCERN 

The consolidated financial statements have been prepared on the going concern basis of accounting, which assumes Kodak will continue to operate 
as  a going  concern and  which  contemplates  the  realization  of  assets  and  the  satisfaction  of  liabilities  and  commitments  in  the  normal  course  of 
business.   

As of December 31, 2020 and 2019, Kodak had approximately $196 million and $233 million of cash and cash equivalents, respectively.  $99 million 
and $72 million was held in the U.S. as of December 31, 2020 and 2019, respectively, and $97 million and $161 million were held outside the U.S. 
Cash balances held outside the U.S. are generally required to support local country operations and may have high tax costs or other limitations that 
delay the ability to repatriate, and therefore may not be readily available for transfer to other jurisdictions.  Outstanding inter-company loans to the 
U.S.  as  of  December 31,  2020  and  2019  were  $449  million  and  $408  million,  respectively,  which  includes  short-term  intercompany  loans  from 
Kodak’s  international  finance  center  of  $150  million  and  $110  million  as  of  December 31,  2020  and  2019,  respectively.  In  China,  where 
approximately  $34  million  and  $89  million  of  cash  and  cash  equivalents  was  held  as  of  December 31,  2020  and  2019,  respectively,  there  are 
limitations related to net asset balances that may impact the ability to make cash available to other jurisdictions in the world.  On May 12, 2020, a 
Chinese subsidiary of Kodak transferred approximately $70 million to a U.S. subsidiary of Kodak in an inter-company transaction.  Kodak had a net 
decrease  in  cash,  cash  equivalents  and  restricted  cash  of  $34  million  for  the  year  ended  December 31,  2020  and  a  net  increase  in  cash,  cash 
equivalents, restricted cash and cash in assets held for sale of $23 million for the year ended December 31, 2019.  Kodak used cash of $35 million in 
operating activities for year ended December 31, 2020 and generated cash from operating activities of $12 million for the year ended  December 31, 
2019.  Cash flow from operations in 2019 benefitted from working capital improvements and individual transactions that occurred during the year.   

U.S.  GAAP  requires  an  evaluation  of  whether  there  are  conditions  or  events,  considered  in  the aggregate,  that  raise  substantial  doubt  about  an 
entity’s ability to continue as a going concern within one year after the date the financial statements are issued. Initially, this evaluation does not 
consider the potential mitigating effect of management’s plans that have not been fully implemented. When substantial doubt exists, management 
evaluates the mitigating effect of its plans if it is probable that (1) the plans will be effectively implemented within one year after the date the financial 
statements are issued, and (2) when implemented, the plans will mitigate the relevant conditions or events that raise substantial doubt about the 
entity’s ability to continue as a going concern within one year after the date the financial statements are issued or prior to the conditions or events 
that create the going concern risk.  

As of December 31, 2020 and 2019 Kodak was facing liquidity challenges due to operating losses and low or negative cash flow from operations.  As 
of December 31, 2020 Kodak had $90 million of letters of credit issued under the Amended and Restated Credit Agreement (the “ABL Credit 
Agreement”) which had a maturity date of May 26, 2021.  The Series A Preferred Stock of $200 million was required to be redeemed on November 
15, 2021 if not converted prior to then.  Additionally, Kodak has significant cash requirements to fund ongoing operations, restructuring programs, 
pension and other postretirement obligations, and other obligations.  Kodak’s plans to return to sustainable positive cash flow include growing 
revenues profitably, reducing operating expenses, simplifying the organizational structure, generating cash from selling and leasing underutilized 
assets and paring investment in new technology by eliminating or delaying product development programs.  Additionally, the Company looks to 
implement ways to reduce collateral needs in the U.S. to free-up cash for use in operations. 

Kodak’s products are sold and serviced in numerous countries across the globe with more than half of sales generated outside the United States.  
Current global economic conditions are highly volatile due to the COVID-19 pandemic.  The economic uncertainties surrounding the COVID-19 
pandemic are adding complexity to Kodak’s plans to return to sustainable positive cash flow. 

54 

 
 
 
 
 
 
 
 
 
 
 
To mitigate the economic impacts of the pandemic Kodak employed temporary furloughs and pay reductions during 2020 and has been modifying 
manufacturing volumes as expectations of demand change. 

On February 26, 2021 the Company entered into a five-year Term Credit Agreement (the “Term Loan Credit Agreement”), a Series C Preferred 
Stock Purchase Agreement (the “Purchase Agreement”), a Securities Purchase Agreement (the “Securities Purchase Agreement”), and a Series A 
Preferred Stock Repurchase and Exchange Agreement (the “Repurchase and Exchange Agreement”).  

The Term Loan Credit Agreement provides for an initial term loan in the amount of $225 million and a commitment to provide delayed draw term 
loans in an aggregate principal amount of up to $50 million on or before February 26, 2023.  The Purchase Agreement provides for the sale of a total 
of $100 million of Series C Preferred Stock with an initial sale of $75 million of Series C Preferred Stock and an additional $25 million of this series of 
preferred stock subject to Hart-Scott-Rodino Antitrust Improvements Act clearance.  The Securities Purchase Agreement provides for the issuance of 
an aggregate of one million shares of common stock for a purchase price of $10.00 in cash per share for an aggregate purchase price of $10 million 
and $25 million aggregate principal amount of the Company’s newly issued 5.0% unsecured convertible promissory notes due May 28, 2026 to the 
lenders under the Term Loan Credit Agreement.  With the proceeds from these transactions, the Company repurchased one million shares of the 
Series A Preferred Stock under the terms of the Repurchase and Exchange Agreement for $100 million plus accrued and unpaid dividends.  In 
addition, Kodak has issued one million shares of Series B Preferred Stock in exchange for the remaining Series A Preferred Stock.  The Company 
received net proceeds of approximately $235 million on February 26, 2021, before fees of approximately $10 million, as a result of these 
transactions. 

If any shares of Series C Preferred Stock have not been converted prior to 91 days following the fifth anniversary of the initial issuance of the Series 
C Preferred Stock, the Company will be required to redeem such shares at a redemption price equal to the liquidation preference of the redeemed 
shares plus the amount of accrued and unpaid dividends thereon; however, the holders of the Series C Preferred Stock have the right to extend such 
date by up to two years.  If any shares of Series B Preferred Stock have not been converted prior to 91 days following the fifth anniversary of the 
initial issuance of the Series B Preferred Stock, the Company will be required to redeem such shares at a redemption price equal to the liquidation 
preference of the redeemed shares plus the amount of accrued and unpaid dividends thereon. 

On February 26, 2021 the Company also entered into a cash collateralized Letter of Credit Facility Agreement for up to $50 million and amended its 
ABL Credit Agreement to decrease the commitments from $110 million to $90 million and extend the maturity date to February 26, 2024, or the date 
that is 90 days prior to the earliest scheduled maturity date or mandatory redemption date of any of the Company’s outstanding term loan, 
convertible notes, Series B Preferred Stock, Series C Preferred Stock or any refinancings of any of the foregoing.            

The recent history of negative operating cash flow, maturity of the ABL Credit Agreement in 2021, redemption date in 2021 for the Series A Preferred 
Stock, increased challenges in managing cash during the COVID-19 pandemic and general lack of certainty regarding the return to positive cash 
flow raised substantial doubt about Kodak’s ability to continue as a going concern as of December 31, 2019.  The additional liquidity provided by the 
financing transactions which closed on February 26, 2021, the extension of the maturity date of the ABL Credit Agreement, and the repurchase and 
exchange of the Series A Preferred Stock alleviated the substantial doubt about Kodak’s ability to continue as a going concern within one year after 
the date these financial statements are issued (March 16, 2021). 

RECLASSIFICATIONS 

Certain amounts for prior periods have been reclassified to conform to the current period classification due to Kodak’s new organization structure as 
of January 2020.  Refer to Note 27, “Segment Information” for additional information  

USE OF ESTIMATES 

The preparation of financial statements in conformity with U.S. GAAP accounting requires management to make estimates and assumptions that 
affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at year end and the reported amounts of 
revenues and expenses during the reporting periods presented.  Actual results could differ from these estimates. 

FOREIGN CURRENCY 

For most subsidiaries and branches outside the U.S., the local currency is the functional currency.  The financial statements of these subsidiaries 
and branches are translated into U.S. dollars as follows: assets and liabilities at year-end exchange rates; revenue, expenses and cash flows at 
average exchange rates; and shareholders’ equity at historical exchange rates.  For those subsidiaries for which the local currency is the functional 
currency, the resulting translation adjustment is recorded as a component of Accumulated other comprehensive loss in the accompanying 
Consolidated Statement of Financial Position. 

55 

 
 
 
 
 
 
 
 
 
 
 
 
For certain other subsidiaries and branches outside the U.S., operations are conducted primarily in U.S. dollars, which is therefore the functional 
currency.  Monetary assets and liabilities of these foreign subsidiaries and branches, which are recorded in local currency, are remeasured at year-
end exchange rates, while the related revenue, expense, and gain and loss accounts, which are recorded in local currency, are remeasured at 
average exchange rates.  Non-monetary assets and liabilities, and the related revenue, expense, and gain and loss accounts, are remeasured at 
historical exchange rates.  Adjustments that result from the remeasurement of the assets and liabilities of these subsidiaries are included in Other 
charges, net in the accompanying Consolidated Statement of Operations. 

The effects of foreign currency transactions, including related hedging activities, are included in Other charges, net, in the accompanying 
Consolidated Statement of Operations. 

CASH EQUIVALENTS 

All highly liquid investments with a remaining maturity of three months or less at date of purchase are considered to be cash equivalents. 

INVENTORIES 

Inventories are stated at the lower of cost or net realizable value.  The cost of all of Kodak’s inventories is determined by the average cost method, 
which approximates current cost.  Kodak provides inventory reserves for excess, obsolete or slow-moving inventory based on changes in customer 
demand, technology developments or other economic factors. 

PROPERTY, PLANT AND EQUIPMENT 

Property, plant and equipment are recorded at cost, net of accumulated depreciation.  Kodak capitalizes additions and improvements while 
maintenance and repairs are charged to expense as incurred.  Upon sale or other disposition, the applicable amounts of asset cost and accumulated 
depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to net (loss) earnings. 

Kodak calculates depreciation expense using the straight-line method over the assets’ estimated useful lives, which are as follows: 

Buildings and building improvements 
Land improvements 
Leasehold improvements 
Equipment 
Tooling 
Furniture and fixtures 

Estimated Useful 
Lives 
5-40 
4-20 
3-20 
3-20 
1-3 
5-10 

Kodak depreciates leasehold improvements over the shorter of the lease term or the assets’ estimated useful life. 

GOODWILL 

Goodwill is not amortized but is required to be assessed for impairment at least annually and whenever events or changes in circumstances occur 
that would more likely than not reduce the fair value of the reporting unit below its carrying amount. 

When testing goodwill for impairment, Kodak may assess qualitative factors for some or all of its reporting units to determine whether it is more likely 
than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill.  If 
Kodak determines based on this qualitative test of impairment that it is more likely than not that a reporting unit’s fair value is less than its carrying 
amount or elects to bypass the qualitative assessment for some or all of its reporting units, then a quantitative goodwill impairment test is performed 
to test for a potential impairment of goodwill.  The amount of goodwill impairment, if any, is calculated as the amount by which a reporting unit’s 
carrying value exceeds its fair value, not to exceed the carrying amount of goodwill.  Determining the fair value of a reporting unit involves the use of 
significant estimates and assumptions.  Refer to Note 5, “Goodwill and Other Intangible Assets”. 

56 

 
  
 
 
 
 
  
  
  
  
  
  
  
  
 
  
WORKERS’ COMPENSATION 

Kodak self-insures and participates in high-deductible insurance programs with retention and per occurrence deductible levels for claims related to 
workers’ compensation. The estimated liability for workers’ compensation is based on actuarially estimated, discounted cost of claims, including 
claims incurred but not reported.   Historical loss development factors are utilized to project the future development of incurred losses, and the 
amounts are adjusted based on actual claim experience, settlements, claim development trends, changes in state regulations and judicial 
interpretations.  Refer to Note 7, “Other Current Liabilities” and Note 8, “Other Long-Term Liabilities” for the estimated liabilities.  Amounts 
recoverable from insurance companies or third parties are estimated using historical experience and estimates of future recoveries.  Estimated 
recoveries are not offset against the related accrual.  The amount recorded for the estimated recoveries at December 31, 2020 and 2019 was $21 
million each year, of which $18 million is reported in Other long-term assets in the Consolidated Statement of Financial Position each year.  The 
remaining $3 million at each year end is reported in Other current assets in the Consolidated Statement of Financial Position.  

LEASES 

Kodak as lessee 
Kodak determines if an arrangement is a lease at inception. The primary criteria used to classify transactions as operating or finance leases are: (1) 
whether the ownership transfers at the end of the lease, (2) whether the lease term is equal to or greater than 75% of the economic life of the asset, 
and (3) whether the present value of the minimum lease payments is equal to or greater than 90% of the fair value of the asset at inception of the 
lease.  Kodak does not have leases that include assets of a specialized nature, generally does not provide residual value guarantees or have any 
leases for which the exercise of end-of-lease purchase options is reasonably assured at lease inception. 

Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make 
lease payments arising from the lease.  ROU assets and liabilities are recognized at the lease commencement date based on the present value of 
lease payments over the lease term.  The operating lease ROU assets are adjusted for prepayments and lease incentives.  Variable lease payments 
are also excluded from the measurement of ROU assets and lease liabilities and are recognized in the period in which the obligation for those 
payments is incurred.   

Kodak’s lease agreements are primarily for real estate space and vehicles.  Arrangements for goods and services are also assessed to determine if 
the arrangement contains a lease at its inception.  Operating leases are included within Operating lease right-of-use assets, Current portion of 
operating leases and Operating leases, net of current portion in the Consolidated Statement of Financial Position.  Finance leases are included in 
Property, plant and equipment, net, Short-term borrowings and current portion of long-term debt and Long-term debt, net of current portion in the 
Consolidated Statement of Financial Position. 

When available, the rate implicit in the lease is used to discount lease payments to present value; however, many leases do not provide a readily 
determinable implicit rate. Therefore, Kodak applies its incremental borrowing rate to discount the lease payments at lease commencement.   
The incremental borrowing rate is the rate of interest that EKC would have to pay to borrow, on a collateralized basis, over a similar term.  Lease 
renewal or extension options and/or termination options are factored into the determination of lease payments only if reasonably certain to be 
exercised.   

Rental expense related to operating leases is recognized on a straight-line basis over the lease term.  The lease agreements have both lease and 
non-lease components.  Kodak does not separate lease and non-lease components of contracts for real estate leases but does separate lease and 
non-lease components for equipment leases.  

Kodak as Lessor 
Kodak places its own equipment at customer sites under sales-type and operating lease arrangements.  Arrangements classified as sales-type 
leases with revenue recognition at inception generally transfer title to the equipment by the end of the lease term or have a lease term that is for a 
major part of the remaining economic life of the equipment; and collectability is considered probable.  If the arrangement meets the criteria for a 
sales-type lease but collectability is not considered probable, Kodak will not derecognize the asset and will record all payments received as a liability 
until the earlier of collectability becoming probable or the termination of the lease.  Arrangements that do not meet the sales-type lease criteria are 
classified as operating leases with revenue recognized over the term.  Contracts with customers may include multiple performance obligations 
including equipment, optional software licenses and service agreements.  For such arrangements, revenue is allocated to each performance 
obligation based on its relative standalone selling price.  

The Eastman Business Park segment’s core operations are to lease real estate. Kodak also leases underutilized portions of other real estate 
properties to third parties under both operating lease and sublease agreements. Payments received under operating lease agreements as part of the 
Eastman Business Park segment are recognized on a straight-line basis over the term and are reported in Revenues in the Consolidated Statement 
of Operations.  Payments received under lease and sublease agreements for underutilized space are recognized on a straight-line basis and 
reported as cost reductions in Cost of revenues, SG&A expenses, R&D costs and Other charges, net. 

Renewal options and/or termination options are factored into the determination of lease payments if considered probable.  Kodak does not separate 
lease and non-lease components of contracts for real estate leases but does separate lease and non-lease components for equipment leases. 

57 

 
 
 
 
 
 
 
Equipment subject to operating leases consists of equipment rented to customers.  Equipment subject to operating leases is included in Property, 
plant and equipment, net in the Consolidated Statement of Financial Position and is depreciated to estimated residual value over its expected useful 
life.  Equipment operating lease terms and depreciable lives generally vary from 3 to 7 years. 

REVENUE 

Kodak’s revenue transactions include sales of products (such as components and consumables for use in Kodak and other manufacturers’ 
equipment and film-based products), equipment, software, services, integrated solutions, intellectual property and brand licensing; and real estate 
management activities.  Revenue from services includes extended warranty, customer support and maintenance agreements, consulting, business 
process services, training and education.  

Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration 
Kodak expects to be entitled to in exchange for those goods or services.  

For product sales (such as plates, film, inks, chemicals and other consumables) revenue is recognized when control has transferred from Kodak to 
the buyer, which may be upon shipment or upon delivery to the customer site, based on contract terms or legal requirements in certain jurisdictions. 
Service revenue is recognized using the time-based method ratably over the contractual period as it best depicts when the customer receives the 
benefit from the service.  Service revenue for time and materials-based agreements is recognized as services are performed.  

Equipment is generally dependent on, and interrelated with, the underlying operating system (firmware) and cannot function without the operating 
system. In these cases, the hardware and software license are accounted for as a single performance obligation. Contracts with customers may 
include multiple performance obligations including equipment and optional software licenses and service agreements. Service agreements may be 
prepaid or paid over-time and range from three months to six years. For such arrangements, revenue is allocated to each performance obligation 
based on its relative standalone selling price.  Kodak applies the residual allocation method for sales of certain complex, highly customized     
equipment due to significant variability in pricing.  Standalone selling prices are based on the prices charged to customers or using expected cost-
plus margin.  

For non-complex equipment installations and software sales (Prepress and PROSPER Components and Software) businesses revenue is 
recognized when control of each distinct performance obligation has transferred from Kodak to the buyer, which is generally met when the 
equipment or software is delivered and installed at the customer site as delivery and installation generally occur within the same period.  For complex 
equipment installations or integrated software solutions (PROSPER Presses, Electrophotographic Printing Solutions Printers, Software) revenue is 
deferred until receipt of customer acceptance and control has transferred to the buyer.  

Software licenses are sold both in bundled equipment arrangements as discussed above or on a stand-alone basis (Software).  Software licenses 
are generally perpetual and are usually sold with post-contract support services (“PCS”) which are considered distinct performance obligations as the 
customer’s use of the existing software is not dependent upon future upgrades. Kodak recognizes software revenue at the time that the customer 
obtains control over the software which generally occurs upon installation while revenue allocated to the PCS is recognized over the service period. 

In service arrangements such as consulting or business process services (Kodak Services for Business) where final acceptance by the customer is 
required, revenue is deferred until all acceptance criteria have been met and Kodak has a legal right to payment.  

Kodak’s licensing revenue is comprised of software licenses as discussed above, licenses to use functional intellectual property (e.g. patents and 
technical know-how) and licenses to use symbolic intellectual property (e.g. brand names and trademarks) (Advanced Materials and Chemicals and 
Brand businesses).  The timing and the amount of revenue recognized from the licensing of intellectual property depends upon a variety of factors, 
including the nature of the performance obligations (functional vs. symbolic licenses), specific terms of each agreement, and the payment terms. 
Aside from software licenses discussed above, Kodak’s functional licenses generally provide the right to use functional intellectual property; 
therefore, non-sales/usage-based revenue is recognized when the customer has the right to use the intellectual property while sales and usage-
based royalties are recognized in the period the related sales and usage occurs.  Revenue for symbolic licenses such as brand licenses are 
recognized over time.  

Real estate management revenue consists primarily of income from tenant leases, including rent and utilities, as well as facility management 
services and hosting onsite events.  Usage based revenue is recognized as earned while tenant lease income is recognized on a straight-line basis 
over the lease term (Refer to Leases; Kodak as Lessor above). 

Deferred revenue is recorded when cash payments are received in advance of satisfying performance obligations such as deposits required in 
advance on equipment orders, prepaid service contracts, prepaid tenant lease income or prepaid royalties on intellectual property arrangements. 
Interest expense is imputed for payments received greater than one year in advance of performance.  

58 

 
 
 
 
 
 
 
 
 
 
 
 
 
Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days. Kodak applies 
the practical expedient with respect to implied financial components and only imputes interest for payment terms greater than one year.  
Sales and usage-based taxes are excluded from revenues. Certain customers may receive cash-based incentives or credits, which are accounted 
for as variable consideration. Kodak estimates these amounts based on the expected amount to be provided to customers. 

Kodak expenses sales commissions when incurred if the amortization period would be one year or less. These costs are recorded in Selling, general 
and administrative expenses. Kodak accrues the estimated cost of post-sale obligations, including basic product warranties, at the time of revenue 
recognition. Shipping and handling costs are accounted for as fulfillment costs and are included in cost of sales.  

Kodak does not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less or for 
which revenue is recognized at the amount to which Kodak has the right to invoice for services performed. Performance obligations with an original 
expected length of greater than one year generally consist of deferred service contracts, operating leases and licensing arrangements. As of 
December 31, 2020, there was approximately $70 million of unrecognized revenue from unsatisfied performance obligations. Approximately 30% of 
the revenue from unsatisfied performance obligations is expected to be recognized in 2021, 25% in 2022, 15% in 2023 and 30% thereafter. 

RESEARCH AND DEVELOPMENT COSTS 

R&D costs, which include costs incurred in connection with new product development, fundamental and exploratory research, process improvement, 
product use technology and product accreditation, are expensed in the period in which they are incurred. 

ADVERTISING 

Advertising costs are expensed as incurred and are included in Selling, general and administrative expenses in the accompanying Consolidated 
Statement of Operations.  Advertising expenses amounted to $2 million and $5 million for the years ended December 31, 2020 and 2019, 
respectively.   

SHIPPING AND HANDLING COSTS 

Amounts charged to customers and costs incurred by Kodak related to shipping and handling are included in net sales and cost of sales, 
respectively. 

IMPAIRMENT OF LONG-LIVED ASSETS 

The carrying values of long-lived assets, other than goodwill and intangible assets with indefinite useful lives, are reviewed for impairment whenever 
events or changes in circumstances indicate that the carrying values may not be recoverable. 

The recoverability of the carrying values of long-lived assets is assessed by first grouping long-lived assets with other assets and liabilities at the 
lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities (the asset group) and, secondly, 
by estimating the undiscounted future cash flows that are directly associated with and that are expected to arise from the use of and eventual 
disposition of such asset group.  Kodak estimates the undiscounted cash flows over the remaining useful life of the primary asset within the asset 
group.  If the carrying value of the asset group exceeds the estimated undiscounted cash flows, Kodak records an impairment charge to the extent 
the carrying value of the long-lived asset exceeds its fair value.  Kodak determines fair value through quoted market prices in active markets or, if 
quoted market prices are unavailable, through the performance of internal analyses of discounted cash flows. 

The remaining useful lives of long-lived assets are reviewed in connection with the assessment of recoverability of long-lived assets and the ongoing 
strategic review of the business and operations.  If the review indicates that the remaining useful life of the long-lived asset has changed significantly, 
the depreciation on that asset is adjusted to facilitate full cost recovery over its revised estimated remaining useful life. 

The carrying values of indefinite-lived intangible assets are evaluated for potential impairment annually or whenever events or changes in 
circumstances indicate that it is more likely than not that the asset is impaired. Refer to Note 5, “Goodwill and Other Intangible Assets.” 

INCOME TAXES 

Kodak recognizes deferred tax liabilities and assets for the expected future tax consequences of operating losses, credit carry-forwards and 
temporary differences between the carrying amounts and tax basis of Kodak’s assets and liabilities.  Kodak records a valuation allowance to reduce 
its net deferred tax assets to the amount that is more likely than not to be realized.  For discussion of the amounts and components of the valuation 
allowances as of December 31, 2020 and 2019, refer to Note 18, “Income Taxes.” 

The undistributed earnings of Kodak’s foreign subsidiaries are not considered permanently reinvested.  Kodak has recognized a deferred tax liability 
(net of related foreign tax credits) on the foreign subsidiaries’ undistributed earnings.  

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS  

59 

 
 
 
 
  
In November 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2018-18, Collaborative 
Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606.   
This guidance amended Topic 808 and Topic 606 to clarify that transactions in a collaborative arrangement should be accounted for under Topic 606 
when the counterparty is a customer for a distinct good or service (i.e., unit of account).  The amendments preclude an entity from presenting 
consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for 
that transaction. The new standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019 
(January 1, 2020 for Kodak).  The amendments should be applied retrospectively to the date of initial application of Topic 606. Kodak adopted this 
ASU on January 1, 2020, and it did not have any impact on Kodak’s consolidated financial statements.   

In September 2018 the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure 
Requirements for Fair Value Measurement, which amends the disclosure requirements in Topic 820 by adding, changing, or removing certain 
disclosures about recurring or nonrecurring fair value measurements.  The additional and/or modified disclosures relate primarily to Level 3 fair value 
measurements while removing certain disclosures related to transfers between Level 1 and Level 2 of the fair value hierarchy.  The ASU is effective 
retrospectively, for fiscal years beginning after December 15, 2019 (January 1, 2020 for Kodak) and interim periods within those fiscal years.  Entities 
are permitted to early adopt any removed or modified disclosures but can delay adoption of the new disclosures until their effective date.  Kodak 
retrospectively early adopted the provisions of the ASU that removed or modified disclosures in the fourth quarter of 2018 and prospectively adopted 
the provisions related to new disclosures January 1, 2020. The standard addresses disclosures only and did not have an impact on Kodak’s 
consolidated financial statements.   

In September 2018, the FASB issued ASU 2018-14, Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): 
Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans, which amends the disclosure requirements in ASC 715-
20 by adding, clarifying, or removing certain disclosures. ASU 2018-14 requires all entities to disclose (1) the weighted average interest crediting 
rates for cash balance plans and other plans with promised interest crediting rates, and (2) an explanation of the reasons for significant gains and 
losses related to changes in the benefit obligation for the period. The ASU also clarifies certain disclosure requirements for entities with two or more 
defined benefit pension plans when aggregate disclosures are presented. The ASU removes other disclosures from the existing guidance, such as 
the requirement to disclose the effects of a one-percentage-point change in the assumed health care cost trend rates. The ASU is effective 
retrospectively for fiscal years ending after December 15, 2020 (the year ended December 31, 2020 for Kodak).  Kodak adopted this ASU on 
January 1, 2020.  The standard addresses disclosures only and did not have an impact on Kodak’s consolidated financial statements.  

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting 
for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which addresses how a customer should account 
for the costs of implementing a cloud computing service arrangement (also referred to as a “hosting arrangement”). Under ASU 2018-15, entities 
should account for costs associated with implementing a cloud computing arrangement that is considered a service contract in the same way as 
implementation costs associated with a software license; implementation costs incurred in the application development stage, such as costs for the 
cloud computing arrangement’s integration with on-premise software, coding, and configuration or customization, should be capitalized and 
amortized over the term of the cloud computing arrangement, including periods covered by certain renewal options. The ASU is effective in fiscal 
years beginning after December 15, 2019 (January 1, 2020 for Kodak) including interim periods within those fiscal years.  The ASU should be 
applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption.  Kodak adopted this ASU prospectively 
on January 1, 2020, and it did not have any impact on Kodak’s consolidated financial statements.  

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). Topic 842 (as amended by ASU’s 2018-01, 10, 11 and 20 and ASU 2019-01) 
requires lessees to recognize most leases on their balance sheets as lease liabilities with corresponding right-of-use assets and eliminates certain 
real estate-specific provisions. Kodak adopted the new standard on the effective date of January 1, 2019, applying the new transition method 
allowed under ASU 2018-11. 

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS 

60 

 
 
 
 
 
 
 
 
In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—
Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies 
accounting for convertible instruments. More convertible debt instruments will be reported as a single liability instrument and more convertible 
preferred stock as a single equity instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement 
conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the 
exception. The ASU also simplifies the diluted EPS calculation in certain circumstances.  The ASU is effective for smaller reporting companies for 
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, (January 1, 2024 for Kodak).  Early adoption is 
permitted for all entities for fiscal years beginning after December 15, 2020.  The ASU allows entities to use either a modified retrospective or full 
retrospective transition method.  Kodak adopted this ASU on January 1, 2021 and it did not have any impact on Kodak’s consolidated financial 
statements. 

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which removes certain 
exceptions related to intra-period tax allocations and deferred tax accounting on outside basis differences in foreign subsidiaries and equity method 
investments. Additionally, it provides other simplifying measures for the accounting for income taxes. The new standard is effective for fiscal years 
beginning after December 15, 2020 (January 1, 2021 for Kodak) with early adoption permitted. Kodak is currently evaluating the impact of this ASU.  
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial 
Instruments.  ASU 2016-13 (as amended by ASUs 2018-19, 2019-04, 2019-05, 2019-10, 2019-11, 2020-02 and 2020-03) requires a financial asset 
(or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected.  In addition, the ASU 
requires credit losses relating to available-for-sale debt securities to be recorded through an allowance for credit losses.  The amendments in this 
ASU broaden the information that an entity must consider in developing its expected credit loss estimate for assets measured either collectively or 
individually. The ASU is effective for smaller reporting companies for fiscal years, and interim periods within those fiscal years, beginning after 
December 15, 2022, (January 1, 2023 for Kodak).  Early adoption is permitted. Kodak is currently evaluating the impact of this ASU. 

NOTE 2: CASH, CASH EQUIVALENTS AND RESTRICTED CASH 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Statement of Financial Position that 
sums to the total of such amounts shown in the Statement of Cash Flows: 

(in millions) 
Cash and cash equivalents 
Restricted cash - current portion 
Restricted cash 
Total cash, cash equivalents and restricted cash shown in the 
   Statement of Cash Flows 

As of December 31, 

2020 

2019 

  $ 

196      $ 
7        
53        

  $ 

256      $ 

233   
12   
45   

290   

Restricted cash - current portion on the Consolidated Statement of Financial Position primarily represents amounts that support hedging activities. In 
addition, as of December 31, 2019, it also contained collateral for a guaranty provided to MIR Bidco, SA (the “Purchaser”) who purchased Kodak’s 
Flexographic Packaging business (“FPD”).  As of December 31, 2020, and, 2019, the cash collateral supporting Kodak’s guaranty was $0 million and 
$4 million, respectively. 

Restricted cash includes $35 million and $22 million as of December 31, 2020 and 2019, respectively, supporting compliance with the Excess 
Availability threshold under the ABL Credit Agreement, as defined in Note 9, “Debt and Finance Leases”.  In addition, Restricted cash as of 
December 31, 2020 and 2019 includes an escrow of $12 million and $14 million, respectively, in China to secure various ongoing obligations under 
the agreements for the strategic relationship with Lucky HuaGuang Graphics Co. Ltd.  Long-term restricted cash also includes $4 million and $5 
million of security posted related to Brazilian legal contingencies as of December 31, 2020 and 2019, respectively.       

NOTE 3:  INVENTORIES, NET 

(in millions) 
Finished goods 
Work in process 
Raw materials 
Total 

As of December 31, 

2020 

2019 

   $ 

   $ 

97      $ 
54        
55        
206      $ 

105   
54   
56   
215   

61 

 
  
 
 
 
 
  
  
  
  
    
  
    
    
 
 
 
 
 
  
  
  
  
    
  
     
     
 
 
NOTE 4:  PROPERTY, PLANT AND EQUIPMENT, NET 

(in millions) 
Land 
Buildings and building improvements 
Machinery and equipment 
Construction in progress 

Accumulated depreciation 
Property, plant and equipment, net 

As of December 31, 

2020 

2019 

   $ 

   $ 

55     $ 
131       
388       
8       
582       
(430 )     
152     $ 

67   
144   
382   
11   
604   
(423 ) 
181   

Depreciation expense was $32 million and $48 million for the years ended December 31, 2020 and 2019, respectively.    

NOTE 5:  GOODWILL AND OTHER INTANGIBLE ASSETS 

The following table presents the changes in the carrying value of goodwill by reportable segment.   

(in millions) 
As of December 31, 2018 

   Traditional Printing       

Digital Printing 

Advanced Materials 
and Chemicals 

Brand 

      Consolidated Total    

Goodwill 
Accumulated impairment losses 
Balance as of December 31, 2018 

  $ 

Impairment 

Balance as of December 31, 2019 

Goodwill reallocation 
As of December 31, 2020 

Goodwill 
Accumulated impairment losses 
Balance as of December 31, 2020 

   $ 

56      $ 
(56 )      
—        
—        
—        
—        
—        

56        
(56 )      
—      $ 

6      $ 
—        
6        
—        
6        
—        
6        

6        
—        
6      $ 

14      $ 
(8 )      
6        
—        
6        
(6 )      
—        

8        
(8 )      
—      $ 

—      $ 
—        
—        
—        
—        
6        
6        

6        
—        
6      $ 

76   
(64 ) 
12   
—   
12   
—   
12   

76   
(64 ) 
12   

As a result of the change in segments that became effective as of January 1, 2020, Kodak’s goodwill reporting units changed.  Refer to Note 27, 
“Segment Information” for additional information on the change to Kodak’s organizational structure.  The Digital Printing segment has three goodwill 
reporting units: Electrophotographic Printing Solutions; Prosper and Versamark; and Software. The Advanced Materials and Chemicals segment has 
two goodwill reporting units: Motion Picture and Industrial Films and Chemicals; and Advanced Materials and Functional Printing.  The Traditional 
Printing segment and Brand segment each have one goodwill reporting unit. 

As of December 31, 2019, the goodwill balance of $12 million under the prior year segment reporting structure was comprised of $6 million for the 
Brand, Film and Imaging segment and $6 million for the Kodak Software segment, which had only one reporting unit (Software).  The goodwill in the 
Brand, Film and Imaging segment was reported in the Consumer Products reporting unit.  The goodwill previously reported in the Consumer 
Products goodwill reporting unit was transferred to the Brand goodwill reporting unit using a relative fair value allocation to affected reporting units.  
Goodwill previously reported in the Software reporting unit was transferred to the Digital Printing segment where it continues to remain its own 
reporting unit.   

Kodak performed interim tests of impairment for goodwill as of June 30, 2020 due to the uncertainty regarding the negative impact of the COVID-19 
pandemic on its operations, and as of March 31, 2020, due to the decline in market capitalization as of that date since the last goodwill impairment 
test (December 31, 2019) and the uncertainty regarding the negative impact of the COVID-19 pandemic at that time.  Based on the results of the 
June 30, 2020 and March 31, 2020 analyses, no impairment of goodwill was indicated.  No interim impairment test for goodwill was performed as of 
September 30, 2020. 

Based upon the results of Kodak’s December 31, 2020 annual impairment test, no impairment of goodwill is indicated.  As of December 31, 2020, 
the Brand reporting unit had negative carrying value. 

62 

 
 
  
  
  
  
    
  
     
     
     
  
     
     
 
 
 
 
     
     
     
         
         
         
         
    
     
     
     
     
     
     
  
       
         
         
         
         
  
     
     
 
 
 
 
The gross carrying amount and accumulated amortization by major intangible asset category as of December 31, 2020 and 2019 were as follows: 

(in millions) 
Technology-based 
Kodak trade name 
Customer-related 
Total 

(in millions) 
Technology-based 
Kodak trade name 
Customer-related 
Total 

   Gross Carrying 

Amount 

Accumulated 
Amortization 

Net 

As of December 31, 2020 

   $ 

   $ 

99      $ 
18        
11        
128      $ 

80      $ 
—        
9        
89      $ 

19     
18     
2     
39        

   Gross Carrying 

Amount 

Accumulated 
Amortization 

Net 

As of December 31, 2019 

   $ 

   $ 

99      $ 
21        
11        
131      $ 

76      $ 
—        
8        
84      $ 

23     
21     
3     
47        

Weighted-Average 
Amortization Period 
5 years 
Indefinite life 
3 years 

Weighted-Average 
Amortization Period 
5 years 
Indefinite life 
4 years 

The annual and interim impairment tests of the Kodak trade name use the income approach, specifically the relief from royalty method.   

In the first quarter of 2020, due to the uncertainty regarding the negative impact of the COVID-19 pandemic at that time, Kodak performed an interim 
test of impairment for the Kodak trade name.  Based on the result of the interim impairment test, Kodak concluded the carrying value of the Kodak 
trade name exceeded its fair value.  Pre-tax impairment charges of $3 million are included in Other operating (income) expense, net for the year 
ended December 31, 2020 in the Consolidated Statement of Operations.  Kodak also performed an interim test of impairment for the Kodak trade 
name as of June 30, 2020 due to the uncertainty regarding the negative impact of the COVID-19 pandemic.   Based on the result of the interim 
impairment test as of June 30, 2020, Kodak concluded the fair value of the Kodak trade name exceeded its’ carrying value resulting in no additional 
impairment.  No interim impairment test for the Kodak tradename was performed as of September 30, 2020.  Based upon the results of Kodak’s 
annual December 31, 2020 impairment test, no impairment of the Kodak trade name was indicated.   

In the fourth quarter of 2019, Kodak concluded the carrying value of the Kodak trade name exceeded its fair value.  Pre-tax impairment charges of 
$4 million are included in Other operating (income) expense, net in the Consolidated Statement of Operations. 

Amortization expense related to intangible assets was $5 million and $7 million for the years ended December 31, 2020 and 2019, respectively.  

Estimated future amortization expense related to intangible assets that are currently being amortized as of December 31, 2020 was as follows: 

 (in millions) 
2021 
2022 
2023 
2024 
2025 
Total 

NOTE 6:  OTHER LONG-TERM ASSETS 

   $ 

   $ 

5   
5   
4   
4   
3   
21   

(in millions) 
Pension assets 
Estimated workers' compensation recoveries 
Long-term receivables, net of allowance of $0 million and $4 million 
Other 

Total 

As of December 31, 

2020 

2019 

262      $ 
18        
11        
26        
317      $ 

173   
18   
11   
26   
228   

   $ 

   $ 

The Other component above consists of other miscellaneous long-term assets that, individually, were less than 5% of the total assets component in 
the accompanying Consolidated Statement of Financial Position, and therefore have been aggregated in accordance with Regulation S-X. 

63 

 
  
 
  
  
  
     
     
  
  
     
  
     
     
     
     
     
 
  
  
  
     
     
  
  
     
  
     
     
     
     
     
 
 
 
 
 
 
    
  
  
     
     
     
     
 
 
 
  
  
  
  
    
  
     
     
     
 
 
NOTE 7:  OTHER CURRENT LIABILITIES 

(in millions) 
Deferred revenue and customer deposits 
Employment-related liabilities 
Customer rebates 
Restructuring liabilities 
Workers' compensation 
Embedded conversion option derivative liability 
Series A Preferred Stock dividends payable 
Deferred consideration on disposed businesses (1) 
Transition services agreement prepayment 
Other 

Total 

As of December 31, 

2020 

2019 

   $ 

   $ 

46      $ 
35        
21        
11        
9        
9        
3        
—        
—        
30        
164      $ 

43   
38   
23   
12   
10   
—   
14   
14   
3   
44   
201   

(1)  On September 3, 2013, Kodak consummated the sale of certain assets and the assumption of certain liabilities of the Personalized Imaging 
and Document Imaging Businesses (“PI/DI Businesses”) to the trustee of the U. K. pension plan (and/or its subsidiaries, collectively the 
“KPP Purchasing Parties”) for net cash consideration of $325 million. Up to $35 million in aggregate of the purchase price was subject to 
repayment if the PI/DI Business did not achieve certain annual adjusted EBITDA targets over the four-year period ending December 31, 
2018.  The PI/DI Business did not achieve the adjusted annual EBITDA target for any year in the four-year period.  The amounts owed for 
2015, 2016 and 2017 were paid in 2016, 2017 and 2018, respectively.  The maximum potential payment related to the year ending 
December 31, 2018 of $14 million was accrued at the time of the divestiture of the business.  The Company did not consider the procedural 
requirements giving rise to the obligation to pay the amount relating to the year ended December 31, 2018 to have been met.  The PI/DI 
Businesses (operating as Kodak Alaris) filed suit against the Company alleging breach of contract based on the failure to pay the $14 million 
amount with respect to 2018.  The Company filed counterclaims seeking contractual penalties related to late payments for goods and 
services provided by Kodak under various separate agreements.  The Company and Kodak Alaris reached a settlement in June 2020 
dismissing the actions and all claims and counterclaims asserted against each other and also amended existing supply agreements.  As a 
part of the settlement agreement, $11 million of the deferred consideration on disposed businesses was offset against receivables of $11 
million for goods and services owed to the Company by Kodak Alaris.  Income of $3 million from the release of the remaining deferred 
consideration on disposed businesses will be recognized as revenue over the term of the amended supply agreements. 

The customer rebate amounts will potentially be settled through customer deductions applied to outstanding trade receivables in lieu of cash 
payments. 

The Other component above consists of other miscellaneous current liabilities that, individually, were less than 5% of the total current liabilities 
component within the Consolidated Statement of Financial Position, and therefore have been aggregated in accordance with Regulation S-X. 

NOTE 8:  OTHER LONG-TERM LIABILITIES 

(in millions) 
Workers' compensation 
Asset retirement obligations 
Deferred taxes 
Deferred brand licensing revenue 
Embedded conversion option derivative liabilities 
Environmental liabilities 
Other 

Total 

As of December 31, 

2020 

2019 

   $ 

   $ 

89      $ 
41        
31        
17        
—        
9        
25        
212      $ 

84   
48   
13   
18   
52   
10   
6   
231   

The Other component above consists of other miscellaneous long-term liabilities that, individually, were less than 5% of the total liabilities component 
in the accompanying Consolidated Statement of Financial Position, and therefore have been aggregated in accordance with Regulation S-X. 

64 

 
 
  
  
  
  
    
  
     
     
     
     
     
     
     
     
     
 
 
 
 
 
 
  
  
  
  
    
  
     
     
     
     
     
     
 
NOTE 9:  DEBT AND FINANCE LEASES  

Debt and finance leases and related maturities and interest rates were as follows at December 31, 2020 and 2019: 

(in millions) 

Current portion: 

Non-current portion: 

Type 

Maturity 

RED-Rochester, 
LLC 
   Finance leases    

2033 

   Convertible debt   
RED-Rochester, 
LLC 
   Finance leases    
Other debt 

2021 

2033 
Various 
Various 

Weighted-Average 
Effective 
Interest Rate 

As of December 31, 

2020 

2019 

Carrying Value 

Carrying Value 

11.42% 
Various 

11.72% 

11.42% 
Various 
Various 

  $ 

1        
1        
2        

—        

12        
3        
2        
17        
19      $ 

1   
1   
2   

91   

13   
4   
1   
109   
111   

Annual maturities of debt and finance leases outstanding at December 31, 2020 were as follows: 

(in millions) 

2021 
2022 
2023 
2024 
2025 
2026 and thereafter 
Total 

Carrying 
Value 

Maturity 
Value 

  $ 

  $ 

2     $ 
2       
1       
1       
1       
12       
19     $ 

2   
2   
1   
1   
1   
12   
19   

Convertible Notes 
On May 20, 2019, the Company and Longleaf Partners Small Cap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust, 
which are investment funds managed by Southeastern Asset Management, Inc. (the “Notes Purchasers”), entered into a Notes Purchase Agreement 
pursuant to which the Company agreed to issue and sell to the Notes Purchasers, and the Notes Purchasers agreed to purchase from the Company, 
$100 million aggregate principal amount of the Company’s Convertible Notes due 2021.  The transaction closed on May 24, 2019.  The proceeds 
were used to repay the remaining first lien term loans outstanding ($83 million) under the Company’s term credit agreement, which was terminated 
with the repayment.  The remaining proceeds were used for general corporate purposes.  The Notes Purchasers also hold all outstanding shares of 
the Company’s Series A Preferred Stock, and are holders of shares of the Company’s common stock, par value $0.01 per share (the “Common 
Stock”), as described below.  The maturity date of the Convertible Notes was November 1, 2021. 

The Convertible Notes bore interest at a rate of 5.00% per annum, which would have been payable in cash on their maturity date and, at the option 
of the Company, in either cash or additional shares of Common Stock on any conversion date.  The payment of interest only at the maturity date had 
the same effect as delivering additional debt instruments to the Holders of the Convertible Notes and therefore is considered Paid-In-Kind interest 
(“PIK”).  Therefore, PIK was added to the carrying value of the debt through the term and interest expense was recorded using the effective interest 
method. 

65 

 
 
  
  
  
  
  
     
  
  
  
  
  
  
  
  
  
     
  
  
  
     
  
  
  
  
  
  
  
  
  
  
    
       
    
    
         
    
  
  
  
  
  
    
  
  
  
  
    
    
  
  
  
    
  
  
    
    
  
  
  
    
  
  
    
         
    
  
  
  
  
    
  
  
    
         
    
  
  
  
    
  
  
  
  
  
    
  
  
  
    
  
  
  
  
  
    
  
  
  
  
  
    
  
  
    
  
  
  
  
  
    
  
  
 
   
  
     
  
    
    
    
    
    
 
 
 
On July 29, 2020, the Company received conversion notices from holders of the Convertible Notes exercising their rights to convert an aggregate of 
$95 million of principal amount of the Convertible Notes (the “Initial Converted Notes”) into shares of the Company’s common stock, par value $.01 
per share (“Common Stock”).  Under the terms of the Convertible Notes, the conversion date of the Initial Converted Notes was July 29, 2020 (the 
“Initial Conversion Date”) and the Company was obligated to deliver an aggregate of 29,922,956 shares of Common Stock (the “Initial Conversion 
Shares”) to the holders of the Initial Converted Notes within five trading days after the Initial Conversion Date.  The Company issued the Initial 
Conversion Shares on August 3, 2020 and paid the $5.6 million of accumulated interest on the Initial Converted Notes in cash.  As a result, the 
Company’s obligations under the Initial Converted Notes were fully discharged and the remaining outstanding principal amount of the Convertible 
Notes was $5 million.  

On September 30, 2020, the Company announced its election to mandatorily convert the remaining $5 million outstanding principal amount of the 
Convertible Notes (the “Mandatory Converted Notes”) into shares of Common Stock.  The conversion of the Mandatory Converted Notes was 
effective on September 30, 2020 (the “Mandatory Conversion Date”).  The Company issued 1,574,892 shares of Common Stock to the holder of the 
Mandatory Converted Notes on September 30, 2020 (the “Mandatory Conversion Shares”).  The Company paid the accrued interest on the 
Mandatory Converted Notes in the form of cash and interest ceased to accrue on the Mandatory Converted Notes on the Mandatory Conversion 
Date.  As a result of the conversion of all the Convertible Notes, the lien granted by the Company on certain of its assets to secure the Convertible 
Notes was released.  

Embedded Derivatives 
The Convertible Notes were considered more akin to a debt-type instrument and the economic characteristics and risks of the embedded conversion 
features and term extension at the Company’s option were not considered clearly and closely related to the Convertible Notes.  Accordingly, these 
embedded features were bifurcated from the Convertible Notes and separately accounted for on a combined basis at fair value as a single derivative 
liability.  Kodak allocated $14 million of the net proceeds received to a derivative liability based on the aggregate fair value of the embedded features 
and term extension on the date of issuance which reduced the net carrying value of the Convertible Notes.  The derivative was being accounted for 
at fair value with subsequent changes in the fair value being reported as part of Other charges, net in the Consolidated Statement of Operations 
(refer to Note 14, “Financial Instruments”). 

The carrying value of the Convertible Notes at the time of issuance, $84 million ($100 million aggregate gross proceeds less $14 million allocated to 
the derivative liability and $2 million in transaction costs), was being accreted to the face amount using the effective interest method from the date of 
issuance through the maturity date. 

Loss on Early Extinguishment  
The calculation of the loss on early extinguishment of debt is shown below: 

(in millions) 
Fair value of Initial Conversion Shares 
Fair value of Mandatory Conversion Shares 
Carrying value of Convertible Notes 
Fair value of pro-rata share of embedded derivatives at Initial Conversion Date 
Fair value of pro-rata share of embedded derivatives at Mandatory Conversion Date 
Total 

   $ 

   $ 

506   
13   
(92 ) 
(416 ) 
(9 ) 
2   

Amended and Restated Credit Agreement  
On September 3, 2013, the Company entered into a Senior Secured First Lien Term Credit Agreement (the “Term Credit Agreement”).  Additionally, 
the Company and the Subsidiary Guarantors entered into an Asset Based Revolving Credit Agreement (together with the Term Credit Agreement, 
the “Credit Agreements”).  Pursuant to the terms of the Credit Agreements, the Company was provided with term loan facilities in an aggregate 
principal amount of $420 million of first-lien term loans (the “First Lien Loans”).  On April 12, 2019, the Company repaid approximately $312 million of 
the First Lien Loans using proceeds from the sale of FPD and on May 24, 2019 repaid the remaining First Lien Loans of approximately $83 million 
with the proceeds from the issuance of the Convertible Notes.    

On May 26, 2016, the Company and the Subsidiary Guarantors entered into an Amended and Restated Credit Agreement (the “ABL Credit 
Agreement”) with the lenders party thereto (the “Lenders”), Bank of America, N.A., as administrative and collateral agent, and Bank of America, N.A. 
and JPMorgan Chase Bank, N.A., as joint lead arrangers and joint bookrunners, which amended and restated the Original ABL Credit Agreement.  

The ABL Credit Agreement provides that the Lenders will make available asset-based revolving loans (the “ABL Loans”) and letters of credit in an 
aggregate amount of up to $150 million, subject to the Borrowing Base. 

On January 27, 2020 Kodak exercised its right under the ABL Credit Agreement to permanently reduce lender commitments from $150 million to 
$120 million.  As a result, the minimum Excess Availability decreased to $15 million from the previous minimum of $18.75 million.   

66 

 
 
 
 
 
 
    
  
  
     
     
     
     
 
 
 
 
 
On March 27, 2020, the Company and the subsidiaries of the Company that are guarantors (the “Subsidiary Guarantors”) entered into Amendment 
No. 3 to the ABL Credit Agreement (the “Amendment”) with the lenders party thereto (the “Lenders”), Bank of America, N.A., as administrative and 
collateral agent, and Bank of America, N.A. and each of the parties to the ABL Credit Agreement as lenders. Each of the capitalized but undefined 
terms used in the context of describing the ABL Credit Agreement and the Amendment has the meaning ascribed to such term in the ABL Credit 
Agreement and the Amendment.  

The Amendment decreased the available ABL Loans and letters of credit from an aggregate amount of up to $120 million to $110 million, subject to 
the Borrowing Base.  As a result of the additional reduction in lender commitments, the minimum Excess Availability decreased to $13.75 million 
from the previous amount of $15 million. 

The Amendment also changed Equipment Availability from (i) the lesser of 75% of Net Orderly Liquidation Value of Eligible Equipment or $6 million 
to (ii) the lesser of 70% of Net Orderly Liquidation Value of Eligible Equipment or $14.75 million as of March 31, 2020.    The $14.75 million amount 
decreases by $1 million per quarter starting on July 1, 2020 until maturity or the amount is decreased to $0, whichever comes first.  

Under the ABL Credit Agreement, Kodak is required to maintain a minimum Fixed Charge Coverage Ratio of 1.00 to 1.00 when Excess Availability is 
less than 12.5% of lender commitments.  As of December 31, 2020 and 2019, 12.5% of lender commitments were $13.75 million and $18.75 million, 
respectively.  

If Excess Availability falls below 12.5% of lender commitments, Kodak may, in addition to the requirement to be in compliance with the minimum 
Fixed Charge Coverage Ratio, become subject to cash dominion control.  Since Excess Availability was greater than 12.5% of lender commitments 
at December 31, 2020 and 2019, Kodak is not required to have a minimum Fixed Charge Coverage Ratio of 1.0 to 1.0. 

The Company has issued approximately $90 million and $80 million of letters of credit under the ABL Credit Agreement as of December 31, 2020 
and 2019,  The Company had approximately $20 million and $22 million of Excess Availability under the ABL Credit Agreement as of December 31, 
2020 and 2019, respectively.  Excess Availability is equal to the sum of (i) 85% of the amount of the Eligible Receivables less a Dilution Reserve, 
(ii) the lesser of 85% of Net Orderly Liquidation Value or 75% of the Eligible Inventory, (iii) the lesser of 70% of Orderly Liquidation Value of Eligible 
Equipment or $12.75 million as of December 31, 2020 and (iv) Eligible Cash less (a) Rent and Charges Reserves, (b) Principal Outstanding and (c) 
Outstanding Letters of Credit.  Availability is subject to the borrowing base calculation, reserves and other limitations.  To maintain Excess 
Availability of greater than 12.5% of lender commitments ($13.75 million and $18.75 million as of December 31, 2020 and 2019, respectively), Kodak 
funded $35 million and $22 million to the Eligible Cash account held with the ABL Credit Agreement Administrative Agent as of December 31, 2020 
and 2019, respectively, which is classified as Restricted Cash in the Consolidated Statement of Financial Position. 

In addition to the changes discussed above, the Amendment increased the interest rate charged on the ABL Loans.  The interest rate on the ABL 
Loans (which is based on Excess Availability) increased to LIBOR plus 3.50% - 4.00% per annum from LIBOR plus 2.25% - 2.75% per annum or the 
Base Rate plus 2.50% - 3.00% per annum from the Base Rate plus 1.25% - 1.75% per annum. 

The ABL Credit Agreement matures on May 26, 2021. 

Each existing direct or indirect U.S. subsidiary of the Company (other than Immaterial Subsidiaries, Unrestricted Subsidiaries and certain other 
subsidiaries) has provided an unconditional guarantee (and any such future subsidiaries must provide an unconditional guarantee) of the obligations 
of the Company under the Credit Agreements.  Obligations under the ABL Agreement are secured by: (i) a first lien on cash, accounts receivable, 
inventory, machinery and equipment (the “ABL Collateral”) and were also secured by (ii) a second lien on the Term Collateral (as defined below).  
Subject to certain exceptions, obligations under the Term Credit Agreement were secured by: (i) a first lien on all assets of the Company and the 
Subsidiary Guarantors, other than the ABL Collateral, including a first lien on 100% of the stock of material domestic subsidiaries and 65% of the 
stock of material first-tier foreign subsidiaries (collectively the “Term Collateral”) and (ii) a second lien on the ABL Collateral.  With the repayment of 
the First Lien Loans, the obligations under the ABL Agreement are now secured by a first lien on the Term Collateral.  The aggregate carrying value 
of the Term Collateral and ABL Collateral as of December 31, 2020 and 2019 was $1,412 million and $1,302 million, respectively 

Under the terms of the ABL Credit Agreement, the Company may designate Restricted Subsidiaries as Unrestricted Subsidiaries provided the 
aggregate sales of all Unrestricted Subsidiaries are less than 7.5% of the consolidated sales of Kodak and the aggregate assets of all Unrestricted 
Subsidiaries are less than 7.5% of Kodak’s consolidated assets.  Further, on a pro forma basis at the time of designation and immediately after 
giving effect thereto, Excess Availability must be at least $30 million and the pro forma Fixed Charge Coverage Ratio must be no less than 1.0 to 1.0.  
Upon designation of Unrestricted Subsidiaries, the Company is required to provide to the Lenders reconciling statements to eliminate all financial 
information pertaining to Unrestricted Subsidiaries which is included in its annual and quarterly financial statements.  

In March 2018, the Company designated five subsidiaries as Unrestricted Subsidiaries: Kodak PE Tech, LLC, Kodak LB Tech, LLC, Kodak Realty, 
Inc., Kodakit Singapore Pte. Limited and KP Services (Jersey) Ltd.  This action allowed the Company to better position assets which may be 
monetized in the future and address costs related to underutilized properties. Collectively, these subsidiaries have sales of approximately $6 million 
and $12 million for the years ended December 31, 2020 and 2019, respectively, which represents 1% of Kodak’s consolidated sales for both periods.  

67 

 
 
 
  
 
 
  
 
 
 
 
These subsidiaries had assets of $15 million and $20 million as of December 31, 2020 and 2019, respectively, which represented 1% of Kodak’s 
consolidated assets as of such dates.  Each of the capitalized but undefined terms has the meaning ascribed to such term in the Credit Agreements. 

Debt Reporting and Other Requirements 
Reporting requirements under the ABL Credit Agreement require the Company to provide annual audited financial statements accompanied by an 
opinion of an independent public accountant without a “going concern” or like qualification or exception and without any qualification or exception as 
to the scope of such audit or other material qualification or exception, except for any such qualification or exception with respect to any indebtedness 
maturing within 364 days after the date of such financial statements, and that the opinion be reasonably acceptable to the agent. On March 6, 2020 
the Company obtained a waiver from the agent and lenders under the ABL Credit Agreement with respect to any event of default under the reporting 
covenant that may be deemed to have occurred in relation to the going concern explanatory paragraph in the 2019 Form 10-K audit report.  

The ABL Credit Agreement limits, among other things, the Company’s and the Subsidiary Guarantors’ ability to (i) incur indebtedness, (ii) incur or 
create liens, (iii) dispose of assets, (iv) make restricted payments (including dividend payments, et al.) and (v) make investments (ABL Credit 
Agreement only).  In addition to other customary affirmative covenants, the ABL Credit Agreement provides for a periodic delivery by the Company of 
its various financial statements as set forth in the ABL Credit Agreement. Events of default under the ABL Credit Agreement include, among others, 
failure to pay any principal, interest or other amount due under the applicable agreement, breach of specific covenants and a change of control of the 
Company.  Upon an event of default, the lenders may declare the outstanding obligations under the ABL Credit Agreement to be immediately due 
and payable and exercise other rights and remedies provided for in such agreement. 

RED-Rochester, LLC  
In January 2019 Kodak entered into a series of agreements with RED-Rochester, LLC (“RED”), which provides utilities to the Eastman Business 
Park.  Kodak received a payment of $14 million from RED. Kodak is required to pay a minimum annual payment to RED of approximately $2 million 
regardless of utility usage. Kodak is accounting for the $14 million payment from RED as debt. The minimum payments required under the 
agreement from Kodak to RED will be reported as a reduction of the debt and interest expense using the effective interest method.  The debt 
payments to RED continue until August 2033. 

NOTE 10: REDEEMABLE, CONVERTIBLE SERIES A PREFERRED STOCK 

On November 15, 2016, the Company issued 2,000,000 shares of 5.50% Series A Preferred Stock, no par value per share, for an aggregate 
purchase price of $200 million, or $100 per share pursuant to a Series A Preferred Stock Purchase Agreement (the “Purchase Agreement”) with 
Southeastern Asset Management, Inc. (“Southeastern”) and Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret 
Mutual Pension Trust, which are investment funds managed by Southeastern (such investment funds, collectively, the “Purchasers”), dated 
November 7, 2016.  The Company received net proceeds of $198 million after issuance costs.    

The Company has classified the Series A Preferred Stock as temporary equity in the Consolidated Statement of Financial Position.   

Dividend and Other Rights 
On November 14, 2016, the Company filed with the Department of Treasury of the State of New Jersey a Certificate of Amendment to the Second 
Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Designations”) which established the designation, number of 
shares, rights, preferences and limitations of the Series A Preferred Stock which became effective upon filing.  The Series A Preferred Stock ranks 
senior to the Company’s common stock (“Common Stock”) with respect to dividend rights and rights on liquidation, winding-up and dissolution.  The 
Series A Preferred Stock has a liquidation preference of $100 per share, and the holders of Series A Preferred Stock are entitled to cumulative 
dividends payable quarterly in cash at a rate of 5.50% per annum.  Until the third quarter of 2018 all dividends owed on the Series A Preferred Stock 
were declared and paid when due.  No quarterly dividend was declared in the third or fourth quarters of 2018 or the first and second quarters of 
2019.  After the second quarter of 2019, the Company has declared quarterly cash dividends in each quarter that were paid when due.  In July 2020, 
the Company declared and paid the four quarterly dividends that were in arrears.  The total amount of dividends in arrears was $11 million.    

Until December 24, 2020, when the Certificate of Designations was amended, holders of Series A Preferred Stock were entitled to vote together with 
the holders of the Common Stock as a single class, in each case, on an as-converted basis, except where a separate class vote was required by 
law.  Holders of Series A Preferred Stock have certain limited special approval rights, including with respect to the issuance of pari passu or senior 
equity securities of the Company.   

Until December 24, 2020, when such contractual right was terminated by amendment, the Purchasers had the right to nominate members to the 
Company’s board of directors proportional to their ownership on an as converted basis, which initially allowed the Purchasers to nominate two 
members to the board.  If dividends on any Series A Preferred Stock are in arrears for six or more consecutive or non-consecutive dividend periods, 
the holders of Series A Preferred Stock, voting with holders of all other preferred stock of the Company whose voting rights are then exercisable, will 
be entitled to vote for the election of two additional directors in the next annual meeting and all subsequent meetings until all accumulated dividends 

68 

 
 
 
 
 
 
 
 
 
 
 
on such Series A Preferred Stock and other voting preferred stock have been paid or set aside.  One of the directors on the Company’s current 
board of directors was nominated by the Purchasers. 

Conversion Features 
Each share of Series A Preferred Stock is convertible, at the option of each holder at any time, into shares of Common Stock at the initial conversion 
rate of 5.7471 (equivalent to an initial conversion price of $17.40 per share of Common Stock).  If a holder elects to convert any shares of Series A 
Preferred Stock during a specified period in connection with a fundamental change (as defined in the Certificate of Designations), the conversion rate 
will be adjusted under certain circumstances and such holder will also be entitled to a payment in respect of accumulated dividends. If a holder elects 
to convert any shares of Series A Preferred Stock during a specified period following a reorganization event (as defined in the Certificate of 
Designations), such holder can elect to have the conversion rate adjusted. In addition, the Company will have the right to require holders to convert 
any shares of Series A Preferred Stock in connection with certain reorganization events, in which case the conversion rate will be adjusted under 
certain circumstances.  If shares of Series A Preferred Stock are not converted in connection with a reorganization event, such shares will become 
convertible into the exchanged property from the reorganization event. 

The Company will have the right to convert Series A Preferred Stock into Common Stock at any time after the second anniversary of the initial 
issuance if the closing price of the Common Stock has equaled or exceeded 125 percent of the then-effective conversion price for 45 trading days 
within a period of 60 consecutive trading days, with the last trading day of such 60 day period ending on the trading day immediately preceding the 
business day on which the Company issues a press release announcing the mandatory conversion.   

The initial conversion rate and the corresponding conversion price are subject to customary anti-dilution adjustments as well as an adjustment if the 
Company is obligated to make a cash payment under the settlement agreement relating to the remediation of historical environmental liabilities at 
EBP, as discussed in Note 13, “Guarantees”. 

The Company concluded that the Series A Preferred Stock is considered more akin to a debt-type instrument and that the economic characteristics 
and risks of the embedded conversion features, except where the conversion price is increased to the liquidation preference, were not considered 
clearly and closely related to the Series A Preferred Stock.  Accordingly, these embedded conversion features were bifurcated from the Series A 
Preferred Stock and separately accounted for on a combined basis at fair value as a single derivative.  The Company allocated $43 million of the net 
proceeds received to the derivative liability based on the aggregate fair value of the embedded conversion features on the date of issuance which 
reduced the original carrying value of the Series A Preferred Stock.  The derivative is being accounted for at fair value with subsequent changes in 
the fair value being reported as part of Other charges, net in the Consolidated Statement of Operations. The fair value of the Series A Preferred 
Stock derivative as of December 31, 2020 was a liability of $9 million and is included in Other current liabilities in the accompanying Consolidated 
Statement of Financial Position.  The fair value of the Series A Preferred Stock derivative as of December 31, 2019 was a liability of $1 million which 
is included in Other long-term liabilities.  Refer to Note 14, “Financial Instruments” for information on the valuation of the derivative. 

The carrying value of the Series A Preferred Stock at the time of issuance, $155 million ($200 million aggregate gross proceeds less $43 million 
allocated to the derivative liability and $2 million in transaction costs) is being accreted to the mandatory redemption amount using the effective 
interest method to Additional paid in capital in the Consolidated Statement of Financial Position as a deemed dividend from the date of issuance 
through the mandatory redemption date, November 15, 2021.   

Redemption Features 
If any shares of Series A Preferred Stock have not been converted prior to the fifth anniversary of the initial issuance of the Series A Preferred Stock, 
the Company is required to redeem such shares at $100 per share plus the amount of accrued and unpaid dividends.  As the Company concluded 
that the Series A Preferred Stock is considered more akin to a debt-type instrument, the redemption feature is considered to be clearly and closely 
related to the host contract and therefore was not required to be separated from the Series A Preferred Stock.   

Series A Registration Rights Agreement 
On November 15, 2016, the Company, Southeastern and the Purchasers entered into a Registration Rights Agreement (the “Series A Registration 
Rights Agreement”), pursuant to which the Company agreed to register under the Securities Act and take certain actions with respect to the offer and 
sale by the Purchasers of shares of Series A Preferred Stock purchased by the Purchasers and shares of Common Stock issuable upon conversion 
of the Series A Preferred Stock and issuable pursuant to the terms of the Series A Preferred Stock (the “Series A registrable securities”).  

Pursuant to the Registration Rights Agreement, the Company has filed with the SEC a shelf registration statement on Form S-3 that relates to the 
resale of the Series A registrable securities and such registration statement has been declared effective by the SEC.  Upon the written demand of 
the relevant Purchaser(s), the Company will facilitate a “takedown” of Series A registrable securities off of the registration statement but the 
Purchaser(s) may not, individually or collectively, make more than four demands in the aggregate. Any demand for an underwritten offering of Series 
A Preferred Stock must have an aggregate market value (based on the most recent closing price of the Common Stock into which the Series A 
Preferred Stock is convertible at the time of the demand) of at least $75 million. 

69 

 
  
 
  
 
 
 
 
 
 
The Series A Registration Rights Agreement does not entitle the Purchasers to piggyback registration rights.  The Series A Registration Rights 
Agreement is binding upon the parties thereto and their successors and will inure to the benefit of each Purchaser and its successors and permitted 
assigns. Neither party may assign the Series A Registration Rights Agreement without the prior written consent of the other party. 

NOTE 11:  LEASES 

Kodak as lessee 
The table below presents the lease-related assets and liabilities on the balance sheet: 

Classification in the 
   Consolidated Statement of Financial Position 

December 31, 

2020 

2019 

Operating lease right-of-use assets 
Property, plant and equipment, net 

  $ 

  $ 

48      $ 
4        
52      $ 

(in millions) 
Assets 
Operating lease assets 
Finance lease assets 
Total lease assets 

Liabilities 
Current 

Operating 
Finance 

Noncurrent 
Operating 
Finance 

Current portion of operating leases 
Short-term borrowings and current portion of long-
term debt 

Operating leases, net of current portion 
Long-term debt, net of current portion 

  $ 

12      $ 

1        

49        
3        
65      $ 

Total lease liabilities 

  $ 

Weighted-average remaining lease term 

Operating 
Finance (1) 

Weighted-average discount rate 

Operating (2) 
Finance 

49   
5   
54   

12   

1   

48   
4   
65   

6 years   
393 years   

13.81 % 
6.86 % 

(1)  One finance lease has a remaining term of 967 years.  The weighted-average lease term excluding the lease with a remaining term of 967 

years is 4 years. 

(2)  Upon adoption of ASC 842, Kodak’s incremental borrowing rate of 16.50% as of January 1, 2019 was used for existing operating leases. 

Lease Costs 
The table below presents certain information related to the lease expense for finance and operating leases.  Lease expense is presented gross of 
sublease income.  See “Kodak as Lessor” section below for income from subleases. 

(in millions) 
Finance lease expense 

Amortization of leased assets 
Interest on lease liabilities 

Operating lease expense 
Variable lease expense (1) 
Total lease expense 

Year Ended December 31, 

2020 

2019 

  $ 

  $ 

1      $ 
—        
21        
9        
31      $ 

3   
—   
25   
10   
38   

(1)  Variable lease expense is related to real estate leases and primarily includes taxes, insurance and operating costs. 

70 

 
  
 
 
  
  
  
  
  
     
  
  
  
    
         
    
  
  
    
  
  
  
  
  
    
         
    
  
  
    
         
    
  
  
    
         
    
  
  
    
  
  
    
         
    
  
    
  
    
  
  
  
  
  
    
         
    
    
         
    
  
  
    
       
  
  
    
       
    
         
    
  
  
    
         
  
  
    
         
 
 
 
 
  
  
  
  
    
  
    
         
    
    
    
    
 
 
Other Information 
The table below presents supplemental cash flow information related to leases. 

(in millions) 
Cash paid for amounts included in the measurement of lease 
liabilities 
Operating cash flows for operating leases 
Operating cash flow for finance leases 
Financing cash flow for finance leases 

Year Ended December 31, 

2020 

2019 

  $ 

  $ 

22      $ 
—        
1        
23      $ 

25   
—   
2   
27   

Undiscounted Cash Flows 
The table below reconciles the undiscounted cash flows for the next five years and thereafter to the finance lease liabilities and operating lease 
liabilities recorded on the balance sheet. 

   Operating Leases 
  $ 

(in millions) 
2021 
2022 
2023 
2024 
2025 
Thereafter 
Total minimum lease payments 
Less: amount of lease payments representing interest 
Present value of future minimum lease payments 
Less: current obligations under leases 
Long-term lease obligations 

  $ 

Finance Leases 

1   
1   
1   
—   
—   
121   
124   
(120 ) 
4   
1   
3   

19      $ 
21        
11        
10        
6        
28        
95        
(34 )      
61        
12        
49      $ 

Kodak as Lessor 
Kodak’s net investment in sales-type leases as of December 31, 2020 was $5 million.  The current portion of the net investment in sales-type leases 
is included in Trade receivables in the Consolidated Statement of Financial Position.  The portion of the net investment in sales-type leases due after 
one year is included in Other long-term assets. 

The table below reconciles the undiscounted cash flows to be received for the next five years and thereafter to the net investment in sales-type 
leases recorded in the Consolidated Statement of Financial Position: 

(in millions) 
2021 
2022 
2023 
2024 and thereafter 
Total minimum lease payments 
Less: unearned interest 
Less: allowance for doubtful accounts 
Net investment in sales-type leases 

   $ 

   $ 

2   
2   
1   
1   
6   
(1 ) 
—   
5   

71 

 
 
  
  
  
  
    
  
    
         
    
    
    
  
 
 
 
    
  
    
    
    
    
    
    
    
    
    
 
 
 
 
     
  
  
     
     
     
     
  
  
  
  
 
Undiscounted cash flows to be received for the next five years and thereafter for operating leases and subleases are: 

(in millions) 
2021 
2022 
2023 
2024 
2025 
Thereafter 
Total minimum lease payments 

   $ 

   $ 

Income recognized on lease arrangements for the years ended December 31, 2020 and 2019 is presented below: 

(in millions) 
Lease income - sales-type leases 
Lease income - operating leases 
Sublease income 
Variable lease income (1) 
Total lease income 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

1      $ 
8        
2        
5        
16      $ 

7   
5   
4   
4   
1   
7   
28   

—   
9   
6   
6   
21   

(1)  Variable lease income primarily represents operating costs under real estate leases and incremental variable income based on usage 

under equipment leases. 

Equipment subject to operating leases and the related accumulated depreciation were as follows: 

(in millions) 
Equipment subject to operating leases 
Accumulated depreciation 
Equipment subject to operating leases, net 

As of December 31, 
2019 
2020 

  $ 

  $ 

24     $ 
(19 )     
5     $ 

29   
(20 ) 
9   

Equipment subject to operating leases, net is included in Property, plant and equipment, net in the Consolidated Statement of Financial Position. 

NOTE 12:  COMMITMENTS AND CONTINGENCIES 

Asset Retirement Obligations 
Kodak’s asset retirement obligations primarily relate to asbestos contained in buildings that Kodak owns.  In many of the countries in which Kodak 
operates, environmental regulations exist that require Kodak to handle and dispose of asbestos in a special manner if a building undergoes major 
renovations or is demolished.  Otherwise, Kodak is not required to remove the asbestos from its buildings.  Kodak records a liability equal to the 
estimated fair value of its obligation to perform asset retirement activities related to the asbestos, computed using an expected present value 
technique, when sufficient information exists to calculate the fair value.  Kodak does not have a liability recorded related to every building that 
contains asbestos because Kodak cannot estimate the fair value of its obligation for certain buildings due to a lack of sufficient information about the 
range of time over which the obligation may be settled through demolition, renovation or sale of the building. 

The following table provides asset retirement obligation activity (in millions): 

Asset Retirement Obligations at start of period 
Liabilities incurred in the current period 
Liabilities settled in the current period 
Accretion expense 
Revision in estimated cash flows 
Asset Retirement Obligations at end of period 

For the Year Ended December 31, 

2020 

2019 

   $ 

   $ 

48      $ 
1        
(9 )      
1        
—        
41      $ 

48   
3   
(6 ) 
2   
1   
48   

72 

 
 
     
  
  
     
     
     
     
     
 
 
  
  
  
  
    
  
     
     
     
 
 
 
  
  
  
  
    
  
    
 
 
 
 
  
  
  
  
  
     
  
     
     
     
     
Other Commitments and Contingencies 
As of December 31, 2020, the Company had outstanding letters of credit of $90 million issued under the ABL Credit Agreement as well as bank 
guarantees and letters of credit of $2 million, surety bonds in the amount of $29 million, and restricted cash of $60 million, primarily to support 
compliance with the Excess Availability threshold under the ABL Credit Agreement, to ensure the payment of possible casualty and workers 
compensation claims, environmental liabilities, legal contingencies, rental payments, and to support various customs, hedging, tax and trade 
activities.  The restricted cash and deposits are recorded in Restricted cash – current portion and Restricted cash in the Consolidated Statement of 
Financial Position. 

Kodak’s Brazilian operations are involved in various litigation matters and have received or been the subject of numerous governmental 
assessments related to indirect and other taxes in various stages of litigation, as well as civil litigation and disputes associated with former 
employees and contract labor.  The tax matters, which comprise the majority of the litigation matters, are primarily related to federal and state value-
added taxes.  Kodak is disputing these matters and intends to vigorously defend its position.  Kodak routinely assesses all these matters as to the 
probability of ultimately incurring a liability in its Brazilian operations and records its best estimate of the ultimate loss in situations where it assesses 
the likelihood of loss as probable.  As of December 31, 2020, the unreserved portion of these contingencies, inclusive of any related interest and 
penalties, for which there was at least a reasonable possibility that a loss may be incurred, amounted to approximately $5 million. 

In connection with assessments in Brazil, local regulations may require Kodak to post security for a portion of the amounts in dispute. As of 
December 31, 2020, Kodak has posted security composed of $4 million of pledged cash reported within Restricted cash in the Consolidated 
Statement of Financial Position and liens on certain Brazilian assets with a net book value of approximately $43 million.  Generally, any 
encumbrances on the Brazilian assets would be removed to the extent the matter is resolved in Kodak's favor. 

On July 28, 2020, the U.S. International Development Finance Corporation (the “DFC”) announced (the “DFC Announcement”) the signing of a non-
binding letter of interest to provide a subsidiary of the Company with a potential $765 million loan (the “DFC Loan”) to support the launch of Kodak 
Pharmaceuticals, an initiative that would manufacture pharmaceutical ingredients for essential generic drugs (the “DFC Pharmaceutical Project”). 

On August 13, 2020 Tiandong Tang commenced a class action lawsuit against the Company, its Executive Chairman and Chief Executive Officer 
and its Chief Financial Officer in Federal District Court in the District of New Jersey, and on August 26, 2020 Jimmie A. McAdams and Judy P. 
McAdams commenced a class action lawsuit against the Company and its Executive Chairman and Chief Executive Officer in Federal District Court 
in the Southern District of New York (collectively, the “Securities Class Actions”).  The Securities Class Actions seek damages and other relief based 
on alleged violations of federal securities laws in the context of the DFC Announcement of the potential DFC Loan and DFC Pharmaceutical Project.  
Since the filing of the Securities Class Actions, procedural activities have been ongoing relating to the determination of venue and lead plaintiff.   

In addition to the Securities Class Actions, on December 29, 2020 Robert Garfield commenced a class action lawsuit against the Company and each 
of the members of its Board of Directors, in the Superior Court of Mercer County, New Jersey seeking equitable relief and damages in favor of the 
Company based on alleged breaches of fiduciary duty by the Company’s Board of Directors associated with alleged false and misleading proxy 
statement disclosure (the “Fiduciary Class Action”).  The Company has also received three requests under New Jersey law demanding, among other 
things, that the Company take certain actions in response to alleged breaches of fiduciary duty relating to option grants and securities transactions in 
the context of the DFC Announcement and alleged proxy statement disclosure deficiencies.  The Company has responded to and engaged in 
discussions concerning these requests, and its response and discussions may serve as the basis for the requestors to bring shareholder derivative 
lawsuits (any such lawsuits, collectively with the Fiduciary Class Action, the “Fiduciary Matters”).   

The DFC Announcement has also prompted investigations by several congressional committees, the SEC and the New York Attorney General’s 
office.   

The Securities Class Actions, Fiduciary Matters and investigations by several congressional committees, the SEC and the New York Attorney 
General’s office pertaining to the DFC Announcement remain ongoing.  The Company intends to vigorously defend itself against the Securities Class 
Actions and Fiduciary Matters and is cooperating in the investigations related to the DFC Announcement.  

Kodak is involved in various lawsuits, claims, investigations, remediations and proceedings, including, from time to time, commercial, customs, 
employment, environmental, tort and health and safety matters, which are being handled and defended in the ordinary course of business. Kodak is 
also subject, from time to time, to various assertions, claims, proceedings and requests for indemnification concerning intellectual property, including 
patent infringement suits involving technologies that are incorporated in a broad spectrum of Kodak’s products and claims arising out of Kodak’s 
licensing its brand. These matters are in various stages of investigation and litigation and are being vigorously defended. Based on information 
currently available, Kodak does not believe that it is probable that the outcomes in any of these matters, individually or collectively, will have a 
material adverse effect on its financial condition or results of operations. Litigation is inherently unpredictable, and judgments could be rendered or 
settlements entered that could adversely affect Kodak’s operating results or cash flows in a particular period. Kodak routinely assesses all of its 
litigation and threatened litigation as to the probability of ultimately incurring a liability and records its best estimate of the ultimate loss in situations 
where it assesses the likelihood of loss as probable. 

73 

 
 
 
 
 
 
NOTE 13:  GUARANTEES 

In accordance with the terms of a settlement agreement concerning certain of the Company’s historical environmental liabilities at EBP, in the event 
the historical liabilities exceed $99 million, the Company will become liable for 50% of the portion above $99 million with no limitation to the maximum 
potential future payments.  There is no liability recorded related to this guarantee. 

Indemnifications 
Kodak may, in certain instances, indemnify third parties when it sells businesses and real estate, and in the ordinary course of business with its 
customers, suppliers, service providers and business partners.  Additionally, Kodak indemnifies officers and directors who are, or were, serving at 
Kodak’s request in such capacities.  Historically, costs incurred to settle claims related to these indemnifications have not been material to Kodak’s 
financial position, results of operations or cash flows.  Further, the fair value of any right to indemnification granted during the year ended 
December 31, 2020 was not material to Kodak’s financial position, results of operations or cash flows. 

Extended Warranty Arrangements 
Kodak offers its customers extended warranty arrangements that are generally one year, but may range from three months to six years after the 
original warranty period.  Kodak provides repair services and routine maintenance under these arrangements.  Kodak has not separated the 
extended warranty costs from the routine maintenance service costs, as it is not practicable to do so.  Therefore, these costs have been aggregated 
in the discussion that follows.  The change in Kodak's deferred revenue balance in relation to these extended warranty and maintenance 
arrangements, which is reflected in Other current liabilities in the accompanying Consolidated Statement of Financial Position, was as follows: 

 (in millions) 
Deferred revenue on extended warranties as of December 31, 2018 
New extended warranty and maintenance arrangements 
Recognition of extended warranty and maintenance arrangement 
   revenue 
Deferred revenue on extended warranties as of December 31, 2019 
New extended warranty and maintenance arrangements 
Recognition of extended warranty and maintenance arrangement 
   revenue 
Deferred revenue on extended warranties as of December 31, 2020 

   $ 

   $ 

22   
98   

(99 ) 
21   
91   

(93 ) 
19   

Costs incurred under these extended warranty and maintenance arrangements for the years ended December 31, 2020 and 2019 amounted to $88 
million and $105 million, respectively. 

NOTE 14:  FINANCIAL INSTRUMENTS 

Kodak, as a result of its global operating and financing activities, is exposed to changes in foreign currency exchange rates and interest rates, which 
may adversely affect its results of operations and financial position.  Kodak manages such exposures, in part, with derivative financial instruments.  
Foreign currency forward contracts are used to mitigate currency risk related to foreign currency denominated assets and liabilities, as well as 
forecasted foreign currency denominated intercompany assets.  Kodak’s exposure to changes in interest rates results from its investing and 
borrowing activities used to meet its liquidity needs.  Kodak does not utilize financial instruments for trading or other speculative purposes. 

Kodak’s foreign currency forward contracts are not designated as hedges and are marked to market through net (loss) earnings at the same time 
that the exposed assets and liabilities are re-measured through net (loss) earnings (both in Other charges, net in the Consolidated Statement of 
Operations).  The notional amount of such contracts open at December 31, 2020 and 2019 was approximately $361 million and $332 million, 
respectively.  The majority of the contracts of this type held by Kodak at December 31, 2020 and 2019 were denominated in euros, Japanese yen, 
Chinese renminbi and Swiss francs.  The net effect of foreign currency forward contracts in the results of operations is shown in the following table: 

(in millions) 
Net (gain) loss from derivatives not designated as hedging 
   instruments 

Year Ended December 31, 

2020 

2019 

   $ 

(11 )    $ 

4   

Kodak had no derivatives designated as hedging instruments for the years ended December 31, 2020 and 2019. 

74 

 
 
 
 
 
 
 
       
  
     
     
     
     
     
 
 
 
 
 
  
  
  
  
    
  
 
Kodak’s derivative counterparties are high-quality investment or commercial banks with significant experience with such instruments.  Kodak 
manages exposure to counterparty credit risk by requiring specific minimum credit standards and diversification of counterparties.  Kodak has 
procedures to monitor the credit exposure amounts.  The maximum credit exposure at December 31, 2020 was not significant to Kodak. 

In the event of a default under the Company’s ABL Credit Agreement, or a default under any derivative contract or similar obligation of Kodak, 
subject to certain minimum thresholds, the derivative counterparties would have the right, although not the obligation, to require immediate 
settlement of some or all open derivative contracts at their then-current fair value, but with liability positions netted against asset positions with the 
same counterparty. 

As discussed in Note 9, “Debt and Finance Leases”, the Company concluded that the Convertible Notes were considered more akin to a debt-type 
instrument and that the economic characteristics and risks of the embedded conversion features and term extension option were not considered 
clearly and closely related to the Convertible Notes.  The embedded conversion features not considered clearly and closely related are the 
conversion at the option of the holder (“Optional Conversion”) and the conversion in the event of a fundamental change or reorganization 
(“Fundamental Change or Reorganization Conversion”).  Accordingly, these embedded conversion features and term extension option were 
bifurcated from the Convertible Notes and separately accounted for on a combined basis as a single derivative asset or liability.  The embedded 
conversion features and term extension option were revalued as of August 3, 2020, when the Initial Conversion Shares were issued, resulting in the 
recognition of $407 million of expense for a pro-rata portion of the embedded conversion features and term extension option.  The remaining 
embedded conversion features and term extension option were revalued again as of the Mandatory Conversion date, resulting in the recognition of 
$9 million of net expense. 

With the conversion of the Convertible Notes in the third quarter of 2020, the embedded conversion features and term extension option expired.  The 
derivative was in a liability position at December 31, 2019 and was reported in Other long-term liabilities in the Consolidated Statement of Financial 
Position.  The derivative was being accounted for at fair value with changes in fair value reported in Other charges, net in the Consolidated 
Statement of Operations. 

As discussed in Note 10, “Redeemable, Convertible, Series A Preferred Stock”, Kodak concluded that the Series A Preferred Stock is considered 
more akin to a debt-type instrument and that the economic characteristics and risks of the embedded conversion features, except where the 
conversion price was increased to the liquidation preference, were not considered clearly and closely related to the Series A Preferred Stock.  The 
embedded conversion features not considered clearly and closely related are the conversion at the option of the holder; the ability of Kodak to 
automatically convert the stock after the second anniversary of issuance and the conversion in the event of a fundamental change or reorganization. 
Accordingly, these embedded conversion features were bifurcated from the Series A Preferred Stock and separately accounted for on a combined 
basis as a single derivative liability which is reported in Other current liabilities in the Consolidated Statement of Financial Position as of December 
31, 2020 and in Other long-term liabilities as of December 31, 2019.  The derivative is being accounted for at fair value with changes in fair value 
being reported in Other charges, net in the Consolidated Statement of Operations. 

Fair Value 
Fair values of Kodak’s foreign currency forward contracts are determined using observable inputs (Level 2 fair value measurements) and are based 
on the present value of expected future cash flows (an income approach valuation technique) considering the risks involved and using discount rates 
appropriate for the duration of the contracts.  The gross fair value of foreign currency forward contracts in an asset position are reported in Other 
current assets in the Consolidated Statement of Financial Position and the gross fair value of foreign currency contracts in a liability position are 
reported in Other current liabilities.  The gross fair value of foreign currency forward contracts in an asset position as of December 31, 2020 and 
2019 was $1 million in both periods. The gross fair value of the foreign currency forward contracts in a liability position as of December 31, 2020 and 
2019 was $0 million in both periods. 

The fair value of the embedded conversion features and term extension option for the Convertible Notes were revalued as of August 3, 2020, and 
again at September 30, 2020. The fair value of the embedded derivative at each conversion date was calculated based on the fair value of the 
shares issued less the fair value of debt. The fair value of shares issued is based on the weighted average stock price on the time of day the shares 
were transferred for August 3, 2020, and the closing stock price as of September 30, 2020. The fair value of debt is based on pricing models based 
on the value of related cash flows discounted at current market interest rates. 

75 

 
 
 
 
 
 
 
 
The following table presents the key inputs in the determination of fair value for the embedded conversion features and termination option derivatives 
at each conversion date: 

Total value of embedded derivative liability immediately 
   prior to extinguishment (in millions) 
Value of embedded derivative liability that expired (in millions) 
Value of remaining embedded derivative liability 
Kodak's stock price (1) 
Risk free rate 
Yield on the Convertible Notes 

Valuation Date 

   September 30,       August 3, 

2020 

2020 

  $ 
  $ 
  $ 
  $ 

9      $ 
9      $ 
—      $ 
8.82      $ 
0.12 %     
8.93 %     

429   
416   
13   
16.91   
0.12 % 
9.47 % 

(1)  The closing stock price was used for the September 30, 2020 valuation.  The weighted average stock price based on 

the time of day the shares were transferred was used for the August 3, 2020 valuation. 

Except as discussed above for the fair value determined at the time of conversion, the fair value of the embedded conversion features and term 
extension option derivatives are calculated using unobservable inputs (Level 3 fair measurements).  The value of the Optional Conversion feature 
associated with both the Convertible Notes and Series A Preferred Stock is calculated using a binomial lattice model.  The value of the term 
extension option reflects the probability weighted average value of the Convertible Notes using the original maturity date and a hypothetical extended 
maturity date, with all other contractual terms unchanged.  The following tables present the key inputs in the determination of fair value for the 
embedded conversion features and termination option derivatives.  

Convertible Notes: 

Total value of embedded derivative liability (in millions) 
Kodak's closing stock price 
Expected stock price volatility 
Risk free rate 
Yield on the Convertible Notes 

Series A Preferred Stock: 

   Valuation Date 
   December 31, 

2019 

   $ 

51   
4.65   
104.61 % 
1.58 % 
11.52 % 

Total value of embedded derivative liability (in millions) 
Kodak's closing stock price 
Expected stock price volatility 
Risk free rate 
Yield on the preferred stock 

Valuation Date 
December 31, 

2020 

2019 

  $ 

9      $ 
8.14        
133.44 %     
0.10 %     
11.97 %     

1   
4.65   
104.61 % 
1.58 % 
16.27 % 

The Fundamental Change and Reorganization Conversion values at issuance were calculated as the difference between the total value of the 
Convertible Notes or Series A Preferred Stock, as applicable, and the sum of the net present value of the cash flows if the Convertible Notes are 
repaid at their maturity or the Series A Preferred Stock is redeemed on its fifth anniversary and the values of the other embedded derivatives. The 
Fundamental Change and Reorganization Conversion value reduces the value of the embedded conversion features and term extension option 
derivative liability.  Other than events which alter the likelihood of a fundamental change or reorganization event, the value of the Fundamental 
Change and Reorganization Conversion reflect the value as of the issuance date, amortized for the passage of time.   

The fair values of long-term borrowings were $17 million and $111 million at December 31, 2020 and 2019, respectively. 

Fair values of long-term borrowings (Level 2 fair value measurements) are determined by reference to quoted market prices, if available, or by 
pricing models based on the value of related cash flows discounted at current market interest rates.  

76 

 
 
  
  
  
  
  
  
  
  
  
  
    
    
 
 
 
 
  
  
  
  
  
  
  
     
     
     
     
 
  
  
  
  
  
  
  
  
  
  
  
    
    
    
    
 
 
 
 
Transfers between levels of the fair value hierarchy are recognized based on the actual date of the event or change in circumstances that caused the 
transfer.  There were no transfers between levels of the fair value hierarchy during the year ended December 31, 2020. 

The carrying values of cash and cash equivalents, restricted cash and the current portion of long-term borrowings approximate their fair values.   

NOTE 15:  REVENUE 

Disaggregation of Revenue 

The following tables present revenue disaggregated by major product, portfolio summary and geography.  

Major product: 

Plates, inks and other 
   consumables 
Ongoing service 
   arrangements (1) 

Equipment & Software 
Film and chemicals 
Other (2) 
Total 

Plates, inks and other 
   consumables 
Ongoing service 
   arrangements (1) 

Equipment & Software 
Film and chemicals 
Other (2) 
Total 

Year Ended 
December 31, 2020 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

Brand 

Other 

Total 

   $ 

463      $ 

64      $ 

5      $ 

—      $ 

—      $ 

532   

Total Annuities      

   $ 

80        
543        
49        
—        
—        
592      $ 

131        
195        
46        
—        
—        
241      $ 

1        
6        
—        
154        
12        
172      $ 

—        
—        
—        
—        
13        
13      $ 

—        
—        
—        
—        
11        
11      $ 

212   
744   
95   
154   
36   
1,029   

Year Ended 
December 31, 2019 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

Brand 

Other 

Total 

   $ 

572      $ 

83      $ 

11      $ 

—      $ 

—      $ 

666   

Total Annuities      

   $ 

86        
658        
56        
—        
13        
727      $ 

155        
238        
55        
—        
—        
293      $ 

3        
14        
—        
166        
20        
200      $ 

—        
—        
—        
—        
12        
12      $ 

—        
—        
—        
—        
10        
10      $ 

244   
910   
111   
166   
55   
1,242   

(1)  Service revenue in the Consolidated Statement of Operations includes the ongoing service revenue shown above as well as revenue from 

project-based document management and managed print services businesses, which is included in Other above. 

(2)  Other includes revenue from professional services, non-recurring engineering services, print and managed media services, tenant rent and 

related property management services and licensing. 

77 

 
 
 
 
  
 
 
  
  
  
  
  
  
  
     
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
     
  
     
     
     
     
  
       
         
        
        
         
         
  
  
  
  
  
  
  
  
     
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
     
  
     
     
     
     
 
 
 
Product Portfolio Summary: 

Growth engines (1) 
Strategic other businesses (2) 
Planned declining 
   businesses (3) 

Growth engines (1) 
Strategic other businesses (2) 
Planned declining 
   businesses (3) 

  $ 

  $ 

  $ 

  $ 

Year Ended 
December 31, 2020 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

Brand 

Other 

Total 

162   
  $ 
430       

—       
  $ 

592   

135   
  $ 
52       

54       
  $ 
241   

3   
  $ 
159       

10       
  $ 
172   

13   
  $ 
—       

—       
  $ 
13   

—   
  $ 
11       

—       
  $ 
11   

313   
652   

64   
1,029   

Year Ended 
December 31, 2019 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

Brand 

Other 

Total 

180   
  $ 
547       

—       
  $ 

727   

140   
  $ 
78       

75       
  $ 
293   

3   
  $ 
172       

25       
  $ 
200   

12   
  $ 
—       

—       
  $ 
12   

—   
  $ 
10       

—       
  $ 
10   

335   
807   

100   
1,242   

(1)  Growth engines consist of Sonora in the Traditional Printing segment, PROSPER and Software in the Digital Printing segment, brand 

licensing and Advanced Materials and Functional Printing in the Advanced Materials and Chemicals segment, excluding intellectual 
property (IP) licensing. 

(2)  Strategic other businesses include plates and CTP equipment and related service in the Traditional Printing segment; Nexpress and 

related toner business in the Digital Printing segment; and Motion Picture and Industrial Film and Chemicals (including external inks) and 
IP licensing in the Advanced Materials and Chemicals segment. 

(3)  Planned declining businesses are product lines where the decision has been made to stop new product development and manage an 

orderly expected decline in the installed product and annuity base or are otherwise not strategic to Kodak. These product families consist 
of Consumer Inkjet, KSB and Kodakit in the Advanced Materials and Chemicals segment and Versamark and Digimaster in the Digital 
Printing segment. 

78 

 
 
  
  
  
  
  
  
  
    
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
     
  
    
    
  
  
      
        
        
        
        
        
  
  
  
  
  
  
  
  
    
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
     
  
    
    
  
 
 
 
 
Geography (1): 

United States 
Canada 

North America 

Europe, Middle East and Africa 
Asia Pacific 
Latin America 
Total Sales 

United States 
Canada 

North America 

Europe, Middle East and Africa 
Asia Pacific 
Latin America 
Total Sales 

  $ 

  $ 

  $ 

  $ 

Year Ended 
December 31, 2020 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

Brand 

Other 

Total 

121   
  $ 
14       
135       
257       
171        
29   
592     $ 

106   

  $ 
8       
114       
86       
37        
4   
241     $ 

115   

  $ 
1       
116       
12       
43        
1   
172     $ 

13   
  $ 
—       
13       
—       
—        
—   
13     $ 

11   
  $ 
—       
11       
—       
—        
—   
11     $ 

366   
23   
389   
355   
251   
34   
1,029   

Year Ended 
December 31, 2019 

Traditional 
Printing 

Digital 
Printing 

Advanced 
Materials and 
Chemicals 

162   
  $ 
13       
175       
300       
208        
44   
727     $ 

147   

  $ 
8       
155       
87       
44        
7   
293     $ 

122   

  $ 
2       
124       
21       
54        
1   
200     $ 

Brand 

Other 

Total 

12   
  $ 
—       
12       
—       
—        
—   
12     $ 

10   
  $ 
—       
10       
—       
—        
—   
10     $ 

453   
23   
476   
408   
306   
52   
1,242   

(1)  Sales are reported in the geographic area in which they originate.  No non-U.S. country generated more than 10% of net sales in the years 

ended December 31, 2020 and 2019. 

Contract Balances 
The timing of revenue recognition, billings and cash collections results in billed trade receivables, unbilled receivables (contract assets), and 
customer advances and deposits (contract liabilities) in the Consolidated Statement of Financial Position.  The contract assets are transferred to 
trade receivables when the rights to consideration become unconditional.   The amounts recorded for contract assets at December 31, 2020 and 
2019 were $2 million and $4 million, respectively, and are reported in Other current assets in the Consolidated Statement of Financial Position.  The 
contract liabilities primarily relate to prepaid service contracts, upfront payments for certain equipment purchases or prepaid royalties on intellectual 
property arrangements.  The amounts recorded for contract liabilities at December 31, 2020 and 2019 were $64 million and $61 million, respectively, 
of which $47 million and $43 million, respectively, are reported in Other current liabilities and $17 million and $18 million, respectively, are reported in 
Other long-term liabilities in the Consolidated Statement of Financial Position. 

Revenue recognized for the years ended December 31, 2020 and 2019 that was included in the contract liability balance at the beginning of the year 
was $43 million and $34 million, respectively, and primarily represented revenue from prepaid service contracts and equipment revenue recognition.  
Contract liabilities as of December 31, 2020 and 2019 included $41 million and $47 million, respectively of cash payments received during the years 
ended December 31, 2020 and 2019, respectively.  

79 

 
  
  
  
  
  
  
  
    
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
    
  
    
    
    
    
    
    
    
    
    
    
  
  
  
  
  
  
  
  
  
    
  
       
  
       
  
       
  
       
  
       
  
  
  
  
     
     
     
     
    
  
    
    
    
    
    
    
    
    
    
    
 
 
 
 
 
NOTE 16:  OTHER OPERATING (INCOME) EXPENSE, NET 

(in millions) 
Expense (income): 
(Gain) loss related to the sales of assets (1), (2) 
Transition services agreement income 
Asset impairments (3), (4) 
Other 

Total 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

(10 )    $ 
(6 )      
3        
(1 )      
(14 )    $ 

14   
(6 ) 
6   
1   
15   

(1) 

(2) 

(3) 

(4) 

In the first quarter of 2020, Kodak sold a property in the U.S. and recognized a gain of $9 million.   

In the third quarter of 2019, Kodak sold its shares of Kodak (China) Graphic Communication Co., Ltd. and recognized a loss of $12 million. 

In the fourth quarter of 2019, Kodak determined the carrying value of one building no longer in use exceeded its fair value and recorded an 
impairment charge of $2 million. 

In the first quarter of 2020 and the fourth quarter of 2019, Kodak recorded impairment charges of $3 million and $4 million, respectively, 
related to the Kodak trade name. Refer to Note 5, “Goodwill and Other Intangible Assets”.   

NOTE 17:  OTHER CHARGES, NET 

(in millions) 
Change in fair value of embedded conversion features 
   derivative (1) 
Loss on foreign exchange transactions 
Other 
Total 

Year Ended December 31, 
2019 
2020 

   $ 

   $ 

382      $ 
5        
(1 )      
386      $ 

42   
3   
1   
46   

(1) 

 Refer to Note 14, “Financial Instruments”. 

NOTE 18:  INCOME TAXES 

The components of (Loss) earnings from continuing operations before income taxes and the related provision for U.S. and other income taxes 
were as follows (in millions): 

(Loss) earnings from continuing operations before 
   income taxes: 
U.S. 
Outside the U.S. 

Total 

U.S. income taxes: 
Current benefit 
Deferred provision 

Income taxes outside the U.S.: 
Current (benefit) provision 
Deferred provision 
Total provision 

80 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

   $ 

   $ 

(388 )    $ 
12        
(376 )    $ 

—      $ 
2        

(3 )      
169        
168      $ 

(68 ) 
8   
(60 ) 

—   
—   

7   
24   
31   

 
 
 
  
  
  
  
    
  
       
         
  
     
     
     
 
 
 
 
 
 
  
 
  
  
  
  
    
  
     
     
 
 
 
 
  
  
  
  
  
    
  
       
         
  
     
       
         
  
     
       
         
  
     
     
The differences between income taxes computed using the U.S. federal income tax rate and the provision for income taxes for continuing operations 
were as follows (in millions): 

Amount computed using the statutory rate 
Increase (reduction) in taxes resulting from: 

Unremitted foreign earnings 
Operations outside the U.S. 
Legislative tax law and rate changes 
Valuation allowance 
Tax settlements and adjustments, including interest 
Embedded derivative liability 

Year Ended December 31, 

2020 

2019 

   $ 

(79 )    $ 

(13 ) 

2        
3        
(11 )      
220        
(43 )      
81        

(5 )      
168      $ 

(1 ) 
22   
1   
11   
2   
9   

—   
31   

Other, net 

Provision from income taxes 

   $ 

The significant components of deferred tax assets and liabilities were as follows (in millions): 

Deferred tax assets 

Pension and postretirement obligations 
Restructuring programs 
Leasing 
Foreign tax credit 
Inventories 
Investment tax credit 
Employee deferred compensation 
Depreciation 
Research and development costs 
Tax loss carryforwards 
Other deferred revenue 
Other 

Total deferred tax assets 

Deferred tax liabilities 
Goodwill/intangibles 
Unremitted foreign earnings 

Total deferred tax liabilities 
Net deferred tax assets before valuation allowance 
Valuation allowance 

Net deferred tax (liabilities) assets 

As of December 31, 
2019 
2020 

   $ 

   $ 

   $ 

   $ 

25     $ 
2       
4       
358       
9       
42       
26       
36       
40       
480       
2       
89       
1,113     $ 

10     $ 
22       
32       
1,081       
1,112       
(31 )   $ 

39   
2   
1   
355   
8   
46   
24   
41   
56   
325   
2   
86   
985   

11   
19   
30   
955   
821   
134   

Deferred tax (liabilities) assets are reported in the following components within the Consolidated Statement of Financial Position (in millions): 

Deferred income taxes 
Other long-term liabilities 
Net deferred tax (liabilities) assets 

As of December 31, 
2019 
2020 

  $ 

  $ 

—     $ 
(31 )     
(31 )   $ 

147   
(13 ) 
134   

As of December 31, 2020, Kodak had available domestic and foreign NOL carry-forwards for income tax purposes of approximately $2,068 million, 
of which approximately $856 million have an indefinite carry-forward period.  The remaining $1,212 million expire between the years 2021 and 2038.  

81 

 
 
 
  
  
  
  
  
    
  
       
         
  
     
     
     
     
     
     
  
       
         
  
     
 
 
  
  
  
  
  
    
  
       
        
  
     
     
     
     
     
     
     
     
     
     
     
  
       
        
  
       
        
  
     
     
     
     
 
 
  
  
  
  
  
    
  
    
 
As of December 31, 2020, Kodak had unused foreign tax credits and investment tax credits of $358 million and $42 million, respectively, with various 
expiration dates through 2039. 

Utilization of NOL carry-forwards and tax credits may be subject to limitations in the event of significant changes in stock ownership of the Company 
in the future. Section 382 of the Internal Revenue Code of 1986, as amended, imposes annual limitations on the utilization of NOL carryforwards, 
other tax carryforwards, and certain built-in losses as defined under that Section, upon an ownership change. In general terms, an ownership change 
may result from transactions that increase the aggregate ownership of certain stockholders in Kodak’s stock by more than 50 percentage points over 
a three-year testing period. 

Kodak had deferred tax liabilities of $22 million and $19 million for potential taxes on the undistributed earnings, including foreign withholding taxes, 
as of December 31, 2020 and 2019, respectively. 

Kodak’s valuation allowance as of December 31, 2020 was $1,112 million.  Of this amount, $374 million was attributable to Kodak’s net 
deferred tax assets outside the U.S. of $364 million, and $738 million related to Kodak’s net deferred tax assets in the U.S. of $717 million, 
for which Kodak believes it is not more likely than not that the assets will be realized.  

As of March 31, 2020, Kodak determined that it was more likely than not that deferred tax assets outside the U.S. which were not offset with 
valuation allowances as of March 31, 2020 would not be realized due to reductions in estimates of future profitability as a result of the COVID-19 
pandemic in locations outside the U.S.  Accordingly, Kodak recorded a provision of $167 million associated with the establishment of a valuation 
allowance on those deferred tax assets.   

Kodak’s valuation allowance as of December 31, 2019 was $821 million.  Of this amount, $168 million was attributable to Kodak’s net 
deferred tax assets outside the U.S. of $322 million, and $653 million related to Kodak’s net deferred tax assets in the U.S. of $633 million, 
for which Kodak believes it is not more likely than not that the assets will be realized.  

During 2019, Kodak determined that it was more likely than not that a portion of the deferred tax assets outside the U.S. would not be realized due to 
reduced sales volumes and profits in locations outside the U.S. and accordingly recorded a provision of $19 million associated with the 
establishment of a valuation allowance on those deferred tax assets.   

Accounting for Uncertainty in Income Taxes 

A reconciliation of the beginning and ending amount of Kodak’s liability for income taxes associated with unrecognized tax benefits is as follows  
(in millions): 

Balance as of January 1 
Tax positions related to the current year: 
Additions 
Tax positions related to prior years: 
Additions 
Reductions 
Settlements with taxing jurisdictions 
Balance as of December 31 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

54      $ 

—        

2        
(42 )      
(6 )      
8      $ 

57   

—   

1   
(1 ) 
(3 ) 
54   

Kodak’s policy regarding interest and/or penalties related to income tax matters is to recognize such items as a component of income tax (benefit) 
expense.  Kodak had approximately $14 million  of interest and penalties associated with uncertain tax benefits accrued as of December 31, 2020 
and 2019. 

Kodak had uncertain tax benefits of approximately $22 million and $20 million as of December 31, 2020 and 2019, respectively, that, if recognized, 
would affect the effective income tax rate.  Kodak has classified certain income tax liabilities as current or noncurrent based on management’s 
estimate of when these liabilities will be settled.  The current liabilities are recorded in Other current liabilities in the Consolidated Statement of 
Financial Position.  Noncurrent income tax liabilities are recorded in Other long-term liabilities in the Consolidated Statement of Financial Position. 

It is reasonably possible that the liability associated with Kodak’s unrecognized tax benefits will increase or decrease within the next twelve months.  
These changes may be the result of settling ongoing audits or the expiration of statutes of limitations.  Such changes to the unrecognized tax 
benefits could range from $0 million to $5 million based on current estimates.  Audit outcomes and the timing of audit settlements are subject to 
significant uncertainty. 

82 

 
 
 
 
 
 
 
 
  
  
  
  
  
    
  
       
         
  
     
       
         
  
     
     
     
 
Although management believes that adequate provision has been made for such issues, there is the possibility that the ultimate resolution of such 
issues could have an adverse effect on the earnings of Kodak.  Conversely, if these issues are resolved favorably in the future, the related provision 
would be reduced, thus having a positive impact on earnings. 

During 2020, Kodak agreed to terms with the IRS and settled the federal audit for calendar years 2013 and 2014.  For these years, Kodak originally 
recorded a federal unrecognized tax position (“UTP”) totaling $41 million, which was fully offset by tax attributes.  This settlement resulted in an 
increase in net deferred tax assets and was fully offset by a corresponding increase in Kodak’s U.S. valuation allowance, resulting in no net tax 
benefit. 

During 2019, Kodak reached a settlement outside of the U.S. and settled an audit for calendar years 2005-2008.  Kodak originally recorded liabilities 
for UTPs totaling $3 million (plus interest of approximately $3 million).  Kodak paid $2 million in 2019 as result of this settlement and paid the 
remaining $4 million in April 2020. 

Kodak is subject to taxation and files income tax returns in the U.S. federal jurisdiction and in many state and foreign jurisdictions.  Kodak has 
substantially concluded all U.S. federal income tax matters for years through 2015 and state income tax matters for years through 2012 with the 
respective tax authorities.  With respect to countries outside the U.S., Kodak has substantially concluded all material foreign income tax matters 
through 2013 with respective foreign tax jurisdiction authorities. 

NOTE 19:  RESTRUCTURING COSTS AND OTHER 

Kodak recognizes the need to continually rationalize its workforce and streamline its operations in the face of ongoing business and economic 
changes.  Charges for restructuring initiatives are recorded in the period in which Kodak commits to a formalized restructuring plan, or executes the 
specific actions contemplated by the plan and all criteria for liability recognition under the applicable accounting guidance have been met. 

The activity in the accrued balances and the non-cash charges and credits incurred in relation to restructuring programs during the two years ended 
December 31, 2020 were as follows (in millions): 

Balance as of December 31, 2018 
Charges 
Utilization/cash payments 
Other adjustments & reclasses (2) 
Balance as of December 31, 2019 
Charges 
Utilization/cash payments 
Other adjustments & reclasses (2) 
Balance as of December 31, 2020 

Severance 
Reserve (1) 

Exit Costs 
Reserve (1) 

Long-lived 
Asset 
Impairments 
and Inventory 
Write-downs (1) 

  $ 

  $ 

6   
16   
(8 ) 
(3 ) 
11   
16   
(14 ) 
(3 ) 
10   

  $ 

  $ 

2   
—   
(1 ) 
—   
1   
1   
(1 ) 
—   
1   

  $ 

  $ 

—   
—   
—   
—   
—   
—   
—   
—   
—   

Total 

  $ 

  $ 

8   
16   
(9 ) 
(3 ) 
12   
17   
(15 ) 
(3 ) 
11   

(1)  The severance and exit costs reserves require the outlay of cash, while long-lived asset impairments, accelerated depreciation and inventory 

write-downs represent non-cash items. 

(2)  The $3 million both in 2020 and 2019 represented severance charges funded from pension plan assets, which were reclassified to Pension and 

other postretirement liabilities.   

2019 Activity 

Restructuring actions taken in 2019 were initiated to reduce Kodak’s cost structure as part of its commitment to drive sustainable profitability and 
included various targeted reductions in manufacturing, service, sales, research and development, and other administrative functions. 

As a result of these actions, for the year ended December 31, 2019 Kodak recorded $16 million of charges which were reported as Restructuring 
costs and other in the accompanying Consolidated Statement of Operations. 

The 2019 severance costs related to the elimination of approximately 220 positions, including approximately 150 administrative, 65 
manufacturing/service, and 5 research and development positions.  The geographic composition of these positions included approximately 90 in the 
U.S. and Canada and 130 throughout the rest of the world. 

83 

 
 
 
 
 
 
 
 
  
  
     
     
     
  
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
 
 
2020 Activity 

Restructuring actions taken in 2020 were initiated to reduce Kodak’s cost structure as part of its commitment to drive sustainable profitability and 
included various targeted reductions in manufacturing, service, sales and other administrative functions. 

As a result of these actions, for the year ended December 31, 2020 Kodak recorded $17 million of charges which were reported as Restructuring 
costs and other in the accompanying Consolidated Statement of Operations. 

The 2020 severance costs related to the elimination of approximately 250 positions, including approximately 160 administrative and 90 
manufacturing/service positions.  The geographic composition of these positions included approximately 140 in the U.S. and Canada and 110 
throughout the rest of the world. 

As a result of these initiatives, the majority of the severance liabilities as of December 31, 2020 will be paid during periods through the end of 2021.  
The exit cost reserves primarily relate to a liability for which timing of the payment is uncertain. 

NOTE 20:  RETIREMENT PLANS 

Substantially all U.S. employees are covered by a noncontributory defined benefit plan, the Kodak Retirement Income Plan (“KRIP”), which is funded 
by Company contributions to an irrevocable trust fund.  The funding policy for KRIP is to contribute amounts sufficient to meet minimum funding 
requirements as determined by employee benefit and tax laws plus any additional amounts the Company determines to be appropriate.  Assets in 
the trust fund are held for the sole benefit of participating employees and retirees.  They are composed of corporate equity and debt securities, U.S. 
government securities, partnership investments, interests in pooled funds, commodities, real estate, and various types of interest rate, foreign 
currency, debt, and equity market financial instruments. 

For U.S. employees hired prior to March 1999, KRIP’s benefits were generally based on a formula recognizing length of service and final average 
earnings.  KRIP included a separate cash balance formula for all U.S. employees hired after February 1999, as well as employees hired prior to that 
date who opted into the cash balance formula during a special election period.  Effective January 1, 2015 the KRIP was amended to provide that all 
participants accrue benefits under a single, revised cash balance formula (the “Cash Balance Plan”).  The Cash Balance Plan credits employees' 
hypothetical accounts with an amount equal to a specified percentage of their pay, plus interest based on the 30-year Treasury bond rate.  Effective 
January 1, 2020, the credits increased from 7% or 8% of pay to either 9% or 10% of pay. 

Many subsidiaries and branches operating outside the U.S. have defined benefit retirement plans covering substantially all employees.  
Contributions by Kodak for these plans are typically deposited under government or other fiduciary-type arrangements.  Retirement benefits are 
generally based on contractual agreements that provide for benefit formulas using years of service and/or compensation prior to retirement.  The 
actuarial assumptions used for these plans reflect the diverse economic environments within the various countries in which Kodak operates. 

Information on the major funded and unfunded U.S. and Non-U.S. defined benefit pension plans is presented below.  The composition of the major 
plans may vary from year to year.  If the major plan composition changes, prior year data is conformed to ensure comparability. 

84 

 
 
 
 
The measurement date used to determine the pension obligation for all funded and unfunded U.S. and Non-U.S. defined benefit plans is December 31. 

(in millions) 
Change in Benefit Obligation 
Projected benefit obligation at beginning of period 

Service cost 
Interest cost 
Benefit payments 
Actuarial loss 
Settlements 
Special termination benefits 
Currency adjustments 

Projected benefit obligation at end of period 

Change in Plan Assets 
Fair value of plan assets at beginning of period 

Gain on plan assets 
Employer contributions 
Benefit payments 
Settlements 
Currency adjustments 

Fair value of plan assets at end of period 

Over (under) funded status at end of period 

Accumulated benefit obligation at end of period 

Year Ended 
December 31, 2020 
U.S. 

      Non-U.S. 

Year Ended 
December 31, 2019 
U.S. 

      Non-U.S. 

   $ 

   $ 

   $ 

   $ 

   $ 

   $ 

3,475      $ 
11        
86        
(277 )      
299        
(121 )      
3        
—        
3,476      $ 

3,610      $ 
495        
—        
(277 )      
(121 )      
—        
3,707      $ 

834      $ 
3        
9        
(47 )      
39        
—        
—        
74        
912      $ 

661      $ 
20        
7        
(47 )      
—        
55        
696      $ 

3,405      $ 
10        
122        
(349 )      
284        
—        
3        
—        
3,475      $ 

3,445      $ 
514        
—        
(349 )      
—        
—        
3,610      $ 

834   
3   
13   
(48 ) 
36   
—   
—   
(4 ) 
834   

671   
28   
10   
(48 ) 
—   
—   
661   

231      $ 

(216 )    $ 

135      $ 

(173 ) 

3,473      $ 

903      $ 

3,474      $ 

825   

The settlement amount of $121 million for the U.S. for the year ended December 31,2020 represents lump sum payments from KRIP. 

Amounts recognized in the Consolidated Statement of Financial Position for all major funded and unfunded U.S. and Non-U.S. defined benefit plans 
are as follows (in millions): 

Other long-term assets 
Pension and other postretirement liabilities 

Net amount recognized 

As of December 31, 

2020 
     Non-U.S. 

U.S. 

2019 
     Non-U.S. 

U.S. 

   $ 

   $ 

231      $ 
—        
231      $ 

16      $ 
(232 )      
(216 )    $ 

135      $ 
—        
135      $ 

26   
(199 ) 
(173 ) 

Information with respect to the major funded and unfunded U.S. and Non-U.S. defined benefit plans with a projected benefit obligation in excess of 
plan assets is as follows (in millions): 

` 

Projected benefit obligation 
Fair value of plan assets 

As of December 31, 

2020 

2019 

U.S. 

      Non-U.S. 

U.S. 

Non-U.S. 

  $ 

—     $ 
—       

618      $ 
386        

—      $ 
—        

568   
368   

85 

 
 
  
  
     
  
  
     
  
       
         
         
         
  
     
     
     
     
     
     
     
  
       
         
         
         
  
       
         
         
         
  
     
     
     
     
     
  
       
         
         
         
  
  
       
         
         
         
  
 
 
 
  
  
  
  
  
    
  
  
  
    
  
     
 
 
  
  
  
  
    
  
  
  
    
     
  
    
 
Information with respect to the major funded and unfunded U.S. and Non-U.S. defined benefit plans with an accumulated benefit obligation in excess 
of plan assets is as follows (in millions): 

Accumulated benefit obligation 
Fair value of plan assets 

As of December 31, 

2020 

2019 

U.S. 

      Non-U.S. 

U.S. 

Non-U.S. 

  $ 

—     $ 
—       

609      $ 
386        

—      $ 
—        

559   
368   

Amounts recognized in accumulated other comprehensive (loss) income for all major funded and unfunded U.S. and Non-U.S. defined benefit plans 
consist of (in millions): 

Prior service credit 
Net actuarial loss 

Total 

As of December 31, 

2020 
     Non-U.S. 

U.S. 

2019 
     Non-U.S. 

U.S. 

   $ 

   $ 

13      $ 
(220 )      
(207 )    $ 

2      $ 
(182 )      
(180 )    $ 

20      $ 
(244 )      
(224 )    $ 

3   
(151 ) 
(148 ) 

Other changes in major plan assets and benefit obligations recognized in Other comprehensive income (expense) are as follows (in millions): 

Newly established gain (loss) 
Amortization of: 

Prior service credit 
Net actuarial loss 

Curtailment gain recognized in expense 
Net loss recognized in expense due to settlement 
Total income (loss) recognized in Other 
   comprehensive income 

Year Ended December 31, 

2020 

2019 

U.S. 

Non-U.S. 

U.S. 

Non-U.S. 

   $ 

—      $ 

(38 )    $ 

16      $ 

(7 )      
15        
—        
9        

—        
7        
—        
—        

(7 )      
—        
(2 )      
—        

   $ 

17      $ 

(31 )    $ 

7      $ 

(30 ) 

—   
5   
—   
—   

(25 ) 

The Non-U.S. losses were driven primarily by discount rate changes.  In the U.S., losses due to discount rate changes were offset by asset gains. 

86 

 
 
  
  
  
  
  
    
  
  
  
    
     
  
    
 
 
  
  
  
  
  
    
  
  
  
    
  
     
 
 
  
  
  
  
  
    
  
  
  
    
    
    
  
       
         
         
         
  
     
     
     
     
 
  
Pension income for all defined benefit plans included (in millions): 

Major defined benefit plans: 

Service cost 
Interest cost 
Expected return on plan assets 
Amortization of: 

Prior service credit 
Actuarial loss 

Pension income before special termination 
   benefits 

Special termination benefits 
Curtailment gains 
Settlement losses 
Net pension income for major 
   defined benefit plans 

Other plans including unfunded plans 
Net pension (income), expense 

Year Ended December 31, 

2020 

2019 

U.S. 

Non-U.S. 

U.S. 

Non-U.S. 

   $ 

   $ 

11      $ 
86        
(196 )      

(7 )      
15        

(91 )      
3        
—        
9        

(79 )      
—        
(79 )    $ 

3      $ 
9        
(19 )      

—        
7        

—        
—        
—        
—        

—   

1        
1      $ 

10      $ 
122        
(214 )      

(7 )      
—        

(89 )      
3        
(2 )      
—        

(88 )      
—        
(88 )    $ 

3   
13   
(22 ) 

—   
5   

(1 ) 
—   
—   
—   

(1 ) 
(3 ) 
(4 ) 

The $2 million curtailment gain for the year ended December 31, 2019 was incurred as a result of the sale of FPD.  In addition, the amounts shown 
in Other Plans for the year ended December 31, 2019 include $5 million of settlement gains due to the transfer of non-major, non-U.S. pension 
liabilities as a result of the sale of FPD.  These amounts are included in Earnings from discontinued operations in the Consolidated Statement of 
Operations. 

The $9 million settlement loss for the year ended December 31, 2020 was incurred as a result of lump sum payments from KRIP. 

The special termination benefits of $3 million for each of the years ended December 31, 2020 and 2019 were incurred as a result of Kodak's 
restructuring actions and, therefore, have been included in Restructuring costs and other in the Consolidated Statement of Operations for those 
periods. 

The weighted-average assumptions used to determine the benefit obligation amounts for all major funded and unfunded U.S. and Non-U.S. defined 
benefit plans were as follows: 

Discount rate 
Salary increase rate 
Interest crediting rate for cash balance plan 

As of December 31, 

2020 

2019 

U.S. 

Non-U.S. 

U.S. 

Non-U.S. 

2.09 %      
3.50 %      
1.75 %   

1.01 %      
1.56 %      
NA         

2.97 %      
3.50 %      
2.50 %   

1.44 % 
1.72 % 
NA   

The weighted-average assumptions used to determine net pension (income) expense for all the major funded and unfunded U.S. and Non-U.S. 
defined benefit plans were as follows: 

Effective rate for service cost 
Effective rate for interest cost 
Salary increase rate 
Expected long-term rate of return on 
   plan assets 
Interest crediting rate for cash balance plan 

Year Ended December 31, 

2020 

2019 

U.S. 

Non-U.S. 

U.S. 

Non-U.S. 

2.97 % 
2.58 %      
3.50 %      

6.00 %      
2.50 %   

1.48 %      
1.19 %      
1.72 %      

3.27 %      
NA         

4.03 % 
3.75 %      
3.50 %      

6.50 %      
2.50 %   

2.47 % 
1.89 % 
2.06 % 

3.46 % 
NA   

87 

 
 
  
  
  
  
  
    
  
  
  
    
    
    
  
       
         
         
         
  
     
     
       
         
         
         
  
     
     
     
     
     
     
     
  
  
     
 
 
 
 
 
  
  
  
  
  
     
  
  
  
     
     
     
  
     
     
     
 
 
  
  
  
  
  
     
  
  
  
     
     
     
  
     
    
    
     
     
     
     
 
 
 
Plan Asset Investment Strategy 

The investment strategy underlying the asset allocation for the pension assets is to achieve an optimal return on assets with an acceptable level of 
risk while providing for the long-term liabilities and maintaining sufficient liquidity to pay current benefits and other cash obligations of the plans.  This 
is primarily achieved by investing in a broad portfolio constructed of various asset classes including equity and equity-like investments, debt and 
debt-like investments, real estate, private equity and other assets and instruments.  Long duration bonds and Treasury bond futures are used to 
partially match the long-term nature of plan liabilities. Other investment objectives include maintaining broad diversification between and within asset 
classes and fund managers and managing asset volatility relative to plan liabilities. 

Every three years, or when market conditions have changed materially, each of Kodak’s major pension plans will undertake an asset allocation or 
asset and liability modeling study.  The asset allocation and expected return on the plans’ assets are individually set to provide for benefits and other 
cash obligations within each country’s legal investment constraints. 

Actual allocations may vary from the target asset allocations due to market value fluctuations, the length of time it takes to implement changes in 
strategy, and the timing of cash contributions and cash requirements of the plans.  The asset allocations are monitored and are rebalanced in 
accordance with the policy set forth for each plan. 

The total plan assets attributable to the major U.S. defined benefit plans as of December 31, 2020 relates to KRIP.  The expected long-term rate of 
return on plan assets assumption (“EROA”) is based on a combination of formal asset and liability studies that include forward-looking return 
expectations given the current asset allocation.  A review of the EROA as of December 31, 2020, based upon the current asset allocation and 
forward-looking expected returns for the various asset classes in which KRIP invests, resulted in an EROA of 5.2%. 

Plan Asset Risk Management 

Kodak evaluates its defined benefit plans’ asset portfolios for the existence of significant concentrations of risk.  Types of concentrations that are 
evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country, and individual fund.  Foreign 
currency contracts and swaps are used to partially hedge foreign currency risk.  Additionally, Kodak’s major defined benefit pension plans invest in 
government bond futures and long duration investment grade bonds to partially hedge the liability risk of the plans.  As of December 31, 2020 and 
2019, there were no significant concentrations (defined as greater than 10% of plan assets) of risk in Kodak’s defined benefit plan assets. 

The Company’s weighted-average asset allocations for its major U.S. defined benefit pension plan by asset category, are as follows: 

Asset Category 
Equity securities 
Debt securities 
Real estate 
Cash and cash equivalents 
Global balanced asset allocation funds 
Other 
Total 

As of December 31, 
2019 
2020 

      2020 Target 

10 %     
42 %     
1 %     
2 %     
14 %     
31 %     
100 %     

10 %   
44 %   
1 %   
1 %   
15 %   
29 %   
100 %     

5-15% 
35-45% 
0-10% 
0-10% 
10-20% 
25-35% 

Kodak’s weighted-average asset allocations for its major Non-U.S. defined benefit pension plans by asset category, are as follows: 

Asset Category 
Equity securities 
Debt securities 
Real estate 
Cash and cash equivalents 
Global balanced asset allocation funds 
Other 
Total 

As of December 31, 
2019 
2020 

      2020 Target 

5 %     
33 %     
2 %     
2 %     
5 %     
53 %     
100 %     

5 %   
31 %   
2 %   
2 %   
5 %   
55 %   
100 %     

0-10% 
25-35% 
0-10% 
0-10% 
0-10% 
50-60% 

88 

 
 
 
 
 
 
 
 
 
  
  
  
    
  
  
     
      
         
       
    
    
    
    
    
    
    
 
 
  
  
  
    
  
  
     
      
         
       
    
    
    
    
    
    
    
 
Fair Value Measurements 

Kodak’s asset allocations by level within the fair value hierarchy at December 31, 2020 and 2019 are presented in the tables below for Kodak’s major 
defined benefit plans.  Kodak’s plan assets are accounted for at fair value and are classified within the fair value hierarchy based on the lowest level 
of input that is significant to the fair value measurement, with the exception of investments for which fair value is measured using the net asset value 
per share expedient.  Kodak’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect 
the valuation of fair value of assets and their placement within the fair value hierarchy levels. 

Assets not utilizing the net asset value per share expedient are valued as follows:  Equity and debt securities traded on an active market are valued 
using a market approach based on the closing price on the last business day of the year. Real estate investments are valued primarily based on 
independent appraisals and discounted cash flow models, taking into consideration discount rates and local market conditions. Cash and cash 
equivalents are valued utilizing cost approach valuation techniques.  Other investments are valued using a combination of market, income, and cost 
approaches, based on the nature of the investment.  Private equity investments are valued primarily based on independent appraisals, discounted 
cash flow models, cost, and comparable market transactions, which include inputs such as discount rates and pricing data from the most recent 
equity financing.  Insurance contracts are primarily valued based on contract values, which approximate fair value.  For investments with lagged 
pricing, Kodak uses the available net asset values, and also considers expected return, subsequent cash flows and relevant material events. 

Major U.S. Plans 
December 31, 2020 

(in millions) 
Cash and cash equivalents 

Equity Securities 

Debt Securities: 

Government Bonds 
Investment Grade Bonds 

Real Estate 

Global Balanced Asset Allocation Funds 

Other: 

Absolute Return 
Private Equity 
Derivatives with unrealized gains 
Derivatives with unrealized losses 

U.S. 

   Quoted Prices 
in Active 
Markets for 
Identical Assets 
(Level 1) 

Significant 
Observable 
Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Measured at 
NAV 

Total 

66   

383   

1,102   
446   

37   

514   

447   
716   
3   
(7 ) 
3,707   

   $ 

—      $ 

—      $ 

—      $ 

66      $ 

—        

—        

—        

383        

—        
446        

—        

—        

5        
—        
—        
—        
451      $ 

—        
—          

1,101        

—        

37        

—        

514        

—        
5        
—        
—        
5      $ 

442        
711        
—        
—        
3,254      $ 

   $ 

1        
—        

—        

—        

—        
—        
3        
(7 )      
(3 )    $ 

89 

 
 
 
 
 
 
  
  
  
     
     
     
     
  
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
       
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
     
     
  
 
Major U.S. Plans 
December 31, 2019 

(in millions) 
Cash and cash equivalents 

Equity Securities 

Debt Securities: 

Government Bonds 
Investment Grade Bonds 

Real Estate 

Global Balanced Asset Allocation Funds 

Other: 

Absolute Return 
Private Equity 
Derivatives with unrealized gains 
Derivatives with unrealized losses 

U.S. 

   Quoted Prices 
in Active 
Markets for 
Identical Assets 
(Level 1) 

Significant 
Observable 
Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Measured at 
NAV 

Total 

   $ 

—      $ 

—      $ 

—      $ 

38      $ 

4        

—        

—        

374        

—        
—        

—        

—        

—        
—        
2        
(18 )      
(12 )    $ 

—        
457        

—        

—        

—        
—        
—        
—        
457      $ 

—        
—        

—        

1,110        
—        

42        

—        

544        

—        
7        
—        
—        
7      $ 

370        
680        
—        
—        
3,158      $ 

   $ 

38   

378   

1,110   
457   

42   

544   

370   
687   
2   
(18 ) 
3,610   

For Kodak’s major U.S. defined benefit pension plans, equity investments are invested broadly in U.S. equity, developed international equity, and 
emerging markets.  Fixed income investments are comprised primarily of long duration U.S. Treasuries and investment-grade corporate bonds.  Real 
estate investments primarily include investments in limited partnerships that invest in office, industrial, retail and apartment properties.  Global 
Balanced Asset Allocation investments are commingled funds that hold a diversified portfolio of passive market exposures, including equities, debt, 
currencies and commodities.  Absolute return investments are comprised of a diversified portfolio of hedge funds using equity, debt, commodity and 
currency strategies held separate from the derivative-linked hedge funds described later in this footnote. Private equity investments are primarily 
comprised of limited partnerships and fund-of-fund investments that invest in distressed investments, venture capital, leveraged buyouts and special 
situations.  Natural resource investments in oil and gas partnerships and timber funds are also included in this category. 

90 

 
  
  
  
     
     
     
     
  
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
     
     
  
 
Major Non-U.S. Plans 
December 31, 2020 

(in millions) 
Cash and cash equivalents 

Equity Securities 

Debt Securities: 

Government Bonds 
Investment Grade Bonds 
Global High Yield & Emerging Market Debt 

Real Estate 

Global Balanced Asset Allocation Funds 

Other: 

Private Equity 
Insurance Contracts 

Non - U.S. 

   Quoted Prices 
in Active 
Markets for 
Identical Assets 
(Level 1) 

Significant 
Observable 
Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Measured at 
NAV 

Total 

   $ 

10      $ 

—      $ 

—      $ 

7      $ 

36        

—        

—        

—        

—        
87        
2        

—        

—        

—        
90        
—        

—        

—        

—        
—        
—        

—        

—        

48        
—        
—        

12        

38        

—        
—        
135      $ 

—        
45        
135      $ 

—        
291        
291      $ 

30        
—        
135      $ 

   $ 

17   

36   

48   
177   
2   

12   

38   

30   
336   
696   

91 

 
 
  
  
  
     
     
     
     
  
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
  
Major Non-U.S. Plans 
December 31, 2019 

(in millions) 
Cash and cash equivalents 

Equity Securities 

Debt Securities: 

Government Bonds 
Inflation-Linked Bonds 
Investment Grade Bonds 
Global High Yield & Emerging Market Debt 

Real Estate 

Global Balanced Asset Allocation Funds 

Other: 

Absolute Return 
Private Equity 
Insurance Contracts 
Derivatives with unrealized gains 

Non - U.S. 

   Quoted Prices 
in Active 
Markets for 
Identical Assets 
(Level 1) 

Significant 
Observable 
Inputs 
(Level 2) 

Significant 
Unobservable 
Inputs 
(Level 3) 

Measured at 
NAV 

Total 

   $ 

5      $ 

—      $ 

—      $ 

8      $ 

—        

—        

—        

33        

—        
—        
—        
—        

—        

—        

—        
—        
—        
1        
6      $ 

—        
—        
61        
—        

—        

—        

—        
—        
317        
—        
378      $ 

—        
—        
—        
—        

—        

—        

—        
—        
—        
—        
—      $ 

51        
4        
65        
26        

11        

34        

7        
38        
—        
—        
277      $ 

   $ 

13   

33   

51   
4   
126   
26   

11   

34   

7   
38   
317   
1   
661   

For Kodak’s major non-U.S. defined benefit pension plans, equity investments are invested broadly in local equity, developed international and 
emerging markets.  Fixed income investments are comprised primarily of government and investment grade corporate bonds.  Real estate 
investments primarily include investments in limited partnerships that invest in office, industrial, and retail properties.  Global Balanced Asset 
Allocation investments are commingled funds that hold a diversified portfolio of passive market exposures, including equities, debt, currencies and 
commodities.  Absolute return investments are comprised of a diversified portfolio of hedge funds using equity, debt, commodity, and currency 
strategies held separate from the derivative-linked hedge funds described later in this footnote.  Private equity investments are comprised of limited 
partnerships and fund-of-fund investments that invest in distressed investments, venture capital and leveraged buyouts.  Insurance contracts are 
typically annuities from life insurance companies covering specific pension obligations. 

For Kodak’s major defined benefit pension plans, certain investment managers are authorized to invest in derivatives such as futures, swaps, and 
currency forward contracts.  Investments in derivatives are used to obtain desired exposure to a particular asset, index or bond duration and require 
only a portion of the total exposure to be invested as cash collateral.  In instances where exposures are obtained via derivatives, the majority of the 
exposure value is available to be invested, and is typically invested, in a diversified portfolio of hedge fund strategies that generate returns in addition 
to the return generated by the derivatives.  Of the December 31, 2020 investments shown in the major U.S. plans table above, 4% of the total 
pension assets represented equity securities exposure obtained via derivatives and are reported in equity securities, and 29% of the total pension 
assets represented U.S. government bond exposure with 11 years duration, obtained via derivatives and are reported in government bonds.  Of the 
December 31, 2019 investments shown in the major U.S. plans table above, 4% of the total pension assets represented equity securities exposure 
obtained via derivatives and are reported in equity securities, and 30% of the total pension assets represented U.S. government bond exposure with 
12 years duration, obtained via derivatives and are reported in government bonds. 

Of the December 31, 2020 investments shown in the major Non-U.S. plans table above, there are no derivative exposures. Of the December 31, 
2019 investments shown in the major Non-U.S. plans table above,  7% of the total pension assets represented derivative exposures to government 
bonds with 2 years duration and are reported in that class. 

92 

 
 
  
  
  
     
     
     
     
  
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
     
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
     
  
        
         
         
         
         
  
        
         
         
         
         
  
     
     
     
     
  
 
The following is a reconciliation of the beginning and ending balances of level 3 assets of Kodak’s major U.S. and non-U.S. defined benefit pension 
plans: 

U.S. 

Net Realized and Unrealized 
Gains 

(in millions) 
Private Equity 
Total 

(in millions) 
Private Equity 
Total 

(in millions) 
Insurance Contracts 
Total 

Balance at 
January 1, 2020     
7       
7     $ 

  $ 

Relating to 
Assets Still 
Held 

Relating to 
Assets Sold 
During the 
Period 

(2 )     
(2 )   $ 

—       
—     $ 

Net 
Purchases, 
Sales and 
Settlements       
—       
—     $ 

Balance at 
December 31, 2020   
5   
5   

U.S. 

Net Realized and Unrealized 
Gains 

Relating to 
Assets Still 
Held 

Relating to 
Assets Sold 
During the 
Period 

2       
2     $ 

—       
—     $ 

Balance at 
January 1, 2019     
6       
6     $ 

  $ 

Net 
Purchases, 
Sales and 
Settlements       
(1 )     
(1 )   $ 

Balance at 
December 31, 2019   
7   
7   

Non - U.S. 
Net Realized and Unrealized 
Gains 

Balance at 
January 1, 2020 
(1) 

Relating to 
Assets Still 
Held 

Relating to 
Assets Sold 
During the 
Period 

  $ 

273       
273     $ 

18       
18     $ 

—       
—     $ 

Net 
Purchases, 
Sales and 
Settlements       
—       
—     $ 

Balance at 
December 31, 2020   
291   
291   

(1)  During 2020 the Company reclassified certain investments from Level 2 to Level 3. 

The following pension benefit payments, which reflect expected future service, are expected to be paid (in millions): 

2021 
2022 
2023 
2024 
2025 
2026 - 2030 

   $ 

U.S. 

Non-U.S. 

297      $ 
284     
270     
259     
246     
1,059     

50   
49   
48   
47   
46   
212   

NOTE 21:  OTHER POSTRETIREMENT BENEFITS 

In Canada, Kodak provides medical, dental, life insurance, and survivor income benefits to eligible retirees.  In the U.K., Kodak provides medical 
benefits to eligible retirees.  The other postretirement benefit plans in Canada and the U.K. are closed to new participants. Information on the 
Canada and U.K. other postretirement benefit plans is presented below. 

The measurement date used to determine the net benefit obligation for Kodak's other postretirement benefit plans is December 31. 

93 

 
 
  
  
  
  
  
  
  
     
       
  
       
  
  
  
     
     
    
 
  
  
  
  
  
  
  
     
       
  
       
  
  
  
     
     
    
 
  
  
  
  
  
  
  
     
       
  
       
  
  
  
    
     
     
    
 
 
 
  
  
    
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
Changes in Kodak’s benefit obligation and funded status were as follows (in millions): 

Net benefit obligation at beginning of period 
Interest cost 
Plan participants’ contributions 
Actuarial loss 
Benefit payments 
Net benefit obligation at end of period 

Underfunded status at end of period 

   Year Ended December 31, 

2020 

2019 

  $ 

  $ 

  $ 

63     $ 
1       
1       
1       
(3 )     
63     $ 

64   
2   
1   
—   
(4 ) 
63   

(63 )   $ 

(63 ) 

Amounts recognized in the Consolidated Statement of Financial Position consist of (in millions): 

Other current liabilities 
Pension and other postretirement liabilities 

Amounts recognized in Accumulated other comprehensive loss consist of (in millions): 

Net actuarial gain 

As of December 31, 
2019 
2020 

  $ 

  $ 

(3 )   $ 
(60 )     
(63 )   $ 

(3 ) 
(60 ) 
(63 ) 

As of December 31, 
2019 
2020 

   $ 

4      $ 

5   

Changes in benefit obligations recognized in Other comprehensive loss (income) consist of (in millions): 

Newly established loss 
Amortization of: 
  Net actuarial gain 
Total gain recognized in Other comprehensive income 

   Year Ended December 31, 

2020 

2019 

   $ 

   $ 

1      $ 

—        
1      $ 

—   

1   
1   

Other postretirement benefit cost included: 

Components of net postretirement benefit cost: 
Service cost 
Interest cost 
Amortization of: 

Actuarial gain 

Other postretirement benefit cost from continuing 
   operations 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

—      $ 
1        

—        

1      $ 

—   
2   

(1 ) 

1   

The weighted-average assumptions used to determine the net benefit obligations were as follows: 

Discount rate 
Salary increase rate 

As of December 31, 
2019 
2020 

2.21 %     
1.80 %     

2.93 % 
1.80 % 

94 

 
 
  
  
  
  
     
  
    
    
    
    
  
      
        
  
 
 
  
  
  
  
  
     
  
    
  
 
 
  
  
  
  
  
     
  
 
 
  
  
  
  
     
  
       
         
  
     
 
 
  
  
  
  
  
    
  
       
         
  
     
       
         
  
     
 
 
  
  
  
  
  
  
  
  
    
    
 
The weighted-average assumptions used to determine the net postretirement benefit cost were as follows: 

Effective rate for interest cost 
Salary increase rate 

Year Ended December 31, 

2020 

2019 

2.67 %      
1.80 %      

3.26 % 
2.35 % 

The weighted-average assumed healthcare cost trend rates used to compute the other postretirement amounts were as follows: 

Healthcare cost trend 
Rate to which the cost trend rate is assumed to decline 
   (the ultimate trend rate) 
Year that the rate reaches the ultimate trend rate 

2020 

2019 

5.33 %      

5.37 % 

3.14 %      
2039         

3.14 % 
2038   

 The following other postretirement benefits, which reflect expected future service, are expected to be paid (in millions): 

2021 
2022 
2023 
2024 
2025 
2026-2030 

  $ 

3   
3   
3   
3   
3   
     16   

NOTE 22:  EARNINGS PER SHARE 

Basic earnings per share are calculated using the weighted-average number of shares of common stock outstanding during the period.  Diluted 
earnings per share calculations include any dilutive effect of potential common shares.  In periods with a net loss from continuing operations, diluted 
earnings per share are calculated using weighted-average basic shares for that period, as utilizing diluted shares would be anti-dilutive to loss per 
share. 

A reconciliation of the amounts used to calculate basic and diluted earnings per share for the years ended December 31, 2020 and 2019 follows (in 
millions): 

Loss from continuing operations attributable to Eastman 
   Kodak Company 
Less: Series A Preferred Stock cash and accrued dividends 
Less: Series A Preferred Stock deemed dividends 
Loss from continuing operations available to common 
   shareholders - basic and diluted 

Net (loss) income attributable to Eastman Kodak Company 
Less: Series A Preferred Stock cash and accrued dividends 
Less: Series A Preferred Stock deemed dividends 
Net (loss) income available to common shareholders - basic and 
   diluted 

Year Ended December 
31, 

2020 

2019 

   $ 

(544 )    $ 
(11 )      
(9 )      

(91 ) 
(11 ) 
(9 ) 

   $ 

(564 )    $ 

(111 ) 

   $ 

(541 )    $ 
(11 )      
(9 )      

116   
(11 ) 
(9 ) 

   $ 

(561 )    $ 

96   

95 

 
 
  
  
  
  
  
  
  
  
     
     
 
 
  
  
  
  
  
     
     
     
 
 
    
    
    
    
 
 
 
 
 
  
  
  
  
  
    
  
     
     
 
     
     
As a result of the net loss from continuing operations available to common shareholders for the years ended December 31, 2020 and 2019, Kodak 
calculated diluted earnings per share using weighted-average basic shares outstanding.  If Kodak reported earnings from continuing operations 
available to common shareholders for the years ended December 31, 2020 and 2019, the calculation of diluted earnings per share would have 
included the assumed conversion of 0.6 million unvested restricted stock units for both periods and 0.7 million  stock options for the year ended 
December 31, 2020. 

The computation of diluted earnings per share for the years ended December 31, 2020 and 2019 excluded the impact of (1) the assumed conversion 
of 2.0 million shares of Series A Preferred Stock, and (2) the assumed conversion of 4.0 million and 6.8 million outstanding employee stock options, 
respectively, because they would have been anti-dilutive.  The computation of diluted earnings per share for the year ended December 31, 2019 also 
excluded the assumed conversion of $100 million of Convertible Notes because the effects would have been anti-dilutive.    

NOTE 23:  STOCK-BASED COMPENSATION 

Kodak’s stock incentive plan is the 2013 Omnibus Incentive Plan (the “2013 Plan”).  The 2013 Plan is administered by the Compensation, 
Nominating and Governance Committee of the Board of Directors. 

Officers, directors and employees of the Company and its consolidated subsidiaries are eligible to receive awards.  Stock options are generally non-
qualified, are at exercise prices equal to or greater than the closing price of Kodak’s stock on the date of grant and expire seven years after the grant 
date.  Stock-based compensation awards granted under Kodak’s stock incentive plan are generally subject to a three-year vesting period from the 
date of grant, or a later date as determined by the Compensation, Nominating and Governance Committee.  Awards are subject to settlement in 
newly-issued shares of common stock.  Unless sooner terminated by the Compensation, Nominating and Governance Committee, no awards may 
be granted under the 2013 Plan after May 20, 2030. 

The maximum number of shares of common stock available for grant under the 2013 Plan is 8.0 million.  For purposes of the number of shares 
available for grant, in accordance with the 2013 Plan, a stock option counts as a fraction of a share, based on the fair market value of the stock 
option relative to the closing stock price on the date of grant, while each restricted stock unit counts as one share.  The total number of shares of 
common stock registered for issuance under the 2013 Plan is approximately 13.5 million.  In addition, under the 2013 Plan, the maximum number of 
shares available for the grant of incentive stock options is 2.0 million shares. The maximum number of shares as to which stock options or stock 
appreciation rights may be granted to any one person under the 2013 Plan in any calendar year is 2.5 million shares.  

The maximum number of awards that may be granted to any non-employee director under the 2013 Plan in any calendar year may not exceed a 
number of awards with a grant date fair value of $450,000, computed as of the grant date. 

Compensation expense is recognized on a straight-line basis over the service or performance period for each separately vesting tranche of the 
award and is adjusted for actual forfeitures before vesting.  Kodak assesses the likelihood that performance-based shares will be earned based on 
the probability of meeting the performance criteria.  For those performance-based awards that are deemed probable of achievement, expense is 
recorded, and for those awards that are deemed not probable of achievement, no expense is recorded. Kodak assesses the probability of 
achievement each quarter. 

Restricted Stock Units 
Restricted stock units are payable in shares of the Company common stock upon vesting.  The fair value is based on the closing market price of the 
Company’s stock on the grant date.  Compensation cost related to restricted stock units was $1 million and $2 million for the years ended December 
31, 2020 and 2019, respectively.  

The weighted average grant date fair value of restricted stock unit awards granted for the years ended December 31, 2020 and 2019 was $2.91 and 
$2.93, respectively.  The total fair value of restricted stock units that vested was $2 million for both the years ended December 31, 2020 and 2019.  
As of December 31, 2020, there was $0.1 million of unrecognized compensation cost related to restricted stock units.  The cost is expected to be 
recognized over a weighted average period of 0.8 years. 

The following table summarizes information about restricted stock unit activity for the year ended December 31, 2020: 

Number of 
Restricted 
Stock Units      

Weighted-
Average 
Grant Date 
Fair Values 

721,801      $ 
351,909      $ 
692,750      $ 
380,960      $ 

3.25   
2.91   
3.05   
3.31   

Outstanding on December 31, 2019 

Granted 
Vested 

Outstanding on December 31, 2020 

96 

 
 
 
 
 
 
 
 
  
  
  
     
     
     
     
 
Stock Options 
The following table summarizes information about stock option activity for the year ended December 31, 2020: 

Outstanding on December 31, 2019 

Granted 
Exercised 
Forfeited 

Outstanding on December 31, 2020 
Exercisable on December 31, 2020 
Expected to vest December 31, 2020 

Shares 
Under 
Option 
6,843,079     $ 
2,917,456     $ 
2,019,187     $ 
16,922      $ 
7,724,426      $ 
7,024,347      $ 
700,080      $ 

Weighted Average 
Exercise 
Price 
Per Share 

Weighted Average 
Remaining 
Contractual Life 
(Years) 

Aggregate 
Intrinsic 
Value 
($ millions)   

10.96     
5.86     
14.51     
12.50       
8.10     
8.41     
4.97     

4.83 
4.69 
6.24 

  $ 
  $ 
  $ 

19.42   
16.86   
2.56   

The aggregate intrinsic value represents the total pretax intrinsic value that option holders would have received had all option holders exercised their 
options on the last trading day of the year.  The aggregate intrinsic value is the difference between the Kodak closing stock price on the last trading 
day of the year and the exercise price, multiplied by the number of in-the-money options.  

The Company issued stock-based compensation grants for 2.4 million stock options on July 27, 2020.  The terms of 1.8 million of the options 
awarded on July 27, 2020 provided for immediate vesting or vesting upon conversion of the Convertible Notes.  As 100% of the Convertible Notes 
were converted during the three months ended September 30, 2020, the 1.8 million options with accelerated vesting terms vested in that same 
period.  The remaining 0.6 million options provide for vesting terms of between two and three years. 

The valuation of the stock options granted on July 27, 2020 resulted in approximately $12.6 million of compensation expense being reported in 
Selling, general and administrative expenses in the Consolidated Statement of Operations in the year ended December 31, 2020. 

There were approximately 2.0 million options exercised in the year ended December 31, 2020 and no options exercised in the year ended 
December 31, 2019.  The options exercised in 2020 included 0.3 million options exercised by ex-employees of Kodak that had previously been 
forfeited.  The Company issued shares to the ex-employees in exchange for proceeds based on the exercise prices of the forfeited options.  The 
Company is accounting for the exercise of the forfeited options as a modification of the original awards. 

The Company has been seeking to recover the fair value of the shares at the time of the sale of the shares by the ex-employees less the exercise 
proceeds and withholding (approximately $3.9 million) and the right to retain any refund of the withholding taxes the Company is seeking to obtain on 
behalf of the ex-employees (approximately $3.0 million).  The Company received $3.6 million during the three months ended December 31, 2020 
from certain of the ex-employees.  The Company is due to receive a $2 million refund of withholding taxes on behalf of those ex-employees.   

The Company recognized compensation expense of approximately $5.1 million in the three months ended September 30, 2020 related to the 0.3 
million previously forfeited options, representing the fair value of the shares issued to the ex-employees less the exercise proceeds received from the 
ex-employees.  Stock compensation expense, reported in Selling, general and administrative expenses in the Consolidated Statement of Operations,  
was reduced by $4.6 million in the three months ended December 31, 2020, representing the cash received for certain of the erroneous grants and 
the refund of withholding taxes due on behalf of the ex-employees.  Income recognized in excess of the original stock compensation expense 
recorded for each individual grant (approximately $1 million) was recognized in Other operating (income) expense, net in the Consolidated 
Statement of Operations. 

The weighted average grant date fair value of options granted for the years ended December 31, 2020 and 2019 was $5.86 and $1.73,  respectively.  
The total fair value of options that vested during the years ended December 31, 2020 and 2019 was $13 million and $7 million, respectively.  
Compensation cost related to stock options for the years ended December 31, 2020 and 2019 was $14 million and $5 million, respectively. 

As of December 31, 2020, there was $3.1 million of unrecognized compensation cost related to stock options.  The cost is expected to be recognized 
over a weighted average period of 1.6 years. 

97 

 
 
  
  
    
    
  
    
  
    
  
  
    
  
    
  
  
    
  
    
  
  
    
      
  
    
    
    
 
 
 
 
 
 
 
 
Other than for the awards granted on July 27, 2020, Kodak utilizes the Black-Scholes option valuation model to estimate the fair value of stock 
options.    

The expected term of options granted is the period of time the options are expected to be outstanding and is calculated using a simplified method 
based on the option’s vesting period and original contractual term.  The Company uses the historical volatility of the Company’s stock to estimate 
expected volatility. The risk-free rate was based on the yield on U.S. Treasury notes with a term equal to the option’s expected term.  

The following inputs were used for the valuation of option grants issued in each year: 

Weighted-average fair value of options granted 
Weighted-average risk-free interest rate 
Expected option lives 
Weighted-average volatility 
Expected dividend yield 

Year Ended December 31, 

   $ 

2020 
1.50 
2.43% 
3.7 years 
98% 
0.00% 

     $ 

2019 
1.73 
2.47% 
4.5 years 
90% 
0.00% 

Given the volatility of the Company’s stock price in the third quarter of 2020, the Company utilized a lattice-based valuation model to value the time-
based vesting awards granted July 27, 2020 and a Monte Carlo simulation valuation model to value the options granted on July 27, 2020 which 
vested upon conversion of the Convertible Notes. 

The following inputs were used in the lattice-based valuation of the July 27, 2020 option grants: 

Weighted-average fair value of options granted 
Range of risk-free interest rates 
Weighted-average term 
Weighted-average volatility 
Weighted-average expected dividend yield 

NOTE 24: SHAREHOLDERS’ EQUITY 

July 27, 2020 

   Option  Awards 
   $ 

6.57 
0.11% - 0.30% 
5.57 years 
98% 
0.00% 

The Company has 560 million shares of authorized stock, consisting of: (i) 500 million shares of common stock, par value $0.01 per share and 
(ii) 60 million shares of preferred stock, no par value, issuable in one or more series. As of December 31, 2020 there were 77.2 million shares of 
common stock outstanding and 2.0 million shares of Series A preferred stock issued and outstanding.  As of December 31, 2019 there were 43.2 
million shares of common stock outstanding and 2.0 million shares of Series A preferred stock issued and outstanding. 

Treasury Stock 
Treasury stock consisted of approximately 0.7 million shares at both December 31, 2020 and 2019. 

Backstop Registration Rights Agreement 
Upon emergence from bankruptcy on September 3, 2013 (“Effective Date”), the Company and GSO Capital Partners LP, on behalf of various 
managed funds, BlueMountain Capital Management, LLC, on behalf of various managed funds, George Karfunkel, United Equities Commodities 
Company, Momar Corporation and Contrarian Capital Management, LLC, on behalf of Contrarian Funds, LLC (collectively, the “Backstop Parties”) 
executed a registration rights agreement (the “Backstop Registration Rights Agreement”). The Backstop Registration Rights Agreement, among 
other rights, provides the Backstop Parties with certain registration rights with respect to common stock offered to the Backstop Parties (and other 
eligible creditors) as part of a rights offering (the “Backstop registrable securities”).  A portion of the shares issued in the rights offerings are restricted 
securities for purposes of Rule 144 under the Securities Act of 1933 and may not be offered, sold or otherwise transferred absent registration under 
the Securities Act of 1933 or an applicable exemption from registration requirements. 

Stockholders holding Backstop registrable securities representing 10% of the outstanding common stock at emergence may require the Company to 
facilitate a registered offering of Backstop registrable securities (such offering, the “Initial Registration”). The Backstop registrable securities 
requested to be sold in the Initial Registration must have an aggregate market value of at least $75 million.  On October 20, 2016, the Initial 
Registration, in the form of a shelf registration statement registering all Backstop registerable securities, was declared effective by the SEC. 

98 

 
 
  
  
  
  
  
    
  
  
  
     
  
  
     
  
  
     
  
  
     
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
Following the Initial Registration, stockholders holding 10% or more of the outstanding Backstop registrable securities may demand that the 
Company file a shelf registration statement and effectuate one or more takedowns off of such shelf, or, if a shelf is not available, effectuate one or 
more stand-alone registered offerings, provided that such non-shelf registered offerings or shelf takedowns may not be requested more than four 
times and, in each case, shall include shares having an aggregate market value of at least $75 million. Beginning on the second anniversary of the 
Effective Date, upon request of a stockholder, the Company shall amend its existing shelf registration statement to register additional Backstop 
registrable securities as set forth in the Registration Rights Agreement. Stockholders also have the right to include their Backstop registrable 
securities in the Initial Registration or any other non-shelf registered offering or shelf takedown of the common stock by the Company for its own 
account or for the account of any holders of common stock. 

NOTE 25:  OTHER COMPREHENSIVE LOSS  

The changes in Other comprehensive loss by component, were as follows: 

(in millions) 
Currency translation adjustments 
Currency translation adjustments 
Amount transferred to net income due to the sale 
   of an investment in a foreign entity 
Currency translation adjustments and other 

Pension and other postretirement benefit plan 
   changes 

Newly established net actuarial loss 
Tax benefit 
Newly established net actuarial loss, net of tax 
Reclassification adjustments: 

Amortization of prior service credit 
Amortization of actuarial losses 
Recognition of gains due to settlements 
   and curtailments 

Total reclassification adjustments 
Tax provision 
Reclassification adjustments, net of tax 

Pension and other postretirement benefit plan changes, 
   net of tax 
Other comprehensive loss 

Year Ended December 31, 
2019 
2020 

   $ 

(a)    

(a)    

(a)    

      $ 

(16 )    $ 

—        
(16 )      

(34 )      
—        
(34 )      

(7 )   
19      

9      
21        
—        
21        

(13 )      
(29 )    $ 

3   

3   
6   

(14 ) 
9   
(5 ) 

(8 ) 
4   

(2 ) 
(6 ) 
(1 ) 
(7 ) 

(12 ) 
(6 ) 

(a)  Reclassified to Pension income - refer to Note 20, "Retirement Plans" and Note 21, "Other Postretirement Benefits" for additional information. 

99 

 
 
 
 
  
  
  
  
  
  
     
  
  
  
  
  
     
  
  
  
  
  
  
  
        
  
          
         
  
          
         
  
       
       
       
         
         
  
  
  
  
  
  
  
       
       
       
        
 
 
 
NOTE 26:  ACCUMULATED OTHER COMPREHENSIVE LOSS 

Accumulated other comprehensive loss is composed of the following: 

(in millions) 
Currency translation adjustments 
Pension and other postretirement benefit plan changes 
Ending balance 

As of December 31, 

2020 

2019 

   $ 

   $ 

(106 )   $ 
(340 )     
(446 )   $ 

(90 ) 
(327 ) 
(417 ) 

NOTE 27:  SEGMENT INFORMATION 

Change in Segments 

Effective January 1, 2020 Kodak changed its organizational structure. Prepress Solutions, formerly part of the Print Systems segment, operates as a 
separate segment named the Traditional Printing segment. Electrophotographic Printing Solutions, formerly part of the Print Systems segment, was 
combined with the Enterprise Inkjet Systems segment and Kodak Software segment to form the Digital Printing segment. The Brand, Film and 
Imaging segment, except for the licensing of the Kodak brand to third parties, was combined with the Advanced Materials and 3D Printing segment 
to form the Advanced Materials and Chemicals segment. The licensing of the Kodak brand to third parties operates as a separate segment named 
the Brand segment. The Eastman Business Park segment is no longer a reportable segment.  A description of Kodak’s reportable segments follows.  

Traditional Printing: The Traditional Printing segment is comprised of Prepress Solutions.  

Digital Printing: The Digital Printing segment is comprised of four lines of business: the Electrophotographic Printing Solutions business, the 
Prosper business, the Versamark business and the Software business.  

Advanced Materials and Chemicals: The Advanced Materials and Chemicals segment is comprised of five lines of business: Industrial Film and 
Chemicals, Motion Picture, Advanced Materials and Functional Printing Technology and Kodak Services for Business.  

Brand: The Brand segment contains the brand licensing business. 

All Other: All Other is comprised of the operations of the Eastman Business Park, a more than 1,200 acre technology center and industrial complex. 

Segment financial information is shown below. Asset information by segment is not disclosed as this information is not separately identified and 
reported to the Chief Operating Decision Maker. 

Net Revenues from Continuing Operations by Reportable Segment 

(in millions) 
Traditional Printing 
Digital Printing 
Advanced Materials and Chemicals 
Brand 

Total of reportable segments 

Other 

Consolidated total 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

592      $ 
241        
172        
13        
1,018        
11        
1,029      $ 

727   
293   
200   
12   
1,232   
10   
1,242   

Segment Measure of Profit and Loss 
Kodak’s segment measure of profit and loss is an adjusted earnings before interest, taxes, depreciation and amortization (“Operational EBITDA”).  
As demonstrated in the table below, Operational EBITDA represents the earnings (loss) from continuing operations excluding the provision (benefit) 
for income taxes; non-service cost components of pension and OPEB income; depreciation and amortization expense; restructuring costs; stock-
based compensation expense; consulting and other costs; idle costs; the former CEO separation agreement compensation; other operating 
(expense) income, net (unless otherwise indicated); interest expense; loss on early extinguishment of debt and other charges, net. 

100 

 
 
  
  
  
  
    
  
     
 
 
 
 
 
 
 
  
  
  
  
  
  
    
  
     
  
       
  
  
     
     
     
     
     
 
Kodak’s segments are measured using Operational EBITDA both before and after allocation of corporate selling, general and administrative 
expenses (“SG&A”).  The segment earnings measure reported is after allocation of corporate SG&A as this most closely aligns with U.S. GAAP.  
Research and development activities not directly related to the other segments are reported within the Advanced Materials and Chemicals segment. 

Segment Operational EBITDA and Consolidated Loss from Continuing Operations Before Income Taxes 

(in millions) 
Traditional Printing 
Digital Printing 
Advanced Materials and Chemicals 
Brand 

Total of reportable segments 

Other 
Depreciation and amortization 
Restructuring costs and other 
Stock-based compensation 
Consulting and other costs (1) 
Idle costs (2) 
Former CEO separation agreement compensation 
Other operating income (expense), net, excluding income 
   from transition services agreement (3) 
Interest expense (4) 
Pension income excluding service cost component (4) 
Loss on early extinguishment of debt 
Other charges, net (4) 
Consolidated loss from continuing operations 
   before income taxes 

Year Ended December 31, 
2019 
2020 

   $ 

21      $ 
(10 )      
(23 )      
11        
(1 )      
1        
(37 )      
(17 )      
(15 )      
(9 )      
(3 )      
—        

7        
(12 )      
98        
(2 )      
(386 )      

   $ 

(376 )    $ 

48   
(9 ) 
(34 ) 
8   
13   
(1 ) 
(55 ) 
(16 ) 
(7 ) 
(7 ) 
(5 ) 
(2 ) 

(22 ) 
(16 ) 
104   
—   
(46 ) 

(60 ) 

(1)  Consulting and other costs are professional services and internal costs associated with certain corporate strategic initiatives and investigations, 

including the divestiture of FPD and debt refinancing in 2019. 

(2)  Consists of third-party costs such as security, maintenance, and utilities required to maintain land and buildings in certain locations not used in 

any Kodak operations and the costs, net of any rental income received, of underutilized portions of certain properties. 

(3)  $6 million of income from the transition services agreement with the Purchaser was recognized in both the years ended December 31, 2020 and 
2019.  The income was reported in Other operating (income) expense, net in the Consolidated Statement of Operations. Other operating 
(income) expense, net is typically excluded from the segment measure. However, the income from the transition services agreement was 
included in the segment measure. 

(4)  As reported in the Consolidated Statement of Operations. 

Kodak increased employee benefit reserves by approximately $4 million in 2020 reflecting an increase in workers’ compensation reserves ($7 
million) partially offset by a decrease in postemployment benefit reserves ($3 million).  In 2019 workers’ compensation reserves increased by 
approximately $3 million.  The increase in reserves in 2020 impacted gross profit and SG&A each by approximately $2 million. The increase in 
reserves in 2019 impacted gross profit by approximately $2 million and SG&A by approximately $1 million.  

Amortization and depreciation expense by segment are not included in the segment measure of profit and loss but are regularly provided to the Chief 
Operating Decision Maker.  

(in millions) 
Intangible asset amortization expense from continuing operations: 
Traditional Printing 
Digital Printing 
Brand 

Consolidated total 

Year Ended December 31, 

2020 

2019 

   $ 

   $ 

1      $ 
3        
1        
5      $ 

2   
4   
1   
7   

101 

 
 
 
    
  
  
    
  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
 
 
 
 
  
  
  
    
  
     
     
 
(in millions) 
Depreciation expense from continuing operations: 
Traditional Printing 
Digital Printing 
Advanced Materials and 3D Printing 
Other 

Consolidated total 

(in millions) 
Long-lived assets (1) located in: 
The United States 
Europe, Middle East and Africa 
Asia Pacific 
Canada and Latin America 

Non-U.S. countries total (2) 
Consolidated total 

Year Ended December 31, 

2020 

2019 

19      $ 
7        
5        
1        
32      $ 

28   
10   
6   
4   
48   

Year Ended December 31, 

2020 

2019 

78      $ 
22        
5        
47        
74        
152      $ 

85   
28   
8   
60   
96   
181   

   $ 

   $ 

   $ 

   $ 

(1)  Long-lived assets are comprised of property, plant and equipment, net.   
(2)  Of the total non-U.S. property, plant and equipment in 2020, $43 million are located in Brazil.  Of the total non-U.S. property, plant and 

equipment in 2019, $56 million was located in Brazil. 

Major Customers 

No single customer represented 10% or more of Kodak’s total net revenue in any year presented. 

NOTE 28:  RELATED PARTY 

Kodak’s Executive Chairman is the Chairman of the Board for a company that purchased $3 million of products in 2019.  At December 31, 2019, the 
company owed Kodak $1 million.  

NOTE 29:  DISCONTINUED OPERATIONS 

Flexographic Packaging segment 

Discontinued operations of Kodak include the former Flexographic Packaging segment comprised of Kodak’s Flexographic Packaging Business 
(“FPD”).  

Kodak consummated the sale of certain assets of FPD to MIR Bidco, SA (the “Purchaser”) on April 8, 2019 for net cash consideration at closing, in 
addition to the assumption by Purchaser of certain liabilities of FPD, of $320 million, pursuant to the Stock and Asset Purchase Agreement (“SAPA”) 
signed in November 2018 and amended in March 2019.  Assets and liabilities of FPD in China were transferred at a deferred closing on July 1, 2019 
for net cash consideration of $5.9 million at closing and a promissory note for $1.4 million in addition to the assumption by Purchaser of certain 
liabilities of FPD, in accordance with the SAPA.  Kodak operated FPD in China, subject to certain covenants, until the deferred closing occurred.  
The promissory note was reduced by a true-up payment of $0.2 million owed by Kodak to the Purchaser which reflected the actual economic benefit 
attributable to the operation of FPD in China from the time of the initial closing through the time of the deferred closing. 

The divested business has the right to use Kodak’s corporate brand for a 10-year period related to Covered Products (as defined in the SAPA) for no 
additional consideration.  Therefore, $10 million of consideration received for the sale of FPD was recognized as deferred revenue related to the 
brand license.  The deferred revenue is reported in Long-term liabilities in the Consolidated Statement of Financial Condition and will be recognized 
as revenue over the term of the license. Proceeds were allocated between the sale of FPD and the brand license based on their relative fair values. 

Kodak recognized an after- tax gain on the sale of FPD of $212 million in the year ended December 31, 2019. 

Simultaneously with entering into the SAPA, the Company and the Purchaser entered into an Earn-out Agreement, pursuant to which the Company 
will be entitled to an aggregate of up to $35 million in additional cash consideration if FPD achieves agreed EBITDA targets for 2018 ($10 million 
earn-out), 2019 ($10 million earn-out) and 2020 ($15 million earn-out).  The EBITDA targets for 2019 and 2018 were not achieved.  The FPD 2020 
results are not yet available. 

102 

 
  
  
  
    
  
     
     
     
 
  
  
  
    
  
     
     
     
     
 
 
 
 
 
 
 
 
 
 
 
 
 
On April 16, 2019 the Purchaser paid Kodak $15 million as a prepayment for services and products to be provided by Kodak to the Purchaser.  The 
Purchaser had the option to satisfy its payment obligations to Kodak through a reduction of the prepayment balance or in cash.  As of December 31, 
2020, the remaining prepayment balance was $0 million. 

The results of operations of FPD are classified as discontinued operations in the Consolidated Statement of Operations for all periods presented.  
Direct operating expenses of the discontinued operations are included in the results of discontinued operations.  Indirect expenses that were 
historically allocated to the discontinued operations have been included in the results of continuing operations.  Prior period results have been 
reclassified to conform to the current period presentation. 

The results of operations of the Business are presented below: 

(in millions) 
Revenues 

Cost of sales 
Selling, general and administrative expenses 
Research and development expenses 
Interest expense 
Gain on divestiture 
Earnings from continuing operations before income taxes 
Provision for income taxes 
Earnings (loss) from discontinued operations 

Year Ended December 31, 

2020 

2019 

—      $ 

—        
—        
—        
—        
—        
—        
—        
—      $ 

44   

28   
10   
2   
7   
(214 ) 
211   
4   
207   

   $ 

   $ 

Interest was allocated to discontinued operations based on an estimated debt paydown of the Term Credit Agreement.   

Earnings from discontinued operations in the Consolidated Statement of Operations for December 31, 2020 includes earnings of $3 million 
associated with businesses disposed of in previous years. 

103 

 
 
 
 
 
  
  
  
  
    
  
       
         
    
     
     
     
     
     
     
     
 
 
 
ITEM 9. 

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 

None. 

ITEM 9A. CONTROLS AND PROCEDURES 

Evaluation of Disclosure Controls and Procedures 
Kodak maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in Kodak’s reports filed or 
submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the 
SEC’s rules and forms, and that such information is accumulated and communicated to management, including Kodak’s Executive Chairman and 
Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  Kodak’s management, with participation of Kodak’s 
Executive Chairman and Chief Financial Officer, has evaluated the effectiveness of Kodak’s disclosure controls and procedures as of the end of the 
fiscal year covered by this Annual Report on Form 10-K.  Kodak’s Executive Chairman and Chief Financial Officer have concluded that, as of the end 
of the period covered by this Annual Report on Form 10-K, Kodak’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) 
under the Exchange Act) were effective. 

Management’s Report on Internal Control Over Financial Reporting 
The management of Kodak is responsible for establishing and maintaining adequate internal control over financial reporting.  Kodak’s internal control 
over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial 
statements for external purposes in accordance with generally accepted accounting principles in the United States of America.  Kodak’s internal 
control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, 
accurately and fairly reflect the transactions and dispositions of the assets of Kodak; (ii) provide reasonable assurance that transactions are recorded 
as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of 
America, and that receipts and expenditures of Kodak are being made only in accordance with authorizations of management and directors of 
Kodak; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of Kodak’s 
assets that could have a material effect on the financial statements. 

Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent 
limitations.  Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment 
or breakdowns resulting from human failures.  Internal control over financial reporting also can be circumvented by collusion or improper 
management override. 

Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over 
financial reporting.  However, these inherent limitations are known features of the financial reporting process.  Therefore, it is possible to design into 
the process safeguards to reduce, though not eliminate, this risk.  Because of its inherent limitations, internal control over financial reporting may not 
prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may 
become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

Management assessed the effectiveness of Kodak’s internal control over financial reporting as of December 31, 2020.  In making this assessment, 
management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in "Internal Control-
Integrated Framework” (2013).  Based on management’s assessment using the COSO criteria, management has concluded that Kodak's internal 
control over financial reporting was effective as of December 31, 2020.   

Changes in Internal Control over Financial Reporting 
There was no change identified in Kodak’s internal control over financial reporting that occurred during Kodak’s fourth fiscal quarter that has 
materially affected, or is reasonably likely to materially affect, Kodak’s internal control over financial reporting other than as follows: 

During the quarter ended September 30, 2020 the Company discovered deficiencies in controls required to safeguard Company assets.  The 
Company did not prevent the unauthorized issuance of the Company’s common stock when previously forfeited non-qualified stock options were 
exercised by five former officers and employees in July 2020.  Errors existed in employee equity accounts for the five former officers and employees 
as well as other current and former officers and employees which could have resulted in additional inappropriate exercises.  Controls were 
inadequate with regard to the timely input and verification of master data updates for equity grants, the maintenance of audit documentation of grant 
activity in the repository of grants serviced by a third-party administrator, and the performance of independent reconciliations of the repository to 
supporting company records for the detection of errors or misstatements in employee equity account balances.  

The Company has remediated these control deficiencies as of December 31, 2020.  Documentation and supervisory review controls around master 
data were strengthened and an audit trail of stock-based compensation award additions and modifications is now being maintained.  A complete 
reconciliation of the repository of equity grants is being performed and controls have been strengthened by employing an independent reconciliation 
process and ensuring appropriate segregation of duties. 

104 

 
 
 
 
 
 
ITEM 9B.  OTHER INFORMATION  

Not applicable. 

PART III 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 

The information required by Item 10 regarding directors is incorporated by reference from the information under the caption "Board of Directors and 
Corporate Governance - Director Nominees" in the Company's Notice of 2021 Annual Meeting and Proxy Statement (the “Proxy Statement”), which will 
be filed within 120 days after December 31, 2020.  The information required by Item 10 regarding audit committee composition and audit committee 
financial expert disclosure is incorporated by reference from the information under the caption "Board of Directors and Corporate Governance - 
Committees of the Board - Audit and Finance Committee" in the Proxy Statement.  The information required by Item 10 regarding executive officers is 
contained in Part I under the caption "Information About Its Executive Officers".  The information required by Item 10 regarding compliance with Section 
16(a) of the Securities Exchange Act of 1934 is incorporated by reference, if necessary, from the information under the caption "Security Ownership of 
Certain Beneficial Owners and Management – Delinquent Section 16(a) Reports" in the Proxy Statement. 

We have adopted a Business Conduct Guide that applies to all of our officers and employees, including our principal executive, principal financial 
and principal accounting officers, or persons performing similar functions, as well as a Directors’ Code of Conduct that applies to our directors.  Our 
Business Conduct Guide and Directors’ Code of Conduct are posted on our website located at http://investor.kodak.com/corporate-
governance/supporting-documents.  We intend to disclose future amendments to certain provisions of the Business Conduct Guide and waivers of 
the Business Conduct Guide granted to executive officers, on the website within four business days following the date of the amendment or waiver. 

ITEM 11. EXECUTIVE COMPENSATION 
The information required by Item 11 is incorporated herein by reference from the information under the following captions in the Proxy Statement: 
"Executive Compensation”, “Director Compensation” and “Board of Directors and Corporate Governance – Executive Compensation Committee 
Interlocks and Insider Participation.” 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 
The information required by Item 12 is incorporated by reference from the information under the captions "Security Ownership of Certain Beneficial 
Owners and Management" and “Proposal 3 – Equity Compensation Plan Information” in the Proxy Statement. 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 
The information required by Item 13 is incorporated by reference from the information under the captions "Certain Relationships and Related 
Transactions" and "Board of Directors and Corporate Governance – Director and Nominee Independence" in the Proxy Statement. 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 
The information required by Item 14 is incorporated by reference from the information under the caption “Principal Accounting Fees and Services” in 
the Proxy Statement. 

ITEM 15.  FINANCIAL STATEMENT SCHEDULES, EXHIBITS 

1.  Valuation and qualifying accounts 

PART IV 

(in millions) 
Year ended December 31, 2020 
Reserve for doubtful accounts 
Deferred tax valuation allowance 

Year ended December 31, 2019 
Reserve for doubtful accounts 
Deferred tax valuation allowance 

Eastman Kodak Company 
Valuation and Qualifying Accounts 

Schedule II 

Beginning 
Balance 

Additions 

   Net Deductions    
and Other 

Ending 
Balance 

8        
821        

7        
344        

5      $ 
53      $ 

10   
1,112   

9        
853        

3        
64        

4      $ 
96      $ 

8   
821   

   $ 
   $ 

   $ 
   $ 

105 

 
 
 
 
 
 
 
 
 
  
  
  
    
  
  
  
  
  
  
  
  
  
  
  
  
     
  
       
  
       
  
       
  
  
  
       
         
         
         
  
     
  
       
  
       
  
       
  
  
All other schedules have been omitted because they are not applicable, or the information required is shown in the financial statements or notes 
thereto. 

106 

 
 
Exhibit 
Number 

Eastman Kodak Company 
Index to Exhibits 

(2.1) 

  Stock and Asset Purchase Agreement, dated as of November 11, 2018, by and between Eastman Kodak Company and MIR 

Bidco SA. (Incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K as filed November 13, 2018). 

(2.2) 

(2.3) 

First Amendment to Stock and Asset Purchase Agreement, dated as of March 29, 2019, by and between Eastman Kodak 
Company and MIR Bidco SA (Incorporated by reference to Exhibit (2.3) of the Company’s Current Report on Form 8-K as filed 
April 9, 2019). 

  Earn-Out Agreement, dated as of November 11, 2018, by and between Eastman Kodak Company and MIR Bidco SA. 
(Incorporated by reference to Exhibit 2.2 of the Company’s Current Report on Form 8-K as filed November 13, 2018). 

(3.1) 

  Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company (Incorporated by reference to Exhibit 

4.1 of the Company’s Registration Statement on Form S-8 as filed on September 3, 2013).  

(3.2) 

(3.3) 

(3.4) 

(3.5) 

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company. 
(Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed November 16, 2016).  

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company 
(Incorporated by reference to Exhibit (3.1) of the Company’s Current Report on Form 8-K as filed September 12, 2019). 

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company 
(Incorporated by reference to Exhibit (3.2) of the Company’s Current Report on Form 8-K as filed September 12, 2019). 

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company 
(Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed December 29, 2020). 

(3.6) 

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company 

(Incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K as filed March 1, 2021). 

(3.7) 

  Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Eastman Kodak Company 

(Incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K as filed March 1, 2021). 

(3.8) 

(4.1) 

Fourth Amended and Restated By-Laws of Eastman Kodak Company (Incorporated by reference to Exhibit (3.5) of the 
Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2020 as filed on May 12, 2020).  

  Registration Rights Agreement between Eastman Kodak Company and certain stockholders listed on Schedule 1 thereto, dated 
September 3, 2013. (Incorporated by reference to Exhibit 4.1 of the Company’s Registration Statement on Form 8-A as filed on 
September 3, 2013).  

(4.2)  

  Registration Rights Agreement by and among Eastman Kodak Company, Southeastern Asset Management, Inc., Longleaf 

Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust, dated November 15, 2016. 
(Incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K as filed November 16, 2016).  

(4.3) 

  Shareholder Agreement, dated as of April 17, 2017, by and among Eastman Kodak Company, Longleaf Partners Small-Cap 

Fund, C2W Partners Master Fund Limited, Deseret Mutual Pension Trust and Southeastern Asset Management, Inc. 
(Incorporated by reference to Exhibit 4.6 of the Company’s Amendment No. 2 to Registration Statement on Form S-3 as filed on 
May 5, 2017).  

(4.4) 

  Amendment No. 1 to Shareholder Agreement, dated as of May 20, 2019 by and among Eastman Kodak Company, 

Southeastern Asset Management, Inc., Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret 
Mutual Pension Trust  (Incorporated by reference to Exhibit (10.2) of the Company’s Current Report on Form 8-K as filed May 
21, 2019). 

(4.5) 

  Registration Rights Agreement, dated as of May 24, 2019, by and among Eastman Kodak Company, Longleaf Partners 

107 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SmallCap Fund, C2W Partners Master Fund Limited and Deseret Mutual Pension Trust (Incorporated by reference to Exhibit 
(4.3) of the Company’s Current Report on Form 8-K as filed May 24, 2019). 

(4.6) 

  Registration Rights Agreement, dated as of February 26, 2021, by and between Eastman Kodak Company and GO EK 

Ventures IV, LLC (Incorporated by reference to Exhibit 10.3 of the Company’s Current Report on Form 8-K as filed March 1, 
2021). 

(4.7) 

  Registration Rights Agreement, dated as of February 26, 2021, by and among Eastman Kodak Company, Kennedy Lewis 

Capital Partners Master Fund LP and Kennedy Lewis Capital Partners Master Fund II LP. (Incorporated by reference to Exhibit 
10.11 of the Company’s Current Report on Form 8-K as filed March 1, 2021). 

(4.8) 

  Board Rights Agreement, dated as of February 26, 2021, by and between Eastman Kodak Company and Kennedy Lewis 

Investment Management LLC (Incorporated by reference to Exhibit 10.7 of the Company’s Current Report on Form 8-K as filed 
March 1, 2021). 

(4.9) 

  Convertible Promissory Note, dated as of February 26, 2021, from Eastman Kodak Company to Kennedy Lewis Capital 

Partners Master Fund LP. (Incorporated by reference to Exhibit 10.8 of the Company’s Current Report on Form 8-K as filed 
March 1, 2021). 

(4.10) 

  Convertible Promissory Note, dated as of February 26, 2021, from Eastman Kodak Company to Kennedy Lewis Capital 

Partners Master Fund II LP. (Incorporated by reference to Exhibit 10.9 of the Company’s Current Report on Form 8-K as filed 
March 1, 2021). 

(4.11) 

  Description of Securities, filed herewith. 

*(10.1) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan (As Amended and Restated effective May 20, 2020 (Incorporated by 
reference to Exhibit (10.1) of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2020 as 
filed on August 11, 2020). 

*(10.2) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit Award Agreement. 

(Incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended 
September 30, 2013 as filed on November 12, 2013).  

*(10.3) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Nonqualified Stock Option Agreement. (Incorporated by 

reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2015 as 
filed on May 7, 2015).  

*(10.4) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit and Nonqualified Stock 
Option Award Agreement (with Modified Accelerated Vesting).(Incorporated by reference to Exhibit 10.5 of the Company’s 
Annual Report on Form 10-K for the fiscal year ended December 31, 2016 as filed on March 7, 2017).  

*(10.5) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit and Nonqualified Stock 

Option Award Agreement (with Continued Vesting). (Incorporated by reference to Exhibit 10.6 of the Company’s Annual Report 
on Form 10-K for the fiscal year ended December 31, 2016 as filed on March 7, 2017).  

*(10.6) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit and Nonqualified Stock 
Option Award Agreement (with Forfeiture upon Termination). (Incorporated by reference to Exhibit 10.2 of the Company’s 
Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2017 as filed on August 9, 2017).  

*(10.7) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Director Restricted Stock Unit Award Agreement. 

(Incorporated by reference to Exhibit 10.3 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 
31, 2013 as filed on March 19, 2014).  

108 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*(10.8) 

*(10.9) 

*(10.10) 

*(10.11) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Director Restricted Stock Unit Award Agreement (One Year 
Vesting). (Incorporated by reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the quarterly period 
ended June 30, 2017 as filed on August 9, 2017).  

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Quarterly Director Restricted Stock Unit Award Agreement 
(Immediate Vesting). (Incorporated by reference to Exhibit 10.1 of the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended September 30, 2019 as filed on November 7, 2019). 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Nonqualifed Stock Option Award Agreement 
(multiple tranches). (Incorporated by reference to Exhibit (10.2) of the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended September 30, 2020 as filed on November 10, 2020). 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Director Nonqualifed Stock Option Award Agreement (multiple 
tranches). (Incorporated by reference to Exhibit (10.3) of the Company’s Quarterly Report on Form 10-Q for the quarterly period 
ended September 30, 2020 as filed on November 10, 2020). 

*(10.12) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit Award Agreement (with 

Immediate Vesting), filed herewith. 

*(10.13) 

  Eastman Kodak Company 2013 Omnibus Incentive Plan Form of Executive Restricted Stock Unit Award Agreement (with 

Modified Accelerated Vesting), filed herewith. 

*(10.14) 

  Eastman Kodak Company Deferred Compensation Plan for Directors dated December 26, 2013. (Incorporated by reference to 

Exhibit 10.23 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 as filed on March 19, 
2014).  

*(10.15) 

  Eastman Kodak Company Officer Severance Policy, effective as of November 10, 2015. (Incorporated by reference to Exhibit 

10.25 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015 as filed on March 15, 2016).  

*(10.16) 

  Eastman Kodak Company Executive Compensation for Excellence and Leadership (as amended and restated January 1, 
2014). (Incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the quarterly period 
ended March 31, 2014 as filed on May 6, 2014).  

*(10.17) 

  Executive Chairman and CEO Agreement between Eastman Kodak Company and James V. Continenza, dated February 26, 

2021, filed herewith. 

*(10.18) 

James V. Continenza Consolidated Award Agreements, Tranches 1-4, dated February 20, 2019 (Incorporated by reference to 
Exhibit (10.24) of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 as filed on April 1, 
2019). 

*(10.19) 

  Employment Agreement between Eastman Kodak Company and David E. Bullwinkle, dated June 20, 2016. (Incorporated by 

reference to Exhibit 10.3 of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2016 as filed 
on August 9, 2016).  

*(10.20) 

  Description of David E. Bullwinkle Compensation Increase.  (Incorporated by reference to the description in Item 5.02 in the 

Company’s Current Report on Form 8-K as filed on November 30, 2018).   

*(10.21) 

  Description of John O’Grady Compensation Increase.  (Incorporated by reference to the description in Item 5.02 in the 

Company’s Current Report on Form 8-K as filed on April 9, 2018).   

*(10.22) 

(10.23) 

Letter Agreement Regarding Special Severance Plan dated May 31, 2018 between Eastman Kodak Company and Roger W. 
Byrd, Incorporated by reference to Exhibit (10.31) of the Company’s Annual Report on Form 10-K for the fiscal year ended 
December 31, 2019 as filed on March 17, 2020). 

  Amendment No. 4 to Amended and Restated Credit Agreement (including attached Amended and Restated Credit Agreement), 
dated as of August 26, 2021 by and among Eastman Kodak Company, the Lenders named therein, the Guarantors named 
therein and Bank of America, N.A., as agent. (Incorporated by reference to Exhibit 10.4 of the Company’s Current Report on 
Form 8-K as filed March 1, 2021). 

109 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(10.24) 

(10.25) 

  Amended and Restated Security Agreement, dated May 26, 2016, from the Grantors referred to therein, as Grantors, to Bank of 
America, N.A., as Agent. (Incorporated by reference to Exhibit 10.2 of the Company’s Quarterly Report on Form 10-Q for the 
quarterly period ended June 30, 2016 as filed on August 9, 2016).  

Letter of Credit Facility Agreement, dated as of February 26, 2021, by and among Eastman Kodak Company, the Lenders 
named therein, the Guarantors named therein, Bank of America, N.A., as administrative agent and collateral agent and Bank of 
America, N.A., as issuing bank. (Incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K as 
filed March 1, 2021).  

(10.26) 

  Security Agreement, dated February 26, 2021, from the Grantors referred to therein, as Grantors, to Bank of America, N.A., as 

Agent, filed herewith. 

(10.27) 

  Credit Agreement, dated as of February 26, 2021, by and among Eastman Kodak Company, the Lenders named therein and 

Alter Domus (US) LLC, as Administrative Agent. (Incorporated by reference to Exhibit 10.6 of the Company’s Current Report on 
Form 8-K as filed March 1, 2021).  

(10.28) 

  Guarantee and Collateral Agreement, dated February 26, 2021, made by the Grantors referred to therein, as Grantors, to Alter 

Domus (US) LLC, as Administrative Agent, filed herewith. 

(10.29) 

(10.30) 

Intercreditor Agreement, dated as of February 26, 2021, among Bank of America, N.A., as Representative with respect to the 
ABL Credit Agreement, Bank of America, N.A., as Representative with respect to the LC Credit Agreement, and Alter Domus 
(US) LLC, as Representative with respect to the Term Loan Agreement, Eastman Kodak Company, and each of the other 
Grantors party thereto, filed herewith. 

Intercreditor Agreement, dated as of February 26, 2021, among Bank of America, N.A., as Representative with respect to the 
ABL Credit Agreement, Bank of America, N.A., as Representative with respect to the LC Credit Agreement, Eastman Kodak 
Company, and each of the other Grantors party thereto, filed herewith. 

(10.31) 

  Series A Preferred Stock Purchase Agreement, dated as of November 7, 2016, by and among Eastman Kodak Company, 

Southeastern Asset Management, Inc., Longleaf Partners Small-Cap Fund, C2W Partners Master Fund Limited and Deseret 
Mutual Pension Trust. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K as filed on 
November 7, 2016).  

(10.32) 

(10.33) 

(10.34) 

  Amendment Number One to Series A Preferred Stock Purchase Agreement, dated as of December 24, 2020, by and among 
Eastman Kodak Company, Southeastern Asset Management, Inc., Longleaf Partners Small-Cap Fund, C2W Partners Master 
Fund Limited and Deseret Mutual Pension Trust, filed herewith. 

  Series A Preferred Stock Repurchase and Exchange Agreement, dated as of February 26, 2021, by and among Eastman 
Kodak Company, Southeastern Asset Management, Inc., Longleaf Partners Small-Cap Fund, C2W Partners Master Fund 
Limited and Deseret Mutual Pension Trust. (Incorporated by reference to Exhibit 10.1 of the Company’s Current Report on 
Form 8-K as filed March 1, 2021).  

  Series C Preferred Stock Purchase Agreement, dated as of February 26, 2021, by and among Eastman Kodak Company and 
GO EK Ventures IV, LLC. (Incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K as filed 
March 1, 2021). 

(10.35) 

  Securities Purchase Agreement, dated as of February 26, 2021, by and among Eastman Kodak Company, Kennedy Lewis 

Capital Partners Master Fund LP and Kennedy Lewis Capital Partners Master Fund II LP. (Incorporated by reference to Exhibit 
10.8 of the Company’s Current Report on Form 8-K as filed March 1, 2021). 

(10.36) 

  Amended and Restated Settlement Agreement (Eastman Business Park) between Eastman Kodak Company, the New York 

State Department of Environmental Conservation, and the New York State Urban Development Corporation d/b/a Empire State 
Development, dated August 6, 2013. (Incorporated by reference to Exhibit 10.10 of the Company’s Quarterly Report on Form 
10-Q for the quarterly period ended September 30, 2013 as filed on November 12, 2013). 

(21) 

  Subsidiaries of Eastman Kodak Company, filed herewith. 

110 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(23.1) 

(23.2) 

(31.1) 

(31.2) 

(32.1) 

  Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm, filed herewith. 

  Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm, filed herewith. 

  Certification signed by James V. Continenza, filed herewith. 

  Certification signed by David E. Bullwinkle, filed herewith. 

  Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 

signed by James V. Continenza, filed herewith. 

(32.2) 

  Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 

signed by David E. Bullwinkle, filed herewith. 

(101.CAL) 

  XBRL Taxonomy Extension Calculation Linkbase. 

(101.INS) 

  XBRL Instance Document. 

(101.LAB) 

  XBRL Taxonomy Extension Label Linkbase. 

(101.PRE) 

  XBRL Taxonomy Extension Presentation Linkbase. 

(101.SCH) 

  XBRL Taxonomy Extension Scheme Linkbase. 

(101.DEF) 

  XBRL Taxonomy Extension Definition Linkbase. 

*  Management contract or compensatory plan or arrangement. 
# Eastman Kodak Company was granted confidential treatment for certain information contained in this exhibit.  Such information was filed 
separately with the Securities and Exchange Commission pursuant to an application for confidential treatment under 17 C.F.R. §§ 200.80(b)(4) and 
240.24b-2 

ITEM 16. FORM 10-K SUMMARY  

None. 

111 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed 
on its behalf by the undersigned, thereunto duly authorized. 

SIGNATURES 

EASTMAN KODAK COMPANY 
(Registrant) 

By:  /s/ James V. Continenza 
James V. Continenza 
Executive Chairman 
March 16, 2021 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the 
registrant and in the capacities and on the date indicated. 

  Signature 

By: 

/s/ James V. Continenza 
James V. Continenza 

By: 

/s/ David E. Bullwinkle 

  David E. Bullwinkle 

By: 

/s/ Eric H. Samuels 

  Eric H. Samuels 

By: 

/s/ Jeffrey D. Engelberg 
Jeffrey D. Engelberg 

By: 

/s/ George Karfunkel 

  George Karfunkel 

By: 

/s/ Philippe D. Katz 

  Philippe D. Katz 

By: 

/s/ Jason New 
Jason New 

By: 

/s/ William G. Parrett 

  William G. Parrett 

Date: March 16, 2021 

  Title 

  Executive Chairman and Chief Executive Officer 

(Principal Executive Officer) 

  Chief Financial Officer 

(Principal Financial Officer) 

  Chief Accounting Officer and Corporate Controller 

(Principal Accounting Officer) 

  Director 

  Director 

  Director 

  Director 

  Director 

112 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
NOTICE OF 2021 ANNUAL MEETING 

AND PROXY STATEMENT 

Date of Notice:   April 9, 2021 

EASTMAN KODAK COMPANY 
343 STATE STREET 
ROCHESTER, NEW YORK 14650 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SECURITY OWNERSHIP OF CERTAIN 
BENEFICIAL OWNERS AND MANAGEMENT 
Beneficial Security Ownership of More Than 5%  

of the Company’s Shares .......................................... 35 

Beneficial Security Ownership of Directors, Nominees 

and Executive Officers .............................................. 37 
Delinquent Section 16(a) Reports ..................................... 39 

CERTAIN RELATIONSHIPS AND RELATED 
TRANSACTIONS 
Interested Transactions ..................................................... 40 

PRINCIPAL ACCOUNTING FEES AND 
SERVICES 
Audit and Non-Audit Fees ................................................. 43 
Policy Regarding Pre-Approval of Services 

Provided by our Independent Accountants ............... 43 

PROPOSAL 4 
Proposal 4 - Ratification of the Audit and Finance 
Committee’s Selection of Ernst & Young LLP 
as our Independent Registered Public  
Accounting Firm ........................................................ 44 

APPENDIX A   
Amended and Restated 2013 Omnibus Incentive Plan 

APPENDIX B  
First Amendment to the Amended and Restated 2013 
Omnibus Incentive Plan 

TABLE OF CONTENTS 

NOTICE OF 2021 ANNUAL MEETING  
Notice of the 2021 Annual Meeting of Shareholders 

PROXY STATEMENT 
QUESTIONS & ANSWERS 
Questions & Answers .......................................................... 1 
Householding of Disclosure Documents ............................. 8 
Printed Copy of 2020 Annual Report on Form 10-K ........... 8 

PROPOSAL 1  
Proposal 1 - Election of Directors ....................................... 9 

BOARD OF DIRECTORS AND 
CORPORATE GOVERNANCE 
Director Nominees ............................................................ 10 
Director and Nominee Independence ............................... 12 
Board Leadership Structure .............................................. 12 
Committees of the Board .................................................. 12 
Corporate Governance Overview ..................................... 14 
Business Conduct Guide and Directors’  

Code of Conduct ....................................................... 14 
Governance Practices ....................................................... 14 
Report of the Audit and Finance Committee ..................... 17 

EXECUTIVE COMPENSATION 
Summary Compensation Table ........................................ 18 
Narrative to Summary Compensation Table ..................... 19 
Outstanding Equity Awards at 2020 

Fiscal Year-End Table .............................................. 22 

DIRECTOR COMPENSATION 
Director Compensation ..................................................... 23 

PROPOSAL 2 
Proposal 2 - Advisory Vote to Approve the  

Compensation of our Named Executive Officers ...... 26 

PROPOSAL 3 
Proposal 3 - Approval of the First Amendment to the 

Amended and Restated 2013  
Omnibus Incentive Plan  ........................................... 27 
Introduction ....................................................................... 27 
Background ....................................................................... 27 
Terms of the First Amendment ......................................... 27 
Summary of the Plan ........................................................ 27 
Federal Tax Treatment ..................................................... 32 
Equity Compensation Plan Information ............................. 34 
Other Information .............................................................. 34 

 
 
 
 
 
 
 
 
 
 
NOTICE OF 2021 ANNUAL MEETING 

Dear Shareholder: 

You are cordially invited to attend our Annual Meeting of Shareholders on Wednesday, May 19, 2021 at 1:00 p.m. Eastern Time. 
The Annual Meeting will be conducted as a virtual meeting of shareholders by means of a live webcast. We believe that hosting 
a virtual meeting enables greater shareholder attendance and participation from any location, especially in light of the public 
health and travel concerns shareholders may have as a result of the ongoing pandemic. You will be able to attend the Annual 
Meeting online, vote your shares electronically, and submit your questions prior to and during the meeting by visiting 
www.meetingcenter.io/219690489 and entering the 15-digit control number on your proxy card or Notice Regarding the 
Availability of Proxy Materials. The password for the meeting is KODK2021. For additional information regarding procedures for 
attending the Annual Meeting, see “What do I need to do to participate in the Annual Meeting?” in the accompanying Proxy 
Statement. 

There is no physical location for the Annual Meeting this year and you will not be able to attend the Annual Meeting in person. If 
the situation regarding the pandemic changes in a way that impacts the Annual Meeting, we will announce any changes by press 
release and posting on our website, www.kodak.com, as well as by filing additional proxy materials with the Securities and 
Exchange Commission. If the Annual Meeting is a hybrid or in-person meeting, you may use your proxy card or Notice 
Regarding the Availability of Proxy Materials, along with proper form of identification, to physically attend the Annual Meeting. 
You will be asked to vote on Company proposals at the Annual Meeting.  

Whether or not you will participate in the Annual Meeting, we hope you will vote as soon as possible. You may vote over the 
internet, as well as by telephone or by mailing a proxy card or voting instruction form. We encourage you to use the internet, as it 
is the most cost-effective way to vote. Even if you have voted by internet, telephone or proxy card, you may still vote 
electronically if you participate in the virtual meeting. We would like to take this opportunity to remind you that your vote is very 
important. 

Sincerely, 

James V. Continenza 
Executive Chairman and Chief Executive Officer 

 
 
 
NOTICE OF THE 2021 ANNUAL MEETING OF SHAREHOLDERS   

The Annual Meeting of Shareholders (Annual Meeting) of Eastman Kodak Company will be held on Wednesday, May 19, 2021 
at 1:00 p.m. Eastern Time. The Annual Meeting will be conducted as a virtual meeting of shareholders by means of a live 
webcast that can be accessed at www.meetingcenter.io/219690489. The password for the meeting is KODK2021. For additional 
information regarding procedures for attending the Annual Meeting, see “What do I need to do to participate in the Annual 
Meeting?” in the accompanying Proxy Statement. We are asking our shareholders to vote on the following proposals at the 
Annual Meeting: 
1.  Election of the seven director nominees named in the Proxy Statement for a term of one year or until their successors are 

duly elected and qualified. 

2.  Advisory vote to approve the compensation of our named executive officers. 
3.  Approval of the First Amendment to the Amended and Restated 2013 Omnibus Incentive Plan. 
4.  Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public 

accounting firm. 

5.  Such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. 

The Board of Directors recommends you vote FOR each of the nominees listed in Proposal 1 and 
FOR Proposals 2, 3 and 4. 

If you held your shares at the close of business on March 29, 2021, you are entitled to vote at the Annual Meeting. 

We follow the Securities and Exchange Commission’s “e-proxy” rules that allow public companies to furnish proxy materials to 
their shareholders over the internet. These rules allow us to provide you with the information you need, while lowering the cost of 
delivery. 

If you have any questions about the Annual Meeting, please contact: Shareholder Services, Eastman Kodak Company, 
343 State Street, Rochester, NY 14650-0235, (585) 724-4053, e-mail: shareholderservices@kodak.com. 

Due to the ongoing impact of the COVID-19 pandemic, we plan to hold the Annual Meeting by means of remote communications 
only. As of the date of this mailing, a state disaster emergency has been declared relating to the COVID-19 pandemic in the 
State of New Jersey and the requirement under New Jersey law that annual meetings be held at a physical location has been 
temporarily suspended. The declaration of a state disaster emergency and the related suspension of physical meetings are 
renewed on a monthly basis. In the event that the state disaster emergency and suspension are lifted prior to the date fixed for 
the Annual Meeting and it is no longer legally permissible for us to hold a completely virtual annual meeting under New Jersey 
law, we will announce alternative arrangements for the Annual Meeting as promptly as practicable, which may include holding a 
hybrid or solely in-person meeting. We will announce any alternative arrangements for the Annual Meeting by press release and 
posting on our website, www.kodak.com, as well as by filing additional proxy materials with the Securities and Exchange 
Commission. If the Annual Meeting is held in person or as a hybrid meeting, you may use your proxy card or Notice Regarding 
the Availability of Proxy Materials, along with proper form of identification, to physically attend the Annual Meeting. The proxy 
card or Notice Regarding the Availability of Proxy Materials will admit only the named shareholder(s). 

By Order of the Board of Directors 

Roger W. Byrd 
General Counsel, Secretary and Senior Vice President 
Eastman Kodak Company 
April 9, 2021 

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting to be held on May 19, 2021. 
The Notice of 2021 Annual Meeting and Proxy Statement and 2020 Annual Report on Form 10-K 
are available at www.edocumentview.com/KODK.

 
 
 
 
PROXY STATEMENT 

QUESTIONS & ANSWERS 

Q.  Why am I receiving these proxy materials? 
A. 

Our Board of Directors (the Board) is providing these proxy materials to you on the internet, or has delivered printed 
versions to you by mail if requested, in connection with our 2021 Annual Meeting of Shareholders (the Annual Meeting), 
which will take place on Wednesday, May 19, 2021 at 1:00 p.m. Eastern Time. The Annual Meeting will be conducted as a 
virtual meeting of shareholders by means of a live webcast. By visiting www.meetingcenter.io/219690489, you will be able 
to attend the Annual Meeting online, vote your shares, and submit your questions prior to and during the meeting via the 
internet (provided that, if your shares are held in “street name” through a bank, broker or other holder of record, and you 
plan to vote at the Annual Meeting, you have contacted your bank, broker or agent to obtain a legal proxy to vote, provided 
the legal proxy to Computershare at legalproxy@computershare.com, received your control number and registered in 
advance to vote during the Annual Meeting). The password for the meeting is KODK2021. There will not be a physical 
meeting location and you will not be able to attend in person unless we hold a hybrid or in-person Annual Meeting as 
described below. As a shareholder, you are invited to attend the Annual Meeting online and are entitled and requested to 
vote on the proposals described in this Proxy Statement. We are making these proxy materials available to you on April 9, 
2021. 

Q.  Could emerging developments regarding the ongoing COVID-19 pandemic affect the Annual Meeting? 
A. 
A.  Due to the ongoing impact of the COVID-19 pandemic, we plan to hold the Annual Meeting by means of remote 

communications only. As of the date of this mailing, a state disaster emergency has been declared relating to the COVID-19 
pandemic in the State of New Jersey and the requirement under New Jersey law that annual meetings be held at a physical 
location has been temporarily suspended. The declaration of a state disaster emergency and the related suspension of 
physical meetings are renewed on a monthly basis. In the event that the state disaster emergency and suspension are lifted 
prior to the date fixed for the Annual Meeting and it is no longer legally permissible for us to hold a completely virtual annual 
meeting under New Jersey law, we will announce alternative arrangements for the Annual Meeting as promptly as 
practicable, which may include holding a hybrid or solely in-person meeting. We will announce any alternative arrangements 
for the Annual Meeting by press release and posting on our website, www.kodak.com, as well as by filing additional proxy 
materials with the Securities and Exchange Commission (the SEC). If the Annual Meeting is held in person or as a hybrid 
meeting, you may use your proxy card or Notice Regarding the Availability of Proxy Materials (the Notice of Internet 
Availability), along with proper form of identification, to physically attend the Annual Meeting. The proxy card or Notice of 
Internet Availability will admit only the named shareholder(s). 
In the event that the logistics of our Annual Meeting are further impacted by developments related to or stemming from the 
COVID-19 pandemic, we will announce such information as promptly as practicable. Please monitor our website at 
www.kodak.com for updated information. As always, we encourage you to vote your shares prior to the Annual Meeting. 
Information included on, or that can be accessed through, our website, other than our Proxy Statement and proxy card, is 
not part of the proxy solicitation materials. 

Q.  What is included in these proxy materials? 
A.  These proxy materials include: 

•  Our 2020 Annual Report on Form 10-K; and 
•  Notice of the Annual Meeting and Proxy Statement. 

If you received printed versions of the proxy materials by mail, these proxy materials also include a proxy card. 

Q.  What am I voting on?  
A.  The Board is soliciting your proxy in connection with the Annual Meeting to be held on Wednesday, May 19, 2021 at 
1:00 p.m. Eastern Time, and any adjournment or postponement thereof. You are voting on the following proposals: 
1.  Election of the seven director nominees named in this Proxy Statement for a term of one year or until their successors 

are duly elected and qualified. 

2.  Advisory vote to approve the compensation of our named executive officers.  
3.  Approval of the First Amendment to the Amended and Restated 2013 Omnibus Incentive Plan. 
4.  Ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP as our independent registered public 

accounting firm. 

The Board recommends you vote FOR each of the director nominees listed in Proposal 1 and FOR Proposals 2, 3 and 4. 

1 

 
Q.  Will any other matters be voted on? 
A.  We are not aware of any other matters that shareholders will be asked to vote on at the Annual Meeting. If any other matter 

is properly brought before the Annual Meeting, the named proxies, James V. Continenza and Roger W. Byrd, will vote for 
you on such matter in their discretion. New Jersey law (under which the Company is incorporated) requires that you be 
given notice of all matters to be voted on, other than procedural matters such as adjournment of the Annual Meeting. 

Q.  Why did I receive a one-page notice in the mail regarding the internet availability of proxy materials instead of a full 

set of proxy materials? 

A.  We follow the SEC’s “e-proxy” rules that allow public companies to furnish proxy materials to shareholders over the internet. 

The “e-proxy” rules remove the requirement for public companies to automatically send shareholders a full, printed copy of 
proxy materials and allow them instead to deliver to their shareholders a “Notice of Internet Availability of Proxy Materials” 
and to provide online access to the documents. As a result, we mailed the Notice of Internet Availability to many of our 
shareholders on April 9, 2021.   

The Notice of Internet Availability provides instructions on how to: 

•  View our proxy materials for the Annual Meeting on the internet and vote; and 
•  Request a printed copy of the proxy materials. 

In addition, shareholders may request to receive proxy materials in printed form by mail or electronically by e-mail on an 
ongoing basis. Choosing to receive your future proxy materials by e-mail will save us the cost of mailing documents to you.  

Q.  Why didn’t I receive a notice in the mail about the internet availability of the proxy materials? 
A.  We are providing some of our shareholders, including those who have previously requested to receive paper copies of the 

proxy materials, with paper copies of the proxy materials instead of the Notice of Internet Availability.  

In addition, we are providing the Notice of Internet Availability by e-mail to those shareholders who have previously elected 
delivery of the proxy materials electronically. Those shareholders should have received an e-mail containing a link to the 
website where the proxy materials are available. 

Q.  Where can I view the proxy materials on the internet? 
A.  We are making this Proxy Statement and voting instructions available to shareholders on April 9, 2021, at 

www.edocumentview.com/KODK. We are also making our 2020 Annual Report on Form 10-K available at the same time 
and by the same method. The 2020 Annual Report on Form 10-K is not a part of the proxy solicitation material and is not 
incorporated herein by reference. 

Q.  How can I receive a printed copy of the proxy materials? 
A.  Shareholder of Record. You may request a printed copy of the proxy materials by any of the following methods: 
•  Telephone: within the U.S.A., U.S. territories and Canada, call toll-free at 1-866-641-4276; or outside of the 

U.S.A., U.S. territories and Canada, call collect at 1-781-575-3170; 

•  Internet at www.envisionreports.com/KODK; or 
•  E-mail at investorvote@computershare.com. Reference “Proxy Materials Eastman Kodak Company” in the 

subject line. In the message, include your full name and address, the number located in the shaded bar on the 
Notice of Internet Availability/proxy card, and state that you want to receive a paper copy of current and/or 
future meeting materials. 

Beneficial Owner. You may request a printed copy of the proxy materials by following the instructions provided to you by 
your broker, trustee or nominee. 

Q.  What is the difference between holding shares as a shareholder of record and as a beneficial owner? 
A.  Most of our shareholders hold their shares through a broker or other nominee (beneficial owner) rather than directly in their 
own name (shareholder of record). As summarized below, there are some distinctions between shareholders of record and 
beneficial owners. 

Shareholder of Record. If your shares are registered in your name with our transfer agent, Computershare, you are 
considered the shareholder of record of these shares, and we are making these proxy materials available directly to you. As 
a shareholder of record, you have the right to give your voting proxy to our management or a third party, or to vote 
electronically via the internet at the Annual Meeting.  

Beneficial Owner. If your shares are held in a brokerage account or by another nominee, you are considered the beneficial 
owner of shares held in “street name,” and your broker, trustee or nominee is making these proxy materials available to you 
together with a voting instruction form. As the beneficial owner, you have the right to direct your broker, trustee or nominee 

2 

 
on how to vote your shares. You are also invited to participate in the Annual Meeting. Your broker, trustee or nominee has 
enclosed or provided voting instructions for you to use in directing the broker, trustee or nominee on how to vote your 
shares. Since a beneficial owner is not the shareholder of record, you may not vote these shares electronically at the 
Annual Meeting unless you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares, giving you the 
right to vote the shares electronically at the Annual Meeting and submitting proof of your legal proxy reflecting the number of 
shares you held as of the record date along with your name to Computershare following the instructions below. Requests for 
registration must be labeled as “Legal Proxy” and be received no later than 5:00 p.m. Eastern Time, on May 17, 2021. You 
will then receive a confirmation of your registration, with a control number, by e-mail. In order to vote your shares, you must 
either: 1) obtain a legal proxy that gives you the right to vote the shares electronically via the internet at the Annual Meeting; 
or 2) provide voting instructions to your broker.  

Q.  How do I vote? 
A.  Shareholder of Record. If you are a shareholder of record, there are four ways to vote: 
•  By internet at www.envisionreports.com/KODK. We encourage you to vote this way. 
•  By touch tone telephone: within the U.S.A., U.S. territories and Canada, call toll-free at 1-800-652-VOTE 

(8683); or outside the U.S.A., U.S. territories and Canada, call collect at 1-781-575-2300. 

•  By completing and mailing your proxy card (if you requested and received a printed copy of the proxy 

materials). 

•  By using electronic voting options included as part of the live webcast during the Annual Meeting. Votes 

submitted during the Annual Meeting must be received no later than the closing of the polls at the Annual 
Meeting. 

Beneficial Owner. If you are a beneficial owner, please follow the voting instructions sent to you by your broker, trustee or 
nominee. 

Whether you are a shareholder of record or a beneficial owner, your shares will be voted as you indicate.  

Q.  What happens if I do not give specific voting instructions? 
A.  Shareholder of Record. If you are a shareholder of record and you: 

•  Indicate when voting on the internet or by telephone that you wish to vote as recommended by our Board; or 
•  Sign and return a proxy card without giving specific voting instructions,  

then the named proxies, James V. Continenza and Roger W. Byrd, will vote your shares in the manner recommended by 
our Board (i.e., FOR each of the director nominees named in Proposal 1 and FOR Proposals 2, 3 and 4) and in their 
discretion with respect to any other matters properly presented for a vote at the Annual Meeting. 

Beneficial Owner. If you do not provide your broker, trustee or nominee with specific voting instructions, or if you do not 
obtain a legal proxy that gives you the right to vote the shares electronically via the internet at the Annual Meeting, your 
shares will not be voted or counted with respect to Proposals 1, 2 and 3, which are non-routine proposals. Your broker, 
trustee or nominee has discretionary authority to vote your uninstructed shares with respect to Proposal 4, which is a routine 
proposal. Uninstructed shares with respect to non-routine proposals (Proposals 1, 2 and 3) as to which your broker does not 
have discretionary authority are known as “broker non-votes.” 

Q.  Who can vote? 
A.  You must be a shareholder of record or a beneficial owner as of the close of business on March 29, 2021, the record date 

for the Annual Meeting, to be eligible to vote at the Annual Meeting. Each share of common stock is entitled to one vote. 
Holders of 5.0% Series C Convertible Preferred Stock (Series C preferred stock) are entitled to vote upon all matters upon 
which holders of common stock have the right to vote, and are entitled to the number of votes equal to the number of full 
shares of common stock into which such shares of Series C preferred stock could be converted at the then applicable 
conversion rate at the record date. Such votes will be counted together with shares of common stock and not separately as 
a class.  As of the record date, each share of Series C preferred stock is convertible into 10 shares of common stock. 

Q.  How can I change my vote or revoke my proxy? 
A.  Shareholder of Record. If you are a shareholder of record, you can change your vote or revoke your proxy before the polls 

close at the Annual Meeting by: 

•  Entering a new vote by internet or telephone (only your latest internet or telephone vote will be counted); 
•  Returning a later-dated proxy card; or 
•  Sending a written notification to Roger W. Byrd, Secretary, at our principal executive office. 

3 

 
Attending the meeting without voting during the meeting will not, by itself, revoke a previously submitted proxy unless you 
specifically request your prior proxy be revoked. 

Beneficial Owner. If you are a beneficial owner, please follow the voting instructions provided by your broker, trustee or 
nominee. 

Q.  What vote is required to approve each proposal? 
A.  The following table describes the voting requirements for each proposal: 

Proposal 1 - Election of Directors 

Proposal 2 - Advisory Vote to Approve the Compensation 
of our Named Executive Officers 

As set forth in our By-laws, the Board has adopted a majority voting 
standard for uncontested director elections. Because the number of 
nominees properly nominated for the Annual Meeting is the same as 
the number of directors to be elected at the Annual Meeting, the 
2021 election of directors is an uncontested election. 
To be elected in an uncontested election, a director nominee must 
be elected by a majority of the votes cast with respect to that 
director nominee. A majority of the votes cast means that the 
number of votes cast FOR a nominee’s election must exceed the 
number of votes cast AGAINST the nominee’s election. Each 
nominee receiving more votes FOR his or her election than votes 
AGAINST his or her election will be elected. 

To be approved, this proposal must receive the affirmative vote of a 
majority of the votes cast at the Annual Meeting by holders entitled 
to vote thereon. However, because this is an advisory vote, the 
results of the vote are not binding on the Board or our 
Compensation, Nominating and Governance Committee who value 
the opinions expressed by our shareholders in their votes on this 
proposal. The outcome of the vote will be taken under advisement 
by the Board and the Compensation, Nominating and Governance 
Committee in future consideration and development of our 
compensation practices.  

Proposal 3 - Approval of the First Amendment to the 
Amended and Restated 2013 Omnibus 
Incentive Plan 

To be approved, this proposal must receive the affirmative vote of a 
majority of the votes cast at the Annual Meeting by holders entitled 
to vote thereon. 

Proposal 4 - Ratification of the Audit and Finance 

Committee’s Selection of Ernst & Young LLP 
as our Independent Registered Public 
Accounting Firm 

To be approved, this proposal must receive the affirmative vote of a 
majority of the votes cast at the Annual Meeting by holders entitled 
to vote thereon.  

Q.  How are votes counted? 
A.  For Proposal 1, you may vote “FOR,” “AGAINST” or “ABSTAIN” with respect to each of the nominees. In tabulating the 

voting results for the election of directors, only “FOR” and “AGAINST” votes are counted. If you elect to abstain in the 
election of directors, the abstention will not impact the outcome of the election. Broker non-votes are not counted and will 
not impact the outcome of the vote. 

You may vote “FOR,” “AGAINST” or “ABSTAIN” with respect to Proposals 2, 3 and 4. In tabulating the voting results for 
these proposals, “FOR” and “AGAINST” votes are counted. For Proposals 2 and 4, abstentions are not counted and will not 
impact the outcome of the vote. For Proposal 3, under NYSE rules, abstentions are treated as votes that are cast against 
the proposal. With respect to Proposals 2 and 3, broker non-votes are not counted and will not impact the outcome of the 
vote. A broker will have discretionary authority to vote on Proposal 4 relating to the ratification of the selection of our 
independent registered public accounting firm. Since brokers have authority to vote on behalf of beneficial owners with 
respect to Proposal 4, there will be no broker non-votes for this proposal. 

Q.  Who will count the vote? 
A.  Computershare will count the votes. A representative from Computershare will serve as the inspector of election. 

4 

 
Q.  Who can attend the virtual Annual Meeting? 
A. 

If you held your shares as of the close of business on March 29, 2021, the record date for the Annual Meeting, you may 
attend the virtual Annual Meeting and electronically vote on the proposals for consideration at the Annual Meeting. 

Q.  What do I need to do to participate in the Annual Meeting?  
A.  The Annual Meeting will be conducted as a virtual meeting of shareholders by means of a live webcast. We aim to 
provide shareholders the same rights and comparable opportunities for participation that have been historically 
provided at our in-person annual meetings.  
You are entitled to participate in the Annual Meeting only if you were a shareholder of the Company as of the close of 
business on the record date or if you hold a valid proxy for the Annual Meeting. No physical meeting will be held this 
year, and you will not be able to attend the Annual Meeting in person unless we hold a hybrid or in-person Annual 
Meeting as described above under “Could emerging developments regarding the ongoing COVID-19 pandemic affect 
the Annual Meeting.” 
Shareholders will be able to attend the Annual Meeting online and submit questions during the meeting by visiting 
www.meetingcenter.io/219690489. You also will be able to vote your shares online by attending the Annual Meeting by 
webcast. To participate in the Annual Meeting, you will need to review the information included on your Notice of 
Internet Availability, on your proxy card or on the instructions that accompanied your proxy materials. You will need to 
enter the 15-digit control number on your proxy card or Notice of Internet Availability. The password for the meeting is 
KODK2021. 
If you hold your shares through an intermediary, such as a bank or broker, you must register in advance using the 
instructions below. 
The online Annual Meeting will begin promptly at 1:00 p.m. Eastern Time. We encourage you to access the meeting 
prior to the start time leaving ample time for the check-in process. Please follow the registration instructions as outlined 
in this Proxy Statement. 

Q.  How do I register to participate in the Annual Meeting? 
A. 

If you are a registered shareholder (i.e., you hold your shares through our transfer agent, Computershare), you do not 
need to register to attend the Annual Meeting virtually on the internet. Please follow the instructions on the Notice of 
Internet Availability or proxy card that you received. 
If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the 
Annual Meeting virtually on the internet. To register to attend the Annual Meeting online by webcast you must submit 
proof of your proxy power (legal proxy) reflecting your Kodak holdings along with your name and e-mail address to 
Computershare. Requests for registration must be labeled as “Legal Proxy” and be received no later than 5:00 p.m., 
Eastern Time, on May 17, 2021. 
You will receive a confirmation of your registration by e-mail after Computershare receives your registration materials.  
Requests for registration should be directed to the following:  
      By e-mail:  

Forward the e-mail from your broker, or attach an image of your legal proxy, to 
legalproxy@computershare.com. 

      By mail:  

Computershare 
Eastman Kodak Company Legal Proxy 
P.O. Box 43001 
Providence, RI 02940-3001 

Q.  How can I ask questions during the Annual Meeting? 
A.  Shareholders participating in the Annual Meeting may, after entering the 15-digit control number on your proxy card or 

Notice of Internet Availability, submit questions during the Annual Meeting. After the business portion of the Annual Meeting 
concludes and the Annual Meeting is adjourned, we will answer questions submitted during the Annual Meeting that are 
pertinent to the Company and that comply with the meeting rules of conduct, as time permits. 

Q.  What is the quorum requirement of the Annual Meeting? 
A.  The holders of shares entitled to cast a majority of the votes on March 29, 2021 will constitute a quorum for voting at the 
Annual Meeting. If you vote, your shares will be part of the quorum. Abstentions and broker non-votes will be counted in 
determining the quorum. On March 29, 2021, there were 78,503,476 shares of our common stock outstanding and 750,000 
shares of our Series C preferred stock outstanding. As of the record date, each share of Series C preferred stock is 
convertible into 10 shares of common stock and holders are entitled to the number of votes equal to the number of full 

5 

 
 
 
 
shares of common stock into which such shares of Series C preferred stock could be converted. Accordingly, holders 
entitled to cast 43,001,739 votes will constitute a quorum for the Annual Meeting. 

Q.  Where can I find the voting results of the Annual Meeting? 
A.  We intend to announce preliminary voting results at the Annual Meeting and disclose final results in a Form 8-K to be filed 

with the SEC within four business days after the Annual Meeting. If final results are not available at such time, the Form 8-K 
will disclose preliminary results, to be followed with an amended Form 8-K when final results are available.  

Q.  Can I nominate someone to the Board? 
A.  Our By-laws provide that any shareholder can nominate a person for election to the Board so long as the shareholder 
follows the procedure outlined in our By-laws as summarized below. This is the procedure to be followed for direct 
nominations, as opposed to recommendations of nominees for consideration by our Compensation, Nominating and 
Governance Committee. The complete description of the procedure for shareholder nominations of director candidates is 
contained in our By-laws. You can request a copy of the full text of this By-law provision by writing to our Secretary at our 
principal executive offices. Our By-laws can also be accessed at http://investor.kodak.com/supporting.cfm. 

For purposes of summarizing this procedure, we have assumed: 1) the date of the upcoming annual meeting is within 30 
days of the anniversary of the annual meeting for the previous year and 2) if the size of the Board is to be increased, that 
both the name of the director nominee and the size of the increased Board are publicly disclosed at least 100 days prior to 
the first anniversary of the previous year’s annual meeting. Based on these assumptions, a shareholder desiring to 
nominate one or more candidates for election at the next annual meeting must deliver written notice of such nomination to 
our Secretary, at our principal executive office, not less than 90 days nor more than 120 days prior to the first anniversary of 
the preceding year’s annual meeting. Accordingly, for our 2022 Annual Meeting of Shareholders (the 2022 Annual Meeting), 
notice of nomination must be delivered to our Secretary no earlier than January 19, 2022 and no later than February 18, 
2022. 

The written notice to our Secretary must contain the following information with respect to each nominee: 1) the proposing 
shareholder’s name and address; 2) the number of shares owned of record and beneficially by the proposing shareholder; 
3) the name of the person to be nominated; 4) the number of shares owned of record and beneficially by the nominee; 5) a 
description of all relationships, arrangements and understandings between the shareholder and the nominee and any other 
person or persons (naming such person or persons) pursuant to which the nomination is to be made by the shareholder; 
6) such other information regarding the nominee as would have been required to be included in the proxy statement filed 
pursuant to the proxy rules of the SEC had the nominee been nominated, or intended to be nominated, by the Board, such 
as the nominee’s name, age and business experience; and 7) the nominee’s signed consent to serve as a director if so 
elected. 

Persons nominated in accordance with this procedure will be eligible for election as directors at the 2022 Annual Meeting. 

Q.  What is the deadline to propose actions for consideration at the 2022 Annual Meeting? 
A.  For a shareholder proposal to be considered for inclusion in our proxy statement for the 2022 Annual Meeting, the Secretary 
must receive the written proposal at our principal executive office no later than the close of business on December 10, 2021. 
Proposals received after this date will be considered untimely. Proposals must comply with SEC regulations under Rule 
14a-8 of the Securities Exchange Act of 1934, as amended (Exchange Act), regarding the inclusion of shareholder 
proposals in company-sponsored proxy materials. Proposals should be addressed to: 

Secretary 
Eastman Kodak Company 
343 State Street 
Rochester, NY 14650-0224 

For a shareholder proposal that is not intended to be included in our proxy statement under Rule 14a-8, the shareholder 
must provide the information required by our By-laws and give timely notice to the Secretary in accordance with our 
By-laws, which, in general, require that the notice be received by the Secretary: 

•  No earlier than the close of business on January 19, 2022; and 
•  No later than the close of business on February 18, 2022. 

If the date of the shareholder meeting is moved more than 30 days before or 30 days after the anniversary of the 2021 
Annual Meeting, then notice of a shareholder proposal that is not intended to be included in our proxy statement under 
Rule 14a-8 must be received no earlier than the close of business 120 days prior to the anniversary of the 2021 Annual 
Meeting and no later than the close of business on the later of the following two dates: 

•  90 days prior to the meeting; and 

6 

 
•  10 days after public announcement of the meeting date. 

You may contact our Secretary at our principal executive office for a copy of the relevant By-law provisions regarding the 
requirements for shareholder proposals. Our By-laws can also be accessed at http://investor.kodak.com/supporting.cfm.  

Q.  Who will pay the cost of this proxy solicitation? 
A.  We will bear all costs related to this proxy solicitation. We will reimburse brokerage houses and other custodians, nominees, 
trustees and fiduciaries representing beneficial owners of shares for their reasonable out-of-pocket expenses for forwarding 
proxy and solicitation materials to such beneficial owners. Our directors, officers and employees may also solicit proxies and 
voting instructions in person, by telephone or by other means of communication. These directors, officers and employees 
will not be additionally compensated but may be reimbursed for reasonable out-of-pocket expenses in connection with these 
solicitations. 

Q.  What other information about us is available? 
A.  The following information is available on our website at http://investor.kodak.com/supporting.cfm:  

•  Corporate Responsibility Principles  
•  Corporate Governance Guidelines 
•  Business Conduct Guide 
•  Eastman Kodak Company By-laws 
•  Charters of the Board’s Committees (Audit and Finance Committee and Compensation, Nominating and 

Governance Committee) 
•  Directors’ Code of Conduct 
•  Board of Directors Policy on Recoupment of Executive Bonuses in the Event of Certain Restatements 
•  Majority Vote Policy 
•  Anti-Hedging and Pledging Policy  
•  Related Party Transactions Policy and Procedures 
•  Corporate Political Contributions and Expenditures Policy  
•  Health, Safety and Environment Sustainability Reports are available on our website at 

https://www.kodak.com/en/company/page/sustainability 

Our 2020 Annual Report on Form 10-K is available on our website at http://investor.kodak.com/financials.cfm. 

You may request printed copies of any of these documents by contacting:  

Shareholder Services 
Eastman Kodak Company 
343 State Street 
Rochester, NY 14650-0235 
(585) 724-4053 

E-mail: shareholderservices@kodak.com 

The address of our principal executive office is: 

Eastman Kodak Company 
343 State Street 
Rochester, NY 14650 

7 

 
 
 
HOUSEHOLDING OF DISCLOSURE DOCUMENTS 

We are sending a Notice of Internet Availability or set of proxy materials to each shareholder of record. This year, we have 
elected not to take advantage of the SEC’s householding rules that allow us to deliver a single set of the Notice of Internet 
Availability or proxy materials to shareholders of record who share the same address. If you are a beneficial owner, your broker 
or other nominee may continue to send a single set of the Notice of Internet Availability or proxy materials to your household. 
Please contact your broker or other nominee if you wish to adjust your preferences regarding the delivery of the Notice of 
Internet Availability or proxy materials. 

PRINTED COPY OF 2020 ANNUAL REPORT ON FORM 10-K 

We will provide you, without charge, upon request, a printed copy of our 2020 Annual Report on Form 10-K. To receive 
a printed copy of the 2020 Annual Report on Form 10-K, please contact:  

Shareholder Services 
Eastman Kodak Company 
343 State Street 
Rochester, NY 14650-0235 
(585) 724-4053 

E-mail: shareholderservices@kodak.com 

8 

 
PROPOSAL 1  

PROPOSAL 1 - ELECTION OF DIRECTORS  

Our By-laws require us to have at least five but no more than 13 directors. The number of directors, which is set by the Board, is 
currently seven. Mr. Continenza, our Executive Chairman and Chief Executive Officer, is the only director who is an employee of 
the Company. 

The following three directors are standing for re-election, having been elected at the 2020 annual meeting, and have been 
recommended for nomination by the Compensation, Nominating and Governance Committee: James V. Continenza, Philippe D. 
Katz, and Jason New. In addition, upon the recommendation of the Compensation, Nominating and Governance Committee, the 
Board has nominated Darren L. Richman, who was appointed to the Board effective April 1, 2021, B. Thomas Golisano, 
Kathleen B. Lynch and Michael E. Sileck, Jr. as directors. All nominees have consented to serve if elected. 

Mr. Richman was appointed to the Board effective April 1, 2021 and is a designee of Kennedy Lewis Investment Management 
LLC (KLIM). In connection with debt financing we obtained from Kennedy Lewis Capital Partners Master Fund LP (KLIM Fund I) 
and Kennedy Lewis Capital Partners Master Fund II LP (KLIM Fund II and, collectively with KLIM Fund I, the KLIM Funds) 
pursuant to the Credit Agreement among the Company, the KLIM Funds, as lenders, and Alter Domus (US) LLC, as 
administrative agent (the Term Loan Credit Agreement), we agreed to appoint an individual designated by KLIM as a Board 
member at or prior to the Annual Meeting. KLIM will have the right to nominate one director at each subsequent shareholder 
meeting until the earlier to occur of (i) February 26, 2024 or (ii) KLIM affiliated funds ceasing to hold at least 50% of the original 
principal amount of the term loans and commitments under the Term Loan Credit Agreement. Until KLIM ceases to hold at least 
50% of the original principal amount of the term loans and commitments under the Term Loan Credit Agreement, at any time that 
KLIM’s designated director is not serving on the Board, KLIM will have the right to designate a non-voting observer to the Board.   

Mr. Golisano is a nominee designated in connection with the Series C Preferred Stock Purchase Agreement (the Series C 
Purchase Agreement) dated as of February 26, 2021, between the Company and GO EK Ventures IV, LLC (GO EK Ventures), 
whereby GO EK Ventures has the contractual right to nominate one director to the Board. This nomination right expires on 
February 26, 2024. Following February 26, 2024, if dividends on the Series C preferred stock are in arrears for six or more 
consecutive or non-consecutive dividend periods, GO EK Ventures will be entitled to nominate one director at the next annual 
shareholder meeting and all subsequent shareholder meetings until all accumulated dividends on such Series C preferred stock 
have been paid in full in the form of additional shares of Series C preferred stock or the liquidation preference has been 
increased by the amount of any unpaid dividends, at which time any such director serving on the Board shall resign. The 
foregoing nomination rights will automatically terminate upon GO EK Ventures ceasing to directly or indirectly hold at least a 
majority of the shares of the Series C preferred stock purchased or the common stock received upon the conversion of such 
shares. Such nomination rights are exclusive to GO EK Ventures and do not transfer with the Series C preferred stock. 

If elected, all of the nominees for director will serve a one year term or until their successors are duly elected and qualified. 
Information about the director nominees is provided in the section entitled “Board of Directors and Corporate Governance” in this 
Proxy Statement. If a nominee is unable to stand for election, the Board may reduce the number of directors or choose a 
substitute. If the Board chooses a substitute, the shares represented by proxies will be voted for the substitute. If a director 
retires, resigns, dies or is unable to serve for any reason, the Board may reduce the number of directors or elect a new director 
to fill the vacancy. 

Director nominees are elected by a majority of votes cast. Each director nominee who receives more “FOR” than “AGAINST” 
votes cast for his election will be elected. If a director nominee receives a greater number of votes “AGAINST” his election than 
votes “FOR” such election, the Board will decide whether to accept the irrevocable letter of resignation the nominee submitted as 
a condition of being nominated to the Board in accordance with our Majority Vote Policy. 

The Board of Directors recommends a vote FOR the election of each of the director nominees. 

9 

 
 
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE 

DIRECTOR NOMINEES  

The Compensation, Nominating and Governance Committee and the Board seek to ensure that the Board is composed of 
members who bring an appropriate mix of skills and experience across a variety of disciplines, including strategic planning, 
organizational management, technology, corporate finance, mergers and acquisitions, marketing, digital technologies, public 
policy, economics, executive compensation, risk management, international operations, corporate governance and internal 
controls, each of which is an important area of responsibility for the Board and its committees.  

The Board and the Compensation, Nominating and Governance Committee believe that each of the director nominees 
possesses important experience and skills that provide the Board with an optimal balance of leadership, competencies and 
qualifications in areas that are important to our company. Each of our director nominees has high ethical standards, acts with 
integrity and exercises careful, mature judgment. Each is committed to employing his or her skills and abilities to aid the long-
term interests of our shareholders.  

In addition to the biographical information in each director nominee’s profile below, the Board and the Compensation, Nominating 
and Governance Committee considered the listed Key Experience, Skills and other Qualifications in its evaluation and 
determination to nominate each director for election or re-election. 

JAMES V. CONTINENZA 

Director since April 2013, Chairman since September 2013, 
Executive Chairman since February 2019, and Chief Executive Officer since July 2020 

James V. Continenza, 58, leads the transformation of Kodak as Executive Chairman and Chief Executive Officer. He was 
appointed by the Board as Executive Chairman on February 20, 2019 and as Chief Executive Officer on July 27, 2020. Mr. 
Continenza joined the Board of Kodak in April 2013 and became Chairman of the Board in September 2013. Mr. Continenza 
brings a proven track record of guiding leading technology companies through transformations. Since September 2012, Mr. 
Continenza has served as the Chairman and Chief Executive Officer of Vivial, Inc., a privately-held marketing technology and 
communications company. He has also held leadership roles at STi Prepaid, LLC, a telecommunications company; Anchor Glass 
Container Corp., a leading manufacturer of glass containers; Teligent, Inc., a provider of communications services including 
voice, data, and internet access; Lucent Technologies Product Finance, a global leader in telecom equipment; and AT&T Inc. 

In addition to his management experience, Mr. Continenza currently serves on the board of directors of Cenveo Corporation, an 
industry leader in transformative publishing solutions. He has also served on the boards of directors of Datasite LLC (formerly 
known as Merrill Corp.), NII Holdings, Inc., Tembec, Inc. and Neff Corporation. He also serves or has served on the boards of a 
number of private companies. 

Key Experience, Skills and other Qualifications:  

Mr. Continenza has extensive experience in the management and governance of a wide range of companies, including 
technology companies, with a particular focus on companies that have undergone significant corporate restructuring. He brings 
to the Board valuable expertise in technology, marketing, operations, strategic planning, mergers and acquisitions, and executive 
compensation. In addition, Mr. Continenza brings corporate governance and risk management expertise to the Board through his 
past and current executive positions and service as a board member of diverse companies. 

B. THOMAS GOLISANO 

2021 director nominee 

B. Thomas Golisano, 79, founded Paychex, Inc. in 1971 and serves as its Chairman of the Board. He served as President and 
Chief Executive Officer of Paychex, Inc. until October 2004. Mr. Golisano also serves on the boards of Cognivue, Inc., Greenlight 
Networks, Inc. and Twinlab Consolidated Holdings, Inc. Mr. Golisano serves, and has served, as a director of numerous other 
non-profit organizations and private companies. He is founder and member of the board of trustees of the B. Thomas Golisano 
Foundation.  

Key Experience, Skills and other Qualifications: 

Mr. Golisano brings to the Board substantial executive leadership experience, including as the founder and chair of a large public 
company. 

PHILIPPE D. KATZ 

Director since February 2019 

Philippe D. Katz, 59, has been a partner of the private investment firm United Equities Commodities Company since February 
1995. Mr. Katz has been a director and officer of Momar Corp., a private investment firm, since May 2010, a partner of Marneu 
Holding Company, a privately held investment company, since February 2007, and a director and officer of 111 John Realty 

10 

 
 
 
 
Corp., a property management company, since December 1995. In addition, Mr. Katz is a managing member of K.F. Investors 
LLC, a privately held investment company, a position he has held since March 2007. Mr. Katz has served on the board of 
directors of Berkshire Bancorp, Inc. since June 2013. Mr. Katz served as an observer to our Board from September 2013 to 
February 2019. 

Key Experience, Skills and other Qualifications: 

Mr. Katz has extensive experience in investing, finance and corporate strategy. Mr. Katz brings to the Board knowledge of capital 
markets, risk management and corporate finance, all of which are considered important to our business. 

KATHLEEN B. LYNCH 

2021 director nominee 

Kathleen B. Lynch, 55, served as the Chief Operating Officer and Group Managing Director of UBS Wealth Management 
Americas and UBS Americas Holding LLC, an intermediate holding company for the U.S. based subsidiaries of UBS Group AG, 
a global wealth manager and financial services firm, from February 2013 until May 2018. Prior to that she served twenty-five 
years at Merrill Lynch/Bank of America in a variety of leadership positions in global markets and investment banking and global 
research. Ms. Lynch has served on the board of directors of UBS Americas Holding LLC since July 2016. She also serves on the 
board of directors of Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the world’s 
financial markets, a position she has held since 2017. For UBS, Ms. Lynch also served as a member of multiple subsidiary 
boards and committees, including Chairperson of the UBS U.S. Service Company and board member of the Wealth 
Management Broker Dealer.  

Key Experience, Skills and other Qualifications: 

In addition to governance and board service as a skill set, Ms. Lynch brings to the Board extensive skills, leadership and deep 
expertise in strategy execution and development, risk and talent management and regulatory matters. Her leadership experience 
is across a diverse set of businesses including wealth management, operations, technology and global markets. She has held 
global, regional, and business responsibilities throughout her career, overseeing major transformation initiatives, business 
integration efforts and implementation of digital strategy and platforms. She brings a strong focus on the full spectrum of all risk 
types in crisis management. 

JASON NEW 

Director since September 2013 

Jason New, 52, is the Co-CEO of Onex Credit, the credit investing arm of Onex Corporation (Onex). Mr. New joined Onex in 
April 2020. Prior to joining Onex, Mr. New was the Senior Managing Director of The Blackstone Group L.P., a global investment 
and advisory firm, and the Head of Special Situation Investing for GSO Capital Partners LP (GSO), a credit-oriented alternative 
asset manager, having served in such positions from 2005 until December 2019. Mr. New joined The Blackstone Group L.P. in 
2008 in connection with its acquisition of GSO. Before joining GSO in 2005, Mr. New was a senior member of Credit Suisse's 
distressed finance group. Mr. New joined Credit Suisse in 2000 when it acquired Donaldson, Lufkin & Jenrette (DLJ), where he 
was a member of DLJ's restructuring group. Prior to joining DLJ in 1999, he was an associate with the law firm Sidley Austin 
LLP, where he practiced in the firm's corporate reorganization group. 

Mr. New served on the board of directors of MPM Holdings Inc. from October 2014 to August 2016. Mr. New also served on the 
boards of directors of Cheniere Energy, Inc. from August 2008 to December 2010 and Global Aviation Holdings Inc. from 
September 2009 to January 2012.  

Key Experience, Skills and other Qualifications: 

Mr. New has significant expertise in investment strategies and opportunities, with a particular focus on companies that have 
experienced distressed economic conditions or are in various stages of restructuring. He brings to the Board skills in developing 
creative financial solutions and strategies, which are critical to our ability to sustain growth and profitability as a technology 
company in a competitive environment. Mr. New is highly experienced in complex financial and investment transactions. He also 
has a legal background, which is useful in the governance and risk management issues facing our company. 

Director since April 2021 

DARREN L. RICHMAN 
Darren L. Richman, 49, is the Co-Founder and a Managing Member of KLIM, an investment adviser, having served in that 
position since November 2017. Since November 2017, Mr. Richman has also been a Managing Member of each of the KLIM 
Funds, investment funds. Mr. Richman was a Senior Managing Director with Blackstone from 2006 to 2016 where he focused on 
special situation and opportunistic investments, and he sat on the Investment Committee for GSO Capital Partner’s opportunistic 
credit funds and special situation funds. Before joining GSO Capital Partners, Mr. Richman worked at DiMaio Ahmad Capital, 
where he was a Founding Member and the Co-Head of its Investment Research Team, from 2003 to 2006. Prior to joining 
DiMaio Ahmad, Mr. Richman was a Vice President and Senior Special Situations Analyst at Goldman Sachs, from 1999 to 2003. 
Mr. Richman began his career with Deloitte & Touche, ultimately serving as a Manager in the firm’s Mergers and Acquisitions 

11 

 
 
 
 
Services Group, from 1994 to 1999. He was formerly a Certified Public Accountant and a Member of the American Institute of 
Certified Public Accountants. Mr. Richman currently serves on the board of directors of Vemo Education, Inc., F45 Training 
Holdings Inc. and Outward Bound USA and previously sat on the board of directors of Sorenson Communications, Seneca 
Mortgage and Warrior Coal. He is a member of the Economic Club of New York and formerly served on its strategic planning 
committee.  

Key Experience, Skills and other Qualifications: 

Mr. Richman brings to the Board valuable financial and special situation experience. His knowledge, expertise and experience, 
especially with respect to special situation and opportunistic investments, are attributes the Board considers valuable. 

MICHAEL E. SILECK, JR. 

2021 director nominee 

Michael E. Sileck, Jr., 60, has served as the President since March 2020 and is an owner of SeaAgri Solutions, a global 
manufacturer and distributor of proprietary ocean minerals for the agricultural and human consumption markets. Mr. Sileck was 
the Chief Operating Officer and Chief Financial Officer of World Wrestling Entertainment from June 2005 to December 2008 and 
previously served as the Chief Financial Officer of Monster Worldwide from  March 2002 to March 2005 and Interactive Corp from 
September 1999 to February 2002. Mr. Sileck has served on the boards of directors of numerous public and private companies.  

Key Experience, Skills and other Qualifications: 

Mr. Sileck brings to the Board expertise in value creation, strategic transformation, and financial and operational leadership.  
Mr. Sileck is an operationally oriented executive with extensive C-suite experience within large public and smaller private companies.  
Mr. Sileck brings to the Board over 20 years of financial and operational leadership experience. 

DIRECTOR AND NOMINEE INDEPENDENCE 

The Board has determined that each of the following nominees and directors, including those that served during our last fiscal 
year, has no material relationship with us (either directly or as a partner, shareholder or officer of an organization that has a 
relationship with us) and is, or was during the period of their service during 2020, independent under our Director Independence 
Standards and the independence standards of the New York Stock Exchange (NYSE): Richard Todd Bradley, Jeffrey D. 
Engelberg, B. Thomas Golisano, George Karfunkel, Philippe D. Katz, Kathleen B. Lynch, Jason New, William G. Parrett,  
Darren L. Richman, and Michael E. Sileck, Jr. As our employee, James V. Continenza, our Executive Chairman and Chief Executive 
Officer, is not independent. In determining the independence of the non-management directors, the Board considered 
Mr. Karfunkel’s shareholdings and the affiliations of Messrs. Bradley, Engelberg, Golisano, Katz, Lynch, New and Richman, as 
affiliates of entities that hold or held an equity interest in our company (discussed under Certain Relationships and Related 
Transactions), and determined that such shareholdings and affiliations did not affect the independence of these directors and 
nominees. 

The Board has adopted Director Independence Standards for use in determining whether a director is independent. The Director 
Independence Standards are consistent with NYSE independence standards. The Board also uses the NYSE independence 
standards in determining whether members of specific committees are independent. The Director Independence Standards are 
part of our Corporate Governance Guidelines, which are posted on our website at http://investor.kodak.com/supporting.cfm. 

BOARD LEADERSHIP STRUCTURE 

The Board recognizes that one of its key responsibilities is to determine the most appropriate leadership structure for our 
company and to provide independent oversight of management. James V. Continenza serves as our Executive Chairman and 
Chief Executive Officer. The Board believes that it is appropriate to have the same person perform the roles of Chairman and 
Chief Executive Officer in order to best oversee our company and management and provide a unified structure ensuring strong 
and consistent leadership. The Company does not have a lead independent director. Instead, in accordance with NYSE listing 
standards and our Corporate Governance Guidelines, our independent directors are required to meet in executive session 
without management and, at each such session, an independent director chosen by the independent directors will preside at 
such executive session. 

COMMITTEES OF THE BOARD 

The Board has two standing committees including an Audit and Finance Committee, and, since May 2020 when the former 
Corporate Governance and Nominating Committee was combined with the former Executive Compensation Committee, the 
Compensation, Nominating and Governance Committee. We describe below the composition and functions of each of our 
standing committees. 

12 

 
 
 
 
Board Committee Membership 

Director Name  

Richard Todd Bradley (2) 
Jeffrey D. Engelberg 
George Karfunkel 
Philippe D. Katz  
Jason New 
William G. Parrett 

Total Meetings in 2020 

Audit and Finance  
Committee  

Former Member 
Member 
Member 

Chair 

8 

Compensation, Nominating and 
Governance Committee (1) 

Former Member 
Member 

Chair 
Member 

5 

(1) On May 20, 2020, the Executive Compensation Committee and Corporate Governance and Nominating Committee were 

combined into one committee. The former Corporate Governance and Nominating Committee consisted of Messrs. Bradley, 
Katz and New (Chair) and held two meetings during 2020 prior to May 20, 2020. The former Executive Compensation 
Committee consisted of Messrs. Bradley, Katz (Chair) and New and held one meeting during 2020 prior to May 20, 2020. 

(2) Mr. Bradley served as a director until December 24, 2020. 

Audit and Finance Committee  

The current members of the Audit and Finance Committee are Messrs. Engelberg, Karfunkel, and Parrett (Chair). The Audit and 
Finance Committee was established in accordance with Section 3(a)(58)(A) of the Exchange Act. The Board has determined that 
all members of the Audit and Finance Committee are independent and financially literate under NYSE listing standards. The 
Board has also determined that Mr. Parrett possesses the qualifications of an “audit committee financial expert,” as defined by 
SEC rules. 

The Audit and Finance Committee assists the Board in overseeing and making recommendations to the Board on such matters 
as: the integrity of our financial statements; our compliance with legal and regulatory requirements; our independent registered 
public accounting firm’s selection, compensation, retention, performance and evaluation, including assessing the firm’s 
qualifications and independence; our systems of disclosure controls and procedures and internal controls over financial 
reporting; and the performance of our internal audit function. The Audit and Finance Committee charter is posted on our website 
at http://investor.kodak.com/supporting.cfm.  

Compensation, Nominating and Governance Committee  

The current members of the Compensation, Nominating and Governance Committee are Messrs. Engelberg, Katz (Chair) and 
New, each of whom the Board has determined is independent under NYSE listing standards. The Compensation, Nominating 
and Governance Committee is responsible for the dual roles of overseeing (a) our corporate governance matters and the 
nomination of director candidates to the board of directors and (b) our compensation program and responsibilities. The 
Compensation, Nominating and Governance Committee charter is posted on our website at 
http://investor.kodak.com/supporting.cfm. 

With respect to its compensation functions, the Compensation, Nominating and Governance Committee assists the Board in 
fulfilling its responsibilities in connection with the compensation of our Chief Executive Officer and Section 16 Executive Officers, 
including our named executive officers. The Compensation, Nominating and Governance Committee also reviews and makes 
recommendations to the Board from time to time regarding compensation of directors, among other responsibilities. With respect 
to its governance and nominating functions, some of the primary duties of the Compensation, Nominating and Governance 
Committee are to oversee our corporate governance structure, which includes the development of our Corporate Governance 
Guidelines, recommend individuals to the Board for nomination as members of the Board and its committees, determine director 
independence, lead the Board in its periodic review of Board performance and review “Interested Transactions” in accordance 
with our Related Party Transactions Policy and Procedures. 

In accordance with its charter, the Compensation, Nominating and Governance Committee may delegate authority to one or 
more subcommittees or management as it deems fit. The Compensation, Nominating and Governance Committee has delegated 
limited authority to our Chief Human Resources Officer to assist in the administration of executive compensation and equity-
based compensation plans. Except as a plan may otherwise provide, the Compensation, Nominating and Governance 
Committee has authorized the Chief Human Resources Officer to amend any executive compensation or equity-based 
compensation plan in which our named executive officers participate, other than to materially increase the benefits accruing to a 

13 

 
 
 
 
 
participant under the plan, increase the number of shares available for issuance under the plan or substantially modify the 
requirements as to eligibility for participation under the plans. In addition, the Chief Human Resources Officer is authorized to 
amend any award agreement and related documents under the plans, other than to increase the benefits accruing to a 
participant. 

CORPORATE GOVERNANCE OVERVIEW 

Ethical business conduct and good corporate governance are well-established practices at Kodak. We practice good corporate 
governance and believe it to be a prerequisite to delivering sustained, long-term value to our shareholders. We monitor 
developments in the area of corporate governance to maintain and implement sound practices. Strong corporate governance is 
an important goal of our Board. 

Our Corporate Governance Guidelines reflect the principles by which our Board operates. From time to time, the Board reviews 
and revises our Corporate Governance Guidelines in response to regulatory requirements and evolving market practices. Our 
Corporate Governance Guidelines are posted on our website at http://investor.kodak.com/supporting.cfm. 

BUSINESS CONDUCT GUIDE AND DIRECTORS’ CODE OF CONDUCT 

Our reputation and our brand have been built by more than a century of ethical business conduct. All of our employees, including 
the Executive Chairman and Chief Executive Officer, the Chief Financial Officer, the Controller, all other senior financial officers 
and all other Section 16 Executive Officers, as defined under Section 16 of the Exchange Act (a Section 16 Executive Officer), 
are required to comply with our code of conduct, the “Business Conduct Guide.” We also have a Directors’ Code of Conduct. Our 
Business Conduct Guide and our Directors’ Code of Conduct are posted on our website at 
http://investor.kodak.com/supporting.cfm. 

GOVERNANCE PRACTICES 

Meeting Attendance 

Our Board has a Director Attendance Policy that is part of our Corporate Governance Guidelines, which is posted on our website 
at http://investor.kodak.com/supporting.cfm. Under this policy, all of our directors are strongly encouraged to attend all Board 
meetings and our Annual Meeting of Shareholders. In 2020, the Board held a total of 11 meetings. Each director attended more 
than 75% of the meetings of the Board and committees of the Board on which the director served, except Mr. Karfunkel. All of 
our then serving directors, except Mr. New, attended the Annual Meeting of Shareholders held on May 20, 2020. 

Executive Sessions 

Each executive session of our non-management directors is chaired by an independent director, chosen by the independent 
directors to preside at such executive session.  

Communications with Our Board 

Shareholders and interested parties who wish to communicate with the Board, the independent directors as a group or an 
individual director, may send an e-mail to our Executive Chairman at chairman@kodak.com or may send a letter to our Executive 
Chairman or to the independent director(s) c/o Secretary, Eastman Kodak Company, 343 State Street, Rochester, NY 14650-
0224. Communications received will be forwarded to the Board, the independent directors as a group or the individual director as 
directed, unless the communication is unduly hostile, threatening, illegal, does not reasonably relate to the Company or its 
business, or is similarly inappropriate. The Executive Chairman and the directors have authority to disregard any inappropriate 
communications or to take other appropriate actions with respect to any such inappropriate communications. 

Consideration of Director Candidates 

The Compensation, Nominating and Governance Committee will consider nominations for director candidates recommended by 
its members, other Board members, management, shareholders and the search firms it retains. The Compensation, Nominating 
and Governance Committee reviews all potential candidates under our Director Selection Process and Qualification Standards 
described below. 

Shareholders wishing to recommend candidates for consideration by the Board may do so by providing the following information, 
in writing, to the Compensation, Nominating and Governance Committee of the Board, c/o Secretary, Eastman Kodak Company, 
343 State Street, Rochester, NY 14650-0224: 1) the name, address and telephone number of the shareholder making the 
request; 2) the number of shares owned, and, if such person is not a shareholder of record or if such shares are held by an 
entity, reasonable evidence of such person’s ownership of such shares or such person’s authority to act on behalf of such entity; 
3) the full name, address and telephone number of the individual being recommended, together with a reasonably detailed 
description of the background, experience and qualifications of that individual; 4) a signed acknowledgement by the individual 

14 

 
being recommended that he or she has consented to: a) serve as director if elected and b) the Company undertaking an inquiry 
into that individual’s background, experience and qualifications; 5) the disclosure of any relationship of the individual being 
recommended with the Company, whether direct or indirect; and 6) if known to the shareholder, any material interest of such 
shareholder or individual being recommended in any proposals or other business to be presented at the next annual meeting of 
shareholders (or a statement to the effect that no material interest is known to such shareholder). 

Director Selection Process and Qualification Standards 

The Compensation, Nominating and Governance Committee is responsible for identifying, screening and recommending 
candidates for Board membership. When reviewing a potential candidate for the Board, the Compensation, Nominating and 
Governance Committee looks to whether the candidate possesses the necessary qualifications to serve as a director. To assist it 
in these determinations, the Compensation, Nominating and Governance Committee has adopted Director Qualification 
Standards and a Director Selection Process, which are posted as part of our Corporate Governance Guidelines on our website at 
http://investor.kodak.com/supporting.cfm.  

The Director Qualification Standards specify that, in addition to any other factors described in the Company’s Corporate 
Governance Guidelines, the Board should at a minimum consider the following factors, as more fully described in our Director 
Qualification Standards, in the nomination or appointment of members of the Board: integrity, reputation, judgment, knowledge, 
experience, maturity, commitment, skills, track record, diversity (including with respect to gender, race, ethnicity and sexual 
orientation), age, independence and ownership stake. The Compensation, Nominating and Governance Committee, in 
accordance with its Director Selection Process, will then consider the candidate’s qualifications in light of the needs of the Board 
and our company at that time, given the then-current mix of director attributes and the Board’s projected strengths and future 
needs. Based on the Compensation, Nominating and Governance Committee’s results of the assessment of Board needs, they 
may develop a target candidate profile. As provided in our Corporate Governance Guidelines, the Compensation, Nominating 
and Governance Committee seeks to create a multi-disciplinary Board that, as a whole, is strong in both its knowledge and 
experience. The Compensation, Nominating and Governance Committee may use the services of a third-party executive search 
firm, as well as the personal network of the Board and senior management, and may consider any previously recommended 
nominees when identifying and evaluating possible nominees for director. The search firm assists in identifying candidates who 
meet the skills and qualifications specified by the Compensation, Nominating and Governance Committee. A list of preferred 
candidates is developed and presented to the full Board, including the Executive Chairman, for review and input. Interest on the 
part of the potential candidate is gauged and an interview and reference check are performed. The full Board makes a 
determination with respect to the candidate. Candidates that are successfully elected to the Board participate in orientation 
sessions to familiarize them with our business. The Board has a mandatory retirement age of 72, unless an extension is 
approved by the Board, but in no event above age 75; however, this requirement does not apply to candidates nominated 
pursuant to contractual nomination rights. 

Although the Compensation, Nominating and Governance Committee does not have a formal policy regarding the consideration 
of diversity in the selection of candidates, the Compensation, Nominating and Governance Committee considers diversity when 
evaluating possible nominees under our Director Qualification Standards, which provide that the Board should be a diverse body, 
with diversity reflecting gender, ethnic background, race, sexual orientation, country of citizenship and professional experience. 
In addition, the Compensation, Nominating and Governance Committee and the Board evaluate diversity as part of the Board’s 
periodic evaluation process. 

Strategic Role of the Board 

The Board plays a key role in developing, reviewing and overseeing the execution of our business strategy. The Board receives 
progress reports from management throughout the year on the implementation of the strategic plan, including business segment 
performance and strategy reviews for each of our key businesses, product line reviews and presentations regarding research 
and development initiatives and our intellectual property portfolio. 

Succession Planning 

The entire Board reviews our succession plans for our Executive Chairman and Chief Executive Officer and other key senior 
management positions and oversees our activities in the areas of leadership and executive development. To assist the Board, 
management periodically reports to the Board on succession planning to ensure that it is a continuous and ongoing effort. 

Majority Voting for Directors 

Our By-laws provide for majority voting in uncontested director elections.  

We also maintain a Majority Vote Policy that requires a director nominee, in connection with his or her nomination to the Board, 
to submit a resignation letter in which the director nominee irrevocably elects to resign if he or she fails to receive the required 
majority vote in the next election and the Board accepts the resignation. The policy requires the Board to nominate for election or 

15 

 
re-election as a director only those candidates who agree to execute such a letter upon his or her nomination. The Majority Vote 
Policy is posted on our website at http://investor.kodak.com/supporting.cfm. 

If a director nominee fails to receive a majority vote in an uncontested election, the Majority Vote Policy provides that the 
Compensation, Nominating and Governance Committee will consider the resignation letter and recommend to the Board whether 
to accept it. The Compensation, Nominating and Governance Committee, in making its recommendation to the Board, and the 
Board, in reaching its decision, may consider relevant factors, including any stated reason why shareholders voted against the 
election of the director, the director’s qualifications, the director’s past and expected future contributions to us, the overall 
composition of the Board and whether accepting the resignation letter would cause us to fail to comply with any applicable rule, 
such as the NYSE’s listing standards. 

The policy provides that the Board will act on the Compensation, Nominating and Governance Committee’s recommendation and 
publicly disclose its decision whether to accept the director’s letter of resignation within 90 days following the certification of the 
shareholder vote. If the letter of resignation is not accepted by the Board within this 90-day period, the resignation will not be 
effective until the next annual meeting. 

All seven director nominees standing for election at the Annual Meeting have submitted an irrevocable letter of resignation as a 
condition of nomination pursuant to the Majority Vote Policy. 

Anti-Hedging and Pledging Policy  

Our Anti-Hedging and Pledging Policy prohibits our directors and executive officers from engaging, directly or indirectly, in any 
transactions that are designed to or that may reasonably be expected to have the effect of hedging or offsetting a decrease in the 
market value of our equity securities. In addition, the policy prohibits directors and executive officers from purchasing our equity 
securities on margin, borrowing against our securities on margin or pledging our equity securities as collateral for a loan. The 
Anti-Hedging and Pledging Policy is posted on our website at http://investor.kodak.com/supporting.cfm. 

Risk Management 

Our Board oversees an enterprise-wide approach to risk management, designed to support the achievement of our objectives, 
including strategic objectives, to improve long-term performance and enhance shareholder value. A fundamental part of risk 
management is not only identifying and prioritizing the risks we face and monitoring the steps management is taking to manage 
those risks, but also determining the level of risk that is appropriate for us. As an integral part of its review and approval of our 
strategic plan, the Board considers the appropriate level of risk that is acceptable. Through this process, the Board assesses risk 
throughout the Company, focusing on four primary risk categories: strategic, operational (including with respect to cybersecurity), 
legal/compliance and financial reporting. The Audit and Finance Committee is responsible for reviewing the results of our 
enterprise risk assessment on an annual basis. The Board also receives reports on management’s progress in mitigating key 
risks. 

The Board has delegated to its committees responsibility for the oversight of risk management in specific risk areas. For 
example, the committees of the Board oversee:  

•  Risk management relating to our financial reporting (including internal controls).  
•  Risk management relating to our compensation programs and awards. 
•  Risk management relating to our capital structure. 
•  Risk management relating to our insurance and pension programs.  
•  Risk management relating to cybersecurity. 

16 

 
REPORT OF THE AUDIT AND FINANCE COMMITTEE  

Management is responsible for our internal control over financial reporting, disclosure controls and procedures, and preparation 
of our consolidated financial statements. Our independent registered public accounting firm (independent accountants) for 2020, 
Ernst & Young LLP, was responsible for performing an independent audit of the consolidated financial statements in accordance 
with standards of the Public Company Accounting Oversight Board (United States) (PCAOB) and for issuing a report of the 
results. As outlined in its charter, the Audit and Finance Committee is responsible for overseeing these processes. 

During 2020, the Audit and Finance Committee met and held discussions with management and the independent accountants on 
a regular basis. Management represented to the Audit and Finance Committee that our consolidated financial statements were 
prepared in accordance with accounting principles generally accepted in the United States of America. The Audit and Finance 
Committee reviewed and discussed the audited consolidated financial statements and significant accounting matters with 
management and the independent accountants. 

The Audit and Finance Committee discussed with the independent accountants the matters required to be discussed under 
auditing standards established from time to time by the PCAOB and by SEC rules. The Audit and Finance Committee has 
received from the independent accountants the written disclosures and letter required by the applicable requirements of the 
PCAOB regarding the independent accountants’ communications with the Audit and Finance Committee concerning 
independence. The Audit and Finance Committee discussed with the independent accountants their independence. 

The Audit and Finance Committee also received reports from our Chief Compliance Officer on the implementation and 
effectiveness of our compliance program. 

The Audit and Finance Committee discussed with the director of internal audit and independent accountants the plans for their 
audits. The Audit and Finance Committee met with the director of internal audit and independent accountants, with and without 
management present. The director of internal audit and independent accountants discussed with or provided to the Audit and 
Finance Committee the results of their examinations, and in the case of internal audit their evaluations of our internal control over 
financial reporting, disclosure controls and procedures, and the quality of our financial reporting. 

Based on these reviews, discussions and reports, the Audit and Finance Committee recommended that the Board approve the 
audited financial statements for inclusion in our Annual Report on Form 10-K for the year ended December 31, 2020, and the 
Board accepted the Audit and Finance Committee’s recommendations.  

The Audit and Finance Committee, with the approval of the Board and the ratification of our shareholders, appointed Ernst & 
Young LLP as our independent accountants for 2020. In addition, the Audit and Finance Committee approved certain non-audit 
services provided by Ernst & Young LLP and the estimated budget for those services. The Audit and Finance Committee has 
adopted an Audit and Non-Audit Services Pre-Approval Policy.  

William G. Parrett, Chair 
Jeffrey D. Engelberg 
George Karfunkel 

17 

 
 
 
EXECUTIVE COMPENSATION 

The following tables and related narrative contain information regarding the compensation paid to our named executive officers 
for our two most recently completed fiscal years, which ended on December 31, 2020 and December 31, 2019.  

Our named executive officers for 2020 are as follows: 

James V. Continenza – Executive Chairman and Chief Executive Officer 

David E. Bullwinkle – Chief Financial Officer, President, Eastman Business Park, and Senior Vice President 

Roger W. Byrd – General Counsel, Secretary and Senior Vice President 

SUMMARY COMPENSATION TABLE 

Name and 
Principal 
Position 

J.V. Continenza 
Executive 
Chairman and 
Chief Executive 
Officer 

D.E. Bullwinkle 
Chief Financial 
Officer, 
President, 
Eastman 
Business Park 
and Senior Vice 
President 

R.W. Byrd 
General 
Counsel, 
Secretary and 
Senior Vice 
President  

Salary 
($)(1) 

Bonus 
($) 

Stock  
Awards 
($)(2) 

Option 
Awards 
($)(3) 

824,040 

0 

0 

11,112,869 

Year 

2020 

2019 

873,152 

0 

250,003 

3,546,000 

2020 

379,059 

2019 

458,397 

0 

0 

0 

322,267 

0 

0 

2020 

267,817 

0 

0 

322,267 

2019 

320,820 

0 

175,002 

175,000 

Non-Equity 
Incentive Plan  
Comp. 
($) 

All Other 
Comp. 
($) 

Total 
($) 

0 

0 

0 

0 

0 

0 

0 

11,936,909 

12,375 

4,681,530 

0 

0 

0 

0 

701,326 

458,397 

590,084 

690,822 

(1) This column reports the base salary paid to each of our named executive officers during each year reported. The base salary 

paid to our named executive officers during 2020 is described under "Base Salary" below. For 2019, the amount shown for Mr. 
Continenza includes $37,619 of cash fees that he received as a director prior to his appointment as our Executive Chairman. 

(2) This column reports the aggregate grant date fair value (as calculated for financial reporting purposes), without any reduction 
for risk of forfeiture, for all restricted stock units (RSUs) granted during each year reported. The amounts reported in this 
column have been calculated in accordance with FASB ASC Topic 718. The terms of the RSUs are described under "Long-
Term Incentive Compensation" below. For 2019, prior to his appointment as our Executive Chairman, Mr. Continenza received 
a grant of RSUs for his service as a director on January 8, 2019. 

(3)  This column reports the aggregate grant date fair value (as calculated for financial reporting purposes), without any reduction 
for risk of forfeiture, for all stock option awards granted during each year reported. The amounts reported in this column have 
been calculated in accordance with FASB ASC Topic 718. For valuation assumptions with respect to our stock option grants, 
please see Note 23 to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended 
December 31, 2020. For 2020, Messrs. Continenza, Bullwinkle and Byrd each received a grant of stock options on July 27, 
2020 to purchase up to 1,650,000 shares, 45,000 shares and 45,000 shares, respectively, with aggregate grant date fair 
values of $11,112,869, $322,267 and $322,267, respectively. The terms of the stock options are described under "Long-Term 
Incentive Compensation" below. The aggregate grant date fair value of the stock options granted to Mr. Continenza during 
2019 has been corrected from the $9,580,500 amount reported in last year's proxy statement to the $3,546,000 amount 
reported above. 

(4)  For 2019, Mr. Continenza received $12,375 for the legal fees we paid on his behalf pursuant to his employment agreement 

relating to the negotiation of such agreement. 

18 

 
NARRATIVE TO SUMMARY COMPENSATION TABLE 

Base Salary 

The base salaries of our named executive officers, except for Mr. Byrd, were established as part of their employment 
agreements.  

In response to the COVID-19 pandemic, the base salaries of each of our named executive officers were temporarily reduced by 
25%, effective from April 13, 2020 through January 4, 2021. During this period, Mr. Continenza’s annual salary was reduced by 
25% from $1,000,000 to $750,000, Mr. Bullwinkle’s annual salary was reduced by 25% from $460,000 to $345,000 and Mr. 
Byrd’s annual salary was reduced by 25% from $325,000 to $243,750. 

Long-Term Incentive Compensation 

On July 27, 2020, Mr. Continenza received a grant of a stock option under our Amended and Restated 2013 Omnibus Incentive 
Plan (the Plan) to purchase up to 1,750,000 shares. The option was granted in four tranches as follows 

•  Tranche 1 (for 981,707 shares) with an exercise price of $3.03 per share;  
•  Tranche 2 (for 298,780 shares) with an exercise price of $4.53 per share; 
•  Tranche 3 (for 298,780 shares) with an exercise price of $6.03 per share; and 
•  Tranche 4 (for 170,733 shares) with an exercise price of $12.00 per share. 

The exercise price of each tranche was above the closing price of our stock of $2.62 on the date of grant. The stock option vests 
as follows: 28.57% of each tranche was immediately vested upon grant, and the remaining 71.43% of each tranche vests upon 
the conversion of $100,000,000 of our outstanding 5% Secured Convertible Promissory Notes due 2021 (the Notes). In the event 
a portion of the Notes is converted, a corresponding pro rata portion of the 71.43% of each tranche will vest. In addition, if any of 
the Notes is repaid or otherwise extinguished without being converted, a corresponding pro rata portion of the 71.43% of each 
tranche will be forfeited upon such repayment. The stock option expires on February 19, 2026.  

The purpose of the grant was to protect Mr. Continenza from the economic dilution attributable to the issuance of the Notes, 
which affected the value of the options granted upon his becoming Executive Chairman of the Company (the Original Grant). 
This stock option has the same exercise prices and term as the Original Grant and was generally designed to put Mr. Continenza 
in the same economic position he would have been in had the Notes been repaid instead of converted into common stock.  

The stock option vested with respect to 471,405 shares (28.57% of each tranche) at the time of grant on July 27, 2020.  The 
stock option vested with respect to an additional 1,119,665 shares (67.86% of each tranche) upon the conversion of 95% of the 
Notes on July 29, 2020, and the stock option vested with respect to the remaining 58,930 shares (3.57% of each tranche) upon 
the conversion of the remaining 5% of the Notes on September 30, 2020. 

On July 27, 2020, Messrs. Bullwinkle and Byrd each received a grant of a stock option under the Plan to purchase up to 45,000 
shares. Each option was granted in four tranches as follows: 

•  Tranche 1 (for 15,000 shares) with an exercise price of $3.03 per share; 
•  Tranche 2 (for 10,000 shares) with an exercise price of $4.53 per share; 
•  Tranche 3 (for 10,000 shares) with an exercise price of $6.03 per share; and 
•  Tranche 4 (for 10,000 shares) with an exercise price of $12.00 per share. 

The exercise price of each tranche was above the closing price of our stock on the date of grant. These stock options vest for 
one-third of each tranche on the first, second and third anniversaries of the date of grant, subject to continued employment 
through such date. These stock options also expire on February 19, 2026. 

Non-Equity Incentive Compensation 

For 2020, the annual variable incentive opportunity, known as Executive Compensation for Excellence and Leadership (EXCEL), 
was suspended and none of the named executive officers received an EXCEL payment.  

Employment Agreements 

James V. Continenza 

During 2020, we employed Mr. Continenza under an employment agreement effective February 20, 2019 with a 
scheduled term ending February 19, 2021. The employment agreement provided Mr. Continenza the following: 

•  An annual base salary of $1 million; 

19 

 
•  Participation in our EXCEL Plan, with an annual target opportunity of 75% of base salary and a maximum of 

200% of target; and  

•  Participation in all benefit plans, policies and arrangements that are provided to employees generally. 

The employment agreement provided that if Mr. Continenza’s employment was terminated by us for any reason other than cause 
prior to February 20, 2020, he would have been eligible to receive (less any applicable withholding and deduction): 

•   an amount equal to any remaining base salary that would have been due had the employment not been terminated 

prior to such date; and 

•  any stock options which are outstanding and unvested as of the date of such termination shall immediately become 

fully vested. 

The employment agreement further provided that if Mr. Continenza’s employment was terminated by us without cause after 
February 20, 2020, he would have been eligible to receive (less any applicable withholding and deduction): 

•   any annual incentive for the fiscal year ending immediately prior to the year in which his employment was terminated 

that was forfeited upon such termination (subject to achievement of applicable performance targets consistent with the 
terms of the EXCEL Plan); and 

•   a pro-rated portion of the annual incentive that was forfeited upon termination in respect of the fiscal year in which his 
termination occurs (subject to achievement of applicable performance targets consistent with the terms of the EXCEL 
Plan). 

Eligibility to receive the post-termination benefits payable in connection with termination without cause after February 20, 2020 
was subject to execution of a general release and covenant not to sue in favor of us. The post-termination payments provided 
under the employment agreement were in lieu of those provided under our Termination Allowance Plan. 

On February 26, 2021, we entered into a new employment agreement with Mr. Continenza, which has a three-year term. The 
new employment agreement replaces in its entirety Mr. Continenza’s prior employment agreement. 

David E. Bullwinkle 

We employ Mr. Bullwinkle under an employment agreement effective July 1, 2016 with no scheduled term ending date. Under 
this employment agreement, Mr. Bullwinkle is eligible for the following: 

•  An annual base salary of $400,000, which was increased to $460,000 effective November 12, 2018; 
•  Participation in our EXCEL Plan with an annual target opportunity of 65% of base salary and a maximum of 

200% of target; and  

•  Participation in all benefit plans, policies and arrangements that are provided to employees generally. 

The employment agreement provides that if Mr. Bullwinkle’s employment is terminated by us without cause or by him with 
good reason, he will be eligible to receive (less applicable withholding): 

•  An amount equal to his annual base salary;  
•  Continued vesting of his equity grants in accordance with the terms of such awards; and 
•  Eligibility for an EXCEL award for the fiscal year in which the termination occurs, if earned, as governed by the 

terms of the EXCEL Plan and applicable Administrative Guide or Award Notice. 

The employment agreement provides that in the event that Mr. Bullwinkle’s employment is terminated due to his disability 
or death, he or his estate, as applicable, will be eligible to receive (less applicable withholding) continued vesting of his 
equity awards in accordance with the terms of such awards and a pro rata EXCEL award, if earned, as governed by the 
terms of the EXCEL Plan and applicable Administrative Guide or Award Notice. 
Eligibility to receive the severance benefits payable in connection with termination without cause or with good reason is subject 
to (1) execution of a general release and covenant not to sue in favor of us; and (2) compliance with a non-compete agreement 
after termination of employment. The severance payments provided under the employment agreement are in lieu of those 
provided under our Termination Allowance Plan. 

Roger W. Byrd 

We provide Mr. Byrd a special severance plan pursuant to a letter agreement dated May 31, 2018. Under this letter agreement, if 
Mr. Byrd’s employment is terminated without cause, he would be eligible to receive (less applicable withholding) an amount 
equal to his annual base salary. Eligibility to receive the severance benefits payable in connection with termination without cause 
is subject to execution of a general release and covenant not to sue in favor of us.  

20 

 
Tax-Qualified Retirement Plans  

Employees’ Savings and Investment Plan (SIP) 

We offer a tax-qualified 401(k) defined contribution plan known as the Employees’ Savings and Investment Plan (SIP) for all U.S. 
employees. Employer contributions to SIP were frozen as of January 1, 2015.  

Kodak Retirement Income Plan (KRIP) 

We fund a tax-qualified defined benefit pension plan known as the Kodak Retirement Income Plan (KRIP) for all U.S. employees. 
Effective January 1, 2000, we amended KRIP to include a cash balance component. KRIP’s cash balance component covers 
employees hired before March 1, 1999 who elected that coverage and all new U.S. employees hired on or after March 1, 1999.  

On January 1, 2015, we froze all benefit accruals in the traditional component of KRIP for all participants. Beginning on that date, 
all future accruals in KRIP are made under the cash balance component for all participating employees in an amount equal to 
8%, for non-exempt employees, and 7%, for exempt employees, of the employee’s monthly pay, which was previously 4% for 
cash balance participants. Effective January 1, 2020, we increased the credits to either 10% or 9% of pay for non-exempt and 
exempt employees, respectively. 

Cash Balance Component 

Under KRIP’s cash balance component, a hypothetical account is established for each participating employee and, for every 
month the employee works, the employee’s account is credited with an amount equal to 7% or 8%, as applicable, of the 
employee’s monthly pay (i.e., base salary and EXCEL awards, including allowances in lieu of salary for authorized periods of 
absence, such as illness, vacation or holidays). Effective January 1, 2020, we increased the credits to the employee’s account to 
an amount equal to 9% or 10%, as applicable. In addition, the ongoing balance of the employee’s account earns interest at the 
30-year Treasury bond rate. Employees rights under the cash balance component are fully vested. Benefits under the cash 
balance component are payable upon normal retirement (age 65), termination or death. Participants in the cash balance 
component of the plan may choose from among various forms of benefits such as a lump sum, a joint and survivor annuity and a 
straight life annuity. 

Non-Qualified Deferred Compensation 

Except for Mr. Continenza, none of our named executive officers have non-qualified deferred compensation. 

Effective December 26, 2013, we adopted the Deferred Compensation Plan for Directors, which allows non-employee directors 
to defer some or all of their RSU awards into a phantom stock account. 

Mr. Continenza received a grant of 88,029 RSUs on January 8, 2019, prior to becoming our Executive Chairman, which vested 
on January 8, 2020. Pursuant to his prior election under the Deferred Compensation Plan for Directors, such RSUs were credited 
to his phantom stock account upon vesting. 

21 

 
 
OUTSTANDING EQUITY AWARDS AT 2020 FISCAL YEAR-END TABLE (1) 

The following table sets forth additional information concerning equity awards held by our named executive officers as of  
December 31, 2020. 

Option Awards 

Stock Awards 

Number of 
Securities 
Underlying 
Unexercised 
Options (#) 
Exercisable 

Number of 
Securities 
Underlying 
Unexercised 
Options (#) 
Unexercisable 

Equity 
Incentive 
Plan 
Awards: 
Number of 
Unearned 
Shares, 
Units or 
Other 
Rights that 
Have Not 
Vested 
(#) 

Equity Incentive 
Plan Awards: 
Market or 
Payout Value of 
Unearned 
Shares, Units or 
Other Rights 
that Have Not 
Vested 
($) 

Number of 
Shares or 
Units of Stock 
Held that Have 
Not Vested 
(#)(2) 

Market Value of 
Shares or Units 
of Stock Held that 
Have Not Vested 
($)(3) 

Option 
Exercise 
Price 
($) 

Option 
Expiration 
Date 

3.03 

02/19/2026 

4.53 

02/19/2026 

6.03 

02/19/2026 

12.00 

02/19/2026 

3.03 

02/19/2026 

4.53 

02/19/2026 

6.03 

02/19/2026 

12.00 

02/19/2026 

Name 

J.V. Continenza 

D.E. Bullwinkle 

R.W. Byrd 

981,707(4) 

298,780(4) 

298,780(4) 

170,733(4) 

1,150,000     

350,000     

350,000  

200,000     

        48,010 

      355,330 

        45,942     

          7,965     

          5,349     

          5,805     

29,914   

30,457  

15,000(5) 

3.03 

02/19/2026 

10,000(5) 

4.53 

02/19/2026 

10,000(5) 

6.03 

02/19/2026 

10,000(5) 

12.00 

02/19/2026 

24,007(6) 

3.90 

12/03/2025 

12.50 

09/13/2024 

16.24 

06/30/2023 

13.76 

09/02/2022 

20.25 

12/14/2021 

23.78 

09/02/2021 

15,000(5) 

3.03 

02/19/2026 

10,000(5) 

4.53 

02/19/2026 

10,000(5) 

6.03 

02/19/2026 

10,000(5) 

12.00 

02/19/2026 

59,830(8) 

3.09 

01/15/2026 

12.50 

09/13/2024 

14,958(7) 

121,758 

(1) This table includes only those awards outstanding as of December 31, 2020. 

(2)  This column represents outstanding awards of RSUs. 

37,757(9) 

307,342 

22 

 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
         
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
  
  
  
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
  
 
  
 
 
 
(3) The market value of shares, units or other rights that have not vested was calculated using a stock price of $8.14, which was 

the closing price of our common stock as of December 31, 2020, the last trading day of the year. 

(4) This stock option was granted on July 27, 2020 in four tranches with separate exercise prices. Pursuant to the terms of the 
award agreement, 471,405 shares (28.57% of each tranche) vested on the grant date, an additional 1,119,665 shares 
(67.86% of each tranche) vested on July 29, 2020 upon the conversion of 95% of our $100,000,000 of our outstanding Notes, 
and the remaining 58,930 shares (3.57% of each tranche) vested on September 30, 2020 upon the conversion of the 
remaining 5% of the Notes.  

(5) This stock option was granted on July 27, 2020 in four tranches with separate exercise prices. This stock option will vest in 

substantially equal installments on the first, second and third anniversaries of the grant date. 

(6) This stock option was granted on December 4, 2018 and the first two of three substantially equal installments vested on 

September 3, 2019 and September 3, 2020. The third installment will vest on September 3, 2021. 

(7) These RSUs were granted on December 4, 2018 and the first two of three substantially equal installments vested on 

September 3, 2019 and September 3, 2020. The third installment will vest on September 3, 2021. 

(8) This stock option was granted on January 16, 2019 and the first of three substantially equal installments vested on January 

16, 2020. The second and third installments will vest on the second and third anniversaries of the grant date. 

(9) These RSUs were granted on January 16, 2019 and the first of three substantially equal installments vested on January 16, 

2020. The second and third installments will vest on the second and third anniversaries of the grant date. 

DIRECTOR COMPENSATION 

Introduction 

Historically, our directors have been compensated through a combination of cash retainers and equity. We do not pay employee 
directors for Board service in addition to their regular employee compensation.  

The Board and Chair Retainers for our non-employee directors under the terms approved on August 11, 2015, which were based 
on the recommendation of our compensation consultant, are as shown below (subject to proration based on length of service as 
a director). In the first quarter of 2020, 75% of each director’s cash retainer and fees was paid in RSUs with immediate vesting. 
For the remaining three quarters of 2020, each director’s cash retainer and fees were paid in the form of Nonqualified Stock 
Options (NQSOs) having an equivalent grant date fair value. These NQSOs were granted on May 20, 2020 and each option 
vested one-third on each of June 30, 2020, September 30, 2020 and December 31, 2020.  

Director Compensation Schedule 

The following table reflects the amounts to be paid or granted to our non-employee directors for a full year of service, and not the 
amounts actually granted, which are reflected in the 2020 Director Compensation Table below.  

Cash Retainer ($) 

Committee Chair ($) 

Equity Value ($) 

Richard Todd Bradley (1) 

Jeffrey D. Engelberg 

George Karfunkel 

Philippe D. Katz  

Jason New (2) 

William G. Parrett 

100,000 

100,000 

100,000 

100,000 

100,000 

100,000 

— 

— 

— 

20,000 

20,000 

20,000 

150,000 

150,000 

150,000 

150,000 

150,000 

150,000 

(1)  Mr. Bradley ceased being a member of the Board effective December 24, 2020. 

(2)  Mr. New ceased being a Chair when the committees were reorganized on May 20, 2020. 

23 

 
 
 
2020 Director Compensation Table 

Our non-employee directors received the following compensation in 2020: 

Name 

Richard Todd Bradley(3) 

Jeffrey D. Engelberg 

George Karfunkel 

Philippe D. Katz  

Jason New 

William G. Parrett 

Fees Earned or 
Paid in Cash ($)(1) 

Stock Awards ($)(2) 

100,000 

100,000 

100,000 

120,000 

104,220(4) 

120,000 

150,000 

150,000 

150,000 

150,000 

150,000 

150,000 

Total ($) 

250,000 

250,000 

250,000 

270,000 

254,220 

270,000 

(1)  The amounts reported in the Fees Earned or Paid in Cash column include both director retainer and fees paid in cash and, 

where applicable, the grant date fair value of the RSUs and NQSOs, respectively, paid to each director in lieu of cash retainer 
and fees. In the first quarter of 2020, 75% of each director's cash retainer and fees were paid in RSUs with immediate vesting. 
As a result, on March 31, 2020, Messrs. Bradley, Engelberg and Karfunkel each received a grant of 10,839 RSUs with a grant 
date fair value equal to $18,750; and Messrs. Katz and Parrett each received a grant of 13,006 RSUs with a grant date fair 
value equal to $22,500; and on April 2, 2020, Mr. New received a grant of 13,006 RSUs with a grant date fair value of 
$21,720. The grant date fair value of these RSUs received in lieu of cash retainer and fees are included in the amounts in this 
column. For the remaining three quarters of 2020, 75% of each director's cash retainer and fees were paid in the form of stock 
options, one-third of which vested on each of June 30, 2020, September 30, 2020 and December 31, 2020. The exercise price 
of 56.10% of these options was $3.03, the exercise price of 17.07% of these options was $4.53, the exercise price of 17.07% 
of these options was $6.03, and the exercise price of the remaining 9.76% of these options was $12.00. As a result, on May 
20, 2020, Messrs. Bradley, Engelberg, Karfunkel and New each received a grant of 37,579 stock options with a grant date fair 
value equal to $56,250; and Messrs. Katz and Parrett each received a grant of 45,095 stock options with a grant date fair 
value equal to $67,500.  The grant date fair value of the stock options was determined using Black-Scholes. The grant date 
fair value of these stock options received in lieu of cash retainer and fees are included in the amounts in this column. 

(2) Pursuant to the previous determination of the Board of Directors that annual director grants be made on the fifth trading day of 
each calendar year, the 2020 equity awards were granted effective January 8, 2020 as RSUs and vested after one year. The 
amounts reported in this column have been calculated in accordance with FASB ASC Topic 718. 

(3) Mr. Bradley ceased to be a member of the Board effective December 24, 2020. The amounts shown for him are the cash fees 

he received prior to his departure.  

(4) Mr. New received a committee chair fee of $5,000 for the first quarter of 2020 for his service as the Chair of the Corporate 

Governance and Nominating Committee before the Board committees were reorganized on May 20, 2020. 

Aggregate Stock and Option Awards Outstanding at Fiscal Year End 

Restricted Stock Units 

Stock Options 

Name 

Unvested (#) 

Richard Todd Bradley 

Jeffrey D. Engelberg 

George Karfunkel 

Philippe Katz 

Jason New 

William G. Parrett 

0  

46,729 

46,729 

46,729 

46,729 

46,729 

Vested (#) 

46,729  (1) 

0 

0 

0 

0 

0 

Unvested (#) 

0 

0 

0 

0 

0 

0 

Vested (#) 

37,579  (1) 

37,579 

37,579 

45,095 

37,579 

45,095 

(1) Upon ceasing to be a member of the Board effective December 24, 2020, the Board accelerated the vesting of Mr. Bradley’s 

outstanding RSUs and options. 

24 

 
 
 
 
 
 
 
 
 
 
 
 
Deferred Compensation 

Effective December 26, 2013, we adopted the Deferred Compensation Plan for Directors, which allows non-employee directors 
to defer some or all of their Board Retainer and RSU awards into a phantom stock account.  

Pursuant to this plan, the following directors elected to defer RSU awards granted on January 8, 2020: 

William G. Parrett – 46,729 RSUs (100%); and 
Philippe Katz – 46,729 RSUs (100%). 

Expense Reimbursement 

We reimburse our directors for reasonable travel expenses incurred in connection with attending Board, committee and 
shareholder meetings and other Board business events. 

25 

 
 
 
PROPOSAL 2 

PROPOSAL 2 - ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE 
OFFICERS 

Our named executive officers are identified in the “Executive Compensation” section of this Proxy Statement. Pursuant to 
Section 14A of the Exchange Act, you are voting on a proposal, commonly known as a “say-on-pay” proposal, which gives our 
shareholders the opportunity to endorse or not endorse our named executive officer pay programs and policies through the 
following resolution: 

RESOLVED, that the shareholders approve the compensation of Eastman Kodak Company’s named executive officers, as 
disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission in the Company’s 
Proxy Statement for the 2021 Annual Meeting of Shareholders. 

At our 2020 annual meeting of shareholders, we recommended, and our shareholders approved, that we hold this non-binding, 
advisory vote on executive compensation on an annual basis. The next required vote on frequency will occur at our 2026 annual 
meeting of shareholders. 

We believe that our executive compensation program is designed to attract, motivate and retain individuals with the skills 
required to achieve our business objectives. Our compensation strategy is to provide opportunities to incentivize and reward our 
named executive officers when they deliver defined performance results that are based on success in a diverse set of 
businesses. We also align the interests of our executives with those of our shareholders and our long-term interests through 
stock ownership. We believe that the compensation of our named executive officers for 2020 was appropriate and aligned with 
our performance results and strategic plan. 

In order to be approved on an advisory basis, this proposal must receive the affirmative vote of the majority of votes cast by 
holders entitled to vote thereon. Because your vote is advisory, it will not be binding on our Board of Directors. However, our 
Board values the opinions that our shareholders express in their votes and will take into account the outcome of the vote when 
considering future executive compensation arrangements as it deems appropriate. 

The Board of Directors recommends you vote FOR the advisory resolution approving the compensation of 
our named executive officers. 

26 

 
PROPOSAL 3 

PROPOSAL 3 – APPROVAL OF THE FIRST AMENDMENT TO THE AMENDED AND RESTATED 2013 
OMNIBUS INCENTIVE PLAN  

INTRODUCTION 

You are being asked to approve the First Amendment to the Amended and Restated 2013 Omnibus Incentive Plan (the Plan) to 
increase the maximum number of shares of common stock of the Company available for grant to participants pursuant to awards 
under the Plan and to change the method of counting Shares granted under the Plan. On March 31, 2021, the Board of Directors 
approved the First Amendment to the Plan and the submission of the First Amendment to the shareholders for their approval. 
Approval of the First Amendment to the Plan by shareholders will enable the Company to continue to grant equity and cash 
awards to employees and directors of the Company. 

Approval of the First Amendment to the Plan requires the affirmative vote of a majority of the votes cast at the Annual Meeting by 
holders entitled to vote thereon. 

BACKGROUND 

The Plan provides for the grant of various types of equity awards (Options, Stock Appreciation Rights (SARs), Restricted Stock 
Awards, Restricted Stock Units (RSUs), Other Stock-Based Awards and cash awards).  

The 2013 Omnibus Incentive Plan (the Original Plan) originally became effective as of September 3, 2013, was amended to 
increase the maximum number of shares available for grant effective May 22, 2018 and was further amended to increase the 
limit on the number of options or stock appreciation rights that may be granted to an employee in any calendar year on  
February 20, 2019. On May 20, 2020, shareholders approved the Plan to increase the number of shares available, remove 
provisions with respect to performance-based compensation exception under Section 162(m) of the U.S. Internal Revenue Code 
of 1986, as amended (the Code) and reduce the maximum aggregate grant date fair value of awards in respect of a calendar 
year that may be granted to a member of the Board of Directors.  

The closing stock price of a share of the Company’s common stock as reported on the NYSE on March 30, 2021 was $8.05.  

TERMS OF THE FIRST AMENDMENT 

The Plan currently provides that the maximum number of shares available for grant to participants pursuant to awards under the 
Plan is 8,000,000 shares. The First Amendment to the Plan would increase this maximum number of available shares to 
13,000,000 shares. Based on our anticipated share usage, we expect these shares to be sufficient for the next three years.   

The First Amendment would also change how shares are counted under the Plan for awards granted after May 19, 2021. Since 
the adoption of the Original Plan in 2013, each share underlying each Option, SAR and similar award has counted as a fraction 
of a share, based on the financial value of each such award relative to a share.  To simplify the administration of the Plan and 
disclosure relating to the Plan for awards granted after May 19, 2021, each Restricted Stock Award, RSU, Option, SAR and other 
award will count as one share. For awards granted on or prior to May 19, 2021, the number of shares granted under the Plan will 
remain determined as follows: (i) each Restricted Stock Award, RSU and similar award will count as one share and (ii) each 
Option, SAR and similar award will count as a fraction of a share, based on the financial value of each such award relative to a 
share.  

The Plan also currently provides that the Plan shall terminate on May 20, 2030. The First Amendment to the Plan would extend 
the term of the Plan to May 19, 2031. 

SUMMARY OF THE PLAN 

The following summary of the Plan, as proposed to be amended, is qualified in its entirety by the terms of the Plan document, a 
copy of which is attached to this Proxy Statement as Appendix A, and the First Amendment to the Plan, a copy of which is 
attached to this Proxy Statement as Appendix B.  

Purpose 

The purpose of the Plan is to attract, retain and motivate officers, employees, and non-employee directors providing services to 
the Company or any of its subsidiaries or affiliates and to promote the success of the Company’s business by providing such 
persons with appropriate incentives. 

27 

 
Administration 

The Compensation, Nominating and Governance Committee (the Committee) will administer the Plan. However, if a Committee 
member does not meet the following requirements, the Committee may delegate some or all of its functions to another 
committee that meets these requirements. Generally, the Committee must consist of two or more directors, each of whom is: 1) 
an independent director under the listing requirements of the NYSE; and 2) a non-employee director within the meaning of Rule 
16b-3 under the Exchange Act. 

Eligibility for Participation 

The following persons are eligible to participate in the Plan: 

•  All employees of the Company, any of its 50% or more owned subsidiaries or any of its affiliates; and 
•  The non-employee directors of the Company. 

The selection of those employees who will receive awards is entirely within the discretion of the Committee. There are currently 
approximately 4,296 employees who are eligible to participate in the Plan, together with the Company’s six non-employee 
directors. 

Types of Awards  

The Plan authorizes the grant of: 

•  Nonqualified and Incentive Stock Options; 
•  SARs; 
•  Restricted Stock Awards and RSUs;  
•  Dividend Equivalent Rights;  
•  Other Stock-Based Awards (stock-based awards granted either as freestanding grants or payments of earned 

performance awards); and 

•  Cash awards (including, without limitation, retainers and meeting-based fees).  

Termination and Amendment of the Plan 

The Committee may from time to time amend, alter, suspend, discontinue or terminate the Plan in any respect whatsoever, 
including in any manner that adversely affects the rights, duties or obligations of any participant; provided that, subject to the 
provisions of the Plan regarding adjustments in authorized shares in the case of certain corporate events or transactions, or as 
otherwise specifically provided in the Plan, no amendment shall materially adversely impair the rights of a participant under any 
award without the participant’s consent.  

Shareholder approval will be required for any amendment to the Plan that: (i) increases the number of shares available under the 
Plan (other than an increase permitted under Article 5 of the Plan); (ii) expands the types of awards available under the Plan; 
(iii) materially extends the term of the Plan; (iv) materially changes the method of determining the option price or grant price per 
share for SARs; or (v) except as permitted pursuant to Article 14 of the Plan, reduces the option price or grant price per share, as 
applicable, of any outstanding Options or SARs. 

Available Shares 

Subject to adjustment as provided in Article 14 of the Plan, following the effectiveness of the First Amendment to the Plan, the 
maximum number of shares available for grant to participants pursuant to awards under the Plan shall be equal to 13,000,000 
shares. The number of shares available for granting Incentive Stock Options under the Plan shall not exceed 2,000,000. The 
shares available for issuance under the Plan may consist, in whole or in part, of authorized and unissued shares or treasury 
shares. The share reserve under the Plan is increased by: (i) any shares delivered to the Company or withheld by the Company 
in payment or satisfaction of the tax withholding obligation of an award (other than an Option or SAR); and (ii) any shares 
underlying awards (counted in accordance with the following paragraph) that expire, are forfeited, cancelled or otherwise 
terminated without the issuance of the shares, or are otherwise settled for cash. The aggregate number of shares will not be 
reduced by shares granted by the Company in assumption of, or exchange for, awards granted by another company as a result 
of a merger or consolidation. The number of shares under the Plan may be adjusted for changes in the Company’s capital 
structure, such as a stock split or merger. 

Following the effectiveness of the First Amendment to the Plan, the number of shares granted under the Plan will be determined 
as follows: (a) for awards granted on or prior to May 19, 2021: (i) each Restricted Stock Award, RSU and similar award will count 
as one share; and (ii) each Option, SAR and similar award will count as a fraction of a share, based on the financial value of 
each such award relative to a share, as determined by the Committee promptly after the effective date of the Plan; and (b) for 
awards granted after May 19, 2021, each Restricted Stock Award, RSU, Option, SAR and other award will count as one share. 

28 

 
Award Limits 

The maximum number of shares for which Options may be granted to any one employee during any calendar year is 
2,500,000 shares, and the maximum number of shares for which SARs may be granted to any one employee during any 
calendar year is 2,000,000 shares. The aggregate fair market value of shares with respect to which Incentive Stock Options are 
exercisable for the first time by an eligible employee during any calendar year under all stock option plans of the Company and of 
any subsidiary may not exceed $100,000.  

The aggregate awards to any one non-employee director for any calendar year may not exceed a number of awards with a grant 
date fair value of $450,000.  

Grants to Non-U.S. Employees 

To facilitate the granting of awards to participants who are employed outside of the United States, the Plan authorizes the 
Committee to modify and amend the terms and conditions of an award to accommodate differences in local law, policy or 
custom. 

Stock Options 

The Committee may grant awards in the form of Options to purchase shares of the Company’s common stock. For each Option 
grant, the Committee will determine the number of shares subject to the Option and the manner and time of the Option’s 
exercise, provided that no Option will be exercisable after ten years from the date of its grant. The Committee may condition the 
grant of Options or the vesting of Options upon the participant’s achievement of one or more performance goals (including the 
participant’s provision of services for a designated time period). The exercise price of an Option may not be less than the fair 
market value of the Company’s common stock on the date the Option is granted. Upon exercise, a participant may pay the 
exercise price in cash, shares of common stock, a combination thereof or such other consideration as the Committee 
determines. Any Option granted in the form of an Incentive Stock Option is intended to satisfy the requirements of Section 422 of 
the Code.  

Stock Appreciation Rights 

The Committee may grant SARs either in tandem with an Option (Tandem SARs) or independent of an Option (Freestanding 
SARs). 

A Tandem SAR may be granted at the time of the grant of the related Option. A Tandem SAR will be exercisable to the extent its 
related Option is exercisable, and the exercise price of such a SAR may not be less than the fair market value of the Company’s 
common stock on the date the SAR is granted. Upon the exercise of an Option as to some or all of the shares covered by the 
award, the related Tandem SAR will automatically be cancelled to the extent of the number of shares covered by the Option 
exercise. Upon the exercise of all or a portion of a Tandem SAR, an equivalent portion of the related Option will be forfeited.  

The Committee will determine the number of shares subject to a Freestanding SAR and the manner and time of the SAR’s 
exercise. Freestanding SARs must be granted for a term of ten years or less and may generally have the same terms and 
conditions as Options. The exercise price of a Freestanding SAR may not be less than the fair market value of the Company’s 
common stock on the date of grant. 

Other Awards 

Awards may be granted in the form of Restricted Stock Awards, RSUs and Other Stock-Based Awards. These awards are 
subject to such terms, restrictions and conditions as the Committee may determine, including the participant’s achievement of 
one or more performance goals (including the participant’s provision of services for a designated time period).  

Participants receiving a Restricted Stock Award, unless otherwise provided in the award agreement, shall have the right to vote 
and receive dividends on the shares underlying such award during the restriction period. At the end of the restriction period, the 
restrictions imposed under the Plan and under the award agreement shall lapse with respect to the number of shares underlying 
the Restricted Stock Award as determined by the Committee, and such number of shares shall be delivered to the participant. 

Participants receiving RSUs will have only the rights of a general unsecured creditor of the Company and no rights as a 
shareholder of the Company until delivery of shares, cash or other securities or property is made as specified in the applicable 
award agreement. On the delivery date specified in the award agreement, with respect to each RSU not previously forfeited or 
terminated, the participant will receive one share, cash or other securities or property equal in value to a share or a combination 
thereof, as specified by the Committee. 

Dividend Equivalent Rights 

For Restricted Stock Awards, RSUs and Other Stock-Based Awards, the Committee may include as part of the award an 
entitlement to receive Dividend Equivalent Rights. In the event such a provision is included in an award agreement, the 

29 

 
Committee will determine whether such payments will be made in cash, in shares or in another form, whether they will be 
conditioned upon the exercise of the award to which they relate, the time or times at which they will be made and such other 
terms and conditions as the Committee will deem appropriate.  

Participants receiving Dividend Equivalent Rights will have only the rights of a general unsecured creditor of the Company until 
payment of such amounts is made as specified in the applicable award agreement. No Dividend Equivalent Rights will be paid at 
a time when any performance-based goals that apply to the Dividend Equivalent Rights or award granted in connection with the 
Dividend Equivalent Rights have not been satisfied and will revert back to the Company if such goals are not satisfied.  

Other Terms 

Awards, other than Options or Restricted Stock Awards, may be paid in cash, shares, a combination of cash and shares, or any 
other form of property as the Committee may determine.  

Adjustments in Authorized Shares and Outstanding Awards 

In the event of any corporate event or transaction involving the Company, a subsidiary and/or an affiliate (including, but not 
limited to, a change in the shares of the Company or the capitalization of the Company), the Committee, to prevent dilution or 
enlargement of participants’ rights under the Plan, shall substitute or adjust (in each case in such manner as it deems equitable 
and appropriate):  

•  The number and kind of shares or other property (including cash) that may be issued under the Plan or under 

particular forms of awards; 

•  The number and kind of shares or other property (including cash) subject to outstanding awards;  
•  The option price, grant price or purchase price applicable to outstanding awards;  
•  Any individual award limits; and/or 
•  Other value determinations applicable to the Plan or outstanding awards.  

Change of Control 

Upon the occurrence of a change of control of the Company, the Committee shall make one or more of the following adjustments 
to the terms and conditions of outstanding awards to the extent determined by the Committee to be permitted under 
Section 409A of the Code: 

•  continuation or assumption of such outstanding awards under the Plan by the Company (if it is the surviving 

company or corporation) or by the surviving company or corporation or its parent;  

•  substitution by the surviving company or corporation or its parent of awards with substantially the same terms 

for such outstanding awards;  

•  accelerated exercisability, vesting and/or lapse of restrictions under outstanding awards immediately prior to 

the occurrence of such event;  

•  upon written notice, provide that any outstanding awards must be exercised, to the extent then exercisable, 
during a reasonable period of time immediately prior to the scheduled consummation of the event, or such 
other period as determined by the Committee (contingent upon the consummation of the event), and at the end 
of such period, such awards shall terminate to the extent not so exercised within the relevant period; 

•  cancellation of all or any portion of outstanding awards for fair value (as determined in the sole discretion of the 

Committee and which may be zero) which, in the case of Options and SARs and similar awards, if the 
Committee so determines, may equal the excess, if any, of the value of the consideration to be paid in the 
Change of Control transaction to holders of the same number of shares subject to such awards (or, if no such 
consideration is paid, fair market value of the shares subject to such outstanding awards or portion thereof 
being canceled) over the aggregate option price or grant price, as applicable, with respect to such awards or 
portion thereof being canceled (which may be zero); or  

•  such other adjustment as determined appropriate by the Committee.  

Clawback/Recoupment 

Awards under the Plan shall be subject to the clawback or recoupment policy, if any, that the Company may adopt from time to 
time, whether before or after the grant of such awards, to the extent provided in such policy and, in accordance with such policy, 
may be subject to the requirement that the awards be repaid to the Company after they have been distributed or paid to the 
participant.  

30 

 
New Plan Benefits  

The following table reflects the benefits or amounts that will be received by or allocated to the following listed individuals and 
specified groups under the Plan as of March 29, 2021. 

Name and Position 

Dollar Value ($)  

Number of Shares 

Amended and Restated 2013 Omnibus 
Incentive Plan (1) 

J.V. Continenza 
Executive Chairman and Chief Executive Officer 

D.E. Bullwinkle 
Chief Financial Officer, President, Eastman 
Business Park and Senior Vice President 

R.W. Byrd 
General Counsel, Secretary and Senior Vice 
President  

Executive Officer Group   

Non-Executive Director Group  

Non-Executive Officer Employee Group  

(2) 

0 

0 

0 

0 

0 

600,000(2) 

0 

0 

0 

0 

0 

(1) Except as set forth in this table, the benefits or amounts to be received by or allocated to participants and the number of 

shares to be granted under the Plan that are subject to approval of the First Amendment to the Plan cannot be determined at 
this time because the amount and form of grants to be made to any eligible participant in any year is determined at the 
discretion of the Committee and the Committee has not determined future awards or who might receive them. Except as set 
forth in this table, no nominee for election as a director, no associate of any executive officer, director or nominee, and no 
other person who received or is to receive five percent of the options or rights under the Plan will receive any options or rights 
that are determinable at this time and subject to the approval of the First Amendment to the Plan. 

(2)  Pursuant to his Executive Chairman and CEO agreement dated February 26, 2021, the Company is obligated to make a grant 
of 300,000 RSUs to Mr. Continenza each year during the three-year term of his agreement, with the first grant having been 
made upon the execution of the agreement. In the event of any automatic renewal of his agreement, the number of RSUs to 
be granted each year during the renewal term shall be determined by dividing $3,000,000 by the volume-weighted average 
price per share for the 20 trading days prior to the date of grant (which shall be an anniversary of the effective date of his 
agreement). The number of shares reflects the current contractual commitment and does not include any RSUs that may 
become contractually required as a result of a renewal of Mr. Continenza’s agreement.  The grant value cannot be determined 
at this time because the grant has not yet occurred. 

31 

 
 
 
 
 
Aggregate Awards Granted 

The following table sets forth information with respect to the number of shares subject to awards previously granted to the 
following listed individuals and specified groups under the Plan since its inception through March 29, 2021, our record date:  

Name and Position 

Number of Shares 
Underlying Options 

Number of Shares 
Underlying Restricted 
Stock Units  

J.V. Continenza 
Executive Chairman and Chief Executive Officer 

3,800,000 

741,589 

D.E. Bullwinkle 
Chief Financial Officer, President, Eastman 
Business Park and Senior Vice President 

R.W. Byrd 
General Counsel, Secretary and Senior Vice 
President  

537,408 

  83,898 

165,201 

60,088 

Executive Officer Group 

(1)

Non-Executive Director Group  

5,453,513 

202,927 

Each Nominee for Election as a Director Group (1) 

3,920,250 

Each associate of any of such directors, executive 
officer or nominees 

Each other person who received or is to receive 5 
percent of such options, warrants or rights 

0 

0 

1,153,575 

734,313 

1,044,330 

0 

0 

Non-Executive Officer Employee Group 

5,527,645 

1,833,996 

(1) This row includes the aggregate awards previously granted to Mr. Continenza set forth above.  

FEDERAL TAX TREATMENT 

The following is a summary of certain U.S. federal income tax consequences of participating in the Plan. This discussion does 
not purport to be a complete statement of all aspects of the U.S. federal income tax consequences in this area, including any 
state, local or foreign tax consequences of participating in the Plan. This section is based on the Code, its legislative history, 
existing and proposed regulations under the Code and published rulings and court decisions, all as currently in effect. These 
laws are subject to change, possibly on a retroactive basis. 

Incentive Stock Options 

A participant will not be subject to tax upon the grant of an Incentive Stock Option (ISO) or upon the exercise of an ISO. 
However, the excess of the fair market value of the shares on the date of exercise over the exercise price paid will be included in 
a participant’s alternative minimum taxable income. Whether a participant is subject to the alternative minimum tax will depend 
on the participant’s particular circumstances. The participant’s basis in the shares received will be equal to the exercise price 
paid, and the participant’s holding period in such shares will begin on the day following the date of exercise. 

If a participant disposes of the shares on or after the later of: 1) the second anniversary of the date of grant of the ISO and 2) the 
first anniversary of the date of exercise of the ISO (the statutory holding period), the participant will recognize a capital gain or 
loss in an amount equal to the difference between the amount realized on such disposition and the participant’s basis in the 
shares. 

If the participant disposes of the shares before the end of the statutory holding period, the participant will have engaged in a 
“disqualifying disposition.” As a result, the participant will be subject to tax: 1) on the excess of the fair market value of the shares 
on the date of exercise (or the amount realized on the disqualifying disposition, if less) over the exercise price paid, as ordinary 
income and 2) on the excess, if any, of the amount realized on such disqualifying disposition over the fair market value of the 

32 

 
  
shares on the date of exercise, as capital gain. If the amount a participant realizes from a disqualifying disposition is less than the 
exercise price paid (i.e., the participant’s basis) and the loss sustained upon such disposition would otherwise be recognized, a 
participant will not recognize any ordinary income from such disqualifying disposition and instead the participant will recognize a 
capital loss. In the event of a disqualifying disposition, subject to applicable provisions of the Code, including Section 162(m), the 
Company will be entitled to a deduction in the same amount. 

Income tax withholding and employment taxes do not apply upon the exercise of an ISO or upon any subsequent disposition, 
including a disqualifying disposition, of shares acquired pursuant to the exercise of the ISO. 

Nonqualified Stock Options  

The participant will not be subject to tax upon the grant of an Option which is a Nonqualified Stock Option. Upon exercise of a 
Nonqualified Stock Option, an amount equal to the excess of the fair market value of the shares acquired on the date of exercise 
over the exercise price paid is taxable to the participant as ordinary income, and subject to applicable provisions of the Code, 
including Section 162(m), the Company will be entitled at that time to a deduction in the same amount. This amount of income 
will be subject to income tax withholding and employment taxes. The participant’s basis in the shares received will equal the fair 
market value of the shares on the date of exercise, and the participant’s holding period in such shares will begin. 

Restricted Stock Awards, Restricted Stock Units and Other Stock-Based Awards 

A participant normally will not recognize taxable income and the Company will not be entitled to a deduction upon the grant of 
Restricted Stock Awards, RSUs or Other Stock-Based Awards. When the Restricted Stock Award vests or the RSUs settle or the 
Other Stock-Based Awards are paid or settle, the participant will recognize taxable ordinary income in an amount equal to the fair 
market value of the shares or other property received at that time, less the amount, if any, paid for the shares, and, subject to 
applicable provisions of the Code, including Section 162(m), the Company will be entitled at that time to a deduction in the same 
amount. However, a participant may elect to recognize taxable ordinary income in the year a Restricted Stock Award is granted 
in an amount equal to the excess of their fair market value at the grant date, determined without regard to certain restrictions, 
over the amount, if any, paid for the shares. In that event, subject to applicable provisions of the Code, including Section 162(m), 
the Company will be entitled to a deduction in such year in the same amount. Any gain or loss realized by the participant upon 
the subsequent disposition of shares received will be taxed as short-term or long-term capital gain or loss, but will not result in 
any further deduction for the Company. 

Limitation on Income Tax Deduction 

Section 162(m) of the Code places a $1,000,000 annual limit on the compensation deductible by the Company that is paid to an 
individual who is a covered employee.  

Tax Withholding 

The Company shall have the power and the right to deduct or withhold (or cause to be deducted or withheld) from any amount 
deliverable under an award or otherwise (including shares otherwise deliverable), or require a participant to remit to the 
Company, the minimum statutory amount to satisfy federal, state and local taxes, domestic or foreign, required by law or 
regulation to be withheld with respect to any taxable event arising as a result of the Plan. With respect to required withholding, 
participants may elect (subject to the Company’s automatic withholding right set out above) to satisfy the withholding 
requirement, in whole or in part, (i) by having the Company withhold shares or (ii) through an independent broker-dealer 
arrangement to sell a sufficient number of shares, in each case, having a fair market value on the date the tax is to be 
determined equal to the minimum statutory total tax that could be imposed on the transaction.  

33 

 
EQUITY COMPENSATION PLAN INFORMATION 

Information as of December 31, 2020 regarding the Company’s equity compensation plans is summarized in the following table:   

Number of Securities to be 
Issued Upon Exercise of 
Outstanding Options and 
Restricted Stock Units 

Weighted-Average 
Exercise Price of 
Outstanding Options (1) 

Plan Category 

(a) 

Equity compensation plans 
approved by security 
holders (3)  

Equity compensation plans 
not approved by security 
holders 

8,105,386 

— 

(b) 

$8.10 

— 

Number of Securities 
Remaining Available for 
Future Issuance Under 
Equity Compensation 
Plans (Excluding 
Securities Reflected in 
Column (a)) (2) 

(c) 

860,631 

— 

(1) Represents the weighted-average exercise price of outstanding stock options. The weighted-average exercise price does not 
take into account the shares issuable upon vesting of outstanding restricted stock units under the Plan, which do not have an 
exercise price. 

(2) For the purposes of the number of shares available under the Plan, each stock option counts as a fraction of a share, based 

on the financial value of the stock option relative to a share.  

(3)  All shares covered by the Plan are now being treated as approved by shareholders based on the approval by shareholders of 

the amendment and restatement of the Plan on May 20, 2020. The shares covered by the Original Plan were previously 
reported as not approved by shareholders because the Original Plan had been approved by the Bankruptcy Court pursuant to 
the Plan of Reorganization. 

OTHER INFORMATION 

Approval of the First Amendment to the Amended and Restated 2013 Omnibus Incentive Plan requires the affirmative vote of a 
majority of the votes cast by the holders of shares entitled to vote.  

The Board of Directors recommends a vote FOR the approval of the First Amendment to the Amended and Restated 
2013 Omnibus Incentive Plan. 

34 

 
 
 
 
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 

BENEFICIAL SECURITY OWNERSHIP OF MORE THAN 5% OF THE COMPANY’S SHARES 

The table below presents certain information as of March 29, 2021 regarding the persons known to us to be the beneficial owner 
of more than 5% of the outstanding shares of our common stock and our Series C preferred stock (as of March 30, 2021 in the 
case of GO EK Ventures IV, LLC), with percentages based on 78,503,476 shares of common stock outstanding as of March 29, 
2021 and 1,000,000 shares of Series C preferred stock outstanding as of March 30, 2021. We also have 1,000,000 shares of 
4.0% Series B Convertible Preferred Stock (Series B preferred stock) outstanding that do not have voting rights at the Annual 
Meeting. 

Name and Address of Beneficial Owner 

Number of 
Common Shares 
Beneficially Owned 

Percent of Class 
Beneficially 
Owned 

Number of Shares of 
Series C Preferred 
Stock Beneficially 
Owned 

Percent of Class 
Beneficially 
Owned 

GO EK Ventures IV, LLC 
B. Thomas Golisano 
7632 County Road 42 
Victor, New York, 14564-8906 

George and Renee Karfunkel 
1671 52nd Street 
Brooklyn, New York 11204 

Philippe D. Katz 
160 Broadway 
New York, New York 10038 

K.F. Investors LLC 
160 Broadway 
New York, New York 10038 

10,054,510(1) 

11.35% 

1,005,451(1) 

100% 

5,020,565 (2) 

6.39% 

10,648,914(3) 

13.56% 

5,044,023(4) 

6.43% 

— 

— 

— 

— 

— 

— 

— 

— 

Southeastern Asset Management, Inc., et al. 
6410 Poplar Avenue, Suite 900 
Memphis, Tennessee 38119 

12,058,701(5) 

13.70% 

(1)  The amount shown includes 750,000 shares of Series C preferred stock, which are convertible at any time, into shares of our 
common stock at the initial conversion price of $10 per share of common stock, corresponding to an initial conversion rate of 
10 shares of common stock for each share of Series C preferred stock, acquired by GO EK Ventures on February 26, 2021, at 
the initial closing of the purchase transaction under the Series C Purchase Agreement. The amount shown also includes an 
additional 250,000 shares of our Series C preferred stock (convertible into 2,500,000 shares of our common stock) issued in a 
second closing under the Series C Purchase Agreement on March 30, 2021. In addition, the amount shown includes 54,510 
shares of common stock issuable upon conversion of 5,451 shares of Series C preferred stock issuable on April 15, 2021 as a 
dividend payable in kind. For purposes of determining the percent of beneficial ownership of GO EK Ventures, the shares of 
common stock underlying the Series C preferred stock are included in the outstanding share amount. GO EK Ventures reports 
sole voting and dispositive power with respect to these shares of our Series C preferred stock. B. Thomas Golisano, a director 
nominee, is the sole member of GO EK Ventures. This information is based on the Schedule 13D filed by GO EK Ventures 
and Mr. Golisano on March 8, 2021.  

(2)  George and Renee Karfunkel report shared voting and dispositive power with respect to 5,020,565 shares of our common 

stock. The amount shown includes Mr. Karfunkel’s presently exercisable options to purchase 37,579 shares of our common 
stock and 500,000 shares of our common stock owned by the Chesed Foundation of America, a charitable foundation 
controlled by Mr. Karfunkel. This information is based on Amendment No. 3 to the Schedule 13D filed by Mr. and Mrs. 
Karfunkel on January 14, 2021 and Section 16 reports filed with the SEC by Mr. and Mrs. Karfunkel. 

(3)  The amount shown includes presently exercisable options to purchase 45,095 shares of our common stock. Philippe Katz has 
an indirect ownership interest in and shares voting and dispositive power over 3,139,741 shares held by Momar Corporation 
and 170,000 shares held by 111 John Realty Corp. (111 John), each an entity in which Mr. Katz has an ownership interest and 
is a member of the board of directors; 1,519,646 shares held by United Equities Commodities Company (United Equities), an 
entity of which Mr. Katz is a general partner; 614,041 shares held by Marneu Holding Company (Marneu), an entity of which 
Mr. Katz is a partner; and 5,044,023 shares held by K.F. Investors (KF Investors), an entity of which Mr. Katz is a managing 
member and a greater than 5% holder of our shares as reported in this table. Mr. Katz is the son-in-law of Moses Marx, a 

35 

 
shareholder who reports having voting and dispositive power over 2,353,687 shares of our common stock. Mr. Katz has 
46,729 shares of phantom stock credited to his account under the Deferred Compensation Plan for Directors. 

(4)  KF Investors has sole voting and dispositive power over these shares. KF Investors, Moses Marx, Momar Corporation, 

Marneu, United Equities and 111 John have agreed to act as a “group” within the meaning of Section 13(d)(3) of the Exchange 
Act. This information is based on Amendment No. 3 to the Schedule 13D filed jointly by KF Investors, Mr. Marx and the entities 
described in this footnote 4 on August 3, 2020 and Section 16 reports filed with the SEC by KF Investors. 

(5) Southeastern, et al. has beneficial ownership of 12,058,701 shares of our common stock, including 9,523,809 shares issuable 
upon conversion of 1,000,000 shares of Series B preferred stock (or 10.8% of the outstanding shares when including these 
shares on an as converted basis in the number of outstanding shares). For purposes of determining the percent of beneficial 
ownership of Southeastern et al., the shares of common stock underlying the Series B preferred stock, which are freely 
convertible, are included in the outstanding share amount. Southeastern shares voting power with Longleaf Partners Small-
Cap Fund (Longleaf), a series of Longleaf Partners Funds Trust, a Massachusetts business trust, with respect to 8,877,619 
shares. Southeastern reports no voting power with respect to 3,181,082 shares. Southeastern has sole dispositive power with 
respect to 170,000 shares and shares dispositive power with respect to 11,888,701 shares, including 8,877,619 shares with 
Longleaf. Mr. O. Mason Hawkins is the Chairman of the Board of Southeastern. All shares reported by Southeastern are 
owned by Southeastern’s investment advisory clients, including Longleaf, and none are owned directly or indirectly by 
Southeastern.  

36 

 
 
 
 
BENEFICIAL SECURITY OWNERSHIP OF DIRECTORS, NOMINEES AND EXECUTIVE OFFICERS 

The table below presents certain information as of March 29, 2021 regarding shares of our common stock and shares of our 
Series C preferred stock held by our directors, nominees, each of our named executive officers and all directors, nominees and 
executive officers as a group. 

Name of Beneficial Owner 

Directors and Nominees 

Jeffrey D. Engelberg 

George Karfunkel 

B. Thomas Golisano 

Philippe D. Katz 

Kathleen B. Lynch 

Jason New 

William G. Parrett  

Darren L. Richman 

Michael E. Sileck, Jr. 

Named Executive Officers 

James V. Continenza (10) 

David Bullwinkle 

Roger Byrd 

All directors, director nominees 
and executive officers as a 
group (16 persons, including the 
above)  

Number of Common 
Shares 
Beneficially Owned (1) 

Number of Shares 
of Series C 
Preferred Stock 
Beneficially Owned 
(1)  

Percent of Class 
Beneficially Owned (1)(2) 

Percent of 
Class 
Beneficially 
Owned (1)(2) 

244,100(3) 

5,020,565(4) 

10,054,510(5) 

10,648,914(6) 

— 

97,314(7) 

73,784(8) 

3,516,437(9) 

10,000 

4,081,644(11) 

522,130(12) 

116,296(13) 

— 

6.39% 

11.35% 

13.56% 

— 

— 

— 

4.37% 

— 

4.99%(11) 

— 

— 

— 

— 

— 

— 

1,005,451(5) 

100% 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

35,361,929(14) (15) 

36.84%(15) 

1,005,451(5) 

100% 

(1)  Under the rules of the SEC, “beneficial ownership” is deemed to include shares for which an individual, directly or indirectly, 
has or shares voting or dispositive power, whether or not they are held for the individual’s benefit, and includes shares that 
may be acquired within 60 days, including, but not limited to, the right to acquire shares by the exercise of options or upon the 
conversion of convertible securities. Shares that may be acquired by the exercise of options within 60 days are referred to in 
the footnotes to this table as “presently exercisable options.” Percentages are based on 78,503,476 shares of common stock 
outstanding and 1,000,000 shares of Series C preferred stock outstanding except where the person has the right to receive 
shares within the next 60 days (as indicated in the other footnotes to this table), which increases the number of shares owned 
by such person and the number of shares outstanding. Unless otherwise indicated in the other footnotes to this table, each 
shareholder named in the table has sole voting and investment power with respect to all of the shares shown as owned by the 
shareholder. 

(2)  We have omitted percentages of less than 1% from the table. 

(3)  The amount shown includes presently exercisable options to purchase 37,579 shares of our common stock. Mr. Engelberg is 
the managing member of Additive Advisory PBC, which receives management fees from C2W Partners Master Fund Limited, 
whose ownership includes 3,011,082 shares and is an investment fund managed by Southeastern, a greater than 5% holder 
as reported in the table “Beneficial Security Ownership of More than 5% of the Company’s Shares” above. Mr. Engelberg 
disclaims beneficial ownership of the shares held by C2W Partners Master Fund Limited. 

(4)  The amount shown includes presently exercisable options to purchase 37,579 shares of our common stock and 500,000 
shares of our common stock owned by the Chesed Foundation of America, a charitable foundation controlled by Mr. 
Karfunkel. Mr. Karfunkel shares voting and dispositive power with respect to our common stock with his spouse. 

37 

 
 
 
 
 
 
 
 
 
 
(5)  The amount shown includes 750,000 shares of Series C preferred stock, which are convertible at any time, into shares of our 
common stock at the initial conversion price of $10 per share of common stock, corresponding to an initial conversion rate of 
10 shares of common stock for each share of Series C preferred stock, acquired by GO EK Ventures on February 26, 2021, at 
the initial closing of the purchase transaction under the Series C Purchase Agreement. The amount shown also includes an 
additional 250,000 shares of our Series C preferred stock (convertible into 2,500,000 shares of our common stock) issued in a 
second closing under the Series C Purchase Agreement on March 30, 2021. In addition, the amount shown includes 54,510 
shares of common stock issuable upon conversion of 5,451 shares of Series C preferred stock issuable on April 15, 2021 as a 
dividend payable in kind. B. Thomas Golisano is the sole member of GO EK Ventures.  

(6)  The amount shown includes presently exercisable options to purchase 45,095 shares of our common stock. Mr. Katz has an 
indirect ownership interest in and shares voting and dispositive power over 3,139,741 shares held by Momar Corporation and 
170,000 shares held by 111 John, each an entity in which Mr. Katz has an ownership interest and is a member of the board of 
directors; 1,519,646 shares held by United Equities, an entity of which Mr. Katz is a general partner; 614,041 shares held by 
Marneu, an entity of which Mr. Katz is a partner; and 5,044,023 shares held by KF Investors, an entity of which Mr. Katz is a 
managing member and a greater than 5% holder of our shares as reported in this table. Mr. Katz is the son-in-law of Moses 
Marx, a shareholder who reports having voting and dispositive power over 2,353,687 shares of our common stock. Mr. Katz 
has 46,729 shares of phantom stock credited to his account under the Deferred Compensation Plan for Directors. 

(7)  The amount shown includes presently exercisable options to purchase 37,579 shares of our common stock.  

(8)  The amount shown includes presently exercisable options to purchase 45,095 shares of our common stock. Mr. Parrett has 

172,065 shares of phantom stock credited to his account under the Deferred Compensation Plan for Directors. 

(9)  The amount shown includes (i) 2,020,196 shares of common stock issuable upon conversion of a convertible note held by 

KLIM Fund II, including 13,196 shares of common stock issuable to KLIM Fund II upon conversion of interest payable in kind 
on April 15, 2021 with respect to such convertible note, (ii) 803,000 shares of common stock held directly by KLIM Fund II, 
(iii) 496,241 shares of common stock issuable upon conversion of a convertible note held by KLIM Fund I, including 3,241 
shares of common stock issuable to KLIM Fund I upon conversion of interest payable in kind on April 15, 2021 with respect to 
such convertible note, and (iv) 197,000 shares of common stock held directly by KLIM Fund I. Kennedy Lewis Management 
LP (the “Adviser”) is the investment adviser to KLIM Fund I and KLIM Fund II. KLM GP LLC (“KLM”) is the general partner of 
the Adviser. KLIM is the owner and control person of KLM. David K. Chene and Darren L. Richman are the managing 
members and control persons of KLIM. Each of the Adviser, KLM and KLIM may be deemed to exercise voting and investment 
power over securities held by each of the KLIM Funds due to their relationship with the KLIM Funds. Kennedy Lewis GP LLC 
(“Fund I GP”) is the general partner of KLIM Fund I. Kennedy Lewis Investment Holdings LLC (“Holdings I”) is the managing 
member of Fund I GP. David K. Chene and Darren L. Richman are the managing members of Holdings I. Each of Fund I GP 
and Holdings I may be deemed to exercise voting and investment power over securities held by KLIM Fund I due to their 
relationship with KLIM Fund I. Kennedy Lewis GP II LLC (“Fund II GP”) is the general partner of KLIM Fund II. Kennedy Lewis 
Investment Holdings II LLC (“Holdings II”) is the managing member of Fund II GP. David K. Chene and Darren L. Richman are 
the managing members of Holdings II. Each of Fund II GP and Holdings II may be deemed to exercise voting and investment 
power over securities held by KLIM Fund II due to their relationship with KLIM Fund II. David K. Chene and Darren L. 
Richman, in their capacities as managing members of KLIM, and managing members of each of Holdings I and Holdings II, 
may be deemed to exercise voting and investment power over securities held by each of the KLIM Funds due to their 
relationships with the KLIM Funds. 

(10) Mr. Continenza has served as our Chief Executive Officer since July 2020, Executive Chairman since February 2019 and as a 

director since April 2013. 

(11) Mr. Continenza holds presently exercisable options to purchase 3,800,000 shares of our common stock. Mr. Continenza also 

has 241,589 shares of phantom stock credited to his account under the Deferred Compensation Plan for Directors. Mr. 
Continenza’s employment agreement provides that he will not have the right to exercise any stock options granted to him 
pursuant to the terms of any award granted to him in February 2019 or July 2020 under the Plan to the extent that, after giving 
effect to the issuance of the common stock resulting from such exercise, Mr. Continenza (together with his affiliates and any 
person acting as a group (as such term is defined in Section 13(d)(3) of the Exchange Act and Rule 13d-5(b)(1) promulgated 
thereunder)), would beneficially own more than 4.99% (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 
13d-3 promulgated thereunder) of the then issued and outstanding shares of our common stock. Accordingly, the shares 
reported on the table above as beneficially owned by Mr. Continenza and his percentage ownership of our outstanding shares 
do not include amounts in excess of Mr. Continenza’s ownership limit. 

(12) The amount shown includes presently exercisable options to purchase 468,401 shares of our common stock. 

(13) The amount shown includes presently exercisable options to purchase 90,285 shares of our common stock. 

(14) The amount shown includes presently exercisable options to purchase an aggregate of 845,951 shares of common stock for 

executive officers who are not named executive officers. 

38 

 
(15) The shares and percentage ownership of our outstanding shares do not include amounts in excess of the ownership limit for 

Mr. Continenza described above in footnote 11 to this table. 

DELINQUENT SECTION 16(a) REPORTS  

Section 16(a) of the Exchange Act requires our directors, executive officers and persons who own more than 10% of our 
common stock to file reports of ownership and changes in ownership with the SEC. Based solely on the written representations 
of our directors and executive officers and copies of reports that they and persons who owned more than 10% of our common 
stock have filed with the SEC, we believe that all of our directors, executive officers and greater than 10% beneficial owners 
timely complied with the filing requirements of Section 16(a) during 2020, except for Jeffrey Engelberg who filed one late Form 4 
with respect to one transaction. 

39 

 
 
 
 
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 

INTERESTED TRANSACTIONS 

Our Board has adopted written policies and procedures relating to approval or ratification of “interested transactions” with “related 
parties.” Under these policies and procedures, which are posted on our website at http://investor.kodak.com/supporting.cfm, our 
Compensation, Nominating and Governance Committee reviews the material facts of all interested transactions that require the 
Committee’s approval. The Compensation, Nominating and Governance Committee will approve or disapprove the interested 
transactions, subject to certain exceptions, by taking into account, among other factors it deems appropriate, whether the interested 
transaction is on terms no less favorable than terms generally available to an unaffiliated third-party under the same or similar 
circumstances and the extent of the related person’s interest in the transaction. No director or board observer may participate in 
any discussion or approval of an interested transaction for which he or she is a related party, other than providing material 
information concerning the interested transaction to the Compensation, Nominating and Governance Committee. If an interested 
transaction will be ongoing, the Compensation, Nominating and Governance Committee may establish guidelines for our 
management to follow in its ongoing dealings with the related party and then, at least annually, must review and assess ongoing 
relationships with the related party. 

Under the Board’s policies and procedures, an “interested transaction” is any transaction, arrangement or relationship, or series 
of similar transactions, arrangements or relationships (including any indebtedness or guarantee of indebtedness), in which the 
aggregate amount involved will or may be expected to exceed $100,000, our company is a participant and any related party has 
or will have a direct or indirect interest (other than solely as a result of being a director or a less than 10% beneficial owner of 
another entity). A “related party” is any person who is or was, since the beginning of the last fiscal year for which we have filed a 
Form 10-K and proxy statement, a Section 16 Executive Officer, director or nominee for election as a director or board observer 
(even if the person does not presently serve in that role), a beneficial owner of greater than 5% of our common stock or any 
immediate family member of any of the foregoing. Immediate family member includes a person’s spouse, parents, stepparents, 
children, stepchildren, siblings, mothers- and fathers-in-law, sons- and daughters-in-law, brothers- and sisters-in-law and anyone 
residing in such person’s home (other than a tenant or employee). 

The Board has granted standing pre-approval or ratification for the categories of interested transactions described below. In 
addition, any interested transaction with a related party in which the aggregate amount involved is expected to be less than 
$120,000 may be pre-approved by the Chair of the Compensation, Nominating and Governance Committee. Pre-approved 
interested transactions include: 

•  Employment of Section 16 Executive Officers either if the related compensation is required to be reported or if 
the Section 16 Executive Officer is not an immediate family member of another Section 16 Executive Officer or 
a director, and the related compensation would be reported if the Section 16 Executive Officer was a “Named 
Executive Officer” and our Executive Compensation Committee approved (or recommended that the Board 
approve) such compensation.  

•  Any compensation paid to a director if the compensation is required to be reported. 
•  Any transaction with another company with which a related person’s only relationship is as an employee (other 

than an executive officer), director or beneficial owner of less than 10% of that company’s shares, if the 
aggregate amount involved does not exceed the greater of $1 million or 2% of that company’s total annual 
revenues. 

•  Any charitable contribution, grant or endowment by our company to a charitable organization, foundation or 

university with which a related person’s only relationship is as an employee (other than an executive officer) or 
a director, if the aggregate amount involved does not exceed the greater of $1 million or 2% of the charitable 
organization’s total annual receipts. 

•  Any transaction where the related person’s interest arises solely from the ownership of our common stock and 

all holders of our common stock received the same benefit on a pro rata basis (e.g., dividends). 

•  Any transaction involving a related party where the rates or charges involved are determined by competitive 

bids. 

•  Any transaction with a related party involving the rendering of services as a common or contract carrier, or 

public utility, at rates or charges fixed in conformity with law or governmental authority. 

•  Any transaction with a related party involving services as a bank depository of funds, transfer agent, registrar, 

trustee under a trust indenture or similar services. 

40 

 
 
 
The Compensation, Nominating and Governance Committee reviews pre-approved transactions at its regularly scheduled 
meetings and considered the following related party relationships and interests as follows: 

•  Mr. Karfunkel, a current director, holds securities of the Company by virtue of a Backstop Commitment 

Agreement that the Company entered into effective upon emergence from bankruptcy in September 2013 and 
has certain registration rights in connection with a related registration rights agreement. Mr. Karfunkel currently 
holds approximately 6.4% of our outstanding common stock (including through a charitable foundation 
controlled by Mr. Karfunkel). 

•  Mr. Engelberg, a current director, and Mr. Bradley, a former director, were designated by the purchasers of the 
Company’s Series A Convertible Preferred Stock (Series A convertible preferred stock) pursuant to the terms of 
the Purchase Agreement dated as of November 7, 2016 between the Company, Southeastern and certain 
investment funds managed by Southeastern. Mr. Engelberg is the managing member of Additive Advisory 
PBC, which receives management fees from C2W Partners Master Fund Limited, one of the purchasers of the 
Series A convertible preferred stock. In May 2019, Longleaf Partners Small-Cap Fund, C2W Partners Master 
Fund Limited and Deseret Mutual Pension Trust, which are investment funds managed by Southeastern, 
purchased $100 million aggregate principal amount of convertible notes. On July 29, 2020, two of the 
investment funds managed by Southeastern converted $95 million of the principal amount of the convertible 
notes, and on September 30, 2020 the Company exercised its right to mandatorily convert the remainder of the 
convertible notes. On February 26, 2021, Southeastern, Longleaf Partners Small-Cap Fund, C2W Partners 
Master Fund Limited and Deseret Mutual Pension Trust (collectively, the Purchasers), and the Company 
entered into a Series A Preferred Stock Repurchase and Exchange Agreement pursuant to which the Company 
agreed to repurchase from the Purchasers an aggregate of 1,000,000 shares of the Series A convertible 
preferred stock, for an aggregate purchase price of $100,641,667. In addition, the Company and the 
Purchasers agreed to exchange the remaining 1,000,000 shares of Series A convertible preferred stock held by 
the Purchasers for shares of Series B preferred stock on a one-for-one basis. Southeastern may be deemed to 
hold approximately 13.7% of our outstanding common stock and C2W Partners Master Fund Limited may be 
deemed to hold approximately 3.8% of our outstanding common stock. The Company granted registration 
rights with respect to the shares of common stock issuable upon conversion of each of the Series A preferred 
stock and the Series B preferred stock. 

•  Mr. Katz, a current director, is affiliated with Momar Corporation, an entity of which Mr. Katz is a director and 

officer and has an ownership interest in, United Equities Commodities Company, an entity of which Mr. Katz is 
a general partner, Marneu Holding Company, an entity of which Mr. Katz is a partner, KF Investors, an entity of 
which Mr. Katz is a managing member, and 111 John Realty Corp., an entity of which Mr. Katz is a managing 
member and has an ownership interest in, each of which holds an equity interest in our company.  KF Investors 
is a greater than 5% holder of our shares as reported above in the table “Beneficial Security Ownership of More 
than 5% of the Company’s Shares.” As a result, Mr. Katz holds an indirect pecuniary interest in approximately 
13.6% of our outstanding common stock. Mr. Katz is also the son-in-law of Moses Marx, a shareholder that has 
sole voting and dispositive power over 2,353,687 shares of our common stock. In addition, certain of the 
entities Mr. Katz is affiliated with have registration rights with respect to some of the securities of the Company 
they hold by virtue of a registration rights agreement that the Company entered into effective upon emergence 
from bankruptcy in September 2013.  

•  Mr. Continenza, our Executive Chairman and Chief Executive Officer, is also the Chairman and Chief Executive 
Officer of Vivial, Inc. (Vivial), a privately held marketing technology and communications company that provides 
a wide range of digital and legacy leads-generating products to local and national advertisers. In January 2020, 
in the ordinary course of business, the Company engaged Vivial on an arm’s length competitive basis to 
provide salesforce optimization consulting services at an expected cost over a two-year period of up to $2 
million. Mr. Continenza did not participate in the negotiation or decision-making process. By virtue of Mr. 
Continenza’s positions, he is deemed to have an indirect material interest in the Company’s transactions with 
Vivial. At its meeting on January 8, 2020, our Corporate Governance and Nominating Committee (which was 
combined with the Executive Compensation Committee to form the Compensation, Nominating and 
Governance Committee) considered the relevant information and pre-approved the transaction with Vivial. 
•  Mr. Richman, a current director, is a managing member of KLIM, the owner and control person of KLM GP LLC 
(KLM). KLM is the general partner of Kennedy Lewis Management LP, which is the investment adviser to the 
KLIM Funds. On February 26, 2021, the Company entered into the Term Loan Credit Agreement with the KLIM 
Funds, as lenders, and Alter Domus (US) LLC, as administrative agent, that provided the Company with (i) an 
initial term loan in the amount of $225,000,000, which was drawn in full on the same date, and (ii) a 
commitment to provide delayed draw term loans in an aggregate principal amount of up to $50,000,000 on or 
before February 26, 2023. In connection with the Term Loan Credit Agreement, we entered into a letter 

41 

 
agreement with KLIM to provide KLIM with certain board nominee rights pursuant to which Mr. Richman was 
appointed a director of the Company. In addition, pursuant to a securities purchase agreement, KLIM Funds 
purchased (i) 1,000,000 shares of our common stock for an aggregate purchase price of $10,000,000, and 
(ii) $25,000,000 aggregate principal amount of the Company’s 5.0% unsecured convertible promissory notes 
due May 28, 2026 in a private placement transaction. The Company granted certain registration rights with 
respect to these shares of common stock and the shares of common stock issuable upon conversion of the 
notes. 

•  Mr. Golisano, a director nominee, is the sole member of GO EK Ventures, a greater than 5% holder of the 
Company’s shares as reported above in the table “Beneficial Security Ownership of More than 5% of the 
Company’s Shares.” On February 26, 2021, the Company and GO EK Ventures, entered into a Series C 
Purchase Agreement pursuant to which the Company sold to GO EK Ventures an aggregate of 1,000,000 
shares of Series C preferred stock for a purchase price of $100 per share, representing $100,000,000 of gross 
proceeds to the Company. In connection with the Series C Purchase Agreement, the Company granted GO EK 
Ventures with certain board nominee rights pursuant to which Mr. Golisano was nominated as a director of the 
Company. On February 26, 2021, the initial portion of the transactions closed, and the Company issued to GO 
EK Ventures an aggregate of 750,000 shares of the Series C preferred stock for a purchase price of 
$75,000,000. The issuance and sale of the remaining 250,000 shares of Series C preferred stock closed on 
March 30, 2021. The Company granted certain registration rights with respect to the shares of common stock 
issuable upon conversion of the Series C preferred stock. 

42 

 
PRINCIPAL ACCOUNTING FEES AND SERVICES 

AUDIT AND NON-AUDIT FEES 

On March 26, 2020, we selected Ernst & Young LLP as our independent registered public accounting firm, effective as of such 
date. See “Proposal 4 - Ratification of the Audit and Finance Committee’s Selection of Ernst & Young LLP as our Independent 
Registered Public Accounting Firm” for more information.  

The following fees were approved by the Audit and Finance Committee and were billed by Ernst & Young LLP, our current 
independent registered public accounting firm (independent accountants), for services rendered in 2020.  

Type of Service (in millions) 

Audit Fees (1) 

Audit-Related Fees (2) 

Tax Fees (3) 

All Other Fees (4) 

  Total 

2020 

$3.07 

0.05 

0.12 

0.005 

$3.25 

(1)  Audit fees related primarily to the annual audit of our consolidated financial statements included in our Annual Report on Form 
10-K, quarterly reviews of interim financial statements included in our Quarterly Reports on Forms 10-Q, and statutory audits 
of certain of our subsidiaries. 

(2)  Audit related fees primarily consisted of fees related to the audit of our subsidiary’s retirement plan. 

(3)  Tax fees were for tax compliance and assistance services. 

(4)  All other fees consisted of non-audit related procurement of an on-line accounting research tool offered by Ernst & Young LLP 

to its clients. 

POLICY REGARDING PRE-APPROVAL OF SERVICES PROVIDED BY OUR INDEPENDENT 
ACCOUNTANTS 

The Audit and Finance Committee has adopted an Audit and Non-Audit Services Pre-Approval Policy (the Pre-Approval Policy) 
requiring the Audit and Finance Committee’s pre-approval of all audit and permissible non-audit services provided by the 
independent accountants. The Pre-Approval Policy sets forth principles that must be considered by the Audit and Finance 
Committee in approving services to ensure that the independent accountant’s independence is not impaired; describes the audit, 
audit-related, tax and other permissible non-audit services that may be provided and the non-audit services that are prohibited; 
and sets forth the pre-approval requirements for all permitted services.  

The Pre-Approval Policy provides for the general pre-approval of specific types of audit, audit-related, tax and other permissible 
non-audit services and annual approval of a budget for such services. As set forth in the Pre-Approval Policy, unless a type of 
service has received general pre-approval, it will require specific pre-approval by the Audit and Finance Committee. In addition, 
any proposed services exceeding pre-approved budgeted amounts will also require specific pre-approval by the Audit and 
Finance Committee. The independent accountant is required to report quarterly to the Audit and Finance Committee regarding 
the extent of services provided in accordance with their pre-approval and the fees for the services performed to date. The Pre-
Approval Policy also delegates to the Audit and Finance Committee’s Chair the authority to pre-approve specific engagements or 
changes to engagements when it is not practical to bring the matter before the Audit and Finance Committee as a whole. The 
Audit and Finance Committee may not delegate its responsibilities to pre-approve services performed by the independent 
accountant to management or to others. 

In 2020, the Audit and Finance Committee pre-approved all services performed by Ernst & Young LLP. 

43 

 
 
 
PROPOSAL 4 

PROPOSAL 4 - RATIFICATION OF THE AUDIT AND FINANCE COMMITTEE’S SELECTION OF ERNST 
& YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

The Audit and Finance Committee is directly responsible for the selection, compensation, retention, performance and evaluation 
of our independent registered public accounting firm. The Audit and Finance Committee assesses the selection of the 
independent registered public accounting firm each year. In addition, the Audit and Finance Committee considers the 
independence of the independent registered public accounting firm each year. 

On March 26, 2020, following the completion of a competitive process to select our independent registered public accounting firm 
for the 2020 fiscal year, the Company engaged Ernst & Young LLP as auditors for the Company, effective as of such date, which 
resulted in the dismissal of PricewaterhouseCoopers LLP (PwC), the Company’s prior independent registered public accounting 
firm, effective as of March 24, 2020. The engagement of Ernst & Young LLP and the resulting dismissal of PwC were approved 
by the Audit and Finance Committee. After consideration of a number of factors, including the firm’s performance and an 
assessment of the firm’s qualifications and resources, the Audit and Finance Committee has selected Ernst & Young LLP as our 
independent registered public accounting firm for the fiscal year ending December 31, 2021. 

The audit reports of PwC on the consolidated financial statements of the Company as of and for the years ended December 31, 
2019 and December 31, 2018 contained no adverse opinion or disclaimer of opinion and were not qualified or modified as to 
audit scope or accounting principle; however, the reports for both years contained a paragraph stating there was substantial 
doubt about the Company's ability to continue as a going concern.  

During the Company's fiscal years ended December 31, 2019 and December 31, 2018 and through March 24, 2020, there were 
no: (i) disagreements with PwC on any matter of accounting principles or practices, financial statement disclosure, or auditing 
scope or procedure, which disagreements if not resolved to the satisfaction of PwC would have caused PwC to make reference 
thereto in its reports on the financial statements of the Company for such years, or (ii) reportable events, as described under Item 
304(a)(1)(v) of Regulation S-K.  

During the fiscal years ended December 31, 2019 and December 31, 2018 and through March 26, 2020, neither the Company 
nor anyone on the Company's behalf consulted Ernst & Young LLP regarding any of the matters referred to in Item 304(a)(2)(i) or 
(ii) of Regulation S-K.  

A representative of Ernst & Young LLP is expected to attend the Annual Meeting to respond to appropriate questions and, if he 
or she desires, make a statement. 

As a matter of good corporate governance, the Audit and Finance Committee has determined to submit its selection of the 
independent registered public accounting firm to our shareholders for ratification. In the event that the selection of Ernst & Young 
LLP is not ratified, the Audit and Finance Committee will review its future selection of an independent registered public 
accounting firm. Even if the selection is ratified, the Audit and Finance Committee in its discretion may select a different 
registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of 
the Company and our shareholders. 

The ratification of the Audit and Finance Committee’s selection of Ernst & Young LLP requires the affirmative vote of a majority 
of the votes cast by holders entitled to vote thereon. 

The Board of Directors recommends a vote FOR ratification of the Audit and Finance Committee’s selection 
of Ernst & Young LLP as our independent registered public accounting firm.  

By Order of the Board of Directors 

Roger W. Byrd 
General Counsel, Secretary and Senior Vice President 
April 9, 2021 

44 

 
 
 
 
 
APPENDIX A 

EASTMAN KODAK COMPANY 
2013 OMNIBUS INCENTIVE PLAN 

(AS AMENDED AND RESTATED EFFECTIVE MAY 20, 2020) 

Article 1.  Establishment & Purpose 

1.1 

Establishment. Eastman Kodak Company, a New Jersey corporation, hereby 
establishes the Eastman Kodak Company 2013 Omnibus Incentive Plan (hereinafter referred 
to as the “Plan”) as set forth in this document.   

1.2 

Purpose. The purpose of this Plan is to attract, retain and motivate officers, 
employees,  and  non-employee  directors  providing  services  to  the  Company,  any  of  its 
Subsidiaries,  or  Affiliates  and  to  promote  the  success  of  the  Company’s  business  by 
providing Participants with appropriate incentives. 

Article 2.  Definitions 

For purposes of the Plan, the following terms have the meanings set forth below: 

2.1 

“Affiliate” means any entity that the Company, either directly or indirectly, 
is in common control with, is controlled by or controls, or any entity in which the Company 
has  a  substantial  equity  interest,  direct  or  indirect; provided,  however,  to  the extent  that 
Awards must cover “service recipient stock” in order to comply with Section 409A, “Affiliate” 
shall  be  limited  to  those  entities  which  could  qualify  as  an  “eligible  issuer”  under 
Section 409A. 

2.2 

“Award” means any award that is granted under the Plan. 

2.3 

“Award  Agreement”  means  a  written  or  electronic  agreement  setting  forth 

the terms and provisions applicable to an Award granted under this Plan. 

2.4 

“Beneficial  Owner”  or  “Beneficial  Ownership”  shall  have  the  meaning 
ascribed  to  such  terms  in  Rule 13d-3  of  the  General  Rules  and  Regulations  under  the 
Exchange Act. 

2.5 

“Board” means the Board of Directors of the Company. 

2.6 

“Cause”  means  (i)  with  respect  to  a  Participant  employed  pursuant  to  a 
written employment agreement that includes a definition of “Cause”, “Cause” as defined in 
such agreement or (ii) with respect to any other Participant, the occurrence of any of the 
following: 

(a) 

(b) 

the Participant’s continued failure, for a period of at least 30 calendar 
days following a written warning, to perform the Participant’s duties in 
a manner deemed satisfactory by the Participant’s supervisor, in the 
exercise of his or her sole discretion; 

the Participant’s failure to follow a lawful written directive of the Chief 
Executive Officer, the Participant’s supervisor or the Board; 

A-1 

 
(c) 

(d) 

(e) 

(f) 

(g) 

the  Participant’s  willful  violation  of  any  material  rule,  regulation,  or 
policy that may be established from time to time for the conduct of the 
Company’s business; 

the Participant’s unlawful possession, use or sale of narcotics or other 
controlled  substances,  or  performing  job  duties  while  illegally  used 
controlled substances are present in the Participant’s system;  

any  act  or  omission  by  the  Participant  in  the  scope  of  his  or  her 
employment (a) which results in the assessment of a civil or criminal 
penalty  against  the  Participant  or  the  Company,  or  (b)  which  in  the 
reasonable judgment of the Participant’s supervisor could result in a 
material  violation  of  any  foreign  or  U.S.  federal,  state  or  local  law  or 
regulation having the force of law; 

the  Participant’s  conviction  of  or  plea  of  guilty  or  no  contest  to  any 
crime involving moral turpitude; 

any  misrepresentation  of  a  material  fact  by  the  Participant  to,  or 
concealment of a material fact from, the Participant’s supervisor or any 
other person in the Company to whom the Participant has a reporting 
relationship in any capacity; or  

(h) 

the Participant’s breach of the Company’s Business Conduct Guide or 
the Eastman Kodak Company Employee’s Agreement.   

For purpose of this definition, no act or failure to act by the Participant shall 
be considered "willful" unless done or omitted to be done by the Participant in bad faith and 
without reasonable belief that the Participant’s action or omission was in the best interests 
of the Company, any of its Subsidiaries, or Affiliates.  Any act, or failure to act, based upon 
authority given pursuant to a resolution duly adopted by the Board or based upon the advice 
of  counsel  for  the  Company  shall  be  conclusively  presumed  to  be  done,  or  omitted  to  be 
done, by the Participant in good faith and in the best interests of the Company, any of its 
Subsidiaries, and Affiliates. 

2.7 

“Change  of  Control”,  unless  otherwise  specified  in  the  Award  Agreement, 

means the occurrence of any of the following events: 

(a) 

any “person” (as such term is defined in Section 3(a)(9) of the Exchange 
Act and as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act), 
is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the 
Exchange  Act),  directly  or  indirectly,  of  the  Company’s  securities 
representing  50%  or  more  of  the  combined  voting  power  of  the 
Company’s then outstanding securities eligible to vote for the election 
of the Board (“Company Voting Securities”); provided, however, that 
the event described in this paragraph (a) shall not be deemed to be a 
Change  of  Control  by  virtue  of  an  acquisition  of  Company  Voting 
Securities:  (i) by the Company or any Subsidiary, (ii) by any employee 
benefit plan (or related trust) sponsored or maintained by the Company 
or  any  Subsidiary,  (iii)  by  any  underwriter  temporarily  holding 
securities pursuant to an offering of such securities or (iv) pursuant to 
a  Non-Qualifying  Transaction  (as  defined  in  paragraph  (b)  of  this 
definition); 

(b) 

the  consummation  of  a  merger,  consolidation,  statutory  share 
exchange  or  similar  form  of  corporate  transaction  involving  the 

A-2 

 
Company  that requires  the  approval  of  the  Company’s  shareholders, 
whether  for  such  transaction  or  the  issuance  of  securities  in  the 
transaction (a “Business Combination”), unless immediately following 
such  Business  Combination:    (i) more  than  50%  of  the  total  voting 
power of (x) the entity resulting from such Business Combination (the 
(y) if  applicable,  the  ultimate  parent 
“Surviving  Entity”),  or 
corporation  that  directly  or  indirectly  has  beneficial  ownership  of  at 
least  95%  of  the  voting  power,  is  represented  by  Company  Voting 
Securities that were outstanding immediately prior to such Business 
Combination  (or,  if  applicable,  is  represented  by  shares  into  which 
such  Company  Voting  Securities  were  converted  pursuant  to  such 
Business  Combination),  and  such  voting  power  among  the  holders 
thereof is in substantially the same proportion as the voting power of 
such  Company  Voting  Securities  among  the  holders  thereof 
immediately  prior  to  the  Business  Combination,  (ii) no  person  (other 
than  any  employee  benefit  plan  (or  related  trust)  sponsored  or 
maintained by the Surviving Entity or the parent), is or becomes the 
beneficial  owner,  directly  or  indirectly,  of  50%  or  more  of  the  total 
voting  power  of  the  outstanding  voting  securities  eligible  to  elect 
directors of the parent (or, if there is no parent, the Surviving Entity) 
and (iii) at least a majority of the members of the board of directors of 
the parent (or, if there is no parent, the Surviving Entity) following the 
consummation of the Business Combination were Incumbent Directors 
at  the  time  of  the  Board’s  approval  of  the  execution  of  the  initial 
agreement  providing  for  such  Business  Combination  (any  Business 
Combination which satisfies all of the criteria specified in (i), (ii) and 
(iii)  of  this  paragraph  (b)  shall  be  deemed  to  be  a  “Non-Qualifying 
Transaction”); 

individuals  who,  on  the  Effective  Date,  constitute  the  Board  (the 
“Incumbent Directors”) cease for any reason to constitute at least a 
majority of the Board within any 24 month period; provided that any 
person  becoming  a  director  subsequent  to  the  Effective  Date,  whose 
election or nomination for election was approved by a vote of at least 
two-thirds of the Incumbent Directors then on the Board (either by a 
specific vote or by approval of the Company’s proxy statement in which 
such  person  is  named  as  a  nominee  for  director,  without  written 
objection  to  such  nomination)  shall  be  an  Incumbent  Director; 
provided, however, that no individual initially elected or nominated as 
a  director  of  the  Company  as  a  result  of  an  actual  or  threatened 
election  contest  with  respect  to  directors  or  as  a  result  of  any  other 
actual or threatened solicitation of proxies or consents by or on behalf 
of  any  person  other  than  the  Board  shall  be  deemed  to  be  an 
Incumbent Director;  

the consummation of a sale of all or substantially all of the Company’s 
assets (other than to an Affiliate); or 

approval by the shareholders of the Company of a complete liquidation 
or dissolution of the Company. 

(c) 

(d) 

(e) 

Notwithstanding  the  foregoing,  a  Change  of  Control  shall  not  be  deemed  to 
occur  solely  because  any  person  acquires  beneficial  ownership  of  more  than  50%  of  the 
Company Voting Securities as a result of the acquisition of Company Voting Securities by 
the  Company  which  reduces  the  number  of  Company  Voting  Securities  outstanding; 

A-3 

 
provided that if after such acquisition by the Company such person becomes the beneficial 
owner of additional Company Voting Securities that increases the percentage of outstanding 
Company Voting Securities beneficially owned by such person (and in all cases results in 
beneficial  ownership  of  more  than  50%  of  the  Company  Voting  Securities),  a  Change  of 
Control shall then occur. 

2.8 

“Code” means the U.S. Internal Revenue Code of 1986, as amended from time 

to time. 

2.9 

“Committee”  means  the  Executive  Compensation  Committee  of  the  Board 
(as  constituted  from  time  to  time,  and  including  any  successor  committee)  or  any  other 
committee  designated by  the  Board  to  administer  this Plan.  To  the  extent  applicable,  the 
Committee  shall  have  at  least  two  members,  each  of  whom  shall  be  (i) a  Non-Employee 
Director and (ii) an “independent director” within the meaning of the listing requirements of 
the New York Stock Exchange. 

2.10  “Company” means Eastman Kodak Company, a New Jersey corporation, and 

any successor thereto. 

2.11  “Director” means a member of the Board who is not an Employee. 

2.12  “Dividend  Equivalent  Right”  means  a  dividend  equivalent  right  under 

Article 10 of the Plan. 

2.13  “Effective Date” means the date set forth in Section 16.19. 

2.14  “Employee” means an officer or other employee of the Company, a Subsidiary 
or  Affiliate,  including  a  member  of  the  Board  who  is  an  employee  of  the  Company,  a 
Subsidiary or Affiliate. 

2.15  “Exchange  Act”  means  the  Securities  Exchange  Act  of  1934,  as  amended 

from time to time. 

2.16  “Fair Market Value” means, as of any date, the per-Share value determined 

as follows: 

(a) 

(b) 

The closing price of a Share on a recognized U.S. national exchange or 
any  established  over-the-counter  trading  system  on  which  dealings 
take place, or if no trades were made on any such day, the immediately 
preceding day on which trades were made; or 

In  the  absence  of  an  established  market  for  the  Shares  of  the  type 
described  in  (a)  above,  the  per  Share  value  determined  by  the 
Committee in good faith and in accordance with applicable provisions 
of Section 409A. 

2.17  “Good Reason” means (i) with respect to a Participant employed pursuant to 
a written employment agreement that includes a definition of “Good Reason”, “Good Reason” 
as defined in such agreement or (ii) with respect to any other Participant, in the absence of 
written consent of such Participant, the occurrence of any of the following: 

(a) 

a reduction, in the aggregate, of the Participant’s base salary and target 
annual  cash  bonus  compensation  (including  variable  and  other 
incentives) or sales and commission opportunities, as applicable, as in 

A-4 

 
effect immediately prior to a Change of Control (or as the same may be 
increased from time to time thereafter) by more than 10%; or 

(b) 

reassignment of the Participant’s primary work site to a new primary 
work site that increases his or her one-way commute to work by more 
than  35  miles,  unless the  Participant  is  in  a position  where periodic 
reassignment is standard practice. 

Notwithstanding the foregoing, a termination for Good Reason shall not have 
occurred  unless  (i)  the  Participant  gives  written  notice  to  the  Company  of  termination  of 
employment within 30 days after the Participant first becomes aware of the occurrence of 
the  circumstances  constituting  Good  Reason,  specifying  in  detail  the  circumstances 
constituting Good Reason, and the Company has failed within 30 days after receipt of such 
notice  to  cure  the  circumstances  constituting  Good  Reason,  and  (ii)  the  Participant’s 
“separation  from  service”  (within  the  meaning  of  Section 409A)  occurs  no  later  than  two 
years following the initial existence of the circumstances giving rise to Good Reason. 

2.18  “Incentive  Stock  Option”  means  an  Option  intended  to  meet  the 
requirements  of  an  incentive  stock  option  as  defined  in  Section 422  of  the  Code  and 
designated as an Incentive Stock Option. 

2.19  “Non-Employee  Director”  means  a  person  defined  in  Rule 16b-3(b)(3) 
promulgated by the Securities and Exchange Commission under the Exchange Act, or any 
successor definition adopted by the Securities and Exchange Commission. 

2.20  “Nonqualified Stock Option” means an Option that is not an Incentive Stock 

Option. 

2.21  “Other Stock-Based Award” means any right granted under Article 11 of the 

Plan. 

2.22  “Option” means any stock option granted under Article 6 of the Plan. 

2.23  “Option Price” means the purchase price per Share subject to an Option, as 

determined pursuant to Section 6.2 of the Plan. 

2.24  “Participant” means any eligible person as set forth in Section 4.1 to whom 

an Award is granted. 

2.25  “Person” shall have the meaning ascribed to such term in Section 3(a)(9) of 
the  Exchange  Act  and  used  in  Sections 13(d)  and  14(d)  thereof,  including  a  “group”  as 
defined in Section 13(d) thereof. 

2.26  “Restricted Stock Award” means any Award granted under Article 8 of the 

Plan. 

2.27  “Restricted  Stock  Unit”  means  any  restricted  stock  unit  granted  under 

Article 9 of the Plan. 

2.28  “Restriction  Period”  means  the  period  during  which  a  Restricted  Stock 

Award is subject to forfeiture. 

2.29  “Section 409A” means Section 409A of the Code, including any amendments 
or  successor  provisions  to  that  section,  and  any  regulations  and  other  administrative 

A-5 

 
guidance  relating  thereto,  in  each  case  as  they  may  be  from  time  to  time  amended  or 
interpreted through further administrative guidance. 

2.30  “Service” means service as an Employee or Director. 

2.31  “Share”  means  a  share  of  common stock  of  the  Company, par  value  $0.01 
per  share,  or  such  other  class  or  kind  of  shares  or  other  securities  resulting  from  the 
application of Article 14 hereof. 

2.32  “Stock Appreciation Right” means any right granted under Article 7 of the 

Plan. 

2.33  “Subsidiary” means any corporation, partnership, limited liability company 
or other legal entity of which the Company, directly or indirectly, owns stock or other equity 
interests possessing 50% or more of the total combined voting power of all classes of stock 
or other equity interests (as determined in a manner consistent with Section 409A). 

Article 3.  Administration 

3.1 

Authority  of  the  Committee.  The  Plan  shall  be  administered  by  the 
Committee,  which  shall  have  full  power  to  interpret  and  administer  the  Plan  and  Award 
Agreements and full authority to select the Employees and Directors to whom Awards will 
be granted, and to determine the type and amount of Awards to be granted to each such 
Employee  or  Director,  and  the  terms  and  conditions  of  Awards  and  Award  Agreements. 
Without limiting the generality of the foregoing, the Committee may, in its sole discretion 
but subject to the limitations in Article 12 and Article 14, clarify, construe or resolve any 
ambiguity in any provision of the Plan or any Award Agreement, extend the term or period 
of exercisability of any Awards, or waive any terms or conditions applicable to any Award. 
Awards may, in the discretion of the Committee, be made under the Plan in assumption of, 
or in substitution for, outstanding awards previously granted by the Company or any of its 
Subsidiaries or Affiliates or a company acquired by the Company or with which the Company 
combines. The Committee shall have full and exclusive discretionary power to adopt rules, 
forms,  instruments,  and  guidelines  for  administering  the  Plan  as  the  Committee  deems 
necessary or proper. All actions taken and all interpretations and determinations made by 
the  Committee  or  by  the  Board  (or  any  other  committee  or  sub-committee  thereof),  as 
applicable,  shall  be  final  and  binding  upon  the  Participants,  the  Company,  and  all  other 
interested individuals. 

3.2  Delegation. The Committee may delegate to one or more of its members or 
one  or  more  executive  officers  of  the  Company  such  duties  or  powers  as  it  may  deem 
advisable; provided that no delegation shall be permitted under the Plan that is prohibited 
by applicable law or applicable rules and regulations of the New York Stock Exchange; and 
provided further that no delegation shall permit an executive officer of the Company to grant, 
amend,  cancel  or  suspend  Awards  granted  to  a  Director  or  an  executive  officer  of  the 
Company.  Notwithstanding anything to the contrary contained herein, the Board may, in 
its sole discretion, at any time and from time to time, grant Awards or administer the Plan.  
In any such case, the Board will have all of the authority and responsibility granted to the 
Committee herein. 

Article 4.  Eligibility and Participation 

4.1 

Eligibility. Participants will consist of such Employees and Directors as the 
Committee in its sole discretion determines and whom the Committee may designate from 
time to time to receive Awards. Designation of a Participant in any year shall not require the 
Committee  to  designate  such  person  to  receive  an  Award  in  any  other  year  or,  once 

A-6 

 
designated, to receive the same type or amount of Award as granted to the Participant in 
any other year. 

4.2 

Type of Awards. Awards under the Plan may be cash-based or stock-based.  
Stock-based  Awards  may  be  in  the  form  of  any  of  the  following:  (i)  Options,  (ii)  Stock 
Appreciation Rights, (iii) Restricted Stock Awards, (iv) Restricted Stock Units, (v) Dividend 
Equivalent Rights, and (vi) Other Stock-Based Awards. Cash-based Awards may be in the 
form of cash awards (including, without limitation, retainers and meeting-based fees) that 
the Committee determines to be consistent with the purposes of the Plan and the interests 
of the Company. Awards granted under the Plan shall be evidenced by Award Agreements 
(which need not be identical) that provide additional terms and conditions associated with 
such Awards, as determined by the Committee in its sole discretion; provided, however, that 
in  the  event  of  any  conflict  between  the  provisions  of  the  Plan  and  any  such  Award 
Agreement, the provisions of the Plan shall prevail. 

Article 5.  Shares Subject to the Plan and Maximum Awards 

5.1  General. Subject to adjustment as provided in Article 14 hereof, the maximum 
number  of  Shares  available  for  grant  to  Participants  pursuant  to  Awards  under  the  Plan 
shall be equal to 8,000,000. The number of Shares available for granting Incentive Stock 
Options  under  the  Plan  shall  not  exceed  2,000,000,  subject  to  Article  14  hereof  and  the 
provisions  of  Sections  422  or  424  of  the  Code  and  any  successor  provisions.  The  Shares 
available for issuance under the Plan may consist, in whole or in part, of authorized and 
unissued  Shares  or  treasury  Shares.    Shares  issued  in  connection  with  awards  that  are 
assumed,  converted  or  substituted  as  a  result  of  the  Company’s  acquisition  of  another 
company  (including  by  way  of  merger,  combination  or  similar  transaction)  (“Acquisition 
Awards”) will not count against the number of Shares that may be granted under the Plan. 

5.2 

Share Counting.  The number of shares of Common Stock granted under the 
Plan  per  year  will  be  determined  as  follows:    (i)  each  Restricted  Stock  Award,  Restricted 
Stock Unit and similar Award will count as one share of Common Stock and (ii) each Option, 
Stock Appreciation Right and similar Award will count as a fraction of a share of Common 
Stock, based on the financial value of each such Award relative to a share of Common Stock, 
as determined by the Committee promptly after the Effective Date.   

5.3  Director  Awards.    Aggregate  Awards  to  any  one  Director  in  respect  of  a 
calendar year may not exceed a number of Awards with a grant date fair value of $450,000 
(computed as of the date of grant in accordance with applicable financial accounting rules). 

5.4 

Additional  Shares.  In  the  event  that  any  outstanding  Award  expires,  is 
forfeited, cancelled or otherwise terminated without the issuance of Shares or is otherwise 
settled for cash, the Shares subject to such Award (counted in accordance with Section 5.2 
of  the  Plan),  to  the  extent  of  any  such  forfeiture,  cancellation,  expiration,  termination  or 
settlement for cash, shall again be available for Awards. Additionally, any shares delivered 
to  the  Company  or  withheld  by  the  Company  in  payment  or  satisfaction  of  the  tax 
withholding obligation of an Award (other than an Option or Stock Appreciation Right) shall 
again be available for Awards. If the Committee authorizes the assumption under this Plan, 
in  connection  with  the  acquisition  of  another  company  (whether  by  way  of  merger, 
consolidation,  acquisition  of  all  or  substantially  all  of  the  assets,  acquisition  of  stock,  or 
reorganization), of awards granted under a plan maintained by such company prior to the 
acquisition of such company, such assumption shall not reduce the maximum number of 
Shares available for issuance under this Plan. 

A-7 

 
Article 6.  Stock Options 

6.1  Grant of  Options. The Committee is hereby authorized to grant Options to 
Participants. Each Option shall permit a Participant to purchase from the Company a stated 
number of Shares at an Option Price established by the Committee, subject to the terms 
and conditions described in this Article 6 and to such additional terms and conditions as 
established by the Committee, in its sole discretion, that are consistent with the provisions 
of the Plan. Options shall be designated as either Incentive Stock Options or Nonqualified 
Stock Options; provided that Options granted to Directors shall only be Nonqualified Stock 
Options. An Option granted as an Incentive Stock Option shall, to the extent it fails to qualify 
as  an  Incentive  Stock  Option,  be  treated  as  a  Nonqualified  Stock  Option.  Neither  the 
Committee, the Company, any of its Subsidiaries or Affiliates, nor any of their employees 
and  representatives  shall  be  liable  to  any  Participant  or  to  any  other  Person  if  it  is 
determined that an Option intended to be an Incentive Stock Option does not qualify as an 
Incentive Stock Option. Each Option shall be evidenced by an Award Agreement which shall 
state the number of Shares covered by such Option. Such agreements shall conform to the 
requirements of the Plan and may contain such other provisions, as the Committee shall 
deem advisable. 

6.2 

Terms  of  Option  Grant.  The  Option  Price  shall  be  determined  by  the 
Committee at the time of grant, but, except as otherwise permitted by Article 14 or in the 
case  of  an  Acquisition  Award,  shall  not  be  less  than  100%  of  the  Fair  Market  Value  of  a 
Share on the date of grant. 

6.3  Option Term. The term of each Option shall be determined by the Committee 
at the time of grant and shall be stated in the Award Agreement, but in no event shall such 
term be greater than 10 years. 

6.4  Method of Exercise. Except as otherwise provided in the Plan or in an Award 
Agreement, an Option may be exercised for all, or from time to time any part, of the Shares 
for which it is then exercisable. For purposes of this Article 6, the exercise date of an Option 
shall  be  the  later  of  the  date  a  notice  of  exercise  is  received  by  the  Company  and,  if 
applicable, the date payment is received by the Company pursuant to clauses (i), (ii), (iii) or 
(iv) of the following sentence (including the applicable tax withholding pursuant to Section 
16.4  of  the  Plan).  The  aggregate  Option  Price  for  the  Shares  as  to  which  an  Option  is 
exercised shall be paid to the Company in full at the time of exercise at the election of the 
Participant (i) in cash or its equivalent (e.g., by cashier’s check), (ii) to the extent permitted 
by the Committee, in Shares previously owned by the Participant having a fair market value 
equal to the aggregate Option Price for the Shares being purchased and satisfying such other 
requirements as may be imposed by the Committee, (iii) partly in cash and, to the extent 
permitted  by  the  Committee,  partly  in  such  Shares  (as  described  in  (ii)  above)  or  (iv)  in 
consideration received by the Company under a cashless exercise program (whether through 
a  broker  or  otherwise)  implemented  by  the  Company  in  connection  with  the  Plan.  The 
Committee may prescribe any other method of payment that it determines to be consistent 
with applicable law and the purpose of the Plan. 

6.5 

Limitations  on  Incentive  Stock  Options.  Incentive  Stock  Options may be 
granted  only  to  employees  of  the  Company  or  of  a  “parent  corporation”  or  “subsidiary 
corporation” (as such terms are defined in Section 424 of the Code) at the date of grant. The 
aggregate fair market value (generally determined as of the time the Option is granted) of 
the Shares with respect to which Incentive Stock Options are exercisable for the first time 
by a Participant during any calendar year under all plans of the Company and of any “parent 
corporation” or “subsidiary corporation” shall not exceed $100,000, or the Option shall be 
treated as a Nonqualified Stock Option. For purposes of the preceding sentence, Incentive 
Stock Options will be taken into account generally in the order in which they are granted. 

A-8 

 
Each provision of the Plan and each Award Agreement relating to an Incentive Stock Option 
shall be construed so that each Incentive Stock Option shall be an incentive stock option as 
defined in Section 422 of the Code, and any provisions of the Award Agreement thereof that 
cannot be so construed shall be disregarded. 

6.6 

Performance  Goals.  The  Committee  may  condition  the  grant  of  Options  or 
the vesting of Options upon the Participant’s achievement of one or more performance goal(s) 
(including the Participant’s provision of Services for a designated time period), as specified 
in the Award Agreement. If the Participant fails to achieve the specified performance goal(s), 
the Committee shall not grant the Option to such Participant or the Option shall not vest, 
as applicable. 

6.7 

Individual  Limitations.    No  Employee  may  be  granted  Options  or  Stock 
Appreciation  Rights  covering  in  excess  of  2,500,000  Shares  in  any  calendar  year  (with 
tandem Options and Stock Appreciation Rights being counted only once with respect to this 
limit), subject to adjustment as provided in Article 14 hereof. 

Article 7.  Stock Appreciation Rights 

7.1  Grant of Stock Appreciation Rights. The Committee is hereby authorized to 
grant  Stock  Appreciation  Rights  to  Participants,  including  a  grant  of  Stock  Appreciation 
Rights  in  tandem  with  any  Option  at  the  same  time  such  Option  is  granted  (a  “Tandem 
SAR”).  Stock  Appreciation  Rights  shall  be  evidenced  by  Award  Agreements  that  shall 
conform  to  the  requirements  of  the  Plan  and  may  contain  such  other  provisions,  as  the 
Committee shall deem advisable. Subject to the terms of the Plan and any applicable Award 
Agreement, a Stock Appreciation Right granted under the Plan shall confer on the holder 
thereof a right to receive, upon exercise thereof, the excess of (i) the fair market value of a 
specified number of Shares on the date of exercise over (ii) the grant price of the right as 
specified by the Committee on the date of the grant. Such payment may be in the form of 
cash, Shares, other property or any combination thereof, as the Committee shall determine 
in its sole discretion. 

7.2 

Terms  of  Stock  Appreciation Right.  Subject  to  the  terms  of  the Plan  and 
any applicable Award Agreement, the grant price (which shall not be less than 100% of the 
Fair Market Value of a Share on the date of grant, except as otherwise permitted by Article 
14 or in the case of an Acquisition Award), term, methods of exercise, methods of settlement, 
and any other terms and conditions of any Stock Appreciation Right shall be as determined 
by the Committee. The Committee may impose such other conditions or restrictions on the 
exercise of any Stock Appreciation Right as it may deem appropriate. No Stock Appreciation 
Right shall have a term of more than 10 years from the date of grant. 

7.3 

Tandem Stock Appreciation Rights and Options. A Tandem SAR shall be 
exercisable only to the extent that the related Option is exercisable and shall expire no later 
than the expiration of the related Option. Upon the exercise of all or a portion of a Tandem 
SAR, a Participant shall be required to forfeit the right to purchase an equivalent portion of 
the related Option (and, when a Share is purchased under the related Option, the Participant 
shall be required to forfeit an equivalent portion of the Stock Appreciation Right). 

7.4 

Individual  Limitations.    No  Employee  may  be  granted  Options  or  Stock 
Appreciation  Rights  covering  in  excess  of  2,000,000  Shares  in  any  calendar  year  (with 
tandem Options and Stock Appreciation Rights being counted only once with respect to this 
limit), subject to adjustment as provided in Article 14 hereof. 

A-9 

 
Article 8.  Restricted Stock Award 

8.1  Grant  of  Restricted  Stock  Award.  The  Committee  is  hereby  authorized  to 
grant a Restricted Stock Award consisting of a specified number of Shares to a Participant, 
which  Shares  are  subject  to  forfeiture  upon  the  occurrence  of  specified  events.  Each 
Restricted Stock Award shall be evidenced by an Award Agreement, which shall conform to 
the requirements of the Plan and may contain such other provisions, as the Committee shall 
deem advisable. 

8.2 

Terms  of  Restricted  Stock  Awards.  Each  Award  Agreement  evidencing  a 
Restricted Stock Award grant shall specify the period(s) of restriction, the number of Shares 
underlying the Restricted Stock Award, the performance, employment or other conditions 
(including the termination of a Participant’s Service whether due to death, disability or other 
reason) under which the Restricted Stock Award may be forfeited to the Company and such 
other provisions, as the Committee shall deem advisable. At the end of the Restriction Period, 
the restrictions imposed hereunder and under the Award Agreement shall lapse with respect 
to  the  number  of  Shares  underlying  the  Restricted  Stock  Award  as  determined  by  the 
Committee, and the legend shall be removed and such number of Shares delivered to the 
Participant (or, where appropriate, the Participant’s legal representative). 

8.3 

Voting  and  Dividend  Rights.  Unless  otherwise  provided  in  an  Award 
Agreement, Participants shall have none of the rights of a shareholder of the Company with 
respect to the Shares underlying the Restricted Stock Award until the end of the Restricted 
Period; provided that Participants shall have the right to vote and receive dividends on the 
Shares underlying the Restricted Stock Award during the Restriction Period. Dividends shall 
be paid to Participants at the same time that other shareholders of common stock of the 
Company receive such dividends.  Notwithstanding the foregoing, no dividends will be paid 
at a time when any performance-based goals that apply to a Restricted Stock Award have 
not  been  satisfied;  until  such  goals  are  satisfied,  all  dividends  paid  upon  the  Shares 
underlying the Restricted Stock Award shall be retained by the Company for the account of 
the Participant and paid to the Participant (without interest) upon satisfaction of such goals 
and revert back to the Company if such goals are not satisfied. 

8.4 

Performance Goals. The Committee may condition the grant of a Restricted 
Stock Award or the expiration of the Restriction Period upon the Participant’s achievement 
of  one  or more performance goal(s)  (including the Participant’s  provision  of  Services  for a 
designated  time  period),  as  specified  in  the  Award  Agreement.  If  the  Participant  fails  to 
achieve the specified performance goal(s), the Committee shall not grant the Restricted Stock 
Award to such Participant or the Participant shall forfeit the Restricted Stock Award to the 
Company, as applicable. 

8.5 

Section 83(b) Election. A Participant may only make an election pursuant to 
Section 83(b) of the Code concerning a Restricted Stock Award with the prior written consent 
of the Company, which may be withheld in its sole discretion.  In the event that a Participant 
makes such  an  election,  the Participant shall  be  required  to  file promptly  a  copy  of such 
election with the Company. 

Article 9.  Restricted Stock Units 

9.1  Grant  of  Restricted  Stock  Units.  The  Committee  is  hereby  authorized  to 
grant Restricted Stock Units to a Participant in such amounts and subject to such terms 
and conditions as the Committee may determine. Restricted Stock Units shall be evidenced 
by  an  Award  Agreement,  which  shall  conform  to  the  requirements  of  the  Plan  and  may 
contain such other provisions as the Committee shall deem advisable.   

A-10 

 
9.2 

Terms of Restricted Stock Units.  With respect to a Restricted Stock Unit, a 
Participant will have only the rights of a general unsecured creditor of the Company until 
delivery of Shares, cash or other securities or property is made as specified in the applicable 
Award Agreement. The terms and conditions set forth by the Committee in the applicable 
Award  Agreement may  relate  to  vesting  and  nontransferability  restrictions  that  will  lapse 
upon the completion of a specified period of Service, the occurrence of an event and/or the 
attainment of performance objectives, as determined by the Committee at the time of grant.  
On the delivery date specified in the Award Agreement, with respect to each Restricted Stock 
Unit not previously forfeited or terminated, the Participant will receive one Share, cash or 
other securities or property equal in value to a Share or a combination thereof, as specified 
by the Committee.   

Article 10.  Dividend Equivalent Rights 

10.1  Grant of Dividend Equivalent Rights.  The Committee, in its sole discretion, 
may include in the Award Agreement with respect to any Award, other than Options and 
Stock  Appreciation  Rights,  a  dividend  equivalent  right  entitling  the  Participant  to  receive 
amounts equal to all or any portion of the regular cash dividends that would be paid on the 
Shares covered by such Award if such Shares had been delivered pursuant to such Award.   

10.2  Terms of Dividend Equivalent Rights.  With respect to a dividend equivalent 
right, a Participant will have only the rights of a general unsecured creditor of the Company 
until payment of such amounts is made as specified in the applicable Award Agreement.  In 
the event such a provision is included in an Award Agreement, the Committee will determine 
whether such payments will be made in cash, in Shares or in another form, whether they 
will be conditioned upon the exercise of the Award to which they relate, the time or times at 
which they will be made, and such other terms and conditions as the Committee will deem 
appropriate.  Notwithstanding anything to the contrary, no dividends or dividend equivalents 
will  be  paid  at  a  time  when  any  performance-based  goals  that  apply  to  the  dividend 
equivalent  right  or  Award  that  is  granted  in  connection  with  a  dividend  or  dividend 
equivalent right have not been satisfied and will revert back to the Company if such goals 
are not satisfied.   

Article 11.  Other Stock-Based Awards 

The Committee, in its sole discretion, may grant Awards of Shares and Awards that 
are valued, in whole or in part, by reference to, or are otherwise based on the fair market 
value of, Shares (the “Other Stock-Based Awards”), including without limitation, phantom 
awards.  Such  Other  Stock-Based  Awards  shall  be  in  such  form,  and  dependent  on  such 
conditions, if any, as the Committee shall determine, including, without limitation, the right 
to  receive  one  or  more  Shares  (or  the  equivalent  cash  value  of  such  Shares)  upon  the 
completion of a specified period of Service, the occurrence of an event and/or the attainment 
of performance objectives. Other Stock-Based Awards may be granted alone or in addition 
to  any  other  Awards  granted  under  the  Plan.  Subject  to  the  provisions  of  the  Plan,  the 
Committee shall determine to whom and when Other Stock-Based Awards will be made, the 
number  of  Shares  to be  awarded under  (or  otherwise related  to)  such  Other  Stock-Based 
Awards,  whether  such  Other  Stock-Based  Awards  shall  be  settled  in  cash,  Shares  or  a 
combination of cash and Shares, and all other terms and conditions of such Awards. 

Article 12.  [Intentionally Omitted] 

Article 13.  Section 409A 

13.1  The Board and the Committee shall have full authority to give effect to any 
statement in an Award Agreement to the effect that an Award is intended to be “deferred 

A-11 

 
compensation” subject to Section 409A, to be exempt from Section 409A or to have other 
intended treatment under Section 409A and/or other provision of the Code.  To the extent 
necessary to give effect to this authority, in the case of any conflict or potential inconsistency 
between  the  Plan  and  a  provision  of  any  Award  or  Award  Agreement  with  respect  to  the 
subject matter of this paragraph, the Plan shall govern. 

13.2  Without  limiting  the  generality  of  Section  13.1,  with  respect  to  any  Award 
made  under  the  Plan  that  is  intended  to  be  “deferred  compensation”  subject  to 
Section  409A: (i) references to termination of the Participant’s employment will mean the 
from  service  with  the  Company  within  the  meaning  of 
Participant’s  separation 
Section  409A; (ii) any payment to be made with respect to such Award in connection with 
the  Participant’s  separation  from  service  with  the  Company  within  the  meaning  of 
Section 409A that would be subject to the limitations in Section 409A(a)(2)(b) of the Code 
shall be delayed until six months after the Participant’s separation from service (or earlier 
death) in accordance with the requirements of Section 409A; (iii) to the extent necessary to 
comply with Section 409A, any cash, other securities, other Awards or other property that 
the Company may deliver in lieu of Shares in respect of an Award shall not have the effect 
of deferring delivery or payment beyond the date on which such delivery or payment would 
occur  with  respect  to  the  Shares  that  would  otherwise  have  been  deliverable  (unless  the 
Committee  elects  a  later  date  for  this  purpose  in  accordance  with  the  requirements  of 
Section  409A);  (iv)  if  the  Award  includes  a  “series  of  installment  payments”  (within  the 
meaning of Section 1.409A-2(b)(2)(iii) of the regulations promulgated under the Code), the 
Participant’s right to the series of installment payments shall be treated as a right to a series 
of  separate  payments  and  not  as  a  right  to  a  single  payment;  (v)  if  the  Award  includes 
“dividend  equivalents”  (within  the  meaning  of  Section  1.409A-3(e)  of  the  regulations 
promulgated  under  the  Code),  the  Participant’s  right  to  the  dividend equivalents shall  be 
treated  separately  from  the  right  to  other  amounts  under  the  Award;  and  (vi)  unless  the 
Committee determines otherwise, for purposes of determining whether the Participant has 
experienced  a  separation  from  service  with  the  Company  within  the  meaning  of  Section 
409A,  “subsidiary”  shall  mean  a corporation  or  other  entity  in  a chain  of  corporations  or 
other entities in which each corporation or other entity, starting with the Company, has a 
controlling  interest  in  another corporation  or  other  entity  in  the  chain,  ending with  such 
corporation or other entity.  For purposes of the preceding sentence, the term “controlling 
interest” has the same meaning as provided in Section 1.414(c)-2(b)(2)(i) of the regulations 
promulgated  under  the  Code;  provided  that  the  language  “at  least  20  percent”  is  used 
instead  of  “at  least  80  percent”  each  place  it  appears  in  Section 1.414(c)-2(b)(2)(i)  of  the 
regulations promulgated under the Code. 

Article 14.  Adjustments 

14.1  Adjustments in Authorized Shares. In the event of any corporate event or 
transaction  involving  the  Company,  a  Subsidiary  and/or  an  Affiliate  (including,  but  not 
limited  to,  a  change  in  the  Shares  of  the  Company  or  the  capitalization  of  the  Company) 
such as a merger, consolidation, reorganization, recapitalization, separation, stock dividend, 
stock split, reverse stock split, split up, spin-off, combination of Shares, exchange of Shares, 
dividend in kind, amalgamation, or other like change in capital structure (other than regular 
cash  dividends  to  shareholders  of  the  Company),  or  any  similar  corporate  event  or 
transaction, the Committee, to prevent dilution or enlargement of Participants’ rights under 
the Plan, shall substitute or adjust (in each case in such manner as it deems equitable or 
appropriate) the number and kind of Shares or other property (including cash) that may be 
issued under the Plan or under particular forms of Awards, the number and kind of Shares 
or other property (including cash) subject to outstanding Awards, the Option Price, grant 
price  or  purchase  price  applicable  to  outstanding  Awards,  any  individual  Award  limits, 
and/or other value determinations applicable to the Plan or outstanding Awards. 

A-12 

 
14.2  Change  of  Control.  Upon  the  occurrence  of  a  Change  of  Control  after  the 
Effective Date, unless otherwise specifically prohibited under applicable laws or by the rules 
and regulations of any governing governmental agencies or national securities exchanges or 
unless  the  Committee shall determine  otherwise  in  the Award Agreement,  the Committee 
shall  make  one  or  more  of  the  following  adjustments  to  the  terms  and  conditions  of 
outstanding  Awards  to  the  extent  determined  by  the  Committee  to  be  permitted  under 
Section 409A: (i) continuation or assumption of such outstanding Awards under the Plan by 
the Company (if it is the surviving company or corporation) or by the surviving company or 
corporation  or  its  parent;  (ii)  substitution  by  the  surviving  company  or  corporation  or  its 
parent  of  awards  with  substantially  the  same  terms  for  such  outstanding  Awards;  (iii) 
accelerated  exercisability,  vesting  and/or  lapse  of  restrictions  under  outstanding  Awards 
immediately prior to the occurrence of such event; (iv) upon written notice, provide that any 
outstanding Awards must be exercised, to the extent then exercisable, during a reasonable 
period of time immediately prior to the scheduled consummation of the event, or such other 
period as determined by the Committee (contingent upon the consummation of the event), 
and at the end of such period, such Awards shall terminate to the extent not so exercised 
within the relevant period; (v) cancellation of all or any portion of outstanding Awards for 
fair value (as determined in the sole discretion of the Committee and which may be zero) 
which,  in  the  case  of  Options  and  Stock  Appreciation  Rights  or  similar  Awards,  if  the 
Committee so determines, may equal the excess, if any, of the value of the consideration to 
be  paid  in  the  Change  of  Control  transaction  to  holders  of  the  same  number  of  Shares 
subject to such Awards (or, if no such consideration is paid, fair market value of the Shares 
subject to such outstanding Awards or portion thereof being canceled) over the aggregate 
Option Price or grant price, as applicable, with respect to such Awards or portion thereof 
being  canceled  (which  may  be  zero)  and  (vi)  such  other  adjustment  as  determined 
appropriate by the Committee.  The Company shall have no liability to any Participant or 
otherwise if the Plan or any Award, vesting, exercise or payment of any Award hereunder is 
subject to the additional tax and penalties under Section 409A or any other Code section. 

Article 15.  Duration, Amendment 

15.1  Duration of the Plan. Unless sooner terminated as provided in Section 15.2, 
the  Plan  shall  terminate  on  the  10th  anniversary  of  the  Effective  Date;  provided  that  all 
Awards made under the Plan before its termination will remain in effect until such Awards 
have been satisfied or terminated in accordance with the terms and provisions of the Plan 
and the applicable Award Agreements. 

15.2  Amendment. The Committee may from time to time amend, alter, suspend, 
discontinue, or terminate the Plan or an Award in any respect whatsoever, including in any 
manner that adversely affects the rights, duties or obligations of any Participant; provided 
that, subject to Section 14.1 or as otherwise specifically provided in the Plan, no amendment 
shall materially adversely impair the rights of a Participant under any Award without such 
Participant’s consent. 

Unless  otherwise  determined  by  the  Committee,  shareholder  approval  of  any 
amendment,  alteration,  suspension  or  discontinuance  will  be  obtained  only  to  the  extent 
necessary to comply with any applicable laws; provided that shareholder approval will be 
required for any amendment to the Plan that, in each case as reasonably determined by the 
Committee:  (i)  increases  the  number  of  Shares  available  under  the  Plan  (other  than  an 
increase permitted under Article 5 absent shareholder approval); (ii) expands the types of 
Awards available under the Plan; (iii) materially extends the term of the Plan; (iv) materially 
changes  the  method  of  determining  the  Option  Price  or  grant  price  per  Share  for  Stock 
Appreciation Rights; or (v) except as permitted pursuant to Article 14, reduces the Option 
Price  or  grant  price  per  Share,  as  applicable,  of  any  outstanding  Options  or  Stock 

A-13 

 
Appreciation Rights, including through amendment, cancellation in exchange for the grant 
of a substitute Award (in each case that has the effect of reducing the Option Price or grant 
price per Share, as applicable) or repurchase for cash or other consideration. 

Article 16.  General Provisions 

16.1  No Right to Service. The granting of an Award under the Plan shall impose 
no obligation on the Company, any Subsidiary or any Affiliate to continue the Service of a 
Participant and shall not lessen or affect any right that the Company, any Subsidiary or any 
Affiliate  may  have  to  terminate  the  Service  of  such  Participant.  No  Participant  or  other 
Person  shall  have  any  claim  to  be  granted  any  Award,  and  there  is  no  obligation  for 
uniformity of treatment of Participants, or holders or beneficiaries of Awards. The terms and 
conditions of Awards and the Committee’s determinations and interpretations with respect 
thereto  need  not  be  the  same  with  respect  to  each  Participant  (whether  or  not  such 
Participants are similarly situated). 

16.2  Foreign  Jurisdictions.  To  the  extent  the  Committee  deems  it  necessary, 
appropriate or desirable to comply with foreign law or practices and to further the purposes 
of  the  Plan,  the  Committee  may,  without  amending  the  Plan,  establish  special  rules 
applicable to Awards to Participants who are foreign nationals, are employed outside of the 
United  States  or  both  and  grant  Awards  (or  amend  existing  Awards)  in  accordance  with 
those rules. 

16.3  Settlement  of  Awards;  Fractional  Shares.  Each  Award  Agreement  shall 
establish  the  form  in  which  the  Award  shall  be  settled.  The  Committee  shall  determine 
whether cash, Awards, other securities or other property shall be issued or paid in lieu of 
fractional Shares or whether such fractional Shares or any rights thereto shall be rounded, 
forfeited or otherwise eliminated. 

16.4  Tax Withholding. The Company shall have the power and the right to deduct 
or withhold (or cause to be deducted or withheld) from any amount deliverable under the 
Award or otherwise (including Shares otherwise deliverable), or require a Participant to remit 
to the Company, the minimum statutory amount to satisfy federal, state, and local taxes, 
domestic or foreign, required by law or regulation to be withheld with respect to any taxable 
event arising as a result of the Plan. With respect to required withholding, Participants may 
elect  (subject  to  the  Company’s  automatic  withholding  right  set  out  above)  to  satisfy  the 
withholding requirement, in whole or in part, (i) by having the Company withhold Shares or 
(ii) through an independent broker-dealer arrangement to sell a sufficient number of Shares, 
in each case, having a fair market value on the date the tax is to be determined equal to the 
minimum statutory total tax that could be imposed on the transaction.  

16.5  No  Guarantees  Regarding  Tax  Treatment.  Participants 

their 
beneficiaries) shall be responsible for all taxes with respect to any Awards under the Plan. 
The  Committee  and  the  Company  make  no  guarantees  to  any  Person  regarding  the  tax 
treatment  of  Awards  or  payments  made  under  the  Plan.  Neither  the  Committee  nor  the 
Company has any obligation to take any action to prevent the assessment of any tax on any 
Person  with  respect  to  any  Award  under  Section  409A  or  otherwise  and  none  of  the 
Company, any of its Subsidiaries or Affiliates, or any of their employees or representatives 
shall have any liability to a Participant with respect thereto. 

(or 

16.6  Non-Transferability  of  Awards.  Unless  otherwise  determined  by  the 
Committee, an Award shall not be transferable or assignable by the Participant except in 
the event of his death (subject to the applicable laws of descent and distribution) and any 
such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance 
shall be void and unenforceable against the Company or any Affiliate. No transfer shall be 

A-14 

 
permitted for value or consideration. An Award exercisable after the death of a Participant 
may  be  exercised  by  the  heirs,  legatees,  personal  representatives  or  distributees  of  the 
Participant. Any permitted transfer of the Awards to heirs, legatees, personal representatives 
or  distributees  of  the  Participant  shall  not  be  effective  to  bind  the  Company  unless  the 
Committee shall have been furnished with written notice thereof and a copy of such evidence 
as  the  Committee  may  deem  necessary  to  establish  the  validity  of  the  transfer  and  the 
acceptance  by  the  transferee  or  transferees  of  the  terms  and conditions  of  the  applicable 
Award Agreement and this Plan. 

16.7  Conditions and Restrictions on Shares. The Committee may impose such 
other conditions or restrictions on any Shares received in connection with an Award as it 
may deem advisable or desirable. These restrictions may include, but shall not be limited 
to, a requirement that the Participant hold the Shares received for a specified period of time 
or a requirement that a Participant represent and warrant in writing that the Participant is 
acquiring the Shares for investment and without any present intention to sell or distribute 
such Shares. The certificates for Shares may include any legend which the Committee deems 
appropriate to reflect any conditions and restrictions applicable to such Shares. 

16.8  Clawback/Recoupment.  Awards  under  the  Plan  shall  be  subject  to  the 
clawback  or  recoupment  policy,  if  any,  that  the  Company  may  adopt  from  time  to  time, 
whether before or after the grant of such Awards, to the extent provided in such policy and, 
in accordance with such policy, may be subject to the requirement that the Awards be repaid 
to the Company after they have been distributed or paid to the Participant. 

16.9  Other Payments or Awards. Nothing contained in the Plan will be deemed in 
any way to limit or restrict the Company from making any award or payment to any person 
under any other plan, arrangement or understanding, whether now existing or hereafter in 
effect.  In addition, Section 5.1 (as adjusted by Article 14) sets forth the only limit on the 
aggregate amount of securities that may be delivered pursuant to this Plan. 

16.10  Compliance with Law. The granting of Awards and the issuance of Shares 
under the Plan shall be subject to all applicable laws, rules, and regulations, and to such 
approvals by any governmental agencies, or any stock exchanges on which the Shares are 
admitted to trading or listed, as may be required. The Company shall have no obligation to 
issue or deliver evidence of title for Shares issued under the Plan prior to: 

(a) 

(b) 

Obtaining  any  approvals  from  governmental  agencies  that  the 
Company determines are necessary or advisable; and 

Completion  of  any  registration  or  other  qualification  of  the  Shares 
under  any  applicable  national,  state  or  foreign  law  or  ruling  of  any 
governmental body  that  the  Company determines  to be necessary  or 
advisable. 

The restrictions  contained  in  this  Section  16.10 shall be  in  addition  to  any  conditions  or 
restrictions that the Committee may impose pursuant to Section 16.7. The inability of the 
Company to obtain authority from any regulatory body having jurisdiction, which authority 
is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any 
Shares hereunder, shall relieve the Company, its Subsidiaries and Affiliates, and all of their 
employees and representatives of any liability in respect of the failure to issue or sell such 
Shares as to which such requisite authority shall not have been obtained. 

16.11  Rights  as  a  Shareholder.  Except  as  otherwise  provided  herein  or  in  the 
applicable Award  Agreement,  a  Participant shall  have  none  of  the rights  of  a shareholder 

A-15 

 
with respect to Shares covered by any Award until the Participant becomes the record holder 
of such Shares. 

16.12  Severability. If  any  provision  of  the  Plan  or any Award  is  or becomes  or  is 
deemed  to be  invalid,  illegal,  or  unenforceable  in any  jurisdiction,  or  as  to  any  Person  or 
Award, or would disqualify the Plan or any Award under any law deemed applicable by the 
Committee, such provision shall be construed or deemed amended to conform to applicable 
laws, or if it cannot be so construed or deemed amended without, in the determination of 
the Committee, materially altering the intent of the Plan or the Award, such provision shall 
be stricken as to such jurisdiction, Person, or Award, and the remainder of the Plan and any 
such Award shall remain in full force and effect. 

16.13  Unfunded Plan. Participants shall have no right, title, or interest whatsoever 
in or to any investments that the Company or any of its Subsidiaries or Affiliates may make 
to aid it in meeting its obligations under the Plan. Nothing contained in the Plan, and no 
action taken pursuant to its provisions, shall create or be construed to create a trust of any 
kind,  or  a  fiduciary  relationship  between  the  Company  and  any  Participant,  beneficiary, 
legal representative, or any other Person. To the extent that any Person acquires a right to 
receive payments from the Company under the Plan, such right shall be no greater than the 
right of an unsecured general creditor of the Company. All payments to be made hereunder 
shall be paid from the general funds of the Company and no special or separate fund shall 
be  established  and  no  segregation  of  assets  shall  be  made  to  assure  payment  of  such 
amounts. 

16.14  No Constraint on Corporate Action. Nothing in the Plan shall be construed 
to (i) limit, impair, or otherwise affect the Company’s right or power to make adjustments, 
reclassifications, reorganizations, or changes of its capital or business structure, or to merge 
or consolidate, or dissolve, liquidate, sell, or transfer all or any part of its business or assets, 
or (ii) limit the right or power of the Company to take any action which such entity deems 
to be necessary or appropriate. 

16.15  Liability. No member of the Board or the Committee or any employee of the 
Company, a Subsidiary or Affiliate (each such person an “Indemnified Person”) shall have 
any  liability  to  any  person  (including,  without  limitation,  any  Participant)  for  any  action 
taken or omitted to be taken or any determination made in good faith with respect to the 
Plan or any Award. Each Indemnified Person shall be indemnified and held harmless by the 
Company against and from any loss, cost, liability or expense (including attorneys’ fees) that 
may  be  imposed  upon  or  incurred  by  such  Indemnified  Person  in  connection  with  or 
resulting from any action, suit or proceeding to which such Indemnified Person may be a 
party or in which such Indemnified Person may be involved by reason of any action taken 
or omitted to be taken under the Plan and against and from any and all amounts paid by 
such Indemnified Person, with the Company’s prior approval, in settlement thereof, or paid 
by  such  Indemnified  Person  in  satisfaction  of  any  judgment  in  any  such  action,  suit  or 
proceeding  against  such  Indemnified  Person,  provided  that  the  Company  shall  have  the 
right, at its own expense, to assume and defend any such action, suit or proceeding and, 
once the Company gives notice of its intent to assume the defense, the Company shall have 
sole control over such defense with counsel chosen by the Company. The foregoing right of 
indemnification shall not be available to an Indemnified Person to the extent that a court of 
competent  jurisdiction in  a  final  judgment  or  other  final  adjudication,  in  either  case,  not 
subject to further appeal, determines that the acts or omissions of such Indemnified Person 
giving rise to the indemnification claim resulted from such Indemnified Person’s bad faith, 
fraud or willful criminal act or omission. The foregoing right of indemnification shall not be 
exclusive of any other rights of indemnification to which Indemnified Persons may be entitled 
under the Company’s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, 

A-16 

 
or any other power that the Company may have to indemnify such persons or hold them 
harmless. 

16.16  Successors.  All  obligations  of  the  Company  under  the  Plan  with  respect  to 
Awards granted hereunder shall be binding on any successor to the Company, whether the 
existence  of  such  successor  is  the  result  of  a  direct  or  indirect  purchase,  merger, 
consolidation,  or  otherwise,  of  all  or  substantially  all  of  the  business  or  assets  of  the 
Company. 

16.17  Governing Law. THE PLAN WILL BE GOVERNED BY AND CONSTRUED IN 
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO 
PRINCIPLES OF CONFLICT OF LAWS. 

16.18  Data Protection. By participating in the Plan, the Participant consents to the 
collection, processing, transmission and storage by the Company in any form whatsoever, 
of  any  data  of  a  professional  or  personal  nature  which  is  necessary  for  the  purposes  of 
introducing  and  administering  the  Plan.  The  Company  may  share  such  information  with 
any Subsidiary or Affiliate, the trustee of any employee benefit trust, its registrars, trustees, 
brokers, other third-party administrator or any Person who obtains control of the Company 
or acquires the Company, undertaking or part-undertaking which employs the Participant, 
wherever situated. 

16.19  Effective Date. The Plan originally became effective as of September 3, 
2013; was amended to increase the maximum number of Shares available for grant to 
Participants pursuant to Awards under the Plan effective May 22, 2018; was amended to 
increase the limit on the number of Options or Stock Appreciation Rights that may be 
granted to an Employee in any calendar year under the Plan effective February 20, 2019; 
and was amended and restated to increase the maximum number of Shares available for 
grant to Participants pursuant to Awards under the Plan and to make certain other 
changes effective May 20, 2020 (the “Effective Date”). 

** *

A-17 

 
This page intentionally left blank.

APPENDIX B 

FIRST AMENDMENT 

TO THE 

EASTMAN KODAK COMPANY 

2013 OMNIBUS INCENTIVE PLAN 

(As Amended and Restated Effective May 20, 2020) 

The Eastman Kodak Company 2013 Omnibus Incentive Plan, as amended 
and restated effective May 20, 2020 (the “Plan”), is hereby amended as follows, 
effective May 19, 2021: 

1.  Section  2.9  of  the  Plan  is  hereby  amended  and  restated  in  its 

entirety to provide as follows: 

“2.9  “Committee”  means  the  Compensation, 
Nominating  and  Governance  Committee  of  the  Board 
(as  constituted  from  time  to  time,  and  including  any 
successor  committee)  or  any  other  committee 
designated by the Board to administer this Plan. To the 
extent  applicable,  the  Committee  shall  have  at  least 
two  members,  each  of  whom  shall  be  (i)  a  Non-
Employee  Director  and  (ii)  an  “independent  director” 
within  the  meaning  of  the  listing  requirements  of  the 
New York Stock Exchange.” 

2.  Section  5.1  of  the  Plan  is  hereby  amended  to  increase  the 
maximum  number  of  Shares  available  for  grant  to  Participants 
pursuant  to  Awards  under  the  Plan  from  8,000,000  Shares  to 
13,000,000 Shares. 

3.  Section  5.2  of  the  Plan  is  hereby  amended  and  restated  in  its 

entirety to provide as follows: 

“5.2  Share Counting. The number of shares of 
Common Stock granted under the Plan per year will be 
determined as follows:   

(a)  for Awards granted on or prior to May 
19,  2021,  (i)  each  Restricted  Stock  Award,  Restricted 
Stock Unit and similar Award will count as one share 
(ii)  each  Option,  Stock 
of  Common  Stock  and 
Appreciation  Right  and  similar  Award  will  count  as  a 
fraction  of  a  share  of  Common  Stock,  based  on  the 
financial value of each such Award relative to a share 

B-1 

 
 
of  Common  Stock,  as  determined  by  the  Committee 
promptly after the Effective Date; and 

(b)  for Awards granted after May 19, 2021, 
each  Restricted  Stock  Award,  Restricted  Stock  Unit, 
Option, Stock Appreciation Right and other Award will 
count as one share of Common Stock.” 

4.  Section 16.19 of the Plan is hereby amended and restated in its 

entirety to provide as follows: 

“16.19  Effective  Date.  The  Plan  originally 
became  effective  as  of  September  3,  2013;  was 
amended to increase the maximum number of Shares 
available for grant to Participants pursuant to Awards 
under  the  Plan  effective  May  22,  2018; was  amended 
to increase the limit on the number of Options or Stock 
Appreciation  Rights  that  may  be  granted  to  an 
Employee in any calendar year under the Plan effective 
February 20, 2019; and was amended and restated to 
increase the maximum number of Shares available for 
grant  to  Participants  pursuant  to  Awards  under  the 
Plan  and  to  make  certain  other  changes  effective 
May 20,  2020;  and  was  amended  to  increase  the 
maximum  number  of  Shares  available  for  grant  to 
Participants pursuant to Awards under the Plan and to 
change the method of counting Shares granted under 
the Plan effective May 19, 2021 (the “Effective Date”).” 

***** 

B-2 

 
 
This page intentionally left blank.

About Kodak

Kodak  is  a  global  technology  company  focused  on 
print,  advanced  materials  and  chemicals.  We  provide 
industry-leading  hardware,  software,  consumables  and 
services  primarily  to  customers  in  commercial  print, 
packaging,  publishing,  manufacturing  and  entertainment. 
We  are  committed  to  environmental  stewardship  and 
ongoing  leadership  in  developing  sustainable  solutions. 
Our  broad  portfolio  of  superior  products,  responsive 
support  and  world-class  R&D  make  Kodak  solutions  a 
smart  investment  for  customers  looking  to  improve 
their  profitability  and  drive  growth.   

For additional information on Kodak, visit us at Kodak.com,  
follow us on Twitter @Kodak or like us on Facebook at Kodak.

 
Eastman Kodak Company 
343 State Street 
Rochester, NY 14650 
www.kodak.com

This document was produced using KODAK INSITE and PREPS prepress portal software, KODAK PRINERGY workflow software, 
KODAK MAGNUS and TRENDSETTER platesetters, KODAK ELECTRA XD thermal printing plates, KODAK plate developing 
products, KODAK APPROVAL proofsetter and other Kodak printing technologies. 

This document was printed using 100% renewable wind energy and soy-based inks.

© 2021 Eastman Kodak Company.  KODAK, INSITE, PREPS, PRINERGY, MAGNUS, TRENDSETTER, ELECTRA and APPROVAL 
are trademarks.

SKU 002CSNBA85